
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/15/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 582</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / 65487U108 / N90064101 / 14147L108 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102 / 09063M205</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Nkarta Inc / Uniqure NV / Cardiff Oncology Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc / Bionomics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Emily Ozpinar / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">01/14/2022</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bloomsbury Publishing rises for a fourth consecutive year</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">01/13/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Coverage Report : A summary of credit analyst recommendations in the Healthcare sector</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.O / BSX.N / BAX.N / BDX.N / BMY.N / CAH.N / CI.N / CVS.N / JNJ.N / LLY.N / MCK.N / MRK.N / TMO.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / ABC.N / BIIB.O / ABBV.N / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amgen Inc / Boston Scientific Corp / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Amerisourcebergen Corp / Biogen Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">U.S. High Grade Credit Analyst Focus List : January 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">AC.TO / AES.N / BMY.N / FDX.N / GM.N / NAB.AX / WMB.N / HUM.N / CNQ.TO / ETR.N / FE.N / TRP.TO / EPR.N / UNM.N / KSS.N / ORCL.N / AVGO.O / HFC.N / ALLY.N / INVH.N</td><td class="leftalignment">Air Canada / AES Corp / Bristol-Myers Squibb Co / FedEx Corp / General Motors Co / National Australia Bank Ltd / Williams Companies Inc / Humana Inc / Canadian Natural Resources Ltd / Entergy Corp / FirstEnergy Corp / TC Energy Corp / EPR Properties / Unum Group / Kohls Corp / Oracle Corp / Broadcom Inc / HollyFrontier Corp / Ally Financial Inc / Invitation Homes Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Canada / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Air Transportation / Automotive / Banks / Beverages & Tobacco / Consumer / Energy / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Info. Tech./Software / Insurance / Manufacturing / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Kabir Caprihan / Mr. Matthew A. Anavy / Carla Casella / Mr. Christian D. Crosby / Brett Gibson / Kevin L. Kwan / Mr. Jonathan D. Rau / Mr. Mark S. Streeter</td></tr>
<tr class="odd"><td class="leftalignment">01/13/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">0925288 / 2126335 / 2486813 / 2050832 / 2219224 / 2270726 / 2542049 / 2317087 / 2670519 / 2455965 / 2689560 / 2684703 / 2048804 / 2799351 / 2900335 / 2857817 / B03PGL4 / B7TL820 / B65SQW4 / B7VD3F2 / BFLR866 / BVVN4Q8 / BYY8XK8 / BK0VHF6 / BJ1FD74 / BKVDFF7 / BFZ1K46 / BLGJ610 / BJJMGL2 / BYXJQG9 / BZ1LFG7 / BD5GSZ4 / BWC52Q6</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Kellogg Co / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelon Corp / Biogen Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sinclair Broadcast Group Inc / Tractor Supply Co / Netflix Inc / NorthWestern Corp / Meta Platforms Inc / Enphase Energy Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / WEC Energy Group Inc / IDEAYA Biosciences Inc / Revolve Group Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Spire Inc / Roku Inc / Infrastructure and Energy Alternatives Inc / Solaredge Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Divergent Returns for ESG in 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">A.N / AAP.N / AEE.N / AES.N / AIG.N / ALB.N / ALK.N / ALL.N / APD.N / AXP.N / BAX.N / BBY.N / BEN.AX / BMY.N / BSX.N / C.N / CCI.N / CCL.N / CI.N / CL.N / ECL.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / FMC.N / HLT.N / IP.N / IR.N / KMB.N / LLY.N / LMT.N / NEM.N / NOC.N / NSC.N / OXY.N / PHM.N / PM.N / PNC.N / PNW.N / RHI.N / RL.N / SEE.N / SLB.N / SO.N / SWK.N / TAP.N / TMO.N / TRV.N / TXT.N / WFC.N / PG.N / WY.N / NUE.N / ROK.N / CPB.N / ETR.N / AAL.L / ADML.L / ETN.N / DHR.N / DIS.N / UNH.N / TFX.N / CMI.N / URI.N / AIZ.N / DE.N / IEX.N / PH.N / PGR.N / IPG.N / KIM.N / UNP.N / CLX.N / CAG.N / VNO.N / LOW.N / GLW.N / LH.N / UPS.N / KR.N / MMM.N / GIS.N / NI.N / XOM.N / AMT.N / WHR.N / RMD.N / DTEGN.F / IT.N / TGT.N / AVY.N / PKG.N / BLL.N / GWW.N / PKI.N / MLM.N / WST.N / COO.N / XEL.N / STZ.N / VFC.N / LNC.N / APH.N / AZO.N / FDS.N / EFX.N / PSA.N / EW.N / OKE.N / BXP.N / ACN.N / ARE.N / RSG.N / SNA.N / CHD.N / TWTR.N / ESS.N / UDR.N / FRT.N / HRL.N / PVH.N / BLK.N / AJG.N / ABC.N / CVX.N / MCO.N / JNPR.N / IRM.N / COP.N / CNP.N / INTC.OQ / CTSH.OQ / AOS.N / ABMD.OQ / AMAT.OQ / ADSK.OQ / CERN.OQ / CINF.OQ / CTAS.OQ / CSCO.OQ / FAST.OQ / JKHY.OQ / JBHT.OQ / LRCX.OQ / ATVI.OQ / NTRS.OQ / PCAR.OQ / PAYX.OQ / PBCT.OQ / TROW.OQ / ROST.OQ / SJM.N / TECH.OQ / ZION.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / ODFL.OQ / INTU.OQ / COST.OQ / CPRT.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / NTAP.OQ / TPR.N / ANSS.OQ / GL.N / AMZN.OQ / TTWO.OQ / VRSN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / ILMN.OQ / EQIX.OQ / GPN.N / WYNN.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / TFC.N / SBNY.OQ / DPZ.N / MOS.N / MKTX.OQ / MPWR.OQ / VIAC.OQ / NDAQ.OQ / ICE.N / LYV.N / MS.N / CMG.N / FIS.N / ADP.PA / AON.N / ULTA.OQ / WRB.N / CME.OQ / NWSA.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / LYB.N / MSI.N / NLSN.N / MPC.N / FBHS.N / XYL.N / ENPH.OQ / EPAM.N / FANG.OQ / CDW.OQ / FOXA.O / LDOS.N / ALLE.N / PTC.OQ / SYF.N / KEYS.N / ANTM.N / QRVO.OQ / SEDG.OQ / ETSY.OQ / ZBH.N / CSX.OQ / SPGI.K / FTV.N / LW.N / BKNG.OQ / CBRE.N / CDAY.N / EVRG.N / TER.OQ / NWL.OQ / LNT.OQ / LHX.N / EXC.OQ / NLOK.OQ / RTX.N / OTIS.N / APA.OQ / VTRS.OQ / BBWI.N / BKR.OQ</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Ameren Corp / AES Corp / American International Group Inc / Albemarle Corp / Alaska Air Group Inc / Allstate Corp / Air Products and Chemicals Inc / American Express Co / Baxter International Inc / Best Buy Co Inc / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Crown Castle International Corp / Carnival Corp / Cigna Corp / Colgate-Palmolive Co / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / FMC Corp / Hilton Worldwide Holdings Inc / International Paper Co / Ingersoll Rand Inc / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Newmont Corporation / Northrop Grumman Corp / Norfolk Southern Corp / Occidental Petroleum Corp / Pultegroup Inc / Philip Morris International Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Robert Half International Inc / Ralph Lauren Corp / Sealed Air Corp / Schlumberger NV / Southern Co / Stanley Black & Decker Inc / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Textron Inc / Wells Fargo & Co / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Campbell Soup Co / Entergy Corp / Anglo American PLC / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Cummins Inc / United Rentals Inc / Assurant Inc / Deere & Co / IDEX Corp / Parker-Hannifin Corp / Progressive Corp / Interpublic Group of Companies Inc / Kimco Realty Corp / Union Pacific Corp / Clorox Co / Conagra Brands Inc / Vornado Realty Trust / Lowe's Companies Inc / Corning Inc / Laboratory Corporation of America Holdings / United Parcel Service Inc / Kroger Co / 3M Co / General Mills Inc / NiSource Inc / Exxon Mobil Corp / American Tower Corp / Whirlpool Corp / Resmed Inc / Deutsche Telekom AG / Gartner Inc / Target Corp / Avery Dennison Corp / Packaging Corp of America / Ball Corp / W W Grainger Inc / PerkinElmer Inc / Martin Marietta Materials Inc / West Pharmaceutical Services Inc / Cooper Companies Inc / Xcel Energy Inc / Constellation Brands Inc / VF Corp / Lincoln National Corp / Amphenol Corp / Autozone Inc / Factset Research Systems Inc / Equifax Inc / Public Storage / Edwards Lifesciences Corp / ONEOK Inc / Boston Properties Inc / Accenture PLC / Alexandria Real Estate Equities Inc / Republic Services Inc / Snap-On Inc / Church & Dwight Co Inc / Twitter Inc / Essex Property Trust Inc / UDR Inc / Federal Realty Investment Trust / Hormel Foods Corp / PVH Corp / BlackRock Inc / Arthur J Gallagher & Co / Amerisourcebergen Corp / Chevron Corp / Moody's Corp / Juniper Networks Inc / Iron Mountain Inc / Conocophillips / CenterPoint Energy Inc / Intel Corp / Cognizant Technology Solutions Corp / A O Smith Corp / ABIOMED Inc / Applied Materials Inc / Autodesk Inc / Cerner Corp / Cincinnati Financial Corp / Cintas Corp / Cisco Systems Inc / Fastenal Co / Jack Henry & Associates Inc / J B Hunt Transport Services Inc / Lam Research Corp / Activision Blizzard Inc / Northern Trust Corp / Paccar Inc / Paychex Inc / People's United Financial Inc / T Rowe Price Group Inc / Ross Stores Inc / J M Smucker Co / Bio-Techne Corp / Zions Bancorporation NA / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Old Dominion Freight Line Inc / Intuit Inc / Costco Wholesale Corp / Copart Inc / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / NetApp Inc / Tapestry Inc / ANSYS Inc / Globe Life Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Verisign Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Illumina Inc / Equinix Inc / Global Payments Inc / Wynn Resorts Ltd / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Truist Financial Corp / Signature Bank / Domino's Pizza Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / ViacomCBS Inc / Nasdaq Inc / Intercontinental Exchange Inc / Live Nation Entertainment Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Ulta Beauty Inc / W R Berkley Corp / CME Group Inc / News Corp / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / LyondellBasell Industries NV / Motorola Solutions Inc / Nielsen Holdings PLC / Marathon Petroleum Corp / Fortune Brands Home & Security Inc / Xylem Inc / Enphase Energy Inc / Epam Systems Inc / Diamondback Energy Inc / CDW Corp / Fox Corp / Leidos Holdings Inc / Allegion PLC / PTC Inc / Synchrony Financial / Keysight Technologies Inc / Anthem Inc / Qorvo Inc / Solaredge Technologies Inc / ETSY Inc / Zimmer Biomet Holdings Inc / CSX Corp / S&P Global Inc / Fortive Corp / Lamb Weston Holdings Inc / Booking Holdings Inc / CBRE Group Inc / Ceridian HCM Holding Inc / Evergy Inc / Teradyne Inc / Newell Brands Inc / Alliant Energy Corp / L3harris Technologies Inc / Exelon Corp / NortonLifeLock Inc / Raytheon Technologies Corp / Otis Worldwide Corp / APA Corp (US) / Viatris Inc / Bath & Body Works Inc / Baker Hughes Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / France / United Kingdom / Ireland / Netherlands / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's A Better Pharmaceutical Pick Over Merck Stock</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CARS / AN=US / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / MCD=US / WEN=US / AGL=US / BLDP=US / AMZN=US / BLD=US / INCY=US / RUN=US / GILD=US / PLUG=US / NOVA=US / LOW=US / THC=US / TTWO=US / LEG=US / VMC=US / HUM=US / CVS=US / CI=US / MLM=US / UNH=US / KFY=US / AMED=US / AMN=US / SWIM=US / ARRY=US / BMRN=US / CBRL=US / KIDS=US / DRI=US / EXEL=US / FCN=US / GFF=US / ABG=US / IBP=US / MAS=US / MHK=US / ASGN=US / REGI=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / CCRN=US / CNC=US / R=US / CNM=US / JAZZ=US / BE=US / DIN=US / ACVA=US / BCO=US / MOH=US / BIIB=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / SPWR=US / CMG=US / REX=US / PGTI=US / GPRE=US / ICFI=US / AWI=US / OC=US / CPRX=US / TAST=US / QSR=US / PRPL=US / LULU=US / IAA=US / ATSG=US / JACK=US / RCUS=US / TREX=US / GNRC=US / FBHS=US / ZNGA=US / ENPH=US / TILE=US / NDLS=US / PTCT=US / FATE=US / CNCE=US / 00770K202 / LOCO=US / OSH=US / UPLD=US / ANTM=US / SHAK=US / GDDY=US / SEDG=US / WING=US / SPNE=US / NVCR=US / 82982L103 / GXO=US / IRTC=US / CRSP=US / ANAB=US / JELD=US / DCPH=US / ALLO=US / FERG=US / AHCO=US / AZEK=US / SHLS=US / PRVA=US / SNPO=US / ROIV=US</td><td class="leftalignment">Cars.com Inc / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / agilon health Inc / Ballard Power Systems Inc / Amazon.com Inc / TopBuild Corp / Incyte Corp / Sunrun Inc / Gilead Sciences Inc / Plug Power Inc / Sunnova Energy International Inc / Lowe's Companies Inc / Tenet Healthcare Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / Vulcan Materials Co / Humana Inc / CVS Health Corp / Cigna Corp / Martin Marietta Materials Inc / UnitedHealth Group Inc / Korn Ferry / Amedisys Inc / AMN Healthcare Services Inc / Latham Group Inc / Array Technologies Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / OrthoPediatrics Corp / Darden Restaurants Inc / Exelixis Inc / FTI Consulting Inc / Griffon Corp / Asbury Automotive Group Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Cross Country Healthcare Inc / Centene Corp / Ryder System Inc / Core & Main Inc / Jazz Pharmaceuticals PLC / Bloom Energy Corp / Dine Brands Global Inc / ACV Auctions Inc / Brinks Co / Molina Healthcare Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / SunPower Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / ICF International Inc / Armstrong World Industries Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lululemon Athletica Inc / IAA Inc / Air Transport Services Group Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Generac Holdings Inc / Fortune Brands Home & Security Inc / Zynga Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Upland Software Inc / Anthem Inc / Shake Shack Inc / GoDaddy Inc / Solaredge Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Novocure Ltd / SiteOne Landscape Supply Inc / GXO Logistics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / AnaptysBio Inc / JELD-WEN Holding Inc / Deciphera Pharmaceuticals Inc / Allogene Therapeutics Inc / Ferguson PLC / Adapthealth Corp / Azek Company Inc / Shoals Technologies Group Inc / Privia Health Group Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2002305 / 2050832 / 2219224 / 2270726 / 2542049 / 2576941 / 2670519 / 2100920 / 2455965 / 2471950 / 2645409 / 2689560 / 2684703 / 7103065 / B00FWN1 / B19FQ48 / 2713317 / 2969637 / B3D7K31 / B23FN39 / B1XGNW4 / B0796X4 / B7TL820 / B7254K9 / B7VD3F2 / B85KFY9 / B8DPDT7 / BFLR866 / BS7K7C9 / BYZLV46 / BFZNYB7 / BK0VHF6 / BD9GVY0 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BYSGPK2 / BDD1B07 / BMXXBD9 / BNKGXX2 / BJ62Z18 / BL53KF5 / BK6L288 / BMBSNX0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Abbott Laboratories / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Biogen Inc / Incyte Corp / NiSource Inc / PG&E Corp / Pfizer Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / DICK'S Sporting Goods Inc / Discovery Inc / Lululemon Athletica Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / AxoGen Inc / Duke Energy Corp / Five Below Inc / Sarepta Therapeutics Inc / Twitter Inc / Nevro Corp / InflaRx NV / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / Evergy Inc / Fox Corp / ViacomCBS Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / ViewRay Inc / Rubius Therapeutics Inc / Figs Inc / Verve Therapeutics Inc / Ultragenyx Pharmaceutical Inc / F45 Training Holdings Inc / Beam Therapeutics Inc / IronNet Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BMY.N / CNX / CP / DHI / DVN / FOR / HFC / KBH / LEN / MDC / MGY / MPC / MRK.N / MTH / NSC / NVR / PFE.N / PHM.N / PSX / TOL / TPH / VLO / PBF / TTWO.O / AMD.O / ILMN.O / CCS.N / ZNGA.O / TMHC.K / LGIH.O / CYAD.O / NVCR.O / OMF / ADAP.O / EDIT.O / INSP.K / FTCH.K</td><td class="leftalignment">Bristol-Myers Squibb Co / CNX Resources Corp / Canadian Pacific Railway Ltd / D R Horton Inc / Devon Energy Corp / Forestar Group Inc / HollyFrontier Corp / KB Home / Lennar Corp / MDC Holdings Inc / Magnolia Oil & Gas Corp / Marathon Petroleum Corp / Merck & Co Inc / Meritage Homes Corp / Norfolk Southern Corp / NVR Inc / Pfizer Inc / Pultegroup Inc / Phillips 66 / Toll Brothers Inc / Tri Pointe Homes Inc (Delaware) / Valero Energy Corp / PBF Energy Inc / Take-Two Interactive Software Inc / Advanced Micro Devices Inc / Illumina Inc / Century Communities Inc / Zynga Inc / Taylor Morrison Home Corp / LGI Homes Inc / Celyad Oncology SA / Novocure Ltd / OneMain Holdings Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Inspire Medical Systems Inc / Farfetch Ltd</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Cayman Islands / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">2022 HC Conf Day 1 Recap : Credit Takeaways from the 40th Annual J.P. Morgan Conference</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N / BAX.N / CAH.N / HUM.N / GILD.O / ABC.N / BIIB.O / ZTS.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Baxter International Inc / Cardinal Health Inc / Humana Inc / Gilead Sciences Inc / Amerisourcebergen Corp / Biogen Inc / Zoetis Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2022's Opening Salvo from Our Coverage Companies: Day 1 Color at Competitor Conference</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2126335 / 7103065 / BD9GVY0 / BNKGXX2</td><td class="leftalignment">Bristol-Myers Squibb Co / Novartis AG / Zai Lab Ltd / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 31, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BMY/MRK: BMY Guidance Helps Bring Expectations Down—MRK Focus on BD Well Ahead of Keytruda LOE</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / MRK.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech Nightcap: Partnerships are good for Pharma/LC biotech but investors looking for M&A</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / INCY=US / GILD=US / BMRN=US / VRTX=US / BIIB=US / RCUS=US / PTCT=US / FATE=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Arcus Biosciences Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First Line of Sight on Revlimid Decline; Key New Product Launch Year Ahead</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Quick Thoughts on 2022 Guidance and $5bn Accelerated Share Repo</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Happening With Bristol Myers Squibb Stock?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FY2022 sales and non-GAAP EPS guidance announced; more details during 4Q21 earnings call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">BMY latest to collaborate in the iPSC space with Century; FATE continues to lead in space</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Takeaways From Presentation; 2022 Guide Removes Revlimid Uncertainty</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US0188021085 / US0236081024 / US0255371017 / US0311621009 / US1101221083 / US1258961002 / US1264081035 / US1270971039 / US1475281036 / US22160K1051 / US2333311072 / US25179M1036 / US25746U1097 / US26875P1012 / US29364G1031 / US30161N1019 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US4592001014 / US5010441013 / US5324571083 / US56418H1005 / US6267171022 / US64125C1099 / US65473P1057 / US6558441084 / US6745991058 / US7170811035 / US7237871071 / US7445731067 / US75281A1097 / US75886F1075 / US7703231032 / AN8068571086 / US8168511090 / US8425871071 / US8454671095 / US87612E1064 / US8851601018 / US9078181081 / US92276F1003 / US92532F1003 / US9746371007 / US98389B1008 / CA1363751027 / CA4530384086 / CA5649051078 / CA1363851017 / US1667641005 / US5658491064 / CA0636711016 / US0017441017 / US20825C1045 / US15189T1079 / US2274831047 / US09062X1037 / CA67072Q1046 / CA2265331074 / US6293775085 / US0534841012 / US1011211018 / US2644115055 / CA6993202069 / CA0906971035 / CA4495861060 / US42809H1077 / BMG383271050 / US4219461047 / US49427F1084 / US89785X1019 / US2120151012 / US38500T1016 / US26884L1098 / CA22576C1014 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / CA00829Q1019 / US26441C2044 / CA89156V1067 / US69327R1014 / US72919P2020 / CA4013393042 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA3565001086 / US70509V1008 / CA04682R1073 / US5764852050 / US29355A1079 / US25278X1090 / CA4882951060 / US71943U1043 / US60468T1051 / US03674X1063 / CA14150G4007 / CA7397211086 / US65341B1061 / US29444U7000 / US30040W1080 / US83417M1045 / US4278255009 / US92939U1060 / US86771W1053 / US0130911037 / US2057683029 / US13462K1097 / US15136A1025 / GB00BDSFG982 / CA46016U1084 / US92840M1027 / US05722G1004 / US12653C1080 / CA35905B1076 / US00191U1025 / US83200N1037 / US87484T1088 / US0937121079 / US08579X1019 / CA7241121077 / CA6744822033 / US86745K1043 / US69047Q1022 / CA4220961078 / CA84678A1021 / US5168062058 / US13123X5086 / CA89055A2039 / US0412421085 / US62955J1034 / US1651677353 / US03743Q1085 / CA00791P1071 / US1374041093</td><td class="leftalignment">Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Amgen Inc / Bristol-Myers Squibb Co / CMS Energy Corp / CSX Corp / Coterra Energy Inc / Caseys General Stores Inc / Costco Wholesale Corp / DTE Energy Co / Devon Energy Corp / Dominion Energy Inc / EOG Resources Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / International Business Machines Corp / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Murphy Oil Corp / Neurocrine Biosciences Inc / NiSource Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Schlumberger NV / Sempra Energy / Southern Co / Southwestern Energy Co / Target Corp / Thor Industries Inc / Union Pacific Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Xcel Energy Inc / Canadian National Railway Co / Imperial Oil Ltd / Maple Leaf Foods Inc / Canadian Natural Resources Ltd / Chevron Corp / Marathon Oil Corp / Bank of Montreal / AMN Healthcare Services Inc / Conocophillips / CenterPoint Energy Inc / Cross Country Healthcare Inc / Biogen Inc / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Avalonbay Communities Inc / Boston Properties Inc / Duke Realty Corp / Paramount Resources Ltd / Birchcliff Energy Ltd / IGM Financial Inc / Hess Corp / GeoPark Ltd / Healthcare Realty Trust Inc / Kilroy Realty Corp / TrueBlue Inc / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Crescent Point Energy Corp / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Africa Oil Corp / Duke Energy Corp / Tourmaline Oil Corp / PDC Energy Inc / Plug Power Inc / Guardian Capital Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Freehold Royalties Ltd / Pebblebrook Hotel Trust / Athabasca Oil Corp / Matador Resources Co / Enphase Energy Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Physicians Realty Trust / Mirati Therapeutics Inc / Antero Resources Corp / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Nextera Energy Partners LP / Equinix Inc / Eversource Energy / Solaredge Technologies Inc / Hersha Hospitality Trust / WEC Energy Group Inc / Sunrun Inc / Albertsons Companies Inc / Comstock Resources Inc / Camping World Holdings Inc / Centennial Resource Development Inc / TechnipFMC PLC / International Petroleum Corp / Vistra Corp / Baker Hughes Co / CNX Resources Corp / Frontera Energy Corp / ASGN Inc / Smartsheet Inc / Talos Energy Inc / Bloom Energy Corp / Berry Corporation (Bry) / Pipestone Energy Corp / Obsidian Energy Ltd / Sunnova Energy International Inc / Ovintiv Inc / Headwater Exploration Inc / Spartan Delta Corp / Laredo Petroleum Inc / Callon Petroleum Co / Topaz Energy Corp / Arko Corp. / Nov Inc / Chesapeake Energy Corp / APA Corp (US) / Advantage Energy Ltd / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pipeline Pulse - Total Number Of Drugs Up 3% YoY; PIII Assets At Historic High</td><td class="leftalignment">English</td><td class="rightalignment">140</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 9.2% Above Pre-Pandemic Base- Week 90</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Equity Strategy: 4Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">A.N / ABT.N / AIG.N / BAC.N / BAX.N / BK.N / BMY.N / C.N / CRM.N / CVS.N / DAL.N / ECL.N / EOG.N / GPS.N / HLT.N / JNJ.N / JPM.N / KO.N / LLY.N / MDT.N / PFE.N / PM.N / PNC.N / SO.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / SPG.N / PG.N / DUK.N / DHR.N / DIS.N / UNH.N / DE.N / UNP.N / GS.N / MCD.N / HD.N / LOW.N / UPS.N / KR.N / XOM.N / AMT.N / LIN.N / TGT.N / VZ.N / COO.N / NRG.N / TJX.N / PSA.N / V.N / PLD.N / BLK.N / CVX.N / MCO.N / TDY.N / HPQ.N / INTC.OQ / ABMD.OQ / AAPL.OQ / AMAT.OQ / ADSK.OQ / CSCO.OQ / FRC.N / FISV.OQ / MSFT.OQ / ROST.OQ / SJM.N / SNPS.OQ / SBUX.OQ / QCOM.OQ / INTU.OQ / XRAY.OQ / DLTR.OQ / AMZN.OQ / NVDA.OQ / ISRG.OQ / ILMN.OQ / EQIX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / TFC.N / DXCM.OQ / CDNS.OQ / MS.N / FIS.N / CME.OQ / AVGO.OQ / SCHW.N / NEE.N / TSLA.OQ / ADI.OQ / ABBV.N / ZTS.N / MAR.OQ / GOOGL.OQ / KEYS.N / PYPL.OQ / HPE.N / CSX.OQ / IQV.N / PEP.OQ / BKNG.OQ / FB.PS / AEP.OQ / VTRS.OQ</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / American International Group Inc / Bank of America Corp / Baxter International Inc / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Citigroup Inc / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Ecolab Inc / EOG Resources Inc / Gap Inc / Hilton Worldwide Holdings Inc / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Medtronic PLC / Pfizer Inc / Philip Morris International Inc / PNC Financial Services Group Inc / Southern Co / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Target Corp / Verizon Communications Inc / Cooper Companies Inc / NRG Energy Inc / TJX Companies Inc / Public Storage / Visa Inc / Prologis Inc / BlackRock Inc / Chevron Corp / Moody's Corp / Teledyne Technologies Inc / HP Inc / Intel Corp / ABIOMED Inc / Apple Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / First Republic Bank / Fiserv Inc / Microsoft Corp / Ross Stores Inc / J M Smucker Co / Synopsys Inc / Starbucks Corp / Qualcomm Inc / Intuit Inc / DENTSPLY SIRONA Inc / Dollar Tree Inc / Amazon.com Inc / NVIDIA Corp / Intuitive Surgical Inc / Illumina Inc / Equinix Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Truist Financial Corp / Dexcom Inc / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / CME Group Inc / Broadcom Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / Analog Devices Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Alphabet Inc / Keysight Technologies Inc / PayPal Holdings Inc / Hewlett Packard Enterprise Co / CSX Corp / IQVIA Holdings Inc / PepsiCo Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / American Electric Power Company Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/08/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 581</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / 65487U108 / N90064101 / 14147L108 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Nkarta Inc / Uniqure NV / Cardiff Oncology Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 07,2022.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BPTH-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BPTH.O / BAX / BMY / SPPI.O / SGEN.O / TLOG.PK</td><td class="leftalignment">Bio Path Holdings Inc / Baxter International Inc / Bristol-Myers Squibb Co / Spectrum Pharmaceuticals Inc / Seagen Inc / TetraLogic Pharmaceuticals Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NNVC-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NNVC.K / BMY / MRK / GILD.O / NBY / GSK / BCRX.O / NVAX.O / CMRX.O</td><td class="leftalignment">NanoViricides Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Gilead Sciences Inc / NovaBay Pharmaceuticals Inc / GlaxoSmithKline PLC / BioCryst Pharmaceuticals Inc / Novavax Inc / Chimerix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ONCY-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ONCY.O / BMY / LLY / HBP.TO / AEZS.O / AVEO.O / MRTX.O / TEVA.K / SPHS.PK</td><td class="leftalignment">Oncolytics Biotech Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Helix Biopharma Corp / Aeterna Zentaris Inc / Aveo Pharmaceuticals Inc / Mirati Therapeutics Inc / Teva Pharmaceutical Industries Ltd / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SPPI-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SPPI.O / ABT / BMY / JNJ / NVS / PFE / GSK / CRIS.O / SGEN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Spectrum Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Curis Inc / Seagen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CBAY-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CBAY.O / BMY / PFE / PTCT.O / XNCR.O</td><td class="leftalignment">Cymabay Therapeutics Inc / Bristol-Myers Squibb Co / Pfizer Inc / PTC Therapeutics Inc / Xencor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">The Cowen Edge - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0028241000 / US00846U1016 / US00971T1016 / US0116591092 / US0231351067 / US0378331005 / US0382221051 / US0463531089 / US0718131099 / US0758871091 / US1011371077 / US1101221083 / US1266501006 / US1727551004 / US22284P1057 / US28176E1082 / US3021301094 / US3156161024 / US37733W1053 / US4364401012 / US4433201062 / US4456581077 / US4781601046 / US5150981018 / US5324571083 / US5951121038 / US66987V1098 / US6701002056 / US6795801009 / US7140461093 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US8168501018 / US8308791024 / US8447411088 / US8610121027 / US8740391003 / US8807701029 / US9029251066 / US91347P1057 / US92343V1044 / US9507551086 / US9581021055 / TW0002330008 / US87157D1090 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US20030N1019 / US6402681083 / US09062X1037 / US1572101053 / US0042251084 / US02043Q1076 / US2538681030 / US19239V3024 / US2090341072 / US12541W2098 / US00206R1023 / ACOR.OQ / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US58933Y1055 / US34959E1091 / US1920051067 / US9100471096 / US03027X1000 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US81762P1021 / US8725901040 / US6974351057 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US22822V1017 / US74736K1016 / US29444U7000 / IE00BTN1Y115 / US00653A1079 / US12685J1051 / US02079K1079 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / CA87241L1094 / US78410G1040 / US83304A1060 / US91325V1089 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US87105L1044 / US57777K1060 / US11135F1012 / US5904791358 / US0197701065 / US0144421072 / US90353T1007 / US18915M1071 / US09203E1055 / CH0499880968 / KYG3902L1095 / US5502411037 / US35909R1086 / US25401T1088 / US20717M1036 / US1920031010 / US02080L1026 / US35909D1090 / US23284C1027 / US2935941078 / KYG393871085 / KYG4701H1092 / US86337R1032 / US10576N1028 / US4181001037 / AU0000185993</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Abbott Laboratories / Agilent Technologies Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amazon.com Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Bristol-Myers Squibb Co / CVS Health Corp / Cirrus Logic Inc / Covenant Logistics Group Inc / Edwards Lifesciences Corp / Expeditors International of Washington Inc / F5 Inc / GlaxoSmithKline PLC / Hologic Inc / Hub Group Inc / J B Hunt Transport Services Inc / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / PerkinElmer Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Semtech Corp / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Taiwan Semiconductor Manufacturing Co Ltd / Teradyne Inc / USA Truck Inc / Universal Display Corp / Verizon Communications Inc / Werner Enterprises Inc / Western Digital Corp / Taiwan Semiconductor Manufacturing Co Ltd / Synaptics Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Nektar Therapeutics / Biogen Inc / CEVA Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Acorda Therapeutics Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Merck & Co Inc / Fortinet Inc / Codexis Inc / United Airlines Holdings Inc / American Tower Corp / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / ServiceNow Inc / T-Mobile US Inc / Palo Alto Networks Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Qorvo Inc / Equinix Inc / Medtronic PLC / Adaptimmune Therapeutics PLC / Cable One Inc / Alphabet Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TFI International Inc / SBA Communications Corp / Snap Inc / Uniti Group Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Switch Inc / MaxCyte Inc / Broadcom Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Uber Technologies Inc / Cloudflare Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / GDS Holdings Ltd / Lumen Technologies Inc / Frontier Group Holdings Inc / DigitalBridge Group Inc / Confluent Inc / Codex DNA Inc / Alpha Teknova Inc / Frontier Communications Parent Inc / Cyxtera Technologies Inc / Enovix Corp / Globalfoundries Inc / IHS Holding Ltd / Stronghold Digital Mining Inc / Braze Inc / Hashicorp Inc / Iris Energy Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - CMS AD NCD & JPM Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 24, 2021 to January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US8336351056 / US0091581068 / US0126531013 / US0234361089 / US0311621009 / US0536111091 / US1101221083 / US2017231034 / US2788651006 / US3755581036 / US3976241071 / US4128221086 / US4180561072 / US4282911084 / US4448591028 / US45337C1027 / US4601461035 / US5324571083 / US5463471053 / US56418H1005 / US5719032022 / US5770811025 / US64125C1099 / US6516391066 / US6703461052 / US6935061076 / US6951561090 / US7170811035 / US7310681025 / US7496851038 / US7549071030 / US75886F1075 / US7703231032 / US7802871084 / US8243481061 / US8581191009 / US9113121068 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA25822C2058 / CA1469001053 / CA0679011084 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US37940X1028 / US2274831047 / US09062X1037 / US46625H1005 / US0605051046 / US20451N1019 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2971781057 / US1331311027 / US1508701034 / US2538681030 / CA8911605092 / CA1360691010 / US1011211018 / US2644115055 / US9290421091 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / US57636Q1040 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US59522J1034 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US5021751020 / US63633D1046 / US5500211090 / US89785X1019 / CA3518581051 / US92826C8394 / US58502B1061 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / CA55903Q1046 / US76131N1019 / US70509V1008 / CA38045Y1025 / US16208T1025 / US78573L1061 / US74965L1017 / US23283R1005 / CA05577W2004 / US71943U1043 / US60468T1051 / US9660842041 / US02665T3068 / US45378A1060 / US11120U1051 / US02005N1000 / US1785871013 / CA45868C1095 / US14174T1079 / BMG0750C1082 / US8621211007 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US9741551033 / US1638511089 / US4278255009 / US96145D1054 / US70450Y1038 / CA8485101031 / US95040Q1040 / US8522341036 / 100607060 / US45688C1071 / US53223X1072 / US0441861046 / CA26829L1076 / US7005171050 / US43300A2033 / US46187W1071 / CA9628791027 / GB00BF3ZNS54 / US87105L1044 / CA53680Q2071 / US46590V1008 / CA2960061091 / US3610081057 / CA8585221051 / US29261A1007 / US00191U1025 / US83200N1037 / US48251W1045 / CA4039254079 / US53814L1089 / IE00BZ12WP82 / CA13000C2058 / US2605571031 / GB00BJT16S69 / US73757R1023 / US26614N1028 / US5012701026 / US42250P1030 / CA92625W5072 / US14316J1088 / US47012E4035 / US69526K1051 / CA67079A1021 / US15202L1070 / CA00076T1057 / US11135E2037 / US00848J1043 / BMG6964L1072 / US0708301041 / US71844V2016 / US27923Q1094 / AU0000193666 / US4576791085</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Air Products and Chemicals Inc / Albemarle Corp / Amedisys Inc / Amgen Inc / Avery Dennison Corp / Bristol-Myers Squibb Co / Commercial Metals Co / Ecolab Inc / Gilead Sciences Inc / Greif Inc / Harley-Davidson Inc / Hasbro Inc / Hexcel Corp / Humana Inc / Incyte Corp / International Paper Co / Eli Lilly and Co / Louisiana-Pacific Corp / ManpowerGroup Inc / Marriott International Inc / Mattel Inc / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / PPG Industries Inc / Packaging Corp of America / Pfizer Inc / Polaris Inc / RPM International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Royal Gold Inc / Sherwin-Williams Co / Steel Dynamics Inc / United Parcel Service Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Dorel Industries Inc / Cascades Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Global Payments Inc / Cross Country Healthcare Inc / Biogen Inc / JPMorgan Chase & Co / Bank of America Corp / Compass Minerals International Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Essex Property Trust Inc / Camden Property Trust / Celanese Corp / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Mastercard Inc / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Mid-America Apartment Communities Inc / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Lululemon Athletica Inc / TrueBlue Inc / Franco-Nevada Corp / Visa Inc / MEDNAX Inc / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / MAG Silver Corp / Retail Opportunity Investments Corp / Pebblebrook Hotel Trust / GoGold Resources Inc / Chatham Lodging Trust / Sabra Health Care REIT Inc / RLJ Lodging Trust / CyrusOne Inc / BRP Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Whitestone REIT / American Homes 4 Rent / Independence Realty Trust Inc / Brixmor Property Group Inc / Ally Financial Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Axalta Coating Systems Ltd / STORE Capital Corp / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Wingstop Inc / Chemours Co / Hersha Hospitality Trust / Westrock Co / PayPal Holdings Inc / Spin Master Corp / Welltower Inc / Block Inc / First-Citizens Bank & Trust Co / Ingevity Corp / Life Storage Inc / Ashland Global Holdings Inc / ECN Capital Corp / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Invitation Homes Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Switch Inc / Lithium Americas Corp / JBG SMITH Properties / Ero Copper Corp / Funko Inc / Stelco Holdings Inc / Encompass Health Corp / ASGN Inc / Smartsheet Inc / KKR & Co Inc / H&R Real Estate Investment Trust / Livent Corp / Linde PLC / Calibre Mining Corp / Dow Inc / Tronox Holdings PLC / Postal Realty Trust Inc / Dupont De Nemours Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Carlyle Group Inc / JAKKS Pacific Inc / Pactiv Evergreen Inc / Nuvei Corp / Centerspace / Abc Technologies Holdings Inc / Broadstone Net Lease Inc / Agiliti Inc / Paysafe Ltd / Bath & Body Works Inc / Phillips Edison & Co Inc / Ecovyst Inc / Allkem Ltd / Innovid Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Chile / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / CARS / FISV=US / LLY=US / AMGN=US / BMY=US / TWTR=US / AMZN=US / EBAY=US / GILD=US / PEB=US / H=US / CRM=US / V=US / MTN=US / VRM=US / MAR=US / EXPE=US / TNL=US / HLT=US / HUM=US / CVS=US / W=US / STZ=US / DV=US / AIR=US / ATRO=US / BLL=US / B=US / BMRN=US / CHH=US / CCK=US / CW=US / DRH=US / DCO=US / EEFT=US / HEI=US / HXL=US / TREE=US / MRCY=US / NRDS=US / REGN=US / ROLL=US / SHOP=US / SFT=US / SNAP=US / TRIP=US / TGI=US / TRUE=US / VSEC=US / VRTX=US / WIX=US / WEX=US / FOUR=US / GPN=US / PYPL=US / BKNG=US / PRI=US / FB=US / MTCH=US / SPR=US / EVOP=US / MQ / DKS=US / PTON=US / BIIB=US / FLT=US / MOG.A=US / APP=US / SHO=US / BLDR=US / FIS=US / TDG=US / HST=US / MA=US / WU=US / KTOS=US / WH=US / IAC=US / 45665G303 / HGV=US / GDOT=US / WWD=US / PCRX=US / RLJ=US / VAC=US / ANGI=US / RHP=US / SSTK=US / ABBV=US / GOOGL=US / BABA=US / AFMD=US / CMPR=US / BVH=US / WBA=US / GDDY=US / ETSY=US / AJRD=US / BWXT=US / ZG=US / SQ=US / IBEX=US / NTLA=US / TTD=US / CRSP=US / TRVG=US / PK=US / PLYA=US / AYX=US / CVNA=US / YEXT=US / RDFN=US / CARG=US / SFIX=US / ROOT=US / MAXR=US / GSKY=US / FTDR=US / EB=US / AXNX=US / LYFT=US / UBER=US / LSPD=US / APLT=US / LHX=US / RPAY=US / ONEW=US / SPCE=US / AZEK=US / TSHA / PAYA=US / ABNB=US / DASH=US / AFRM=US / VMEO=US / MNTV=US / SQSP=US / 00152K101</td><td class="leftalignment">Albany International Corp / Cars.com Inc / Fiserv Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Twitter Inc / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / CVS Health Corp / Wayfair Inc / Constellation Brands Inc / DoubleVerify Holdings Inc / AAR Corp / Astronics Corp / Ball Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Crown Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Euronet Worldwide Inc / HEICO Corp / Hexcel Corp / Lendingtree Inc / Mercury Systems Inc / Nerdwallet Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Shopify Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / Triumph Group Inc / TrueCar Inc / VSE Corp / Vertex Pharmaceuticals Inc / Wix.Com Ltd / WEX Inc / Shift4 Payments Inc / Global Payments Inc / PayPal Holdings Inc / Booking Holdings Inc / Primerica Inc / Meta Platforms Inc / Match Group Inc / Spirit AeroSystems Holdings Inc / EVO Payments Inc / Marqeta Inc / DICK'S Sporting Goods Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Moog Inc / Applovin Corp / Sunstone Hotel Investors Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Western Union Co / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / Green Dot Corp / Woodward Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Shutterstock Inc / Abbvie Inc / Alphabet Inc / Alibaba Group Holding Ltd / Affimed NV / Cimpress PLC / Bluegreen Vacations Holding Corp / Walgreens Boots Alliance Inc / GoDaddy Inc / ETSY Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Zillow Group Inc / Block Inc / Ibex Ltd / Intellia Therapeutics Inc / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Alteryx Inc / Carvana Co / Yext Inc / Redfin Corp / CarGurus Inc / Stitch Fix Inc / Root Inc / Maxar Technologies Inc / GreenSky Inc / Frontdoor Inc / Eventbrite Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Applied Therapeutics Inc / L3harris Technologies Inc / Repay Holdings Corp / OneWater Marine Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Taysha Gene Therapies Inc / Paya Holdings Inc / Airbnb Inc / DoorDash Inc / Affirm Holdings Inc / Vimeo Inc / Momentive Global Inc / Squarespace Inc / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US8336351056 / US0126531013 / US0311621009 / US1101221083 / US3755581036 / US4448591028 / US45337C1027 / US5324571083 / US5463471053 / US5719032022 / US64125C1099 / US6516391066 / US7170811035 / US7549071030 / US75886F1075 / US7802871084 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA0679011084 / CA9528451052 / US09062X1037 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2538681030 / US1011211018 / US2644115055 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US63633D1046 / CA3518581051 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / US70509V1008 / US16208T1025 / US78573L1061 / US71943U1043 / US60468T1051 / CA45868C1095 / US14174T1079 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / CA9628791027 / US87105L1044 / CA53680Q2071 / CA2960061091 / US53814L1089 / CA13000C2058 / US2605571031 / US73757R1023 / US5012701026 / US42250P1030 / CA92625W5072 / US15202L1070 / US11135E2037 / US0708301041 / AU0000193666</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Albemarle Corp / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Humana Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Marriott International Inc / Neurocrine Biosciences Inc / Newmont Corporation / Pfizer Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Biogen Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Digital Realty Trust Inc / Boston Properties Inc / Duke Realty Corp / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / National Health Investors Inc / Franco-Nevada Corp / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Sabra Health Care REIT Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Interfor Corp / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Wheaton Precious Metals Corp / Switch Inc / Lithium Americas Corp / Ero Copper Corp / Livent Corp / Calibre Mining Corp / Dow Inc / Postal Realty Trust Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Centerspace / Broadstone Net Lease Inc / Bath & Body Works Inc / Allkem Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FY2022 Large-Cap Biotech Preview</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">AMGN=US / BIIB=US / LLY=US / BMY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / ABBV=US</td><td class="leftalignment">Amgen Inc / Biogen Inc / Eli Lilly and Co / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Navigating the Virtual Circus: Expectations and Mgmt Qs for Next Week's Conf.</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">MarketGrader</td><td class="leftalignment">MarketGrader Research Report on Bloomsbury Publishing Plc</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAP / AR / AZO / BBY / BMY.N / BP.N / CHD / CL / CLR / CLX / CNX / COP / CPE / CVX / DVN / EL / EOG / EQT / FND / HD / HES / KMB / KO / LLY.N / LOW / MGY / MRK.N / MRO / MUR / OLN / OXY / PFE.N / PG / PXD / RH / RRC / SLB.N / SM / SPB / STZ / SWN / TAP.N / W / WLK / WLL / WSM / CNQ.TO / GILD.O / AMGN.O / HAL.N / EPC / MGM.N / SU.TO / BBBY.O / XOM / LBRT.N / PENN.O / LPI / REGN.O / VRTX.O / TSCO.O / COCO.O / SMG.N / WYNN.O / MNST.O / ORLY.O / WOOF.O / BIIB.O / NOV.N / RDSb / NOG.A / CZR.O / BKR.N / ESTE.K / MTDR.K / PDCE.O / AMBA.O / FANG.O / ABBV.N / GTLS.N / COTY.K / CIVI.K / TCON.O / CDEV.O / CVNA.K / IOVA.O / EYE.O / PEP.O / INSP.K / KDP.N / AVRO.O / BRY.O / NWL.O / FLTRF.L / OAS.O / OVV.N / DKNG.O / VRM.O / CTRA.K / GRWG.O / SFT.O / BALY.N / RSI.N / HYFM.O / CHK.O / JOAN.O / ZVIA.N / WEBR.N</td><td class="leftalignment">Advance Auto Parts Inc / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bristol-Myers Squibb Co / BP PLC / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Conocophillips / Callon Petroleum Co / Chevron Corp / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Home Depot Inc / Hess Corp / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Merck & Co Inc / Marathon Oil Corp / Murphy Oil Corp / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Procter & Gamble Co / Pioneer Natural Resources Co / RH / Range Resources Corp / Schlumberger NV / SM Energy Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Southwestern Energy Co / Molson Coors Beverage Co / Wayfair Inc / Westlake Chemical Corp / Whiting Petroleum Corp / Williams-Sonoma Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Halliburton Co / Edgewell Personal Care Co / MGM Resorts International / Suncor Energy Inc / Bed Bath & Beyond Inc / Exxon Mobil Corp / Liberty Oilfield Services Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Tractor Supply Co / Vita Coco Company Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / Monster Beverage Corp / O'Reilly Automotive Inc / Petco Health and Wellness Company Inc / Biogen Inc / Nov Inc / Royal Dutch Shell PLC / Northern Oil and Gas Inc / Caesars Entertainment Inc / Baker Hughes Co / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / Abbvie Inc / Chart Industries Inc / Coty Inc / Civitas Resources Inc / TRACON Pharmaceuticals Inc / Centennial Resource Development Inc / Carvana Co / Iovance Biotherapeutics Inc / National Vision Holdings Inc / PepsiCo Inc / Inspire Medical Systems Inc / Keurig Dr Pepper Inc / AVROBIO Inc / Berry Corporation (Bry) / Newell Brands Inc / Flutter Entertainment PLC / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Vroom Inc / Coterra Energy Inc / GrowGeneration Corp / Shift Technologies Inc / Bally's Corp / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Joann Inc / Zevia PBC / Weber Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Biopharma—Feedback From our Recent Launch; Slides attached–CC TMRW (1/5) 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1088</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">January "Monthly Controversies" report & '22 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">163</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Omicron Drives Unprecedented Number of Infections, Potentially Offsetting Decreased Severity; Oral Antivirals Get EUAs</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2206657 / 2270726 / 2684703 / 7103065 / B067BM3 / 2857817 / B02R1L6 / B7TL820 / B7254K9 / BHC8X90 / BD8DJ71 / BJ2Z0H2 / BDT5KT5 / BYSGPK2 / BYXR425 / BGDQ8B3 / BMYRFV6 / BPH0546 / BMHRMK1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Coca-Cola Co / Walt Disney Co / Pfizer Inc / Novartis AG / Molson Coors Beverage Co / Netflix Inc / ALLETE Inc / Meta Platforms Inc / AxoGen Inc / Novo Nordisk A/S / Snap Inc / Pinterest Inc / Inspire Medical Systems Inc / ViewRay Inc / RH / Axonics Inc / Procept Biorobotics Corp / Life Time Group Holdings Inc / Vita Coco Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2022 Global Pharmaceuticals Outlook: Relative P/E Valuation Attractive to Value Investors, but Slowing Growth, 2026+ Patent Cliff, & Limited 2022 Catalysts Likely Caps Upside</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">2126335 / 0989529 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">INBX: INBRX-106 Ph1 Part 3: Dose Escalation Combo Well-Tolerated, Program Progressing</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">INBX.OQ / BMY.N / AZN.L / AMGN.OQ / INCY.OQ / AGEN.OQ</td><td class="leftalignment">Inhibrx Inc / Bristol-Myers Squibb Co / AstraZeneca PLC / Amgen Inc / Incyte Corp / Agenus Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">20 Events In 2022 That Could Change Practice, Alter Companies, Move Stocks</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US6402681083 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Nektar Therapeutics / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch First Quarter 2022</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">014442107 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Alector Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / John Boyle / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 4 2022</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FR0000120271 / GB0007980591 / US00971T1016 / US0116591092 / US0463531089 / US0556221044 / US1101221083 / US30231G1022 / US37733W1053 / US4062161017 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US91913Y1001 / US92343V1044 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US80105N1054 / US20030N1019 / LU0156801721 / US6402681083 / US88031M1099 / US09062X1037 / US0042251084 / US02043Q1076 / GB00B03MLX29 / US2538681030 / US19239V3024 / RDSa.AS / US2090341072 / US00206R1023 / US1314761032 / PAP310761054 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US00507V1098 / US58933Y1055 / US88160R1014 / US9100471096 / US0995021062 / US4361061082 / US56585A1025 / US03027X1000 / US7185461040 / US69318G1067 / US00287Y1091 / US98978V1035 / US81762P1021 / US8725901040 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US69888T2078 / US0465131078 / CA0089118776 / US22822V1017 / US29444U7000 / US00653A1079 / US12685J1051 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / GB00BDSFG982 / US78410G1040 / US91325V1089 / US05722G1004 / US24665A1034 / US02156K1034 / US87105L1044 / US5904791358 / US28414H1032 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968 / US15872M1045 / KYG3902L1095 / US62955J1034 / US5502411037 / US25401T1088 / US20717M1036 / US35909D1090 / KYG4701H1092 / US10576N1028 / US4181001037</td><td class="leftalignment">TotalEnergies SE / BP PLC / Akamai Technologies Inc / Alaska Air Group Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Exxon Mobil Corp / GlaxoSmithKline PLC / Halliburton Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Valero Energy Corp / Verizon Communications Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Tenaris SA / Nektar Therapeutics / Tenaris SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Royal Dutch Shell PLC / Consolidated Communications Holdings Inc / AT&T Inc / Calumet Specialty Products Partners LP / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Activision Blizzard Inc / Merck & Co Inc / Tesla Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / HollyFrontier Corp / Marathon Petroleum Corp / American Tower Corp / Phillips 66 / PBF Energy Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / T-Mobile US Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Equinix Inc / Adaptimmune Therapeutics PLC / Cable One Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TechnipFMC PLC / SBA Communications Corp / Uniti Group Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Switch Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / ChampionX Corp / GDS Holdings Ltd / Nov Inc / Lumen Technologies Inc / DigitalBridge Group Inc / Confluent Inc / Frontier Communications Parent Inc / IHS Holding Ltd / Braze Inc / Hashicorp Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Luxembourg / Mexico / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">01/01/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 580</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb increases 2.9% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb up 4.8% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVO / BMY / LLY / PFE / RHHBY.PK / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Bristol-Myers Squibb Company</td><td class="leftalignment">English</td><td class="rightalignment">116</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Bristol-Myers Squibb Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">805</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biotech 2021 Recap and Predictions for 2022</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">04683R106 / 09061G101 / 03116210 / 64125C109 / 110122108 / 09062X103 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Atea Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended October 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2002305 / 2973821 / 2542049 / 2689560 / 2684703 / 7103065 / B125XQ6 / B1XGNW4 / B0796X4 / BTN1Y11 / BFNR303 / BF3W461</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Abbott Laboratories / Alliant Energy Corp / Dominion Energy Inc / PG&E Corp / Pfizer Inc / Novartis AG / Portland General Electric Co / Insulet Corp / Dexcom Inc / Medtronic PLC / Northwest Natural Holding Co / Tandem Diabetes Care Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/27/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb top market value gainer in Birchview Capital [ranked 1 out of 26] since Sep 30</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bloomsbury Publishing increases 3.8% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 17 to 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US02553E1064 / US0311621009 / US0530151036 / US0584981064 / US0936711052 / US1101221083 / US2017231034 / US2371941053 / US3647601083 / US3703341046 / US3755581036 / US45337C1027 / US5324571083 / US5951121038 / US64125C1099 / US6541061031 / US6556641008 / US6703461052 / US7043261079 / US7170811035 / US75886F1075 / US7782961038 / US8000131040 / US8168511090 / US8270481091 / US8354951027 / US8581191009 / US8589121081 / US8725401090 / US9170471026 / US9182041080 / US92276F1003 / US92532F1003 / US9746371007 / CA1249003098 / CA8029121057 / CA30150P1099 / CA1469001053 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US2283681060 / US2274831047 / US09062X1037 / US0534841012 / US29476L1070 / US2971781057 / CA8911605092 / CA1360691010 / US74144T1088 / US1011211018 / US2644115055 / US9290421091 / CA6445351068 / US9043111072 / US7376301039 / CA1375761048 / US9026531049 / US25960P1093 / US49427F1084 / CA3499151080 / US5500211090 / US02913V1035 / US90384S3031 / US3886891015 / US58933Y1055 / US18538R1032 / US74340W1036 / US6936561009 / US7512121010 / CA07380N1042 / CA96145A2002 / US4440971095 / US78573L1061 / GB00B11DNM70 / US60468T1051 / US1220171060 / US2921041065 / US1785871013 / CA45868C1095 / US14174T1079 / US96145D1054 / US72703H1014 / US95040Q1040 / CA26829L1076 / US7495271071 / CA9628791027 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / US03843E1047 / KYG370921069 / VGG1890L1076 / US73757R1023 / US76156B1070 / US88339P1012 / CA29446Y5020 / US70614W1009 / CA04302L1004 / US82575P1075 / US26484T1060 / US15202L1070 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027 / US1374041093</td><td class="leftalignment">American Eagle Outfitters Inc / Amgen Inc / Automatic Data Processing Inc / Ball Corp / H & R Block Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darden Restaurants Inc / Gap Inc / General Mills Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Micron Technology Inc / Neurocrine Biosciences Inc / Nike Inc / Nordstrom Inc / Nucor Corp / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sanderson Farms Inc / Sempra Energy / Silgan Holdings Inc / Sonoco Products Co / Steel Dynamics Inc / Stericycle Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / CCL Industries Inc / Saputo Inc / Exco Technologies Ltd / Cascades Inc / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Crown Holdings Inc / Cross Country Healthcare Inc / Biogen Inc / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / T Rowe Price Group Inc / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / New Gold Inc / Under Armour Inc / Potlatchdeltic Corp / Canfor Corp / UDR Inc / Douglas Emmett Inc / Kilroy Realty Corp / Fortuna Silver Mines Inc / Lululemon Athletica Inc / American Public Education Inc / Ulta Beauty Inc / Graphic Packaging Holding Co / Merck & Co Inc / Clearwater Paper Corp / Prologis Inc / PVH Corp / Ralph Lauren Corp / Bear Creek Mining Corp / Westshore Terminals Investment Corp / Hudson Pacific Properties Inc / Sabra Health Care REIT Inc / Horizonte Minerals PLC / Mirati Therapeutics Inc / Burlington Stores Inc / Empire State Realty Trust Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Westrock Co / Planet Fitness Inc / Welltower Inc / ECN Capital Corp / REV Group Inc / Wheaton Precious Metals Corp / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Aquestive Therapeutics Inc / Galaxy Digital Holdings Ltd / Capri Holdings Ltd / Postal Realty Trust Inc / Revolve Group Inc / RealReal Inc / Equinox Gold Corp / Peloton Interactive Inc / Artemis Gold Inc / Sibanye Stillwater Ltd / Dun & Bradstreet Holdings Inc / Centerspace / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 579</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE0006969603 / US09061G1013 / US0311621009 / US0718131099 / US1101221083 / US1311931042 / US1985161066 / US2435371073 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US6541061031 / US66987V1098 / US75886F1075 / US7782961038 / US8006771062 / US8305661055 / US8725401090 / US87612E1064 / US9021041085 / US9139031002 / US9182041080 / US92532F1003 / US3448491049 / US6402681083 / US21036P1084 / US2533931026 / US09062X1037 / US0042251084 / US02043Q1076 / US9043111072 / BREMBRACNOR4 / US4103451021 / US03152W1099 / US5500211090 / US36315X1019 / US58933Y1055 / US46333X1081 / US13100M5094 / DE000A1EWWW0 / US29082A1079 / US40412C1018 / US6936561009 / US7512121010 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US1220171060 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US74967X1037 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US89610F1012 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US98585X1046 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US0843101017 / US75943R1023 / US02875D1090 / US07373B1098 / US56854Q2003 / US81181C1045 / US74006W1080 / US55406W1036 / US30260D1037 / US38870X1046 / KYG7614L1095 / US98422T1007 / US01675A1097</td><td class="leftalignment">Puma SE / Biomarin Pharmaceutical Inc / Amgen Inc / Baxter International Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Columbia Sportswear Co / Deckers Outdoor Corp / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Nike Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sangamo Therapeutics Inc / Skechers USA Inc / TJX Companies Inc / Target Corp / II-VI Inc / Universal Health Services Inc / VF Corp / Vertex Pharmaceuticals Inc / Foot Locker Inc / Nektar Therapeutics / Constellation Brands Inc / DICK'S Sporting Goods Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Embraer SA / HanesBrands Inc / Amicus Therapeutics Inc / Lululemon Athletica Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Adidas AG / Embraer SA / HCA Healthcare Inc / PVH Corp / Ralph Lauren Corp / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Burlington Stores Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / RH / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Tricida Inc / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Yeti Holdings Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Berkeley Lights Inc / Relay Therapeutics Inc / American Outdoor Brands Inc / Beam Global / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / MYT Netherlands Parent BV / Figs Inc / Graphite Bio Inc / Rockley Photonics Holdings Ltd / Xilio Therapeutics Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Brazil / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Top 10 Potential Surprises Of 2022</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US09062X1037 / US89610F1012 / US09061G1013 / US0311621009 / US1101221083 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US66987V1098 / US75886F1075 / US8006771062 / US92532F1003 / US6402681083 / US21036P1084 / US0042251084 / US02043Q1076 / US03152W1099 / US36315X1019 / US58933Y1055 / US46333X1081 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US75943R1023 / US56854Q2003 / US81181C1045 / US74006W1080 / US38870X1046 / US98422T1007</td><td class="leftalignment">Biogen Inc / Tricida Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Constellation Brands Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Relay Therapeutics Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / Graphite Bio Inc / Xilio Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Omicron Eclipses Delta to Become Dominant in U.S., Increased Transmissibility a Concern but Boosters Remain Effective</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2640147 / 2778844 / 2219224 / 2270726 / 2542049 / 2317087 / 2455965 / 2689560 / 2684703 / 7103065 / 2713317 / 2857817 / B125XQ6 / BHC8X90 / BJJMGL2 / BKTNTR9 / BJXBP30 / BYYWPW6 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Nike Inc / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Biogen Inc / PG&E Corp / Pfizer Inc / Novartis AG / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Novo Nordisk A/S / Fox Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Beigene Ltd / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - BeiGene: TIGIT deal continues to support globalisation strategy and strengthens Novartis collaboration. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGNE.OQ / 6160.HK / NOVN.S / BMY.N / ROG.S / GSK.L / GILD.OQ / AGEN.OQ</td><td class="leftalignment">Beigene Ltd / Beigene Ltd / Novartis AG / Bristol-Myers Squibb Co / Roche Holding AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Agenus Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Takeaways from Management Meetings</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">12/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.8% Above Pre-Pandemic Base- Week 89</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/18/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1206</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">12/18/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">An unfavourable environment weighs on BLOOMSBURY, which sees a downgrade to Slightly Negative</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Publishing</td><td class="leftalignment">Europe</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 578</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Sarah Schram / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">12/18/2021</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Bristol Myers Squibb Co: 1 director</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - ASH & 2022 Outlook Edition</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 10 to 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US00724F1012 / US0236081024 / US0311621009 / US0351282068 / US0383361039 / US0394831020 / US0536111091 / US0584981064 / US1101221083 / US1264081035 / US1564311082 / US2017231034 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4227041062 / US5324571083 / US5463471053 / US6516391066 / US65473P1057 / US6703461052 / US7170811035 / US7445731067 / US7802871084 / US8581191009 / US92276F1003 / US9746371007 / US98389B1008 / CA13321L1085 / CA6979001089 / CA8787422044 / CA2918434077 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA1349211054 / CA0636711016 / CA0641491075 / CA8765111064 / CA3359341052 / US20825C1045 / US35671D8570 / AU000000FMG4 / US09062X1037 / CA98462Y1007 / US02043Q1076 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / CA39138C1068 / CA4436281022 / CA1360691010 / US3546131018 / US74144T1088 / US09247X1019 / US44107P1049 / CA95083R1001 / US40637H1095 / CA1375761048 / US74460D1090 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / US30225T1025 / CA0966311064 / CA29258Y1034 / CA1999101001 / CA2271071094 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA46071W2058 / BMG491BT1088 / CA3518581051 / GB00B2QPKJ12 / GB0004300496 / US26884L1098 / US91912E1055 / US1921085049 / IE00B4BNMY34 / CA69946Q1046 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US2296631094 / CA54928Q1081 / AU000000EVN4 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09739D1000 / JE00B5TT1872 / US09609G1004 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3874371147 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0158571053 / CA0213611001 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA8661201167 / CA38045Y1025 / US16208T1025 / CA5054401073 / US45845P1084 / CA0266951064 / CA33812R1091 / CA17039A1066 / CA46579R1047 / US45378A1060 / CA65340P1062 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / CA45868C1095 / CA26153P1045 / CA1264621006 / CA7397211086 / US14174T1079 / CA68827L1013 / US78667J1088 / CA30606C1086 / IE00BQPVQZ61 / CA5503711080 / US30040W1080 / CA74273V1067 / US6378701063 / AU000000S320 / US4278255009 / CA0115321089 / CA05329M1041 / US95040Q1040 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / US53223X1072 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / US43300A2033 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US23355L1061 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / US03753U1060 / CA2960061091 / CA7766521099 / CA8585221051 / US92645B1035 / US3843135084 / US03168L1052 / US2997341035 / CA05585D1033 / US03836N1037 / CA0717341071 / US03843E1047 / CA4039254079 / US04335A1051 / CA38119T8077 / CA13000C2058 / US03990B1017 / CA72765Q8829 / US1255231003 / CA2849025093 / CA45075E1043 / US63253R2013 / AU0000018236 / CA7426943006 / CA57776F4050 / US09260D1072 / CA5625684025 / CA48086P1009 / US30205M1018 / CA29446Y5020 / US03768E1055 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / CA31890B1031 / US14316J1088 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA67079A1021 / US12529R1077 / US3773201062 / CA9004352071 / US3680361090 / CA64782A1075 / CA00288U1066 / CA36261G1028 / US15202L1070 / US24343R1068 / CA65401N1078 / US90364P1057 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA50202P1053 / CA65343M2094 / US1374041093 / CA0156581070 / CA24477T1003 / CA22289D1078 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Adobe Inc / Ameren Corp / Amgen Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Ball Corp / Bristol-Myers Squibb Co / CSX Corp / Century Aluminum Co / Commercial Metals Co / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hecla Mining Co / Eli Lilly and Co / Louisiana-Pacific Corp / Newmont Corporation / NiSource Inc / Nucor Corp / Pfizer Inc / Public Service Enterprise Group Inc / Royal Gold Inc / Steel Dynamics Inc / Ventas Inc / Winnebago Industries Inc / Xcel Energy Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Empire Company Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Canadian Apartment Properties Real Estate Investment Trust / Bank of Montreal / Bank of Nova Scotia / Taseko Mines Ltd / First Quantum Minerals Ltd / Conocophillips / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Great-West Lifeco Inc / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Host Hotels & Resorts Inc / Wesdome Gold Mines Ltd / Halozyme Therapeutics Inc / Canfor Corp / Public Storage / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Extra Space Storage Inc / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Cominar Real Estate Investment Trust / Crombie Real Estate Investment Trust / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / InterRent Real Estate Investment Trust / Invesco Ltd / Franco-Nevada Corp / Fresnillo PLC / Pan African Resources PLC / EQT Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Parex Resources Inc / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / CubeSmart / Lucara Diamond Corp / Evolution Mining Ltd / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / Boise Cascade Co / Centamin PLC / bluebird bio Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Granite Real Estate Investment Trust / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Algonquin Power & Utilities Corp / AltaGas Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / Summit Industrial Income REIT / GoGold Resources Inc / Chatham Lodging Trust / Labrador Iron Ore Royalty Corp / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Fission Uranium Corp / Choice Properties Real Estate Investment Trust / Ivanhoe Mines Ltd / Independence Realty Trust Inc / Nexgen Energy Ltd / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / Interfor Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / Prairiesky Royalty Ltd / CareTrust REIT Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Falco Resources Ltd / Horizon Therapeutics PLC / Lundin Gold Inc / Eversource Energy / Probe Metals Inc / National Storage Affiliates Trust / South32 Ltd / Hersha Hospitality Trust / Alamos Gold Inc / Automotive Properties Real Estate Investment Trust / Welltower Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Life Storage Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Hilton Worldwide Holdings Inc / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / DXC Technology Co / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Apellis Pharmaceuticals Inc / Ero Copper Corp / Roots Corp / Stelco Holdings Inc / Victory Capital Holdings Inc / GrafTech International Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Aptinyx Inc / Bausch Health Companies Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Golden Star Resources Ltd / Calibre Mining Corp / Ares Management Corp / Platinum Group Metals Ltd / Cigna Corp / Eldorado Gold Corp / iA Financial Corporation Inc / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / Maverix Metals Inc / Blackstone Inc / Mandalay Resources Corp / Josemaria Resources Inc / Exicure Inc / Equinox Gold Corp / Apollo Global Management Inc / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / First Capital Real Estate Investment Trust / Carlyle Group Inc / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Abcellera Biologics Inc / G Mining Ventures Corp / Centerspace / Decibel Therapeutics Inc / Nickel 28 Capital Corp / UiPath Inc / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / Li-Cycle Holdings Corp / NextSource Materials Inc / Candel Therapeutics Inc / Algoma Steel Group Inc / Definity Financial Corp / Coveo Solutions Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 17/12/2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.L / CNA.L / CNE.L / IBE.MC / SAE.L / TLW.L / ZTF.L / SSE.L / HBR.L / GLO.L / NG.L / IOG.L / CEG.L / DRX.L / SQZ.L / IGAS.L / JSE.L / SMSS.L / GOODG.L / HUR.L / SEPL.L / TUNE.L / KOS.L / ENOG.L / LITL.L / PHARP.L / LUNE.ST / DEC.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Centrica PLC / Capricorn Energy PLC / Iberdrola SA / SIMEC Atlantis Energy Ltd / Tullow Oil PLC / Zotefoams PLC / SSE PLC / Harbour Energy PLC / ContourGlobal PLC / National Grid PLC / Iog PLC / Challenger Energy Group PLC / Drax Group PLC / Serica Energy PLC / IGas Energy PLC / Jadestone Energy PLC / Smart Metering Systems PLC / Good Energy Group PLC / Hurricane Energy PLC / Seplat Energy PLC / Focusrite PLC / Kosmos Energy Ltd / Energean PLC / Litigation Capital Management Ltd / Pharos Energy PLC / Lundin Energy AB / Diversified Energy Company PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Spain / United Kingdom / Nigeria / Singapore / Sweden / United States / Isle of Man</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Alastair P. Reid / Mr. Andrew Blain / Mr. Ben C. Bourne / Mr. Martin C. Young / Mr. Michael Donnelly / Mr. Rahim N. Karim / Ross Broadfoot / Thomas Rands, CFA / Tom Brookhouse</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Bloomsbury Publishing : Multiple levers for growth - Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">IL0006290147 / US00724F1012 / US0311621009 / US0383361039 / US0584981064 / US1101221083 / US31428X1063 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US81211K1007 / US8581191009 / US92532F1003 / CA59162N1096 / CA5394811015 / CA2918434077 / US9129091081 / CA1349211054 / US7665596034 / US09062X1037 / US02043Q1076 / US3546131018 / US74144T1088 / US09247X1019 / US40637H1095 / CA1375761048 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA46071W2058 / BMG491BT1088 / IE00B4BNMY34 / US58933Y1055 / CA0985461049 / JE00B4T3BW64 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09609G1004 / CA3874371147 / CA16141A1030 / IE00B4Q5ZN47 / CA8661201167 / CA38045Y1025 / CA6674951059 / US6951271005 / US45845P1084 / CA0266951064 / CA58546R1091 / CA17039A1066 / US60468T1051 / US45378A1060 / US31189P1021 / CA72820F1036 / IE00BJ3V9050 / US03820J1007 / CA26153P1045 / CA1264621006 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / US4622221004 / CA49410M1023 / US5588681057 / US68404V1008 / US03753U1060 / CA46136U1030 / IL0011417206 / US92645B1035 / US03168L1052 / US2997341035 / CA05585D1033 / US80706P1030 / US03836N1037 / US48251W1045 / CA0717341071 / CA60448E1034 / US76029N1063 / US03843E1047 / CA4039254079 / US04335A1051 / US50015M1099 / US03990B1017 / CA2849025093 / US62921N1054 / CA7426943006 / US61775R1059 / US09260D1072 / US03768E1055 / US71722W1071 / CA92625W5072 / CA31890B1031 / US14316J1088 / US80810D1037 / US6544051096 / IL0011326795 / CA67079A1021 / US12529R1077 / US3773201062 / CA33843T1084 / US92556V1061 / CA00288U1066 / CA65342N3159 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Adobe Inc / Amgen Inc / Aptargroup Inc / Ball Corp / Bristol-Myers Squibb Co / FedEx Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Steel Dynamics Inc / Vertex Pharmaceuticals Inc / Metro Inc / Loblaw Companies Ltd / Empire Company Ltd / United States Steel Corp / Canadian Apartment Properties Real Estate Investment Trust / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Halozyme Therapeutics Inc / Canfor Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / InterRent Real Estate Investment Trust / Invesco Ltd / Accenture PLC / Merck & Co Inc / Bonterra Energy Corp / Glencore PLC / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / bluebird bio Inc / Granite Real Estate Investment Trust / Chartwell Retirement Residences / Jazz Pharmaceuticals PLC / Summit Industrial Income REIT / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Mirati Therapeutics Inc / Independence Realty Trust Inc / Fate Therapeutics Inc / Plaza Retail REIT / Endo International PLC / Applied Genetic Technologies Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Ionis Pharmaceuticals Inc / Killam Apartment REIT / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Invesque Inc / Sol Gel Technologies Ltd / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Scholar Rock Holding Corp / Aptinyx Inc / KKR & Co Inc / Bausch Health Companies Inc / Minto Apartment Real Estate Investment Trust / Replimune Group Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Kodiak Sciences Inc / Ares Management Corp / Eldorado Gold Corp / NGM Biopharmaceuticals Inc / PRO Real Estate Investment Trust / Morphic Holding Inc / Blackstone Inc / Apollo Global Management Inc / Phathom Pharmaceuticals Inc / Victoria Gold Corp / First Capital Real Estate Investment Trust / Carlyle Group Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Flagship Communities Real Estate Investment Trust / Viatris Inc / Abcellera Biologics Inc / Nexus Real Estate Investment Trust / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback - Read-across on FDA approvability of Chinese of PD-(L)1s</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.L / ROG.S / BMY.N / LLY.N / MRK.N / SASY.PA / GSK.L / BGNE.OQ</td><td class="leftalignment">AstraZeneca PLC / Roche Holding AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Sanofi SA / GlaxoSmithKline PLC / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2022 BioPharma Outlook: A Light at the End of the Tunnel as Sector Sentiment Likely to Improve</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">IL0006290147 / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US7665596034 / US09062X1037 / US02043Q1076 / US40637H1095 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US6951271005 / US45845P1084 / US60468T1051 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / US4622221004 / US5588681057 / US68404V1008 / US03753U1060 / IL0011417206 / US03168L1052 / US2997341035 / US80706P1030 / US03836N1037 / CA0717341071 / US76029N1063 / US03843E1047 / US04335A1051 / US50015M1099 / US62921N1054 / US61775R1059 / US71722W1071 / US80810D1037 / US6544051096 / IL0011326795 / US12529R1077 / US92556V1061 / CA00288U1066 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Sol Gel Technologies Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Aptinyx Inc / Bausch Health Companies Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Arvinas Inc / Kodiak Sciences Inc / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Phathom Pharmaceuticals Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / C4 Therapeutics Inc / Viatris Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 16/12/2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BMY.L / HTG.L / MCB.L / SAE.L / AMS.L / FRP.L / RWA.L / DOM.L / ITM.L / BOOH.L / DFCH.L / HYVE.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Hunting PLC / McBride PLC / SIMEC Atlantis Energy Ltd / Advanced Medical Solutions Group PLC / Frp Advisory Group PLC / Robert Walters PLC / Domino's Pizza Group PLC / ITM Power PLC / boohoo group plc / Distribution Finance Capital Holdings PLC / Hyve Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Alastair P. Reid / Alex Smith / Mr. Ben C. Bourne / Mr. Ben Hunt, CFA, CFA / Dr. Andrew M. Whitney / Harold C. Hutchinson / Mr. Ian Gordon / Ms. Kate S. Calvert / Mr. Martin C. Young / Mr. Michael Donnelly / Nicola V. Mallard / Ross Broadfoot / Thomas Rands, CFA / Tom Brookhouse / Mr. Tom Callan</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">First Take: Bloomsbury Publishing - Exciting Academic expansion</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Bristol Myers Squibb (Buy, TP=$94) - 12m target upgrade - Long-term guidance offers scope for upside surprise - J. Smith (3p)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America / Global</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Justin S. Smith / Florent Cespedes / Dinesh Choudhary</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US0341641035 / US0351282068 / US0394831020 / US1101221083 / US1564311082 / US2017231034 / US2372661015 / US3755581036 / US38059T1060 / US4227041062 / US4404521001 / US5324571083 / US6516391066 / US6703461052 / US75886F1075 / US7802871084 / US8000131040 / US8581191009 / US9024941034 / US9746371007 / CA13321L1085 / CA6979001089 / CA8787422044 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / CA8765111064 / CA3359341052 / US35671D8570 / AU000000FMG4 / BMG169621056 / CA98462Y1007 / CA5503721063 / CA8911605092 / CA4436281022 / CA1360691010 / CA95083R1001 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA29258Y1034 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / US3932221043 / GB00B2QPKJ12 / GB0004300496 / US91912E1055 / US1921085049 / CA69946Q1046 / US72147K1088 / CA66510M2040 / JE00B4T3BW64 / CA54928Q1081 / US4571871023 / AU000000EVN4 / JE00B5TT1872 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0213611001 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA5054401073 / CA33812R1091 / CA46579R1047 / CA65340P1062 / CA7397211086 / CA68827L1013 / CA30606C1086 / CA5503711080 / CA74273V1067 / AU000000S320 / CA0115321089 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / CA2960061091 / CA8585221051 / US3843135084 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA57776F4050 / CA5625684025 / CA48086P1009 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA9004352071 / US3680361090 / CA64782A1075 / CA36261G1028 / CA65401N1078 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA65343M2094 / CA0156581070 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Andersons Inc / AngloGold Ashanti Ltd / Archer-Daniels-Midland Co / Bristol-Myers Squibb Co / Century Aluminum Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Hormel Foods Corp / Eli Lilly and Co / Newmont Corporation / Nucor Corp / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Sanderson Farms Inc / Steel Dynamics Inc / Tyson Foods Inc / Winnebago Industries Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Taseko Mines Ltd / First Quantum Minerals Ltd / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Bunge Ltd / Yamana Gold Inc / Lundin Mining Corp / Toronto-Dominion Bank / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Wesdome Gold Mines Ltd / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Endeavour Silver Corp / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Green Plains Inc / Fresnillo PLC / Pan African Resources PLC / Vale SA / Coeur Mining Inc / Parex Resources Inc / Pilgrims Pride Corp / Northern Dynasty Minerals Ltd / Glencore PLC / Lucara Diamond Corp / Ingredion Inc / Evolution Mining Ltd / Centamin PLC / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / AltaGas Ltd / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / Labrador Iron Ore Royalty Corp / Fission Uranium Corp / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Prairiesky Royalty Ltd / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Probe Metals Inc / South32 Ltd / Alamos Gold Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / GrafTech International Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / Maverix Metals Inc / Mandalay Resources Corp / Josemaria Resources Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / NextSource Materials Inc / Algoma Steel Group Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ASH Recap: Updates on First- and Second-Line DLBCL Treatment, BCMA CAR-Ts and Bispecifics, and Hemoglobinopathy Treatments</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">07373V105 / 09609G100 / 110122108 / 640268108 / 45337C102 / 45253H101 / 15117K103 / 462222100 / 05280R100 / 37890U108 / 77313F106 / 74019P108 / N90064101 / 00507W206 / 151205200</td><td class="leftalignment">Beam Therapeutics Inc / bluebird bio Inc / Bristol-Myers Squibb Co / Nektar Therapeutics / Incyte Corp / ImmunoGen Inc / Cellectis SA / Ionis Pharmaceuticals Inc / Autolus Therapeutics PLC / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Precision BioSciences Inc / Uniqure NV / Actinium Pharmaceuticals Inc / Celyad Oncology SA</td><td class="leftalignment"></td><td class="leftalignment">Belgium / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sarah Schram</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Biotechnology - ASH 2021: potential winners start to emerge</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">FR0000120578 / GB0009252882 / DK0010272202 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Genmab A/S / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Xian Deng</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback - Key takeaways from ASH DLBCL & CAR-T expert call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GMAB.CO / ROG.S / BMY.N / JNJ.N / NOVN.S / GILD.OQ</td><td class="leftalignment">Genmab A/S / Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Novartis AG / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Matt S. Miksic / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Bloomsbury Publishing PLC Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Apparel & Textiles / Appliances / Automotive / Broadcasting & Cable / Building & Building Materials / Consumer / Electronics / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Photography / Publishing / Retailing / Services / Tire & Rubber / Internet / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Should Investors Steer Clear of the Bristol-Myers Squibb Co?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Transcript: ASH Doctor Call</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US1101221083 / US3755581036 / US75886F1075</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">BRISTOL MYERS SQUIBB sees an upgrade to Slightly Positive due to a better fundamental star rating</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">US0236081024 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US5463471053 / US75886F1075 / US9621661043 / CA9528451052 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / CA8911605092 / CA1360691010 / US7376301039 / CA1375761048 / US00287Y1091 / US09739D1000 / CA0158571053 / CA04016A1012 / CA45868C1095 / US78667J1088 / US23355L1061 / CA7766521099 / US90364P1057 / CA50202P1053</td><td class="leftalignment">Ameren Corp / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Regeneron Pharmaceuticals Inc / Weyerhaeuser Co / West Fraser Timber Co Ltd / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Potlatchdeltic Corp / Canfor Corp / Abbvie Inc / Boise Cascade Co / Algonquin Power & Utilities Corp / Argonaut Gold Inc / Interfor Corp / SAGE Therapeutics Inc / DXC Technology Co / Roots Corp / UiPath Inc / Li-Cycle Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended September 13,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Doc Call Follow-Up: Focus on CAR-T in DLBCL After Practice Changing Data</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US00287Y1091</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2008154 / 2778844 / 2050832 / 2270726 / 2829515 / 2689560 / 2684703 / 2048804 / 7103065 / 2857817 / B3D7K31 / BCZS820 / BBGVT40 / BFLR866 / BFZNYB7 / BKVDFF7 / BFZ1K46 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BZ05388 / BJVR9Y9 / BYY88Y7 / BG0Q4Y1 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Adobe Inc / Merck & Co Inc / Ameren Corp / Walt Disney Co / Edison International / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Netflix Inc / Discovery Inc / Fate Therapeutics Inc / News Corp / Twitter Inc / Allogene Therapeutics Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / iHeartMedia Inc / Alphabet Inc / Exicure Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - 2022: Let's hope it's a good one</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended December 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC - BUY - Preclinical Data Highlight ORIC-533 (CD73i) Potential in Multiple Myeloma; Pipeline Advancing with 3 New Trials to Commence by Early 2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKVDFF7 / 0989529 / 2126335 / 2516152 / 2023607 / 7103065</td><td class="leftalignment">Oric Pharmaceuticals Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AGR / AMAT.O / AXP / BMY.N / CNC.N / CRM.N / CVS.N / HD / KNX / LOW / PFE.N / PNM / RNG / ADBE.O / SU.TO / SGMO.O / ARNA.O / SNPS.O / ACGL.O / CDNS.O / FATE.O / FIVN.O / MDWD.O / EDIT.O / NTLA.O / EVBG.O / WDAY.O / EGHT.K / ZM.O / ZI.O / NWE.O / BLND.N / WKME.O</td><td class="leftalignment">Avangrid Inc / Applied Materials Inc / American Express Co / Bristol-Myers Squibb Co / Centene Corp / Salesforce.Com Inc / CVS Health Corp / Home Depot Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Pfizer Inc / PNM Resources Inc / RingCentral Inc / Adobe Inc / Suncor Energy Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / Synopsys Inc / Arch Capital Group Ltd / Cadence Design Systems Inc / Fate Therapeutics Inc / Five9 Inc / Mediwound Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Everbridge Inc / Workday Inc / 8x8 Inc / Zoom Video Communications Inc / ZoomInfo Technologies Inc / NorthWestern Corp / Blend Labs Inc / Walkme Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / China / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 3, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Pfizer/Arena Deal Signals Start to Immuno-Inflammation Diversification by Big Pharma and Big Biotech</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">00461U105 / 01671P100 / 03116210 / 110122108 / 49372L100</td><td class="leftalignment">Aclaris Therapeutics Inc / Allakos Inc / Amgen Inc / Bristol-Myers Squibb Co / Kezar Life Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: ARNA Deal Opens a $3B OPPY for PFE; Valuation Appears Reasonable</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARNA.OQ / PFE.N / BMY.N / ARNA.O</td><td class="leftalignment">Arena Pharmaceuticals Inc / Pfizer Inc / Bristol-Myers Squibb Co / Arena Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / Mr. Derek Archila / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Toe in the Water: Arena Likely the First of Many Acquisitions for Pfizer</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US7170811035 / US1101221083</td><td class="leftalignment">Pfizer Inc / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASH 2021: Key Pharma Highlights From The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US1101221083 / US7170811035 / US7711951043</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE=US / BMY=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / PG=US / WEN=US / AMZN=US / DVN=US / EBAY=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / IGT=US / MGY=US / SWN=US / VRM=US / MUR=US / BYD=US / MAR=US / MRO=US / EXPE=US / TNL=US / MGM=US / HLT=US / PENN=US / NWL=US / W=US / FLO=US / STZ=US / BMRN=US / CBRL=US / CTRA=US / CHD=US / COLL=US / CNX=US / DRI=US / DRH=US / EPC=US / EQT=US / GFF=US / GPOR=US / TREE=US / NOW=US / TEAM=US / REGN=US / SGMO=US / SMG=US / SNAP=US / TRIP=US / WIX=US / CVX=US / POST=US / CGEN=US / SGMS=US / BKNG=US / CNC=US / SNV=US / FB=US / MTCH=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / BDSI=US / MNST=US / PTON=US / IGMS=US / NOMD=US / RNG=US / CZR=US / SHO=US / PLAY=US / FRPT=US / DENN=US / XM=US / THS=US / ESMT=US / CMG=US / ELF=US / TAST=US / CENTA=US / QSR=US / CLR=US / WH=US / NOG=US / IAC=US / JACK=US / AGS=US / RCUS=US / UTZ=US / 45665G303 / INSE / AR=US / OAS=US / HGV=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / SSTK=US / NCLH=US / NDLS=US / GLPI=US / GOOGL=US / VNOM=US / LOCO=US / BABA=US / CIVI=US / CMPR=US / BVH=US / SHAK=US / GDDY=US / ETSY=US / WING=US / ZG=US / EVRI=US / TTD=US / EVBG=US / CDEV=US / TRVG=US / PK=US / PLYA=US / CVNA=US / YEXT=US / SBOW=US / RDFN=US / PETQ=US / CARG=US / SFIX=US / KDP=US / FTDR=US / EB=US / ARVN=US / HARP=US / LYFT=US / UBER=US / FERG=US / BRBR=US / OVV=US / REYN=US / NGMS=US / HYFM=US / CELU=US / ROCC=US / REPX=US / 67421J108 / MNTV=US / DNUT=US / GAMB=US / EWCZ=US / USER=US</td><td class="leftalignment">Pfizer Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Procter & Gamble Co / Wendys Co / Amazon.com Inc / Devon Energy Corp / eBay Inc / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Vroom Inc / Murphy Oil Corp / Boyd Gaming Corp / Marriott International Inc / Marathon Oil Corp / Expedia Group Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Newell Brands Inc / Wayfair Inc / Flowers Foods Inc / Constellation Brands Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Coterra Energy Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Darden Restaurants Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Gulfport Energy Corp / Lendingtree Inc / ServiceNow Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Post Holdings Inc / Compugen Ltd / Scientific Games Corp / Booking Holdings Inc / Centene Corp / Synovus Financial Corp / Meta Platforms Inc / Match Group Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Peloton Interactive Inc / IGM Biosciences Inc / Nomad Foods Ltd / RingCentral Inc / Caesars Entertainment Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Qualtrics International Inc / TreeHouse Foods Inc / EngageSmart Inc / Chipotle Mexican Grill Inc / elf Beauty Inc / Carrols Restaurant Group Inc / Central Garden & Pet Co / Restaurant Brands International Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / PlayAGS Inc / Arcus Biosciences Inc / UTZ Brands Inc / Infinity Pharmaceuticals Inc / Inspired Entertainment Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Shutterstock Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Gaming and Leisure Properties Inc / Alphabet Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Alibaba Group Holding Ltd / Civitas Resources Inc / Cimpress PLC / Bluegreen Vacations Holding Corp / Shake Shack Inc / GoDaddy Inc / ETSY Inc / Wingstop Inc / Zillow Group Inc / Everi Holdings Inc / Trade Desk Inc / Everbridge Inc / Centennial Resource Development Inc / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Yext Inc / SilverBow Resources Inc / Redfin Corp / PetIQ Inc / CarGurus Inc / Stitch Fix Inc / Keurig Dr Pepper Inc / Frontdoor Inc / Eventbrite Inc / Arvinas Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Reynolds Consumer Products Inc / NeoGames SA / Hydrofarm Holdings Group Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc / Oatly Group AB / Momentive Global Inc / Krispy Kreme Inc / Gambling.com Group Ltd / European Wax Center Inc / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US0311621009 / US0394831020 / US0536111091 / US1101221083 / US1266501006 / US3755581036 / US3976241071 / US45337C1027 / US5324571083 / US5719032022 / US64125C1099 / US65473P1057 / US7170811035 / US7445731067 / US75886F1075 / US92276F1003 / US92532F1003 / US98389B1008 / CA51925D1069 / US09062X1037 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US44107P1049 / US74460D1090 / US9026531049 / US30225T1025 / US58933Y1055 / US65339F1012 / US2296631094 / US09609G1004 / US70509V1008 / US16208T1025 / US60468T1051 / US14174T1079 / US9840171030 / US30040W1080 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / US03753U1060 / US04335A1051 / US15202L1070 / US4718711033 / US1374041093 / CA24477T1003 / CA22289D1078</td><td class="leftalignment">Amgen Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Bristol-Myers Squibb Co / CVS Health Corp / Gilead Sciences Inc / Greif Inc / Incyte Corp / Eli Lilly and Co / Marriott International Inc / Neurocrine Biosciences Inc / NiSource Inc / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Xcel Energy Inc / Laurentian Bank of Canada / Biogen Inc / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Host Hotels & Resorts Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Merck & Co Inc / Nextera Energy Inc / CubeSmart / bluebird bio Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Mirati Therapeutics Inc / CareTrust REIT Inc / Xenia Hotels & Resorts Inc / Eversource Energy / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Apellis Pharmaceuticals Inc / Arvinas Inc / Centerspace / Jasper Therapeutics Inc / Candel Therapeutics Inc / Definity Financial Corp / Coveo Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AJG / ALL / AM / AMT / AR / AXP / BA.N / BAX / BMY.N / CB / CCI / CLR / CNC.N / CNX / COO / CPE / CPK / CRM.N / CVS.N / D / DG / DGX / DK / DLR / DVN / DY / EOG / EQT / HD / HEP / HIG / IFF / KNX / LOW / MCHP.O / MGY / MMP / MRK.N / MRO / OKE / OLN / OXY / PFE.N / PGR / PNM / PXD / QCOM.O / RKT / RMBS.O / RNG / RRC / SJI / SLG / SM / SWN / T / TFX / TOL / USM / WES / WLK / WLL / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / IRM / MGM.N / ADBE.O / PAA.N / SBAC.O / MXL / ADI.O / VZ / NWN / ARNA.O / SMTC.O / SLAB.O / SNPS.O / DLTR.O / BYD.N / ARGX.O / PENN.O / ISRG.O / LPI / CHDN.O / REGN.O / VRTX.O / MRVL.O / SMG.N / WYNN.O / SIVB.O / DIOD.O / ACGL.O / EQIX.O / OMCL.O / SWKS.O / BIIB.O / DKL / LVS.N / CDNS.O / CNSL.O / CLMT.O / CCOI.O / NOG.A / WRB.N / TSLA.O / NXPI.O / CZR.O / HZNP.O / ESTE.K / MTDR.K / TRGP.K / PDCE.O / AMBA.O / FANG.O / MPLX.K / ABBV.N / PFSI.K / PSXP.K / LGIH.O / FIVN.O / RXDX.O / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / CYAD.O / GBT.O / TMUS.O / RRR.O / EVBG.O / UNIT.O / CLLS.O / CDEV.O / WDAY.O / HESM.K / RYTM.O / SWCH.K / APLS.O / EGHT.K / AUTL.O / BRY.O / KZR.O / AXNX.O / SWAV.O / ZM.O / FLTRF.L / RTLR.O / MORF.O / CABA.O / OAS.O / OVV.N / PGEN.O / BEAM.O / DKNG.O / ZI.O / CTRA.K / GRWG.O / 45258J102 / NWE.O / LUMN.K / BALY.N / ALGM.O / RSI.N / HYFM.O / GRCL.O / CHK.O / HMPT.O / DBRG.N / BLND.N / YOU.N / WKME.O / KLTR.O / WOLF.N / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / American Tower Corp / Antero Resources Corp / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Continental Resources Inc / Centene Corp / CNX Resources Corp / Cooper Companies Inc / Callon Petroleum Co / Chesapeake Utilities Corp / Salesforce.Com Inc / CVS Health Corp / Dominion Energy Inc / Dollar General Corp / Quest Diagnostics Inc / Delek US Holdings Inc / Digital Realty Trust Inc / Devon Energy Corp / Dycom Industries Inc / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / International Flavors & Fragrances Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Microchip Technology Inc / Magnolia Oil & Gas Corp / Magellan Midstream Partners LP / Merck & Co Inc / Marathon Oil Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / PNM Resources Inc / Pioneer Natural Resources Co / Qualcomm Inc / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / SM Energy Co / Southwestern Energy Co / AT&T Inc / Teleflex Inc / Toll Brothers Inc / United States Cellular Corp / Western Midstream Partners LP / Westlake Chemical Corp / Whiting Petroleum Corp / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Iron Mountain Inc / MGM Resorts International / Adobe Inc / Plains All American Pipeline LP / SBA Communications Corp / Maxlinear Inc / Analog Devices Inc / Verizon Communications Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Dollar Tree Inc / Boyd Gaming Corp / argenx SE / Penn National Gaming Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / Churchill Downs Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / SVB Financial Group / Diodes Inc / Arch Capital Group Ltd / Equinix Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / Las Vegas Sands Corp / Cadence Design Systems Inc / Consolidated Communications Holdings Inc / Calumet Specialty Products Partners LP / Cogent Communications Holdings Inc / Northern Oil and Gas Inc / W R Berkley Corp / Tesla Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Horizon Therapeutics PLC / Earthstone Energy Inc / Matador Resources Co / Targa Resources Corp / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / MPLX LP / Abbvie Inc / PennyMac Financial Services Inc / Phillips 66 Partners LP / LGI Homes Inc / Five9 Inc / Prometheus Biosciences Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Celyad Oncology SA / Global Blood Therapeutics Inc / T-Mobile US Inc / Red Rock Resorts Inc / Everbridge Inc / Uniti Group Inc / Cellectis SA / Centennial Resource Development Inc / Workday Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Switch Inc / Apellis Pharmaceuticals Inc / 8x8 Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Flutter Entertainment PLC / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Oasis Petroleum Inc / Ovintiv Inc / Precigen Inc / Beam Therapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / NorthWestern Corp / Lumen Technologies Inc / Bally's Corp / Allegro Microsystems Inc / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / DigitalBridge Group Inc / Blend Labs Inc / Clear Secure Inc / Walkme Ltd / Kaltura Inc / Wolfspeed Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2126335 / 2516152 / 2000019 / 2094670 / 2008154 / 2065159 / 2280220 / 2270726 / 2542049 / 2829515 / 2457864 / 2689560 / 2680905 / 2684703 / 2857817 / B3D7K31 / BBGVT40 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BJLFHW7 / BD8DJ71 / BKS3SM8 / BFZ1K46 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BYNQ369 / BDZ30Q0 / BN2R582 / BMDCDP2 / BN7K304 / BNTB3N8 / BMGGJK8 / BKPGJQ1 / BMXXBD9 / BNLYJ60</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Best Buy Co Inc / Adobe Inc / Autodesk Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / ImmunoGen Inc / PG&E Corp / PPL Corp / Pfizer Inc / Netflix Inc / Discovery Inc / News Corp / Twitter Inc / Wix.Com Ltd / Shopify Inc / Chewy Inc / Snap Inc / IGM Biosciences Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Albertsons Companies Inc / Arvinas Inc / Relay Therapeutics Inc / Bigcommerce Holdings Inc / Academy Sports and Outdoors Inc / Vizio Holding Corp / Valneva SE / Squarespace Inc / Figs Inc / Imago BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Alto Neuroscience Inc.: Our Q&A With Management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Sarah Schram</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Trial Nuances Add Layers of Caveats in Comparing TRANSFORM and ZUMA-7, Though Breyanzi May Have Edge With Safety Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Read-through of Roche's TIGIT OS data: Benefiting BeiGene's global ambition</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BGNE.OQ / BMY.N / PFE.N / AZN.L / ROG.S / NOVN.S / MRCG.DE / GSK.L / GILD.OQ / 1801.HK / GMAB.CO / IMAB.OQ</td><td class="leftalignment">Beigene Ltd / Bristol-Myers Squibb Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Innovent Biologics Inc / Genmab A/S / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 2: More Data Updates With GILD's Yescarta/ZUMA-7 in the Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GILD.OQ / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US09609G1004 / US03753U1060 / US4718711033</td><td class="leftalignment">Gilead Sciences Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Apellis Pharmaceuticals Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 1: Some Encouraging Updates, but We Expect Limited Impact to Shares</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US75886F1075 / US58933Y1055 / US09609G1004 / US03753U1060</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Merck & Co Inc / bluebird bio Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASH Updates (Part 4): ZUMA-7 updates as potential 2L therapy in R/R LBCL</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY=US / GILD=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CD19 CAR-T Face-Off in 2L LBCL; GILD Data Supports Approval, BMY Approaching</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / 37555810 / 11012210</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 577</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 88</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Insights from CITYSCAPE and our Recent Discussion with Genentech</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">11012210 / 37555810 / M2572210 / 640268108 / 771195104 / 58933Y10 / 00653A107 / 58949210 / 09075V10 / 07725L10 / G3910J11 / 81181C10 / 46565G10 / 03969F10 / 05370A10</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Compugen Ltd / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Adaptimmune Therapeutics PLC / Mereo Biopharma Group PLC / BioNTech SE / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Iteos Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Andrew Berens, M.D. / Jeffrey La Rosa / Dilip Joseph / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Weekly Highlights—December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AJG / ALL / AM / AR / BA.N / BAX / BMY.N / CB / CLR / CNX / COO / CPK / CRM.N / D / DG / DK / DVN / EOG / EQT / HD / HEP / HIG / LOW / MMP / MRK.N / OKE / OLN / OXY / PFE.N / PGR / RRC / SJI / SLG / SWN / WES / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / PAA.N / ADI.O / NWN / ARNA.O / ARGX.O / ISRG.O / REGN.O / VRTX.O / SMG.N / SIVB.O / ACGL.O / OMCL.O / BIIB.O / DKL / CLMT.O / WRB.N / TSLA.O / HZNP.O / TRGP.K / FANG.O / MPLX.K / ABBV.N / PSXP.K / LGIH.O / RXDX.O / SHLX.K / NVRO.K / CIVI.K / PBFX.K / CDEV.O / HESM.K / RYTM.O / APLS.O / BRY.O / KZR.O / AXNX.O / SWAV.O / RTLR.O / MORF.O / CABA.O / CTRA.K / GRWG.O / 45258J102 / HYFM.O / CHK.O / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / Antero Resources Corp / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Continental Resources Inc / CNX Resources Corp / Cooper Companies Inc / Chesapeake Utilities Corp / Salesforce.Com Inc / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / Lowe's Companies Inc / Magellan Midstream Partners LP / Merck & Co Inc / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / Southwestern Energy Co / Western Midstream Partners LP / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Plains All American Pipeline LP / Analog Devices Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / argenx SE / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Scotts Miracle-Gro Co / SVB Financial Group / Arch Capital Group Ltd / Omnicell Inc / Biogen Inc / Delek Logistics Partners LP / Calumet Specialty Products Partners LP / W R Berkley Corp / Tesla Inc / Horizon Therapeutics PLC / Targa Resources Corp / Diamondback Energy Inc / MPLX LP / Abbvie Inc / Phillips 66 Partners LP / LGI Homes Inc / Prometheus Biosciences Inc / Shell Midstream Partners LP / Nevro Corp / Civitas Resources Inc / PBF Logistics LP / Centennial Resource Development Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Rivian Automotive Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Denmark / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT / ACI / AIG / AJG / ALC / ALL / AM / AMAT.O / AMT / AON / AR / ARW / BA.N / BAX / BDX / BEP / BK / BMY.N / BP.N / BSX / CB / CLR / CMA / CNX / COO / COP / COST.O / CPK / CRM.N / CVX / D / DG / DK / DVN / EOG / EQT / F.N / FITB.O / GM.N / HD / HEP / HES / HFC / HIG / INTC.O / JNJ / KLAC.O / KR / LNC / LOW / LRCX.O / MCHP.O / MDT / MET / MMC / MMP / MPC / MRK.N / MUR / NTRS.O / OGE / OKE / OLN / OXY / PEN / PFE.N / PGR / PNC / PRU / PSX / QCOM.O / RE / RKT / RMBS.O / RNG / RNR / RRC / SJI / SLB.N / SLG / STT / SWN / SYK / TFC / TFX / TRV / VLO / WES / WMB / WMT / XLNX.O / ASND.O / AMZN.O / CNQ.TO / GILD.O / ET / AMGN.O / EW / BRO / AAPL.O / CSCO.O / HAL.N / NVDA.O / SU.TO / XOM / PAA.N / PBF / MXL / LBRT.N / IART.O / AMD.O / ADI.O / NWN / NTAP.O / ARNA.O / BJ.N / SMTC.O / SLAB.O / SNPS.O / ARGX.O / AXS / ISRG.O / REGN.O / VRTX.O / MU.O / MRVL.O / HPQ / HPE / AVGO.O / BE.N / SMG.N / FCEL.OQ / PLUG.OQ / SIVB.O / BLUE.O / DIOD.O / MMSI.O / ACGL.O / MKSI.O / OMCL.O / SWKS.O / BIIB.O / DKL / VIAC.O / NOV.N / BLDP.OQ / RDSb / DXCM.O / CDNS.O / STX.O / CLMT.O / CVLT.O / PODD.O / TNDM.OQ / WRB.N / JNPR.K / TSLA.O / NXPI.O / LUNG.O / BKR.N / HZNP.O / WDC.O / TRGP.K / AMBA.O / FANG.O / MPLX.K / UIHC.O / ABBV.N / GTLS.N / VOYA.K / PFSI.K / RNA.O / PSXP.K / FATE.O / LGIH.O / RXDX.O / ANET.K / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / GKOS.K / ZBH / CYAD.O / PSTG.K / NVCR.O / IONS.O / WLTW.O / EDIT.O / NTLA.O / NTNX.O / CLLS.O / CDEV.O / BHF.O / IOVA.O / HESM.K / RYTM.O / APLS.O / EQH / AVT.O / INSP.K / AUTL.O / BRY.O / KZR.O / STRO.O / AXNX.O / DELL.K / SWAV.O / RTLR.O / MORF.O / CHWY.K / BRP.O / CABA.O / PGEN.O / NARI.O / AVNT.K / CTRA.K / BEPC.K / GRWG.O / 45258J102 / ASO.O / EAR.O / ROOT.O / ALGM.O / HYFM.O / GRCL.O / CHK.O / HMPT.O / NPCE.O / RYAN.N / RXST.O / WOLF.N / ARBE.O / RIVN.O</td><td class="leftalignment">Abbott Laboratories / Albertsons Companies Inc / American International Group Inc / Arthur J Gallagher & Co / Alcon AG / Allstate Corp / Antero Midstream Corp / Applied Materials Inc / American Tower Corp / Aon PLC / Antero Resources Corp / Arrow Electronics Inc / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / BP PLC / Boston Scientific Corp / Chubb Ltd / Continental Resources Inc / Comerica Inc / CNX Resources Corp / Cooper Companies Inc / Conocophillips / Costco Wholesale Corp / Chesapeake Utilities Corp / Salesforce.Com Inc / Chevron Corp / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Ford Motor Co / Fifth Third Bancorp / General Motors Co / Home Depot Inc / Holly Energy Partners LP / Hess Corp / HollyFrontier Corp / Hartford Financial Services Group Inc / Intel Corp / Johnson & Johnson / KLA Corp / Kroger Co / Lincoln National Corp / Lowe's Companies Inc / Lam Research Corp / Microchip Technology Inc / Medtronic PLC / MetLife Inc / Marsh & McLennan Companies Inc / Magellan Midstream Partners LP / Marathon Petroleum Corp / Merck & Co Inc / Murphy Oil Corp / Northern Trust Corp / OGE Energy Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Penumbra Inc / Pfizer Inc / Progressive Corp / PNC Financial Services Group Inc / Prudential Financial Inc / Phillips 66 / Qualcomm Inc / Everest Re Group Ltd / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Renaissancere Holdings Ltd / Range Resources Corp / South Jersey Industries Inc / Schlumberger NV / SL Green Realty Corp / State Street Corp / Southwestern Energy Co / Stryker Corp / Truist Financial Corp / Teleflex Inc / Travelers Companies Inc / Valero Energy Corp / Western Midstream Partners LP / Williams Companies Inc / Walmart Inc / Xilinx Inc / Ascendis Pharma A/S / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / Halliburton Co / NVIDIA Corp / Suncor Energy Inc / Exxon Mobil Corp / Plains All American Pipeline LP / PBF Energy Inc / Maxlinear Inc / Liberty Oilfield Services Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Northwest Natural Holding Co / NetApp Inc / Arena Pharmaceuticals Inc / BJ's Wholesale Club Holdings Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / argenx SE / AXIS Capital Holdings Ltd / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Micron Technology Inc / Marvell Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Bloom Energy Corp / Scotts Miracle-Gro Co / Fuelcell Energy Inc / Plug Power Inc / SVB Financial Group / bluebird bio Inc / Diodes Inc / Merit Medical Systems Inc / Arch Capital Group Ltd / MKS Instruments Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / ViacomCBS Inc / Nov Inc / Ballard Power Systems Inc / Royal Dutch Shell PLC / Dexcom Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Calumet Specialty Products Partners LP / Commvault Systems Inc / Insulet Corp / Tandem Diabetes Care Inc / W R Berkley Corp / Juniper Networks Inc / Tesla Inc / NXP Semiconductors NV / Pulmonx Corp / Baker Hughes Co / Horizon Therapeutics PLC / Western Digital Corp / Targa Resources Corp / Ambarella Inc / Diamondback Energy Inc / MPLX LP / United Insurance Holdings Corp / Abbvie Inc / Chart Industries Inc / Voya Financial Inc / PennyMac Financial Services Inc / Avidity Biosciences Inc / Phillips 66 Partners LP / Fate Therapeutics Inc / LGI Homes Inc / Prometheus Biosciences Inc / Arista Networks Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Pure Storage Inc / Novocure Ltd / Ionis Pharmaceuticals Inc / Willis Towers Watson PLC / Editas Medicine Inc / Intellia Therapeutics Inc / Nutanix Inc / Cellectis SA / Centennial Resource Development Inc / Brighthouse Financial Inc / Iovance Biotherapeutics Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Equitable Holdings Inc / Avnet Inc / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Sutro Biopharma Inc / Axonics Inc / Dell Technologies Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Chewy Inc / BRP Group Inc / Cabaletta Bio Inc / Precigen Inc / Inari Medical Inc / Avient Corp / Coterra Energy Inc / Brookfield Renewable Corp / GrowGeneration Corp / Immunovant Inc / Academy Sports and Outdoors Inc / Eargo Inc / Root Inc / Allegro Microsystems Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / Neuropace Inc / Ryan Specialty Group Holdings Inc / Rxsight Inc / Wolfspeed Inc / Arbe Robotics Ltd / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video Link - ASH & Launch Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 3 to 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AU000000CIA2 / US0079031078 / US0091581068 / US0311621009 / US0383361039 / US1101221083 / US1264081035 / US1266501006 / US1270971039 / US1475281036 / US1844961078 / US2017231034 / US22160K1051 / US2372661015 / US25179M1036 / US26875P1012 / US30231G1022 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4404521001 / US4433201062 / US4456581077 / US45337C1027 / US4581401001 / US4601461035 / US5324571083 / US56418H1005 / US5962781010 / US6267171022 / US64125C1099 / US6558441084 / US6703461052 / US6745991058 / US6819191064 / US68389X1054 / US7170811035 / US7237871071 / US75281A1097 / US8454671095 / US8851601018 / US9024941034 / US9078181081 / US9113121068 / CA53278L1076 / CA1363751027 / CA29250N1050 / CA0977512007 / CA4530384086 / CA8787422044 / CA1247651088 / CA2918434077 / CA1469001053 / CA0679011084 / CA1363851017 / CA0099051009 / CA7029251088 / CA8959451037 / US1667641005 / CA13645T1003 / US5658491064 / CA13677F1018 / US0017441017 / US20825C1045 / US2274831047 / US09062X1037 / CA8676EP1086 / CA2052491057 / US14040H1059 / BMG169621056 / CA67072Q1046 / CA2265331074 / US6293775085 / CA98462Y1007 / US02043Q1076 / CA4969024047 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US1331311027 / CA8935781044 / CA2935701078 / US12008R1077 / CA6993202069 / US8288061091 / US1252691001 / US12541W2098 / CA1125851040 / CA0906971035 / US42809H1077 / US57636Q1040 / CA30041N1078 / US59522J1034 / BMG383271050 / US9026531049 / CA2945051027 / CA6179141065 / CA14068G1046 / US5500211090 / US3932221043 / US3886891015 / US2120151012 / US38500T1016 / US26884L1098 / CA6252841045 / CA89154B1022 / CA9838911027 / CA22576C1014 / CA8672241079 / CA25675T1075 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / US98986T1088 / CA00829Q1019 / US30303M1027 / US4571871023 / CA7063271034 / US6092071058 / US00287Y1091 / CA89156V1067 / US1091941005 / JE00B5TT1872 / US09609G1004 / US69327R1014 / CA04364G1063 / CA02215R1073 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA8204391079 / CA0805581091 / CA0213611001 / CA3565001086 / CA69338U1012 / CA74061A1084 / CA96145A2002 / CA09202D2077 / IE00B4Q5ZN47 / CA38045Y1025 / CA81373C1023 / CA04682R1073 / CA29269R1055 / CA3748252069 / US5764852050 / US25278X1090 / CA4882951060 / CA46579R1047 / US31189P1021 / US03674X1063 / US2267181046 / US1630921096 / CA14150G4007 / US02005N1000 / US14174T1079 / IE00BQPVQZ61 / US2383371091 / CA0089118776 / BMG0750C1082 / CA8310211005 / US1638511089 / CA83179X1087 / US95040Q1040 / US4622221004 / CA17040T3001 / US2057683029 / BMG162341090 / US13462K1097 / US15136A1025 / CA87241L1094 / CA46016U1084 / CA85859H1055 / CA6632782083 / CA15713J1049 / US12653C1080 / US8608971078 / CA35905B1076 / US03753U1060 / CA2960061091 / US00191U1025 / US11135F1012 / US87484T1088 / US76029N1063 / US34417P1003 / US08579X1019 / US04335A1051 / VGG1890L1076 / CA7241121077 / CA14179V5036 / US22052L1044 / CA6744822033 / US03768E1055 / US70614W1009 / US91734M1036 / CA31890B1031 / US69047Q1022 / US80810D1037 / MHY0436Q1098 / CA36168Q1046 / CA4220961078 / US03940R1077 / CA84678A1021 / US5168062058 / US05478C1053 / CA2674881040 / US13123X5086 / CA67079A1021 / CA89055A2039 / US23821D1000 / CA74022D4075 / US03750L1098 / US86333M1080 / US15202L1070 / CA83615X4075 / CA1295844056 / US78440X8048 / US1651677353 / US03743Q1085 / US90364P1057 / CA5362211040 / US44891N2080 / US92719V1008 / CA65532M6062 / CA00791P1071 / CA24874B1085 / US60646V1052 / CA03253E1079 / IE0003LFZ4U7 / CA53229C1077 / US98955K1043 / US4718711033 / US1374041093 / CA23344V1085 / CA0156581070</td><td class="leftalignment">Champion Iron Ltd / Advanced Micro Devices Inc / Air Products and Chemicals Inc / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / CSX Corp / CVS Health Corp / Coterra Energy Inc / Caseys General Stores Inc / Clean Harbors Inc / Commercial Metals Co / Costco Wholesale Corp / Darling Ingredients Inc / Devon Energy Corp / EOG Resources Inc / Exxon Mobil Corp / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hormel Foods Corp / Hub Group Inc / J B Hunt Transport Services Inc / Incyte Corp / Intel Corp / International Paper Co / Eli Lilly and Co / ManpowerGroup Inc / Middleby Corp / Murphy Oil Corp / Neurocrine Biosciences Inc / Norfolk Southern Corp / Nucor Corp / Occidental Petroleum Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Southwestern Energy Co / Thor Industries Inc / Tyson Foods Inc / Union Pacific Corp / United Parcel Service Inc / Linamar Corp / Canadian National Railway Co / Enbridge Inc / Bombardier Inc / Imperial Oil Ltd / Teck Resources Ltd / CAE Inc / Empire Company Ltd / Cascades Inc / Barrick Gold Corp / Canadian Natural Resources Ltd / AKITA Drilling Ltd / Pason Systems Inc / Trican Well Service Ltd / Chevron Corp / Canadian Pacific Railway Ltd / Marathon Oil Corp / Canadian Western Bank / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Biogen Inc / Sunopta Inc / Computer Modelling Group Ltd / Capital One Financial Corp / Bunge Ltd / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Kinross Gold Corp / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Camden Property Trust / Transcontinental Inc / Ensign Energy Services Inc / Builders FirstSource Inc / Paramount Resources Ltd / Simon Property Group Inc / CF Industries Holdings Inc / CH Robinson Worldwide Inc / Brookfield Asset Management Inc / Birchcliff Energy Ltd / Hess Corp / Mastercard Inc / Evertz Technologies Ltd / Mid-America Apartment Communities Inc / GeoPark Ltd / UDR Inc / Equitable Group Inc / Morguard Real Estate Investment Trust / Capstone Mining Corp / Lululemon Athletica Inc / Green Plains Inc / Graphic Packaging Holding Co / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Mullen Group Ltd / Total Energy Services Inc / Xebec Adsorption Inc / Crescent Point Energy Corp / Suncor Energy Inc / Dollarama Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Zynga Inc / Africa Oil Corp / Meta Platforms Inc / Ingredion Inc / Pembina Pipeline Corp / Mondelez International Inc / Abbvie Inc / Tourmaline Oil Corp / Bright Horizons Family Solutions Inc / Centamin PLC / bluebird bio Inc / PDC Energy Inc / Ascot Resources Ltd / Altus Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Shawcor Ltd / Belo Sun Mining Corp / AltaGas Ltd / Freehold Royalties Ltd / PHX Energy Services Corp / Premium Brands Holdings Corp / Westshore Terminals Investment Corp / Black Diamond Group Ltd / Jazz Pharmaceuticals PLC / GoGold Resources Inc / Secure Energy Services Inc / Athabasca Oil Corp / Enerflex Ltd / Gibson Energy Inc / Matador Resources Co / Diamondback Energy Inc / Kelt Exploration Ltd / Ivanhoe Mines Ltd / Fate Therapeutics Inc / Antero Resources Corp / Criteo SA / Chegg Inc / Cardinal Energy Ltd (Alberta) / Ally Financial Inc / CareTrust REIT Inc / Horizon Therapeutics PLC / Dave & Buster's Entertainment Inc / Air Canada / Axalta Coating Systems Ltd / Slate Office REIT / Chemours Co / SmartCentres Real Estate Investment Trust / Welltower Inc / Ionis Pharmaceuticals Inc / Chorus Aviation Inc / Comstock Resources Inc / Brookfield Business Partners LP / Camping World Holdings Inc / Centennial Resource Development Inc / TFI International Inc / International Petroleum Corp / Step Energy Services Ltd / North West Company Inc / CES Energy Solutions Corp / CNX Resources Corp / Stitch Fix Inc / Frontera Energy Corp / Apellis Pharmaceuticals Inc / Ero Copper Corp / ASGN Inc / Broadcom Inc / Talos Energy Inc / Replimune Group Inc / Focus Financial Partners Inc / Berry Corporation (Bry) / Arvinas Inc / Capri Holdings Ltd / Pipestone Energy Corp / Cargojet Inc / Corteva Inc / Obsidian Energy Ltd / Apollo Global Management Inc / Peloton Interactive Inc / US Ecology Inc / First Capital Real Estate Investment Trust / Ovintiv Inc / Schrodinger Inc / Atlas Corp / GFL Environmental Inc / Headwater Exploration Inc / Arch Resources Inc / Spartan Delta Corp / Laredo Petroleum Inc / Azek Company Inc / Dye & Durham Ltd / Callon Petroleum Co / Nuvei Corp / Topaz Energy Corp / Datto Holding Corp / Precision Drilling Corp / Apartment Income REIT Corp / Stride Inc / Centerspace / Source Energy Services Ltd / Calfrac Well Services Ltd / SL Green Realty Corp / Chesapeake Energy Corp / APA Corp (US) / UiPath Inc / Lion Electric Co / IAC/Interactivecorp / Vimeo Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Mister Car Wash Inc / Anaergia Inc / Dole PLC / Lightspeed Commerce Inc / Zevia PBC / Jasper Therapeutics Inc / Candel Therapeutics Inc / D2L Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / France / Ireland / United States / Virgin Islands, British / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: ESMO IO: Roche's TIGIT survival data impresses</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ROG.S / BMY.N / AZN.L / GSK.L / GILD.OQ</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / AstraZeneca PLC / GlaxoSmithKline PLC / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Harbour BioMed: R&D Day takeaways. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2142.HK / BMY.N</td><td class="leftalignment">Hbm Holdings Ltd / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Bristol-Myers Squibb Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Institutional ownership of BMY at Sep 30: 576 (26%) exits from Bristol Myers Squibb</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / LH / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / AFMD.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Laboratory Corporation of America Holdings / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Affimed NV / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—December 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Virtual pharma tour update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / BMY.N</td><td class="leftalignment">Eisai Co Ltd / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - バーチャルファーマツアー・アップデート</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / BMY.N</td><td class="leftalignment">Eisai Co Ltd / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AJG / BMY.N / EMN / H / KO / LLY.N / MRK.N / OLN / PFE.N / PK / RKT / S.N / SWK / ASND.O / AMZN.O / HT / GILD.O / AMGN.O / EW / ARNA.O / CHH.N / GSK.N / ARGX.O / BMRN.O / REGN.O / VRTX.O / DOL.TO / SIVB.O / BIIB.O / SHO.N / HST.N / HZNP.O / SRPT.O / RHP.N / ABBV.N / PFSI.K / QURE.O / RXDX.O / XHR.N / APLE.N / RYTM.O / SFIX.O / APLS.O / KZR.O / MORF.O / CABA.O / 45258J102 / HMPT.O</td><td class="leftalignment">Arthur J Gallagher & Co / Bristol-Myers Squibb Co / Eastman Chemical Co / Hyatt Hotels Corp / Coca-Cola Co / Eli Lilly and Co / Merck & Co Inc / Olin Corp / Pfizer Inc / Park Hotels & Resorts Inc / Rocket Companies Inc / SentinelOne Inc / Stanley Black & Decker Inc / Ascendis Pharma A/S / Amazon.com Inc / Hersha Hospitality Trust / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Arena Pharmaceuticals Inc / Choice Hotels International Inc / GlaxoSmithKline PLC / argenx SE / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Dollarama Inc / SVB Financial Group / Biogen Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Horizon Therapeutics PLC / Sarepta Therapeutics Inc / Ryman Hospitality Properties Inc / Abbvie Inc / PennyMac Financial Services Inc / Uniqure NV / Prometheus Biosciences Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Rhythm Pharmaceuticals Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / Kezar Life Sciences Inc / Morphic Holding Inc / Cabaletta Bio Inc / Immunovant Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">The Skies Are Clearing but Stock Selection Still Important</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BMY: More Pipeline Needed to Counter IP Loss; Initiate at Equal Weight</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Invest Heroes</td><td class="leftalignment">Bristol-Myers Squibb: financial results for Q3 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dmitrii Novichkov</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">December 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ASH 2021 Preview Webinar: Today, Wednesday, December 8, at 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">110122108 / 45337C102 / 04651310 / 05280R100 / 019770106 / 37890U108 / 471871103</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Atara Biotherapeutics Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / Global Blood Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Raju Prasad, PHD / Matt Phipps, PHD / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">US0091581068 / US0311621009 / US1101221083 / US2017231034 / US2372661015 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US8718291078 / US8851601018 / US9078181081 / US9111631035 / US92532F1003 / US9746371007 / CA29250N1050 / CA1247651088 / CA2918434077 / US09062X1037 / BMG169621056 / US6293775085 / US12008R1077 / US1252691001 / CA6179141065 / US58933Y1055 / US65339F1012 / CA04364G1063 / CA0805581091 / CA38045Y1025 / US85208M1027 / US60468T1051 / US2383371091 / US1638511089 / US4622221004 / US13462K1097 / US8608971078 / US80810D1037 / US92719V1008 / US1374041093</td><td class="leftalignment">Air Products and Chemicals Inc / Amgen Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sysco Corp / Thor Industries Inc / Union Pacific Corp / United Natural Foods Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Enbridge Inc / CAE Inc / Empire Company Ltd / Biogen Inc / Bunge Ltd / NRG Energy Inc / Builders FirstSource Inc / CF Industries Holdings Inc / Morguard Real Estate Investment Trust / Merck & Co Inc / Nextera Energy Inc / Ascot Resources Ltd / Belo Sun Mining Corp / GoGold Resources Inc / Sprouts Farmers Market Inc / Mirati Therapeutics Inc / Dave & Buster's Entertainment Inc / Chemours Co / Ionis Pharmaceuticals Inc / Camping World Holdings Inc / Stitch Fix Inc / Schrodinger Inc / Vimeo Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Feedback From Our Launch: PFE’s Longer-Term COVID Benefit Clearer w/ Omicron</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Flow of Funds Report for Bloomsbury Publishing Plc - prepared by Wright Investors Service</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Bloomsbury Publishing Plc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended September 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 06,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ASH 2021 Preview: Updates on Approaches in SCD/TDT, Autologous and Allogeneic Cell Therapy Data, ADCs, and Rare Diseases</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">110122108 / 05280R100 / 640268108 / 45337C102 / 45253H101 / 15117K103 / 04651310 / 462222100 / 09609G100 / 019770106 / H17182108 / 37890U108 / 77313F106 / 07373V105 / 74019P108 / N90064101 / 73730P108 / 81181C104 / 00507W206 / 13089P101 / 151205200 / 471871103</td><td class="leftalignment">Bristol-Myers Squibb Co / Autolus Therapeutics PLC / Nektar Therapeutics / Incyte Corp / ImmunoGen Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / bluebird bio Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Beam Therapeutics Inc / Precision BioSciences Inc / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / Calithera Biosciences Inc / Celyad Oncology SA / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sarah Schram</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Amid Seasonal Delta-Driven Wave; Clarity on Omicron’s Impact on Vaccines, Trajectory, and Disease Severity in Near Term</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">US02553E1064 / US1101221083 / US2017231034 / US3647601083 / US3755581036 / US45337C1027 / US5324571083 / US6541061031 / US6556641008 / US6703461052 / US6819191064 / US68389X1054 / US7170811035 / US75886F1075 / US7782961038 / US8581191009 / US8725401090 / US8851601018 / US9170471026 / US9182041080 / CA8787422044 / CA87971M1032 / US9129091081 / US02043Q1076 / US9043111072 / US5500211090 / US90384S3031 / CA22576C1014 / US58933Y1055 / US6936561009 / US7512121010 / US98986T1088 / US00287Y1091 / US09609G1004 / CA1348082035 / CA96467A2002 / IE00B4Q5ZN47 / CA3748252069 / US31189P1021 / US1220171060 / US14174T1079 / US72703H1014 / US8760301072 / US8608971078 / US03753U1060 / US63845R1077 / CA8585221051 / US76029N1063 / VGG1890L1076 / US76156B1070 / US88339P1012 / US70614W1009 / US80810D1037 / CA2674881040 / US78440X8048 / US44891N2080 / CA00791P1071 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US4718711033 / US53190C1027 / CA0156581070</td><td class="leftalignment">American Eagle Outfitters Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Gap Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Nucor Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Steel Dynamics Inc / TJX Companies Inc / Thor Industries Inc / Urban Outfitters Inc / VF Corp / Teck Resources Ltd / Telus Corp / United States Steel Corp / Alnylam Pharmaceuticals Inc / Under Armour Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Crescent Point Energy Corp / Merck & Co Inc / PVH Corp / Ralph Lauren Corp / Zynga Inc / Abbvie Inc / bluebird bio Inc / Canacol Energy Ltd / Whitecap Resources Inc / Jazz Pharmaceuticals PLC / Gibson Energy Inc / Fate Therapeutics Inc / Burlington Stores Inc / CareTrust REIT Inc / Planet Fitness Inc / Tapestry Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / National Vision Holdings Inc / Stelco Holdings Inc / Replimune Group Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Peloton Interactive Inc / Schrodinger Inc / Dye & Durham Ltd / SL Green Realty Corp / IAC/Interactivecorp / Advantage Energy Ltd / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Jasper Therapeutics Inc / Life Time Group Holdings Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2868165 / 2126335 / 2516152 / 2778844 / 2219224 / 2216850 / 2270726 / 2542049 / 2272476 / 2317087 / 2670519 / 2328915 / 2684703 / 2440637 / 7103065 / 2713317 / 2857817 / B125XQ6 / B3D7K31 / B1XGNW4 / 2855930 / B3P93Y7 / B0796X4 / BYVFC94 / BZBY005 / BJ2Z0H2 / BFZ1K46 / BYXJQG9 / BZ1LFG7 / BYY88Y7 / BF3W461 / BMC5RV6 / BMDJ397 / BF0QTY9 / BMDW0R3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Sysco Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Dollar Tree Inc / Entergy Corp / Exelon Corp / Nextera Energy Inc / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Insulet Corp / Overstock.com Inc / Anheuser Busch Inbev SA / Dexcom Inc / US Foods Holding Corp / Merus NV / Pinterest Inc / Spotify Technology SA / Spire Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / Adicet Bio Inc / Bolt Biotherapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Weave Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT - BUY - BDC-1001 "ISAC" Update Highlights Good Tolerability, But Efficacy Below Investor Expectations; Addl Dose-Optimization Planned; PT to $15</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMDJ397 / 2126335</td><td class="leftalignment">Bolt Biotherapeutics Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2021 ASH Preview and Itinerary Planner</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US7170811035 / US75886F1075 / US02043Q1076 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US31189P1021 / US03753U1060 / US80810D1037 / US4718711033</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc / Schrodinger Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Georgia / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini / Evan Hua</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Dec. 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ALB.N / ALK.N / BA.N / BAC.N / BMY.N / C.N / CCL.N / CL.N / EOG.N / F.N / FLT.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / MDT.N / OXY.N / PFE.N / PM.N / RHI.N / T.N / TMO.N / WFC.N / SPG.N / NUE.N / DIS.N / UNH.N / TFX.N / UNP.N / RCL.N / HD.N / LOW.N / MRO.N / XOM.N / DVN.N / NKE.N / IT.N / GWW.N / VZ.N / DVA.N / V.N / ACN.N / TWTR.N / HPQ.N / COP.N / INTC.OQ / AOS.N / ADBE.OQ / AMGN.OQ / AAPL.OQ / ADSK.OQ / FISV.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / SIVB.OQ / XLNX.OQ / ODFL.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / MTCH.OQ / GPN.N / VRTX.OQ / WYNN.OQ / CMCSA.OQ / EXR.N / MKTX.OQ / LVS.N / VIAC.OQ / DISCA.OQ / FIS.N / STX.AX / MA.N / WU.N / IPGP.OQ / MRNA.OQ / AVGO.OQ / FTNT.OQ / TSLA.OQ / AMD.OQ / ENPH.OQ / FANG.OQ / PTC.OQ / NCLH.N / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / PYPL.OQ / TMUS.OQ / LW.N / FB.PS / TER.OQ / APA.OQ / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / Alaska Air Group Inc / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Citigroup Inc / Carnival Corp / Colgate-Palmolive Co / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Simon Property Group Inc / Nucor Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Union Pacific Corp / Royal Caribbean Cruises Ltd / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Gartner Inc / W W Grainger Inc / Verizon Communications Inc / DaVita Inc / Visa Inc / Accenture PLC / Twitter Inc / HP Inc / Conocophillips / Intel Corp / A O Smith Corp / Adobe Inc / Amgen Inc / Apple Inc / Autodesk Inc / Fiserv Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / SVB Financial Group / Xilinx Inc / Old Dominion Freight Line Inc / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / Pool Corp / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Wynn Resorts Ltd / Comcast Corp / Extra Space Storage Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / Western Union Co / IPG Photonics Corp / Moderna Inc / Broadcom Inc / Fortinet Inc / Tesla Inc / Advanced Micro Devices Inc / Enphase Energy Inc / Diamondback Energy Inc / PTC Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / San Miguel Food and Beverage Inc / Teradyne Inc / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Ireland / Liberia / Panama / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">12/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 87</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 576</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is A Rise Imminent For Bristol Myers Squibb Stock?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 11012210 / 71708110 / 00846U10 / 88162420 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 80105N10 / NOVO B / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Sanofi SA / Novo Nordisk A/S / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / BMY=US / IP=US / GILD=US / PEB=US / H=US / CRM=US / MTN=US / MAR=US / TNL=US / HLT=US / AKR=US / APH=US / CHH=US / CSTR=US / DRH=US / REGN=US / ROLL=US / VRTX=US / CVX=US / PSA=US / SPG=US / SNOW=US / SGMS=US / FBK=US / MTCH=US / SRC=US / AUTL=US / BRX=US / PNFP=US / IGMS=US / STRO=US / BIIB=US / EXR=US / BECN=US / SHO=US / PLAY=US / HST=US / WH=US / IAC=US / EPRT=US / HGV=US / RLJ=US / VAC=US / CUBE=US / SPLK=US / RHP=US / ABBV=US / FATE=US / 00770K202 / AFMD=US / BVH=US / NSA=US / EDIT=US / NTLA=US / PK=US / PLYA=US / OKTA=US / ALLO=US / ESTC=US / HARP=US / CRWD=US / GMAB=US / NCNO=US / CELU=US / DHT.UN=CA / REPX=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Bristol-Myers Squibb Co / International Paper Co / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Amphenol Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Public Storage / Simon Property Group Inc / Snowflake Inc. / Scientific Games Corp / FB Financial Corp / Match Group Inc / Spirit Realty Capital Inc / Autolus Therapeutics PLC / Brixmor Property Group Inc / Pinnacle Financial Partners Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Splunk Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Fate Therapeutics Inc / Aemetis Inc / Affimed NV / Bluegreen Vacations Holding Corp / National Storage Affiliates Trust / Editas Medicine Inc / Intellia Therapeutics Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Allogene Therapeutics Inc / Elastic NV / Harpoon Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / nCino Inc / Celularity Inc / Dri Healthcare Trust / Riley Exploration Permian Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: ASH Planner Highlights 200+ Datapoints Not To Be Missed + Late Breakers</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GILD=US / REGN=US / AUTL=US / IGMS=US / STRO=US / ABBV=US / FATE=US / AFMD=US / EDIT=US / NTLA=US / ALLO=US / HARP=US / GMAB=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Autolus Therapeutics PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Abbvie Inc / Fate Therapeutics Inc / Affimed NV / Editas Medicine Inc / Intellia Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Healthcare Insights: Impact of HOLT's Recently Introduced 4-Factor Discount Rate on U.S Healthcare Firms</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BMY.N / UHS.N / RMD.N / DXCM.OQ / TDOC.N / IQV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Universal Health Services Inc / Resmed Inc / Dexcom Inc / Teladoc Health Inc / IQVIA Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steven Bock / Angelo Policicchio / HOLT Americas</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US -  Dividend Quality Analysis, for the period ended August 25,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb sinks 10.7% from 2 week high</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is A Rise Imminent For Merck Stock After An 8% Fall In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2936921 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2190750 / 2216850 / 2270726 / 2317087 / 2670519 / 2328915 / 2415204 / 2684703 / 7103065 / 2857817 / B3D7K31 / B7TL820 / B7VD3F2 / BDZCRX3 / BFLR866 / BVVN4Q8 / BXDZ9Z0 / BMYML02 / BFMXGR0 / BKTNTR9 / BWY52P3 / BYY88Y7 / BD6JX35 / BM8MM05 / BYQCZ35 / BD5GSZ4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / Chesapeake Utilities Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Hawaiian Electric Industries Inc / Pfizer Inc / Novartis AG / Netflix Inc / Discovery Inc / Meta Platforms Inc / Duke Energy Corp / RingCentral Inc / Twitter Inc / Eversource Energy / Shopify Inc / DraftKings Inc / Evergy Inc / ViacomCBS Inc / Blueprint Medicines Corp / Alphabet Inc / Krystal Biotech Inc / Madison Square Garden Entertainment Corp / Madison Square Garden Sports Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - Key Questions for management ahead of R&D day</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NOVN.S / BMY.N / LLY.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / REGN.OQ / GILD.OQ / BAYGN.DE / MOLN.S</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Bayer AG / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4587.T: PeptiDream - R&D briefing: Projects delayed by COVID in 2021, await tangible outcomes in 2022</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4587.T / 4502.T / BMY.N / 4552.T</td><td class="leftalignment">PeptiDream Inc / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / JCR Pharmaceuticals Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4587.T: ペプチドリーム - R&D説明会を開催：2021年はコロナ禍で計画遅れ気味、22年には成果結実に期待</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4587.T / 4502.T / BMY.N / 4552.T</td><td class="leftalignment">PeptiDream Inc / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / JCR Pharmaceuticals Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">This Pharmaceuticals Stock Is A Better Pick Over Bristol Myers Squibb</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Chase a Check (Vol. 2) — Biopharma/MedTech Cash Runway Map</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">11012210 / 71708110 / 37555810 / 00422510 / 771195104 / 03152W10 / 58933Y10 / 02311120 / 45766930 / 80360710 / 05463X10 / 31572Q80 / 00653A107 / 04351P101 / XERS / 98401F10 / 04004760 / 21232630 / 05337M104 / 23283X20 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 98420N10 / 58949210 / 90041T10 / 09627Y10 / Y9530810 / 30052C10 / 09075V10 / 00289Y10 / 09609G10 / 75901B10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / 01438T10 / 74374N10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 98978L20 / 04685N10 / 13089P10 / 34633R10 / 38341P10 / 43906K10 / 46565G10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 98887Q10 / 98943L10 / 45845P10 / 4525EP10 / 78667J10 / 46116X10 / 90400D10 / 69014510 / 35961610 / 55886810 / 05454B10 / 04539610 / 45249V10 / 80405P10 / 75955J40 / 56400P70 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 28617K10 / 03824M10 / 36322Q10 / N4444510 / 45258J10 / 56854Q20 / 74623710 / H9060V101 / 89422G10 / 82939910 / 87410C10 / 36870G10 / 64128810 / 28036F10 / N5749R10 / 24343R10 / 52634L10 / 49705R10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 29251M10 / 81064810 / G637AM10 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Gilead Sciences Inc / ACADIA Pharmaceuticals Inc / Roche Holding AG / Amicus Therapeutics Inc / Merck & Co Inc / Amarin Corporation PLC / Insmed Inc / Sarepta Therapeutics Inc / AxoGen Inc / FibroGen Inc / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Xeris Biopharma Holdings Inc / Xencor Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Xenon Pharmaceuticals Inc / Mereo Biopharma Group PLC / Turning Point Therapeutics Inc / Blueprint Medicines Corp / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Abeona Therapeutics Inc / bluebird bio Inc / Regenxbio Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Zogenix Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Iteos Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Zai Lab Ltd / Zentalis Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Intra-Cellular Therapies Inc / Ultragenyx Pharmaceutical Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Assembly Biosciences Inc / Imara Inc / Satsuma Pharmaceuticals Inc / Relmada Therapeutics Inc / MannKind Corp / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / Eledon Pharmaceuticals Inc / Applied Molecular Transport Inc. / Galecto Inc / Immatics NV / Immunovant Inc / Marinus Pharmaceuticals Inc / PureTech Health PLC / VectivBio Holding AG / Travere Therapeutics Inc / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Gemini Therapeutics Inc / Neuropace Inc / Edgewise Therapeutics Inc / Merus NV / Decibel Therapeutics Inc / LENSAR Inc / Kinnate Biopharma Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Netherlands / Singapore / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Joseph P. Schwartz / Mr. Thomas J. Smith / Geoffrey Porges, MBBS / Greco Song, Ph.D. / Priya Sachdeva / Rudy Li, Ph.D. / Jeffrey La Rosa / Will Soghikian / Mike Kratky, CFA / Anna Baran, CFA / Ms. Danielle J. Antalffy / Andrew Berens, M.D. / Mr. Rick Bienkowski, Ph.D. / Jonathan Chang, Ph.D., CFA / Mr. Marc Goodman / Daina Graybosch, Ph.D. / Christopher Liu, Pharm.D. / Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 86</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward 575</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Bristol-Myers Squibb Company in Global Hematuria Treatment Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Bristol-Myers Squibb Company in Global Blood Brain Barrier Technologies Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-GB -  Dividend Quality Analysis, for the period ended August 27,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BLPU.L / ERM.L / PSON.L / QRT.L / FUTR.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Euromoney Institutional Investor PLC / Pearson PLC / Quarto Group Inc / Future PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - ASH Late Breaking abstracts: Kymriah BELINDA study in 2L aNHL, was failure due to study design?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NOVN.S / BMY.N / GILD.OQ</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-GB Company reports financial results for the half-year ended August 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BLPU.L / ERM.L / PSON.L / QRT.L / FUTR.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Euromoney Institutional Investor PLC / Pearson PLC / Quarto Group Inc / Future PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Seasonal COVID-19 Wave Continues as Holidays Approach, Thankful for Broad Adult Booster Approval, Ramping Up Pediatric Shots</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2000019 / 2023607 / 2293819 / 2778844 / 2050832 / 2026242 / 2270726 / 2317087 / 2670519 / 2415204 / 2623911 / 2684703 / 2967589 / 7103065 / 2170473 / 2857817 / B3D7K31 / 2855930 / BBPK0J0 / BZ07BW4 / BZ1LFB2 / BJ1FD74 / BWTN5N1 / BFD20M9 / BFZ1K46 / BYXJQG9 / BKTNTR9 / BYY88Y7 / BJMLSD2 / BD5GSZ4 / BM8NHS1 / BP2P6L0 / BMFPHK2 / BL6G4S4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / eBay Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Hawaiian Electric Industries Inc / Neurocrine Biosciences Inc / Pfizer Inc / Williams-Sonoma Inc / Novartis AG / Constellation Brands Inc / Netflix Inc / Discovery Inc / Overstock.com Inc / Mirati Therapeutics Inc / Monster Beverage Corp / Deciphera Pharmaceuticals Inc / Revolve Group Inc / ETSY Inc / Farfetch Ltd / Spotify Technology SA / Spire Inc / ViacomCBS Inc / Alphabet Inc / Karuna Therapeutics Inc / Infrastructure and Energy Alternatives Inc / Adagio Therapeutics Inc / Tango Therapeutics Inc / ThredUp Inc / Poshmark Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US -  Dividend Quality Analysis, for the period ended November 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / TMO / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / Thermo Fisher Scientific Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Bristol Myers Squibb - $79.29 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">0989529 / 0925288 / 2126335 / 2000019 / 2008154 / 2640147 / 2778844 / 2437071 / 2219224 / 2216850 / 2542049 / 2317087 / 2345022 / 2459020 / 2630513 / 2684703 / 2707677 / 2746711 / 2829601 / 2980906 / 2503529 / B00FWN1 / B2R3PV1 / B3D7K31 / B7TL820 / B7JYSG3 / B87ZMX0 / BFZCHN7 / BNGY4Q0 / BXDZ9Z0 / BK0VHF6 / BD9GVY0 / BFZ1K46 / BYXJQG9 / BJFSR99 / BKTNTR9 / BYQHPK7 / BYY88Y7 / BMH0MR7 / BDZ30Q0 / BMG75B4 / BN4RD42 / BMGGJK8 / BKPGJQ1 / BM8NHS1 / BNV0RN1</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Adobe Inc / Nike Inc / Merck & Co Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Consolidated Edison Inc / Dominion Energy Inc / Entergy Corp / Macy's Inc / Intuit Inc / New Jersey Resources Corp / Pfizer Inc / Public Service Enterprise Group Inc / Ross Stores Inc / Southern Co / Foot Locker Inc / World Wrestling Entertainment Inc / Alnylam Pharmaceuticals Inc / American Water Works Company Inc / Discovery Inc / Meta Platforms Inc / Guidewire Software Inc / Palo Alto Networks Inc / Wix.Com Ltd / Nextera Energy Partners LP / Shopify Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / Spotify Technology SA / Spire Inc / Revance Therapeutics Inc / ViacomCBS Inc / Zymeworks Inc / Alphabet Inc / Zendesk Inc / Arvinas Inc / Inventiva SA / CureVac NV / Valneva SE / Squarespace Inc / Adagio Therapeutics Inc / Portillos Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Nov 12: Focus on Tagrisso</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Investor Targeting - November 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.6% Above Pre-Pandemic Base- Week 85</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 574</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AHA 2021 Recap: Milvexian Effective as Focus Turns to SSP Trial Bleed Rates; REVERSE-IT Hits; Oral PCSK9 Decent Without Food</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">110122108 / 717224109 / 03116210 / 462222100 / 77313F106</td><td class="leftalignment">Bristol-Myers Squibb Co / PhaseBio Pharmaceuticals Inc / Amgen Inc / Ionis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Sami Corwin, PHD / Sarah Schram / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY: Mavacamten – So there is a delay after all! Just of a different variety</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 12 to 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / US8336351056 / GB0000456144 / US0311621009 / US0341641035 / US0351282068 / US0383361039 / US0394831020 / US0530151036 / US1101221083 / US1564311082 / US1924461023 / US2017231034 / US2310211063 / US3755581036 / US38059T1060 / US4227041062 / US45337C1027 / US4891701009 / US5324571083 / US64125C1099 / US6516391066 / US6703461052 / US67066G1040 / US7170811035 / US75886F1075 / US7782961038 / US7802871084 / US8581191009 / US87612E1064 / US9024941034 / US92532F1003 / US9311421039 / CA13321L1085 / CA59162N1096 / CA5394811015 / CA4296951094 / CA9611485090 / CA85472N1096 / CA90457D1006 / CA4609191032 / CA5649051078 / CA6979001089 / CA78460T1057 / CA8787422044 / CA0679011084 / US9129091081 / CA3039011026 / CA1349211054 / CA8765111064 / US0017441017 / CA3359341052 / CA09950M3003 / CA00762V1094 / US2274831047 / US35671D8570 / AU000000FMG4 / US09062X1037 / BMG169621056 / US20451N1019 / CA98462Y1007 / CA56501R1064 / CA4969024047 / CA5503721063 / CA4436281022 / US1011211018 / CA6445351068 / CA95083R1001 / CA0906971035 / US8666741041 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA0966311064 / CA29258Y1034 / CA4369131079 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / BMG162521014 / US00507V1098 / GB00B2QPKJ12 / CA86828P1036 / US91912E1055 / US1921085049 / IE00B4BNMY34 / US58933Y1055 / CA07317Q1054 / CA00208D4084 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US74340W1036 / US95058W1009 / CA54928Q1081 / CA00829Q1019 / AU000000EVN4 / JE00B5TT1872 / US09609G1004 / US98138H1014 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA3807381049 / CA0805581091 / CA9323971023 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA6674951059 / CA04682R1073 / US16208T1025 / CA89531J1093 / GB00B11DNM70 / US29355A1079 / US8486371045 / US6974351057 / US08579W1036 / CA5054401073 / US23283R1005 / CA33812R1091 / US60468T1051 / CA46579R1047 / CA65340P1062 / US31189P1021 / US03674X1063 / US11120U1051 / CA92938W2022 / CA68827L1013 / CA30606C1086 / CA5503711080 / US29444U7000 / CA74273V1067 / CA82621K1021 / AU000000S320 / CA0115321089 / CA83179X1087 / CA83125J1049 / CA05329M1041 / US72703H1014 / CA8283631015 / CY0106002112 / CA19239C1068 / AU000000NST8 / CA17040T3001 / CA4991131083 / CA6882811046 / CA8910546032 / US5588681057 / CA31730E1016 / CA89621C1059 / US0441861046 / US15136A1025 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA75601Y1007 / CA9628791027 / CY0103562118 / CA7847301032 / CA15713J1049 / CA53680Q2071 / US68404V1008 / LU1701428291 / CA2960061091 / CA8585221051 / CA46136U1030 / US00191U1025 / US3843135084 / US76029N1063 / US08579X1019 / KYG370921069 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA7426943006 / CA33767E2024 / CA57776F4050 / US26614N1028 / CA5625684025 / CA48086P1009 / US2681501092 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / MHY0436Q1098 / CA4220961078 / CA3901437093 / CA36352H1001 / US6544051096 / US03940R1077 / CA70137W1086 / US44862P1093 / US05478C1053 / US7501021056 / CA33843T1084 / CA9004352071 / US3680361090 / CA64782A1075 / US87969B1017 / US03750L1098 / CA36261G1028 / CA65401N1078 / US11135E2037 / CA55292X1087 / AU0000143729 / US00848J1043 / US05356F1057 / CA53227W1059 / CA65532M6062 / CA00791P1071 / CA24874B1085 / GB00BL6K5J42 / CA66979W8429 / US45828L1089 / US0708301041 / US9264001028 / US98955K1043 / US89269P1030 / US9778521024 / US4718711033 / US1374041093 / 116833187</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Sociedad Quimica y Minera de Chile SA / Antofagasta PLC / Amgen Inc / Andersons Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Automatic Data Processing Inc / Bristol-Myers Squibb Co / Century Aluminum Co / Cognizant Technology Solutions Corp / Commercial Metals Co / Cummins Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Incyte Corp / Kennametal Inc / Eli Lilly and Co / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / NVIDIA Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / Target Corp / Tyson Foods Inc / Vertex Pharmaceuticals Inc / Walmart Inc / Cameco Corp / Metro Inc / Loblaw Companies Ltd / High Liner Foods Inc / George Weston Ltd / Stantec Inc / Uni-Select Inc / Intertape Polymer Group Inc / Maple Leaf Foods Inc / Pan American Silver Corp / SNC-Lavalin Group Inc / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Fairfax Financial Holdings Ltd / Canadian Apartment Properties Real Estate Investment Trust / Taseko Mines Ltd / AMN Healthcare Services Inc / First Quantum Minerals Ltd / Boralex Inc / Aecon Group Inc / Cross Country Healthcare Inc / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Bunge Ltd / Compass Minerals International Inc / Yamana Gold Inc / Manulife Financial Corp / Kinross Gold Corp / Lundin Mining Corp / Hudbay Minerals Inc / Boston Properties Inc / New Gold Inc / Wesdome Gold Mines Ltd / Birchcliff Energy Ltd / Sun Communities Inc / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Home Capital Group Inc / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Brookfield Infrastructure Partners LP / Activision Blizzard Inc / Fresnillo PLC / Superior Plus Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Merck & Co Inc / Baytex Energy Corp / ARC Resources Ltd / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / Prologis Inc / Wendys Co / Lucara Diamond Corp / Africa Oil Corp / Evolution Mining Ltd / Centamin PLC / bluebird bio Inc / Workday Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Gold Standard Ventures Corp / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Athabasca Oil Corp / Chatham Lodging Trust / Trevali Mining Corp / Horizonte Minerals PLC / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / CyrusOne Inc / Fission Uranium Corp / Mirati Therapeutics Inc / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Fate Therapeutics Inc / Antero Resources Corp / Brixmor Property Group Inc / WSP Global Inc / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Equinix Inc / Probe Metals Inc / Sienna Senior Living Inc / South32 Ltd / Alamos Gold Inc / SmartCentres Real Estate Investment Trust / Sleep Country Canada Holdings Inc / Automotive Properties Real Estate Investment Trust / Planet Fitness Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Cogeco Communications Inc / Northern Star Resources Ltd / Chorus Aviation Inc / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Filo Mining Corp / Trilogy Metals Inc / Ashland Global Holdings Inc / Centennial Resource Development Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Real Matters Inc / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / CES Energy Solutions Corp / Lithium Americas Corp / OptiNose Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / Invesque Inc / ASGN Inc / GrafTech International Ltd / Replimune Group Inc / Berry Corporation (Bry) / Galaxy Digital Holdings Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / FirstService Corp / Maverix Metals Inc / Dupont De Nemours Inc / Mandalay Resources Corp / Josemaria Resources Inc / Dynatrace Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Atlas Corp / Headwater Exploration Inc / Great Bear Resources Ltd / Galiano Gold Inc / 9 Meters Biopharma Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Azek Company Inc / Rackspace Technology Inc / Flagship Communities Real Estate Investment Trust / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Telos Corp / Apartment Income REIT Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Broadstone Net Lease Inc / MDA Ltd / Sunrise Energy Metals Ltd / Agiliti Inc / Aveanna Healthcare Holdings Inc / LifeWorks Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Endeavour Mining PLC / Nouveau Monde Graphite Inc / Integral Ad Science Holding Corp / Bath & Body Works Inc / Victoria's Secret & Co / Zevia PBC / Traeger Inc / Wolfspeed Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc / NextSource Materials Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Chile / Cayman Islands / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Mavacamten Delay Not Going to Ease Lingering Concerns but Appears Fairy Innocuous</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: Mavacamten's REMS-Related FDA Pushout Opens Door for Panel & Delays Key Overhang; Confidence in oHCM Value & Peak Sales Potential Unchanged</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US8336351056 / US0311621009 / US0383361039 / US1101221083 / US1270971039 / US1924461023 / US25179M1036 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US5324571083 / US64125C1099 / US6745991058 / US7170811035 / US7237871071 / US75281A1097 / US75886F1075 / US7782961038 / AN8068571086 / US81211K1007 / US89531P1057 / US92532F1003 / CA9611485090 / US1667641005 / US5658491064 / US20825C1045 / US09062X1037 / US42809H1077 / US58933Y1055 / US09609G1004 / US98138H1014 / US34964C1062 / US6974351057 / US08579W1036 / US60468T1051 / US03674X1063 / US2057683029 / GB00BDSFG982 / US87484T1088 / US26614N1028 / US69047Q1022 / US05478C1053 / CA33843T1084 / US62955J1034 / US1651677353 / US45828L1089 / US1374041093</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / Coterra Energy Inc / Cognizant Technology Solutions Corp / Devon Energy Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Schlumberger NV / Sealed Air Corp / Trex Company Inc / Vertex Pharmaceuticals Inc / George Weston Ltd / Chevron Corp / Marathon Oil Corp / Conocophillips / Biogen Inc / Hess Corp / Merck & Co Inc / bluebird bio Inc / Workday Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Berry Global Group Inc / Mirati Therapeutics Inc / Antero Resources Corp / Comstock Resources Inc / TechnipFMC PLC / Talos Energy Inc / Dupont De Nemours Inc / Ovintiv Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Nov Inc / Chesapeake Energy Corp / Integral Ad Science Holding Corp / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare Reform: Impact of Build Back Better on global branded pharma</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">4502.T / 4503.T / BMY.N / JNJ.N / LLY.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / AMGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Herr. Christoph Gretler / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Tiago Fauth</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Bullish on BioPharma as We Emerge From COVID-19: Finding Alpha in the Sector That Saved the World</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Initiating at OP: The Worst of the Storm Has Passed, With Sunnier Days Ahead</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">2259101 / 2126335 / 2000019 / 2050832 / 2208073 / 2270726 / 2317087 / 2328915 / 2440637 / 2862532 / 2989301 / 2931034 / 2857817 / B2R3PV1 / B3D7K31 / B87ZMX0 / BFLR866 / BD8DJ71 / BJ2Z0H2 / BLGJ610 / BKTNTR9 / BZ1LFG7 / BMDJ085 / BD5GSZ4 / BMHR7K6</td><td class="leftalignment">Target Corp / Bristol-Myers Squibb Co / Amazon.com Inc / Ameren Corp / Copart Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / CenterPoint Energy Inc / E W Scripps Co / TJX Companies Inc / Vertex Pharmaceuticals Inc / Netflix Inc / American Water Works Company Inc / Discovery Inc / Palo Alto Networks Inc / Twitter Inc / Snap Inc / Pinterest Inc / Warner Music Group Corp / ViacomCBS Inc / Roku Inc / Shoals Technologies Group Inc / Infrastructure and Energy Alternatives Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Bloomsbury Publishing PLC</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Apparel & Textiles / Appliances / Automotive / Broadcasting & Cable / Building & Building Materials / Consumer / Electronics / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Photography / Publishing / Retailing / Services / Tire & Rubber / Internet / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Investor Day Highlights Increasing Confidence in New Product Portfolio to More than Offset LOEs</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Nov. 17, 2021 / 8:45AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Analyst Meeting: Reiterated Story And Their Confidence But Key Data Upcoming</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: Investor Event Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">2434209 / 2936921 / 2126335 / 2000019 / 2778844 / 2270726 / 2317087 / 2455965 / 2684703 / 2829601 / 2822019 / B1HMF22 / 2857817 / B7TL820 / B65SQW4 / B7VD3F2 / BFDV8K0 / B87ZMX0 / BDZCRX3 / B424494 / BFLR866 / BQPVQZ6 / BYVY8G0 / BYZLV46 / BZBY005 / BD8DJ71 / BGCYWN8 / BFZ1K46 / BLGJ610 / BJJMGL2 / BFNR303 / BYQHPK7 / BZ1LFG7 / BYY88Y7 / BKX9VD3 / BDVLM39 / BF3N4P3 / BMPRZV5 / BGDQ8B3 / 021513106 / BMDJ397 / BMZ9Z11 / BNGJQZ8 / BP96C52</td><td class="leftalignment">Home Depot Inc / Walmart Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Merck & Co Inc / Walt Disney Co / Entergy Corp / Biogen Inc / Pfizer Inc / Southern Co / Advance Auto Parts Inc / First Solar Inc / Netflix Inc / Meta Platforms Inc / Enphase Energy Inc / Duke Energy Corp / MacroGenics Inc / Palo Alto Networks Inc / RingCentral Inc / Splunk Inc / Twitter Inc / Horizon Therapeutics PLC / Alphabet Inc / InflaRx NV / Merus NV / Snap Inc / Xencor Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Northwest Natural Holding Co / Zymeworks Inc / Roku Inc / Alphabet Inc / Arcutis Biotherapeutics Inc / argenx SE / Arena Pharmaceuticals Inc / Kymera Therapeutics Inc / Axonics Inc / Alto Ingredients Inc / Bolt Biotherapeutics Inc / Prometheus Biosciences Inc / Porch Group Inc / Surrozen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Healthcare: AstraZeneca- Most attractive valuation in HOLT in 5-years</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / PFE.N / SASY.PA / NOVOB.CO / MRCG.DE / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Novo Nordisk A/S / Merck KGaA / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe / Emilie Fung</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Analyst Meeting Highlights Mid- to Late-Stage Pipeline Outlook Well Ahead of Consensus</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY: 3-hour analyst day summarized in 4 pages</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT - BUY - Competitor Setbacks Set Stage For BOLT Update at ESMO-IO (12/8-11)</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMDJ397 / 2126335 / 2778844</td><td class="leftalignment">Bolt Biotherapeutics Inc / Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Nov. 16, 2021 / 9:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2360326 / 2126335 / 2516152 / 2778844 / 2050832 / 2270726 / 2542049 / 2317087 / 2328915 / 2345022 / 2100920 / 2630513 / 2657802 / 2689560 / 2684703 / 2707677 / 2825933 / 7103065 / B00FWN1 / 2822019 / 2857817 / B3D7K31 / 2390817 / B65LWX6 / B7TL820 / B7VD3F2 / BCZS820 / BVVN4Q8 / BTF8CF0 / BYZLV46 / BK0VHF6 / BD8DJ71 / BL2HYY7 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BJ9NFQ3 / BYY88Y7 / BDRW1L7 / BNGJQZ8 / BMHR7K6 / BNNTQY0 / BL98755 / BL53KF5 / BP0TJN7 / BPH0546 / BMV6Y64</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Gap Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Macy's Inc / FirstEnergy Corp / New Jersey Resources Corp / OGE Energy Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / South Jersey Industries Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Advance Auto Parts Inc / Netflix Inc / Discovery Inc / Gray Television Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / Fate Therapeutics Inc / Eversource Energy / Restaurant Brands International Inc / InflaRx NV / IDEAYA Biosciences Inc / Snap Inc / Casper Sleep Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / Spire Inc / ViacomCBS Inc / Neoleukin Therapeutics Inc / Alphabet Inc / AnaptysBio Inc / Porch Group Inc / Impel Neuropharma Inc / Oatly Group AB / Beachbody Company Inc / F45 Training Holdings Inc / Xponential Fitness Inc / Life Time Group Holdings Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Luxembourg / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Initial Data for Milvexian in Total Knee Replacement Setting Encouraging Ahead of Secondary Stroke Prevention Data in 2022</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Next-Gen Interleukin Primer - Cranking Up the Thermostat as Winter Weather Approaches</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2457864 / 2471950 / 2730190 / 7103065 / 2982924 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BMC5RV6 / BF3NP05 / BMDJ397 / BN2RM92 / BLF0CW7 / BP7KZP7 / BMW5084 / BNLYJ60 / BNLYBF3 / BMVBZF5 / BP2P6L0 / BMV6Y64</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Spectrum Pharmaceuticals Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / PMV Pharmaceuticals Inc / Imago BioSciences Inc / Erasca Inc / Immuneering Corp / Tango Therapeutics Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Encouraging Milvexian (Factor XIa) Phase 2 Profile In VTE Prevention</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: Investor Event Preview - What We Hope to Hear More About</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 5, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Drug Pricing Reform Proposal: Is This The Long-Awaited Clearing Event?</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.9% Above Pre-Pandemic Base- Week 84</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 573</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bloomsbury Publishing jumps 23% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for BMY. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / BMY=US / HD=US / AMZN=US / T=US / AMT=US / PEB=US / H=US / LOW=US / ENR=US / VRM=US / EXPE=US / LEG=US / W=US / FLO=US / ARRY=US / BLL=US / CCK=US / DRH=US / EPC=US / SAFE=US / MAPS=US / MHK=US / HOOK=US / SFT=US / SNAP=US / TRIP=US / WIX=US / PSA=US / CGEN=US / BKNG=US / FB=US / KRT=US / MTCH=US / WRE=US / AUTL=US / OGN / PTON=US / STRO=US / BIIB=US / TPX=US / APP=US / SHO=US / HST=US / PGTI=US / PRPL=US / WH=US / UTZ=US / INSE / CLDT=US / NXPI=US / RLJ=US / FBHS=US / ANGI=US / RHP=US / GOOGL=US / 00770K202 / BABA=US / CMPR=US / RLMD=US / GDDY=US / SQ=US / PK=US / GDS=US / CVNA=US / IOVA=US / SFIX=US / ROOT=US / FTDR=US / SITC=US / LYFT=US / UBER=US / TCRR=US / XAIR=US / GMAB=US / NGMS=US / HYFM=US / PRVA=US / VMEO=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Home Depot Inc / Amazon.com Inc / AT&T Inc / American Tower Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Lowe's Companies Inc / Energizer Holdings Inc / Vroom Inc / Expedia Group Inc / Leggett & Platt Inc / Wayfair Inc / Flowers Foods Inc / Array Technologies Inc / Ball Corp / Crown Holdings Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Safehold Inc / WM Technology Inc / Mohawk Industries Inc / HOOKIPA Pharma Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Public Storage / Compugen Ltd / Booking Holdings Inc / Meta Platforms Inc / Karat Packaging Inc / Match Group Inc / Washington Real Estate Investment Trust / Autolus Therapeutics PLC / Organon & Co / Peloton Interactive Inc / Sutro Biopharma Inc / Biogen Inc / Tempur Sealy International Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / PGT Innovations Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / UTZ Brands Inc / Inspired Entertainment Inc / Chatham Lodging Trust / NXP Semiconductors NV / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Ryman Hospitality Properties Inc / Alphabet Inc / Aemetis Inc / Alibaba Group Holding Ltd / Cimpress PLC / Relmada Therapeutics Inc / GoDaddy Inc / Block Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / Carvana Co / Iovance Biotherapeutics Inc / Stitch Fix Inc / Root Inc / Frontdoor Inc / Site Centers Corp / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Beyond Air Inc / Genmab A/S / NeoGames SA / Hydrofarm Holdings Group Inc / Privia Health Group Inc / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2126335 / 2026242 / 2437071 / 2280220 / 2270726 / 2542049 / 2317087 / 2670519 / 2100920 / 2415204 / 2630513 / 2657802 / 2680905 / 2048804 / 2857817 / B125XQ6 / B3D7K31 / B7VD3F2 / BDZCRX3 / BFLR866 / BFZCHN7 / BVVN4Q8 / BYY8XK8 / BF09HX3 / BD9GVY0 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BZ05388 / BYY88Y7 / BJMLSD2 / BK71LV3 / BYQCZ35 / BNKGXX2 / BP0TJN7 / BMFKLL6</td><td class="leftalignment">Bristol-Myers Squibb Co / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelon Corp / FirstEnergy Corp / Hawaiian Electric Industries Inc / New Jersey Resources Corp / OGE Energy Corp / PPL Corp / Pinnacle West Capital Corp / Netflix Inc / Portland General Electric Co / Discovery Inc / Duke Energy Corp / RingCentral Inc / Twitter Inc / Wix.Com Ltd / Eversource Energy / WEC Energy Group Inc / Tapestry Inc / Zai Lab Ltd / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / Alphabet Inc / Karuna Therapeutics Inc / Relmada Therapeutics Inc / Madison Square Garden Sports Corp / Verve Therapeutics Inc / Xponential Fitness Inc / Aeye Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AHA Preview: Flip the REVERSE-IT Card for Bentracimab; First Look at Oral Factor XIa and PCSK9 Inhibitors; RP-A501 Danon Data</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">110122108 / 717224109 / 03116210 / 462222100 / 77313F106</td><td class="leftalignment">Bristol-Myers Squibb Co / PhaseBio Pharmaceuticals Inc / Amgen Inc / Ionis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Raju Prasad, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sarah Schram / Sami Corwin, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ONTX - BUY - 3Q Wrap-Up: Updates in Line with Our Expectations; Pipeline Progressing Well and Set for Multiple Data Readouts in 2022</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.N / 2126335</td><td class="leftalignment">Bristol-Myers Squibb Co / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">China / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Bristol's Expanded Collaboration Is Nice Validation To COM701</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CGEN=US / BMY=US</td><td class="leftalignment">Compugen Ltd / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Earnings Recap: Updating Our Model, All Eyes On STRO-002 Update</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">STRO=US / MRK=US / BMY=US</td><td class="leftalignment">Sutro Biopharma Inc / Merck & Co Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / LSI=US / AMGN=US / BMY=US / DIS=US / MCD=US / WEN=US / PLD=US / BLDP=US / AMZN=US / GILD=US / PEB=US / REI=US / PLUG=US / H=US / V=US / MTN=US / ENR=US / VRM=US / MAR=US / TNL=US / HLT=US / AKR=US / HUM=US / EQR=US / AMK=US / SWIM=US / CBRL=US / CHH=US / DRI=US / DRH=US / MAIN=US / NTST=US / PDM=US / SGMO=US / SHOP=US / FORG=US / VRTX=US / WIX=US / FOUR=US / AEL=US / GPN=US / HIW=US / SNV=US / ADC=US / FRT=US / INTA=US / OHI=US / SRC=US / REG=US / ENSG=US / BRX=US / DIN=US / ACVA=US / MQ / CRD.B=US / APP=US / SHO=US / PLAY=US / DENN=US / ESMT=US / SCPL=US / CMG=US / HST=US / MA=US / RPRX=US / GPRE=US / OC=US / CPRX=US / TAST=US / QSR=US / LUMN=US / WH=US / JACK=US / UTZ=US / BLND=US / HGV=US / SBRA=US / APTS=US / RLJ=US / VAC=US / ZNGA=US / SPLK=US / MEIP=US / RHP=US / NDLS=US / VRNS=US / 00770K202 / LOCO=US / AFMD=US / BVH=US / SHAK=US / CHCT=US / WING=US / MCFT=US / SQ=US / WVE=US / PK=US / PLYA=US / OKTA=US / ROOT=US / BTAI=US / AMTB=US / LSPD=US / ARQT=US / TSHA / DASH=US / AFRM=US / SHLS=US / HLLY=US / OLPX=US / GTLB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Life Storage Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / McDonald's Corp / Wendys Co / Prologis Inc / Ballard Power Systems Inc / Amazon.com Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Ring Energy Inc / Plug Power Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Energizer Holdings Inc / Vroom Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Humana Inc / Equity Residential / AssetMark Financial Holdings Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Main Street Capital Corp / Netstreit Corp / Piedmont Office Realty Trust Inc / Sangamo Therapeutics Inc / Shopify Inc / ForgeRock Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Shift4 Payments Inc / American Equity Investment Life Holding Co / Global Payments Inc / Highwoods Properties Inc / Synovus Financial Corp / Agree Realty Corp / Federal Realty Investment Trust / Intapp Inc / Omega Healthcare Investors Inc / Spirit Realty Capital Inc / Regency Centers Corp / Ensign Group Inc / Brixmor Property Group Inc / Dine Brands Global Inc / ACV Auctions Inc / Marqeta Inc / Crawford & Co / Applovin Corp / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / EngageSmart Inc / Sciplay Corp / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / Mastercard Inc / Royalty Pharma PLC / Green Plains Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / UTZ Brands Inc / Blend Labs Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Preferred Apartment Communities Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Splunk Inc / MEI Pharma Inc / Ryman Hospitality Properties Inc / Noodles & Co / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Affimed NV / Bluegreen Vacations Holding Corp / Shake Shack Inc / Community Healthcare Trust Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Block Inc / WAVE Life Sciences Ltd / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Root Inc / BioXcel Therapeutics Inc / Amerant Bancorp Inc / Lightspeed Commerce Inc / Arcutis Biotherapeutics Inc / Taysha Gene Therapies Inc / DoorDash Inc / Affirm Holdings Inc / Shoals Technologies Group Inc / Holley Inc / Olaplex Holdings Inc / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IKNA: Credit Suisse Healthcare Conference: Fireside Chat Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">IKNA.OQ / BMY.N / NOVN.S</td><td class="leftalignment">Ikena Oncology Inc / Bristol-Myers Squibb Co / Novartis AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GLUE - BUY - MRT-2359 Selected as Development Candidate for the GSPT1 MGD Program; IND Filing in Mid-2022</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BP7KZP7 / 0989529 / 2126335 / 7103065 / BDZ30Q0 / BMPRZV5</td><td class="leftalignment">Monte Rosa Therapeutics Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Novartis AG / Arvinas Inc / Kymera Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Common threads from investor feedback on Treg competitive landscape</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / LLY=US / MRK=US / BMY=US / GILD=US / SGMO=US</td><td class="leftalignment">Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Sangamo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / BMY=US / OXY=US / AMD=US / RRC=US / IP=US / MDT=US / DVN=US / INCY=US / GILD=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / PLUG=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / IGT=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / ESS=US / CLI=US / DV=US / AVGO=US / BLL=US / BNL=US / ENV=US / ELY=US / CTRA=US / CNX=US / CCK=US / EQT=US / GPOR=US / DOC=US / HOOK=US / REGI=US / TRIP=US / TGI=US / CVX=US / CGEN=US / SGMS=US / BDN=US / OFC=US / CUZ=US / PRI=US / DCP=US / EGP=US / FR=US / JAZZ=US / KIM=US / NHI=US / PRA=US / DRE=US / NLS=US / COP=US / MRNS=US / PTON=US / MMP=US / BIIB=US / RNG=US / APTX=US / NUVA=US / EXR=US / WRK=US / CLR=US / PRPL=US / SEAS=US / TIL=US / NOG=US / RCUS=US / HTA=US / OLO=US / AR=US / OAS=US / HGV=US / ESTE=US / CUBE=US / MTDR=US / PDCE=US / FANG=US / MODN=US / CNCE=US / VNOM=US / CIVI=US / OSH=US / VCEL=US / GSBD=US / NSA=US / EVBG=US / CDEV=US / VRNA=US / SBOW=US / IOVA=US / CARG=US / SAIL=US / COLD=US / FSK=US / RPAY=US / GMAB=US / GOCO=US / PNTG=US / OVV=US / CRMD.US / AZYO=US / ABNB=US / DASH=US / SHLS=US / ROCC=US / DHT.UN=CA / REPX=US / MNTV=US / DNUT=US / PYCR=US / PKG=U / 00152K101</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Bristol-Myers Squibb Co / Occidental Petroleum Corp / Advanced Micro Devices Inc / Range Resources Corp / International Paper Co / Medtronic PLC / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Essex Property Trust Inc / Veris Residential Inc / DoubleVerify Holdings Inc / Broadcom Inc / Ball Corp / Bunzl plc / Envestnet Inc / Callaway Golf Co / Coterra Energy Inc / CNX Resources Corp / Crown Holdings Inc / EQT Corp / Gulfport Energy Corp / Physicians Realty Trust / HOOKIPA Pharma Inc / Renewable Energy Group Inc / Tripadvisor Inc / Triumph Group Inc / Chevron Corp / Compugen Ltd / Scientific Games Corp / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / Primerica Inc / DCP Midstream LP / Eastgroup Properties Inc / First Industrial Realty Trust Inc / Jazz Pharmaceuticals PLC / Kimco Realty Corp / National Health Investors Inc / ProAssurance Corp / Duke Realty Corp / Nautilus Inc / Conocophillips / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Magellan Midstream Partners LP / Biogen Inc / RingCentral Inc / Aptinyx Inc / NuVasive Inc / Extra Space Storage Inc / Westrock Co / Continental Resources Inc / Purple Innovation Inc / SeaWorld Entertainment Inc / Instil Bio Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Healthcare Trust Of America Inc / Olo Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Earthstone Energy Inc / CubeSmart / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Model N Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Civitas Resources Inc / Oak Street Health Inc / Vericel Corp / Goldman Sachs BDC Inc / National Storage Affiliates Trust / Everbridge Inc / Centennial Resource Development Inc / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / CarGurus Inc / SailPoint Technologies Holdings Inc / Americold Realty Trust / FS KKR Capital Corp / Repay Holdings Corp / Genmab A/S / Gohealth Inc / Pennant Group Inc / Ovintiv Inc / CorMedix Inc / Aziyo Biologics Inc / Airbnb Inc / DoorDash Inc / Shoals Technologies Group Inc / Ranger Oil Corp / Dri Healthcare Trust / Riley Exploration Permian Inc / Momentive Global Inc / Krispy Kreme Inc / Paycor HCM Inc / Packaging Corp of America / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">31</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SUPN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">SUPN.O / ABT / BMY / JNJ / LLY / UTHR.O / ZGNX.O</td><td class="leftalignment">Supernus Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / United Therapeutics Corp / Zogenix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN / BMY / GILD / JNJ / LLY / MRK / PFE / ACRS / UTHR / ACRX / BIIB / ABBV / AERI / ALDX</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aclaris Therapeutics Inc / United Therapeutics Corp / AcelRx Pharmaceuticals Inc / Biogen Inc / Abbvie Inc / Aerie Pharmaceuticals Inc / Aldeyra Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Bristol-Myers Squibb (BMY US) - Pipeline not priced in: Buy</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">SITC Abs: COM701 Triplet Combo Is Safe. Await Efficacy Data In The Poster</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CGEN=US / MRK=US / BMY=US / RCUS=US</td><td class="leftalignment">Compugen Ltd / Merck & Co Inc / Bristol-Myers Squibb Co / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Inflections Suggest Early Stages of Seasonal COVID-19 Wave; Growing Armamentarium to Blunt Future Spikes in Severe Disease</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">DNB / BMY=US / HD=US / MCD=US / WEN=US / BLDP=US / BLD=US / NVDA=US / PLUG=US / V=US / LOW=US / THC=US / MAR=US / TTWO=US / LEG=US / VMC=US / HLT=US / BKI=US / MLM=US / ARCC=US / SWIM=US / ATRO=US / CBRL=US / ENV=US / DRI=US / GFF=US / IBP=US / MAIN=US / HZO=US / MAS=US / MCHP=US / MHK=US / ORCC=US / REGI=US / TRIP=US / FNF=US / PYPL=US / CNM=US / PRI=US / FB=US / NHI=US / AUTL=US / DIN=US / INST=US / PRAA=US / IGMS=US / PRG=US / TPX=US / EXP=US / AINV=US / BECN=US / TXRH=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / SIBN=US / CMG=US / REX=US / FIS=US / MA=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / TAST=US / QSR=US / PNNT=US / PRPL=US / APEI=US / JACK=US / RCUS=US / 45665G303 / VRSK=US / TREX=US / APTS=US / VAC=US / FBHS=US / ZNGA=US / EA=US / TILE=US / NDLS=US / PTCT=US / TSLX=US / FIVN=US / HRTG=US / 00770K202 / MTNB=US / 70806A106 / LOCO=US / AFMD=US / OSH=US / NVRO=US / NEWR=US / SHAK=US / GSBD=US / WING=US / AXSM=US / WLTW=US / EDIT=US / 82982L103 / TTD=US / JELD=US / ALLO=US / FSK=US / NXTC=US / FERG=US / GMAB=US / PNTG=US / SPCE=US / AZEK=US / 96758W101 / VTRS=US / RBLX=US / PRVA=US / VMEO=US / SQSP=US / SNPO=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / Ballard Power Systems Inc / TopBuild Corp / NVIDIA Corp / Plug Power Inc / Visa Inc / Lowe's Companies Inc / Tenet Healthcare Corp / Marriott International Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Black Knight Inc / Martin Marietta Materials Inc / Ares Capital Corp / Latham Group Inc / Astronics Corp / Cracker Barrel Old Country Store Inc / Envestnet Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Main Street Capital Corp / MarineMax Inc / Masco Corp / Microchip Technology Inc / Mohawk Industries Inc / Owl Rock Capital Corp / Renewable Energy Group Inc / Tripadvisor Inc / Fidelity National Financial Inc / PayPal Holdings Inc / Core & Main Inc / Primerica Inc / Meta Platforms Inc / National Health Investors Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Instructure Holdings Inc / PRA Group Inc / IGM Biosciences Inc / PROG Holdings Inc / Tempur Sealy International Inc / Eagle Materials Inc / Apollo Investment Corp / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Mastercard Inc / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Pennantpark Investment Corp / Purple Innovation Inc / American Public Education Inc / Jack in the Box Inc / Arcus Biosciences Inc / Infinity Pharmaceuticals Inc / Verisk Analytics Inc / Trex Company Inc / Preferred Apartment Communities Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Sixth Street Specialty Lending Inc / Five9 Inc / Heritage Insurance Holdings Inc / Aemetis Inc / Matinas BioPharma Holdings Inc / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Affimed NV / Oak Street Health Inc / Nevro Corp / New Relic Inc / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Axsome Therapeutics Inc / Willis Towers Watson PLC / Editas Medicine Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / JELD-WEN Holding Inc / Allogene Therapeutics Inc / FS KKR Capital Corp / NextCure Inc / Ferguson PLC / Genmab A/S / Pennant Group Inc / Virgin Galactic Holdings Inc / Azek Company Inc / WideOpenWest Inc / Viatris Inc / Roblox Corp / Privia Health Group Inc / Vimeo Inc / Squarespace Inc / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2732635 / 2229126 / 2270726 / 2345022 / 2121352 / 2459202 / 2613990 / 2515030 / 2630085 / 2684703 / 2862532 / 2943523 / 2931034 / 7103065 / B0X7DZ3 / 2713317 / 2857817 / 2951452 / 2598246 / B44C366 / B7TL820 / B8L2798 / BBPK0J0 / BDZCRX3 / B95WG16 / BS7K7C9 / BYVFC94 / BYQHP96 / BF5L3T2 / BJLT387 / BJLKVS6 / BZB1XF2 / BYZR4X4 / BJ5FZ74 / BGCYWN8 / BZ8FPH3 / BKVDFF7 / BFXC911 / BHZSB82 / BDH65C8 / BP3YM85 / BL95N25 / BYY88Y7 / BKC9SX3 / BD6JX35 / BKS3RS7 / BYTJZL1 / BDD1B07 / BFY7DC4 / BKPGJQ1 / BFYVZ75 / BF0QTY9 / BMW15J8 / BYYGK12</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / AutoNation Inc / Columbia Sportswear Co / Walt Disney Co / Macy's Inc / Group 1 Automotive Inc / IDEXX Laboratories Inc / Illumina Inc / Lithia Motors Inc / Neogen Corp / Pfizer Inc / E W Scripps Co / Penske Automotive Group Inc / Vertex Pharmaceuticals Inc / Novartis AG / Chipotle Mexican Grill Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / J M Smucker Co / Neogenomics Inc / Heska Corp / Meta Platforms Inc / Hemisphere Media Group Inc / Mirati Therapeutics Inc / RingCentral Inc / Zoetis Inc / Nevro Corp / US Foods Holding Corp / Floor & Decor Holdings Inc / Elanco Animal Health Inc / Avantor Inc / Phathom Pharmaceuticals Inc / Tactile Systems Technology Inc / Axsome Therapeutics Inc / Adaptive Biotechnologies Corp / Xencor Inc / Editas Medicine Inc / Oric Pharmaceuticals Inc / Guardant Health Inc / Covetrus Inc / PetIQ Inc / Trupanion Inc / Phibro Animal Health Corp / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / 10X Genomics Inc / Zogenix Inc / Rubius Therapeutics Inc / Altimmune Inc / Squarespace Inc / Seelos Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Renalytix PLC / TPI Composites Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Solid Progress In 3Q21. And Addressing Investor Inbounds On EDIT-301</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">EDIT=US / BMY=US / ALLO=US</td><td class="leftalignment">Editas Medicine Inc / Bristol-Myers Squibb Co / Allogene Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">XNCR - BUY - Early Signs of Efficacy for XmAb306 as Pipeline Heads into Near-Term Data; Vibecotamab Discontinuation Unsurprising, in Our View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BGCYWN8 / 2126335 / 2023607 / 7103065</td><td class="leftalignment">Xencor Inc / Bristol-Myers Squibb Co / Amgen Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">CheckMate-816 EFS Hits Opening an Additional Early-Stage Opportunity; Milvexian Data at AHA Next Key Catalyst</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 83</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/06/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Bristol Myers Squibb Company: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/06/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">BMY: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 572</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">11012210 / 71708110 / 00846U10 / 88162420 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ASH Abstracts: CAR-T Moves Up the Treatment Line in DLBCL; Next-Gen Autologous and Allogeneic CD19 Programs Look to Compete</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">110122108 / 05280R100 / 15117K103 / 019770106 / 74019P108</td><td class="leftalignment">Bristol-Myers Squibb Co / Autolus Therapeutics PLC / Cellectis SA / Allogene Therapeutics Inc / Precision BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Raju Prasad, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sami Corwin, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Healthcare - 30th Annual Credit Suisse Healthcare Conference in HOLT</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">ABT.N / TMO.N / BMY.N / BSX.N / CVS.N / SYK.N / RMD.N / HCA.N / REGN.OQ / OMCL.OQ / VRTX.OQ / NUVA.OQ / ICLR.OQ / ADUS.OQ / HZNP.OQ / GMED.N / ANTM.N / MEDP.OQ</td><td class="leftalignment">Abbott Laboratories / Thermo Fisher Scientific Inc / Bristol-Myers Squibb Co / Boston Scientific Corp / CVS Health Corp / Stryker Corp / Resmed Inc / HCA Healthcare Inc / Regeneron Pharmaceuticals Inc / Omnicell Inc / Vertex Pharmaceuticals Inc / NuVasive Inc / ICON PLC / Addus Homecare Corp / Horizon Therapeutics PLC / Globus Medical Inc / Anthem Inc / Medpace Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steven Bock / HOLT Americas</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ASH Abstracts Highlight the Growing Number of Gene Therapy, Small Molecule, and Antibody Approaches for SCD</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09609G100 / 37890U108 / 110122108 / 15117K103 / 462222100 / H17182108 / 07373V105</td><td class="leftalignment">bluebird bio Inc / Global Blood Therapeutics Inc / Bristol-Myers Squibb Co / Cellectis SA / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Beam Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Raju Prasad, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Sarah Schram</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BGNE - NEUTRAL - Product Sales Beat Driven by Brukinsa While Tislelizumab Growth in China Slowed Down, May Raise Concerns</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BYYWPW6 / 0989529 / 2126335 / 2023607</td><td class="leftalignment">Beigene Ltd / AstraZeneca PLC / Bristol-Myers Squibb Co / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Bristol-Myers Squibb</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Merck Stock After An Upbeat Q3?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Stocks/Sectors that Benefit from Inflation</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">A.N / AAP.N / AEE.N / AES.N / AIG.N / ALB.N / ALK.N / ALL.N / APD.N / AXP.N / BA.N / BAX.N / BBY.N / BEN.AX / BMY.N / BSX.N / C.N / CCI.N / CCL.N / CI.N / CL.N / ECL.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / FMC.N / HLT.N / IP.N / IR.N / KMB.N / LLY.N / LMT.N / MDT.N / NEM.N / NOC.N / NSC.N / OXY.N / PHM.N / PM.N / PNC.N / PNW.N / RHI.N / RL.N / SEE.N / SLB.N / SO.N / SWK.N / TAP.N / TMO.N / TRV.N / TXT.N / WFC.N / PG.N / WY.N / NUE.N / ROK.N / CPB.N / ETR.N / AAL.L / ADML.L / ETN.N / DHR.N / DIS.N / UNH.N / TFX.N / CMI.N / D.N / URI.N / AIZ.N / DE.N / IEX.N / PH.N / PGR.N / IPG.N / UNP.N / CLX.N / CAG.N / VNO.N / LOW.N / GLW.N / LH.N / UPS.N / KR.N / MMM.N / GIS.N / NI.N / XOM.N / AMT.N / WHR.N / RMD.N / DTEGN.F / IT.N / TGT.N / AVY.N / PKG.N / BLL.N / GWW.N / PKI.N / MLM.N / WST.N / REG.N / COO.N / STZ.N / VFC.N / LNC.N / APH.N / AZO.N / EFX.N / PSA.N / EW.N / OKE.N / BXP.N / ACN.N / ARE.N / RSG.N / SNA.N / CHD.N / TWTR.N / ESS.N / FRT.N / HRL.N / PVH.N / BLK.N / AJG.N / ABC.N / CVX.N / MCO.N / JNPR.N / IRM.N / COP.N / CNP.N / INTC.OQ / CTSH.OQ / AOS.N / ABMD.OQ / AMAT.OQ / ADSK.OQ / CERN.OQ / CINF.OQ / CTAS.OQ / CSCO.OQ / FAST.OQ / JKHY.OQ / JBHT.OQ / LRCX.OQ / ATVI.OQ / NTRS.OQ / PCAR.OQ / PAYX.OQ / PBCT.OQ / TROW.OQ / ROST.OQ / SJM.N / TECH.OQ / ZION.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / ODFL.OQ / INTU.OQ / COST.OQ / CPRT.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / NTAP.OQ / TPR.N / ANSS.OQ / GL.N / AMZN.OQ / TTWO.OQ / VRSN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / ILMN.OQ / EQIX.OQ / GPN.N / MNST.OQ / TXN.OQ / CMCSA.OQ / TFC.N / DPZ.N / MOS.N / MKTX.OQ / MPWR.OQ / VIAC.OQ / NDAQ.OQ / ICE.N / LYV.N / MS.N / CMG.N / FIS.N / ADP.PA / HBI.N / WU.N / AON.N / ULTA.OQ / WRB.N / CME.OQ / NWSA.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / LYB.N / MSI.N / NLSN.N / MPC.N / FBHS.N / XYL.N / ENPH.OQ / FANG.OQ / LEGN.DE / CDW.OQ / FOXA.O / LDOS.N / ALLE.N / PTC.OQ / SYF.N / CTLT.N / KEYS.N / ANTM.N / QRVO.OQ / ETSY.OQ / ZBH.N / WRK.N / CSX.OQ / SPGI.K / FTV.N / LW.N / XEL.OQ / BKNG.OQ / CBRE.N / CDAY.N / EVRG.N / TER.OQ / NWL.OQ / LNT.OQ / LHX.N / EXC.OQ / NLOK.OQ / RTX.N / OTIS.N / APA.OQ / VTRS.OQ</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Ameren Corp / AES Corp / American International Group Inc / Albemarle Corp / Alaska Air Group Inc / Allstate Corp / Air Products and Chemicals Inc / American Express Co / Boeing Co / Baxter International Inc / Best Buy Co Inc / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Crown Castle International Corp / Carnival Corp / Cigna Corp / Colgate-Palmolive Co / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / FMC Corp / Hilton Worldwide Holdings Inc / International Paper Co / Ingersoll Rand Inc / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Medtronic PLC / Newmont Corporation / Northrop Grumman Corp / Norfolk Southern Corp / Occidental Petroleum Corp / Pultegroup Inc / Philip Morris International Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Robert Half International Inc / Ralph Lauren Corp / Sealed Air Corp / Schlumberger NV / Southern Co / Stanley Black & Decker Inc / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Textron Inc / Wells Fargo & Co / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Campbell Soup Co / Entergy Corp / Anglo American PLC / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Cummins Inc / Dominion Energy Inc / United Rentals Inc / Assurant Inc / Deere & Co / IDEX Corp / Parker-Hannifin Corp / Progressive Corp / Interpublic Group of Companies Inc / Union Pacific Corp / Clorox Co / Conagra Brands Inc / Vornado Realty Trust / Lowe's Companies Inc / Corning Inc / Laboratory Corporation of America Holdings / United Parcel Service Inc / Kroger Co / 3M Co / General Mills Inc / NiSource Inc / Exxon Mobil Corp / American Tower Corp / Whirlpool Corp / Resmed Inc / Deutsche Telekom AG / Gartner Inc / Target Corp / Avery Dennison Corp / Packaging Corp of America / Ball Corp / W W Grainger Inc / PerkinElmer Inc / Martin Marietta Materials Inc / West Pharmaceutical Services Inc / Regency Centers Corp / Cooper Companies Inc / Constellation Brands Inc / VF Corp / Lincoln National Corp / Amphenol Corp / Autozone Inc / Equifax Inc / Public Storage / Edwards Lifesciences Corp / ONEOK Inc / Boston Properties Inc / Accenture PLC / Alexandria Real Estate Equities Inc / Republic Services Inc / Snap-On Inc / Church & Dwight Co Inc / Twitter Inc / Essex Property Trust Inc / Federal Realty Investment Trust / Hormel Foods Corp / PVH Corp / BlackRock Inc / Arthur J Gallagher & Co / Amerisourcebergen Corp / Chevron Corp / Moody's Corp / Juniper Networks Inc / Iron Mountain Inc / Conocophillips / CenterPoint Energy Inc / Intel Corp / Cognizant Technology Solutions Corp / A O Smith Corp / ABIOMED Inc / Applied Materials Inc / Autodesk Inc / Cerner Corp / Cincinnati Financial Corp / Cintas Corp / Cisco Systems Inc / Fastenal Co / Jack Henry & Associates Inc / J B Hunt Transport Services Inc / Lam Research Corp / Activision Blizzard Inc / Northern Trust Corp / Paccar Inc / Paychex Inc / People's United Financial Inc / T Rowe Price Group Inc / Ross Stores Inc / J M Smucker Co / Bio-Techne Corp / Zions Bancorporation NA / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Old Dominion Freight Line Inc / Intuit Inc / Costco Wholesale Corp / Copart Inc / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / NetApp Inc / Tapestry Inc / ANSYS Inc / Globe Life Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Verisign Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Illumina Inc / Equinix Inc / Global Payments Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Truist Financial Corp / Domino's Pizza Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / ViacomCBS Inc / Nasdaq Inc / Intercontinental Exchange Inc / Live Nation Entertainment Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / HanesBrands Inc / Western Union Co / Aon PLC / Ulta Beauty Inc / W R Berkley Corp / CME Group Inc / News Corp / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / LyondellBasell Industries NV / Motorola Solutions Inc / Nielsen Holdings PLC / Marathon Petroleum Corp / Fortune Brands Home & Security Inc / Xylem Inc / Enphase Energy Inc / Diamondback Energy Inc / LEG Immobilien SE / CDW Corp / Fox Corp / Leidos Holdings Inc / Allegion PLC / PTC Inc / Synchrony Financial / Catalent Inc / Keysight Technologies Inc / Anthem Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / Westrock Co / CSX Corp / S&P Global Inc / Fortive Corp / Lamb Weston Holdings Inc / Xcel Energy Inc / Booking Holdings Inc / CBRE Group Inc / Ceridian HCM Holding Inc / Evergy Inc / Teradyne Inc / Newell Brands Inc / Alliant Energy Corp / L3harris Technologies Inc / Exelon Corp / NortonLifeLock Inc / Raytheon Technologies Corp / Otis Worldwide Corp / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / France / United Kingdom / Ireland / Netherlands / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / GILD.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended November 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">OPK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OPK.O / ABT / BMY / JNJ / LH / REGN.O / ALNY.O / ARDX.O / TEVA.K</td><td class="leftalignment">OPKO Health Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ardelyx Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third-Quarter Earnings; Milestone Revenue Back Weighted to Year-end; Search for Pipeline Wins Reflected in Upped R&D Spend</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">462222100 / 110122108 / 69366J200</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Bristol-Myers Squibb Co / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Sarah Schram</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0311621009 / US1101221083 / US2666051048 / US4448591028 / US45337C1027 / US92532F1003 / US7665596034 / US40637H1095 / US14862Q1004 / CA1380351009 / US88870R1023 / US88688T1007 / CA39342L1085 / CA58507M1077 / CA22587M1068 / CA89788C1041 / CA23126M1023 / CA00489Y6001</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / DURECT Corp / Humana Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Halozyme Therapeutics Inc / Castlight Health Inc / Canopy Growth Corp / Tivity Health Inc / Tilray Brands Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Cresco Labs Inc / Trulieve Cannabis Corp / Curaleaf Holdings Inc / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">MarketGrader</td><td class="leftalignment">MarketGrader Research Report on Bloomsbury Publishing Plc</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q21 - Wave 2 Drives Rev Beat, with Possible Tsunami on the Way</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US40637H1095 / US1101221083</td><td class="leftalignment">Halozyme Therapeutics Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FISV=US / MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / KO=US / MCD=US / OXY=US / ADI=US / RRC=US / GBT=US / WEN=US / DVN=US / INCY=US / TXN=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / EXPE=US / LEG=US / SEIC=US / KFRC=US / AMK=US / BNL=US / CBRL=US / ENV=US / CTRA=US / CNX=US / DRI=US / EQT=US / EXEL=US / GPOR=US / HZO=US / MCHP=US / REGI=US / SBAC=US / SSNC=US / TRIP=US / WIX=US / CVX=US / PSA=US / SPG=US / CGEN=US / BKNG=US / ADC=US / CUZ=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / MGNI=US / OGN / JRVR=US / BIIB=US / TXRH=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / TIL=US / NOG=US / EPRT=US / JACK=US / RCUS=US / GNRC=US / AR=US / OAS=US / NXPI=US / LPLA=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / ABBV=US / NDLS=US / ANIP=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / BWXT=US / WING=US / MCFT=US / WLTW=US / GXO=US / CDEV=US / CRSP=US / TRVG=US / JELD=US / SBOW=US / IOVA=US / FOCS=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / PNTG=US / OVV=US / ZI=US / VTRS=US / ABNB=US / CELU=US / ROCC=US / REPX=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Range Resources Corp / Global Blood Therapeutics Inc / Wendys Co / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / SEI Investments Co / Kforce Inc / AssetMark Financial Holdings Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Envestnet Inc / Coterra Energy Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Gulfport Energy Corp / MarineMax Inc / Microchip Technology Inc / Renewable Energy Group Inc / SBA Communications Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Public Storage / Simon Property Group Inc / Compugen Ltd / Booking Holdings Inc / Agree Realty Corp / Cousins Properties Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / Organon & Co / James River Group Holdings Ltd / Biogen Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / Generac Holdings Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / ANI Pharmaceuticals Inc / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / BWX Technologies Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Willis Towers Watson PLC / GXO Logistics Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Focus Financial Partners Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Pennant Group Inc / Ovintiv Inc / ZoomInfo Technologies Inc / Viatris Inc / Airbnb Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2000019 / 2778844 / 2045623 / 2206657 / 2270726 / 2829515 / 2317087 / 2670519 / 2100920 / 2623911 / 2689560 / 2684703 / 2048804 / 7103065 / B125XQ6 / B2R3PV1 / B5B2106 / B3SWPT2 / B7TL820 / BBGVT40 / B95N910 / BVVN4Q8 / BD3W133 / BJLT387 / BK7Y2V9 / BD8DJ71 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BGSP7M9 / BD6D4Y5 / BYY88Y7 / BZ0P3Z5 / BMG75B4 / BN0XTW4 / BFY7DC4 / BNTB3N8 / BMW15J8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / ANSYS Inc / Coca-Cola Co / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / FirstEnergy Corp / Neurocrine Biosciences Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Portland General Electric Co / American Water Works Company Inc / Fortinet Inc / Ameresco Inc / Meta Platforms Inc / News Corp / PTC Inc / Eversource Energy / Keurig Dr Pepper Inc / Avantor Inc / Akero Therapeutics Inc / Snap Inc / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc / Altair Engineering Inc / Alphabet Inc / Tegna Inc / Inventiva SA / Orphazyme A/S / Altimmune Inc / Vizio Holding Corp / Renalytix PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Nov. 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ALB.N / BAC.N / BMY.N / CL.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / JPM.N / LLY.N / LMT.N / NEM.N / OXY.N / PNW.N / RHI.N / T.N / TMO.N / WFC.N / SPG.N / PXD.N / NUE.N / CPB.N / DIS.N / UNH.N / D.N / MGM.N / CLX.N / HD.N / MRO.N / WEC.N / XOM.N / DVN.N / IT.N / VZ.N / V.N / MKC.N / HRL.N / CVX.N / COP.N / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / FISV.OQ / ATVI.OQ / MSFT.OQ / SIVB.OQ / ODFL.OQ / QCOM.OQ / INTU.OQ / INCY.OQ / PENN.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / ISRG.OQ / GPN.N / VRTX.OQ / NFLX.OQ / WYNN.OQ / EXR.N / MOS.N / MKTX.OQ / LVS.N / DISCA.OQ / FIS.N / STX.AX / MA.N / WU.N / IPGP.OQ / FTNT.OQ / TSLA.OQ / MPC.N / FANG.OQ / GOOGL.OQ / TMUS.OQ / LW.N / XEL.OQ / FB.PS / AEP.OQ / VTRS.OQ / BBWI.N</td><td class="leftalignment">Albemarle Corp / Bank of America Corp / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / JPMorgan Chase & Co / Eli Lilly and Co / Lockheed Martin Corp / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Simon Property Group Inc / Pioneer Natural Resources Co / Nucor Corp / Campbell Soup Co / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / MGM Resorts International / Clorox Co / Home Depot Inc / Marathon Oil Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / Verizon Communications Inc / Visa Inc / McCormick & Company Inc / Hormel Foods Corp / Chevron Corp / Conocophillips / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Fiserv Inc / Activision Blizzard Inc / Microsoft Corp / SVB Financial Group / Old Dominion Freight Line Inc / Qualcomm Inc / Intuit Inc / Incyte Corp / Penn National Gaming Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Intuitive Surgical Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Wynn Resorts Ltd / Extra Space Storage Inc / Mosaic Co / Marketaxess Holdings Inc / Las Vegas Sands Corp / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / Western Union Co / IPG Photonics Corp / Fortinet Inc / Tesla Inc / Marathon Petroleum Corp / Diamondback Energy Inc / Alphabet Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / Xcel Energy Inc / San Miguel Food and Beverage Inc / American Electric Power Company Inc / Viatris Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q3 2021: Bristol Myers Squibb reports 46.5% sequential rise in Quarterly Net Profit</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb down 2.2% from 4 week high</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for BMY</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, BMY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE / RATINGS CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: UPDATED SITC Planner Highlights 60+ Datapoints Not To Be Missed + Late Breakers</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BMY=US / INCY=US / GILD=US / EXEL=US / CGEN=US / TIL=US / RCUS=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Exelixis Inc / Compugen Ltd / Instil Bio Inc / Arcus Biosciences Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2936921 / 2126335 / 2000019 / 2778844 / 2026242 / 2219224 / 2270726 / 2317087 / 2100920 / 2457864 / 2459020 / 2048804 / 2829601 / 2931034 / 2181334 / 7103065 / 2783815 / 2713317 / 2857817 / B125XQ6 / B3P93Y7 / B7TL820 / B7254K9 / B7VD3F2 / BFLR866 / BFH3N85 / BTN1Y11 / BXDZ9Z0 / BHC8X90 / BD8DJ71 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BD6JX35 / BMH0MR7 / BDZ30Q0 / BJTJGC4 / BMPRZV5 / BGDQ8B3 / BNTB3N8 / BNGJQZ8 / BP7KZP7 / BF0QTY9 / BPH0546</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Walmart Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Merck & Co Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Entergy Corp / FirstEnergy Corp / ImmunoGen Inc / Intuit Inc / Pinnacle West Capital Corp / Southern Co / Vertex Pharmaceuticals Inc / Check Point Software Technologies Ltd / Novartis AG / Zimmer Biomet Holdings Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Anheuser Busch Inbev SA / Meta Platforms Inc / AxoGen Inc / Duke Energy Corp / Twitter Inc / Veeva Systems Inc / Medtronic PLC / Shopify Inc / Novo Nordisk A/S / Snap Inc / Fox Corp / Spire Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Krystal Biotech Inc / Zendesk Inc / Arvinas Inc / Kontoor Brands Inc / Kymera Therapeutics Inc / Axonics Inc / Vizio Holding Corp / Porch Group Inc / Monte Rosa Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 22</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - 2Q results: 1H results announced during the market on 1 Nov; full-year guidance raised</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / BMY.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Bristol-Myers Squibb Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 2Q決算：11月1日場中に1H決算発表：通期予想を上方修正</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / BMY.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Bristol-Myers Squibb Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">10/31/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Peer Group Analytics - Q3 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/30/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Information Content of Earnings Releases 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">10/30/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Bristol-Myers Squibb Co Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Bristol Myers Squibb (BMY: $58.40) wipes off $5 billion in MCap in October, highest loser in Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: Model Update Post 3Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next In Biotech? "Field Report" From Targeted Protein Degradation Summit (ARVN, KYMR, GLUE, NRIX, AZN-LN, JNJ, NOVN-SW, BMY, SAN-FP, others)</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">BMY.N / ARVN.OQ / GLUE.OQ / KYMR.OQ / 5671735 / 0989529 / 2126335 / 2684703 / 7103065 / BMQ5T49 / BYYWPW6 / BDZ30Q0 / BMPRZV5 / BP7KZP7</td><td class="leftalignment">Bristol-Myers Squibb Co / Arvinas Inc / Monte Rosa Therapeutics Inc / Kymera Therapeutics Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Novartis AG / Zentalis Pharmaceuticals Inc / Beigene Ltd / Arvinas Inc / Kymera Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Paul Jeng, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III / Mr. Seamus Fernandez</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BPTH-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BPTH.O / BAX / BMY / SPPI.O / SGEN.O / TLOG.PK</td><td class="leftalignment">Bio Path Holdings Inc / Baxter International Inc / Bristol-Myers Squibb Co / Spectrum Pharmaceuticals Inc / Seagen Inc / TetraLogic Pharmaceuticals Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NNVC-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NNVC.K / BMY / MRK / GILD.O / NBY / GSK / BCRX.O / NVAX.O / CMRX.O</td><td class="leftalignment">NanoViricides Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Gilead Sciences Inc / NovaBay Pharmaceuticals Inc / GlaxoSmithKline PLC / BioCryst Pharmaceuticals Inc / Novavax Inc / Chimerix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ONCY-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ONCY.O / BMY / LLY / HBP.TO / AEZS.O / AVEO.O / MRTX.O / TEVA.K / SPHS.PK</td><td class="leftalignment">Oncolytics Biotech Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Helix Biopharma Corp / Aeterna Zentaris Inc / Aveo Pharmaceuticals Inc / Mirati Therapeutics Inc / Teva Pharmaceutical Industries Ltd / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CBAY-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CBAY.O / BMY / PFE / PTCT.O / XNCR.O</td><td class="leftalignment">Cymabay Therapeutics Inc / Bristol-Myers Squibb Co / Pfizer Inc / PTC Therapeutics Inc / Xencor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SPPI-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SPPI.O / ABT / BMY / JNJ / NVS / PFE / GSK / CRIS.O / SGEN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Spectrum Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Curis Inc / Seagen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZIOP-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ZIOP.O / BAX / BMY / AMGN.O / CYTR.PK</td><td class="leftalignment">ZIOPHARM Oncology Inc / Baxter International Inc / Bristol-Myers Squibb Co / Amgen Inc / CytRx Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Invest Heroes</td><td class="leftalignment">Bristol-Myers Squibb: финансовые результаты за 3 кв. 2021 года</td><td class="leftalignment">Russian</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dmitrii Novichkov</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AIN / FISV=US / BSX=US / CACI=US / AMGN=US / BMY=US / HD=US / KO=US / MCD=US / AMD=US / RRC=US / IP=US / AVB=US / DT=US / EBAY=US / PEB=US / H=US / CONE=US / NOVA=US / MTN=US / CRK=US / CHKP=US / PB=US / VRM=US / XLNX=US / BYD=US / MAR=US / SPOT=US / TTMI=US / TNL=US / MGM=US / HLT=US / PENN=US / EQR=US / CI=US / AIR=US / APH=US / ATRO=US / BLL=US / B=US / BMRN=US / CHH=US / CYH=US / CCK=US / CW=US / DRH=US / DCO=US / EQT=US / HEI=US / HXL=US / NOW=US / MAS=US / MCRI=US / MNRO=US / ASGN=US / PDM=US / REGN=US / ROLL=US / SLGN=US / SFT=US / VSEC=US / SGMS=US / R=US / MAA=US / SSB=US / SPR=US / DRE=US / ENSG=US / AMSF=US / BCO=US / MOH=US / MOG.A=US / CZR=US / EXR=US / SHO=US / FIS=US / HST=US / SIX=US / PAG=US / TEL=US / OC=US / EHC=US / WH=US / 45665G303 / INSE / AR=US / HGV=US / NXPI=US / WWD=US / RLJ=US / VAC=US / MTDR=US / RHP=US / ABBV=US / NDLS=US / LDOS=US / NEWR=US / BVH=US / LOB=US / EVRI=US / EVBG=US / PK=US / PLYA=US / CVNA=US / GSHD=US / FTDR=US / HARP=US / DDOG=US / TSHA / NGMS=US</td><td class="leftalignment">Albany International Corp / Fiserv Inc / Boston Scientific Corp / CACI International Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Advanced Micro Devices Inc / Range Resources Corp / International Paper Co / Avalonbay Communities Inc / Dynatrace Inc / eBay Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / CyrusOne Inc / Sunnova Energy International Inc / Vail Resorts Inc / Comstock Resources Inc / Check Point Software Technologies Ltd / Prosperity Bancshares Inc / Vroom Inc / Xilinx Inc / Boyd Gaming Corp / Marriott International Inc / Spotify Technology SA / TTM Technologies Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Equity Residential / Cigna Corp / AAR Corp / Amphenol Corp / Astronics Corp / Ball Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Community Health Systems Inc / Crown Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / EQT Corp / HEICO Corp / Hexcel Corp / ServiceNow Inc / Masco Corp / Monarch Casino & Resort Inc / Monro Inc / ASGN Inc / Piedmont Office Realty Trust Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Silgan Holdings Inc / Shift Technologies Inc / VSE Corp / Scientific Games Corp / Ryder System Inc / Mid-America Apartment Communities Inc / SouthState Corp / Spirit AeroSystems Holdings Inc / Duke Realty Corp / Ensign Group Inc / Amerisafe Inc / Brinks Co / Molina Healthcare Inc / Moog Inc / Caesars Entertainment Inc / Extra Space Storage Inc / Sunstone Hotel Investors Inc / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Six Flags Entertainment Corp / Penske Automotive Group Inc / TE Connectivity Ltd / Owens Corning / Encompass Health Corp / Wyndham Hotels & Resorts Inc / Infinity Pharmaceuticals Inc / Inspired Entertainment Inc / Antero Resources Corp / Hilton Grand Vacations Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Matador Resources Co / Ryman Hospitality Properties Inc / Abbvie Inc / Noodles & Co / Leidos Holdings Inc / New Relic Inc / Bluegreen Vacations Holding Corp / Live Oak Bancshares Inc / Everi Holdings Inc / Everbridge Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Goosehead Insurance Inc / Frontdoor Inc / Harpoon Therapeutics Inc / Datadog Inc / Taysha Gene Therapies Inc / NeoGames SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0925288 / 2126335 / 2000019 / 2293819 / 2026242 / 2437071 / 2113434 / 2206657 / 2280220 / 2567116 / 2317087 / 2670519 / 2328915 / 2459020 / 2600088 / 2048804 / 2943523 / 2857817 / B65LWX6 / B7TL820 / B7VD3F2 / BDZCRX3 / BFLR866 / BFH3N85 / BYRY499 / BYZLV46 / BXDZ9Z0 / BK1KWF7 / BD8DJ71 / BJ2Z0H2 / BFZ1K46 / BMYML02 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BMPRZV5 / BMC5RV6 / BNGJQZ8 / BJ9N563</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / eBay Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / Boston Scientific Corp / Coca-Cola Co / DTE Energy Co / Edwards Lifesciences Corp / Entergy Corp / Exelon Corp / Nextera Energy Inc / Intuit Inc / Monro Inc / Pinnacle West Capital Corp / Penske Automotive Group Inc / Netflix Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / RingCentral Inc / Twitter Inc / Veeva Systems Inc / Kraft Heinz Co / InflaRx NV / Shopify Inc / Grocery Outlet Holding Corp / Snap Inc / Pinterest Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Porch Group Inc / Sunnova Energy International Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IMAB: I-Mab Biopharma - Global innovation with differentiated product portfolio to drive upside</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">IMAB.OQ / 4502.T / BMY.N / LLY.N / PFE.N / AZN.L / NOVN.S / GSK.L / GILD.OQ / 000661.SZ / 095700.KQ / 300009.SZ / ABBV.N / TGTX.OQ / MGNX.OQ / BGNE.OQ / CRVS.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / ALXO.OQ</td><td class="leftalignment">I-Mab / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Changchun High & New Technology Industries Group Inc / Genexine Inc / Anhui Anke Biotechnology Group Co Ltd / Abbvie Inc / TG Therapeutics Inc / MacroGenics Inc / Beigene Ltd / Corvus Pharmaceuticals Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Post 3Q21 Model Update</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY: 3Q21 Postview – okay Q3; lots of events ahead to think about</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">3Q21 takeaways: mgmt confident in new launches and focused on renewing the portfolio</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : 3Q Takeaways – Positive New Launch Trends, Pipeline/LOE Controversies Remain in Focus</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 3Q21 Earnings (BMY, BSX, LLY, TMO) — What Mattered for Credit</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / BSX.N / LLY.N / TMO.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Eli Lilly and Co / Thermo Fisher Scientific Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">In-Line Quarter But Encouraging Signs Maintained in New Brands With Important Catalysts Before Year-End</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY: 3Q21 - They said what? Highlights from conference call that just ended</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 EPS Beat; 2021 EPS Guidance Raised At Lower End</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : 3Q First Impressions: Positive New Launch Trends Offset Flattening Opdivo Recovery</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on October 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MCD.N / AFL.N / BA.N / BG.N / BMY.N / BP.L / F.N / GM.N / HLT.N / IBM.N / IP.N / KO.N / MAS.N / NSC.N / SLB.N / TMO.N / AVB.N / DRE.N / HAL.N / GD.N / URI.N / WAB.N / DTE.N / DBKGN.DE / XOM.N / AVY.N / RE.N / APH.N / EW.N / GSK.L / CLB.N / MAA.N / TEL.N / TDY.N / OII.N / CTSH.OQ / AAPL.OQ / CINF.OQ / FISV.OQ / KLAC.OQ / MSFT.OQ / ROL.N / TYL.N / XLNX.OQ / SBUX.OQ / ODFL.OQ / ORLY.OQ / AMZN.OQ / EBAY.OQ / GRMN.OQ / ALGN.OQ / 0700.HK / EXR.N / RDSA.L / AEM.TO / HES.N / 9999.HK / ALGT.OQ / PAG.N / CME.OQ / ADP.OQ / BKR.N / NOW.N / KHC.OQ / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / 9618.HK / ABNB.OQ / CHX.OQ</td><td class="leftalignment">McDonald's Corp / Aflac Inc / Boeing Co / Bunge Ltd / Bristol-Myers Squibb Co / BP PLC / Ford Motor Co / General Motors Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / International Paper Co / Coca-Cola Co / Masco Corp / Norfolk Southern Corp / Schlumberger NV / Thermo Fisher Scientific Inc / Avalonbay Communities Inc / Duke Realty Corp / Halliburton Co / General Dynamics Corp / United Rentals Inc / Westinghouse Air Brake Technologies Corp / DTE Energy Co / Deutsche Bank AG / Exxon Mobil Corp / Avery Dennison Corp / Everest Re Group Ltd / Amphenol Corp / Edwards Lifesciences Corp / GlaxoSmithKline PLC / Core Laboratories NV / Mid-America Apartment Communities Inc / TE Connectivity Ltd / Teledyne Technologies Inc / Oceaneering International Inc / Cognizant Technology Solutions Corp / Apple Inc / Cincinnati Financial Corp / Fiserv Inc / KLA Corp / Microsoft Corp / Rollins Inc / Tyler Technologies Inc / Xilinx Inc / Starbucks Corp / Old Dominion Freight Line Inc / O'Reilly Automotive Inc / Amazon.com Inc / eBay Inc / Garmin Ltd / Align Technology Inc / Tencent Holdings Ltd / Extra Space Storage Inc / Royal Dutch Shell PLC / Agnico Eagle Mines Ltd / Hess Corp / NetEase Inc / Allegiant Travel Co / Penske Automotive Group Inc / CME Group Inc / Automatic Data Processing Inc / Baker Hughes Co / ServiceNow Inc / Kraft Heinz Co / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc / ChampionX Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: Sales/EPS Beat Driven by Core Products & Boosted By Better Op Margin & Lower Tax Rate; Lower End of EPS Guidance Increased</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Brief of Bristol-Myers Squibb Co conference call, Oct. 27, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Oct. 27, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 27/10/2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.L / RSTP.L / TBCG.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Restore PLC / TBC Bank Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Alastair P. Reid / Mr. Ian Gordon / Ross Broadfoot / Tom Brookhouse / Mr. Tom Callan</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 EPS Beat; 2022 The Next Focus</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third-Quarter Quick Take: Growth of New Brands and Lower Expenses Drive Bottom-Line Beat; Lower End of EPS Guidance Raised</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Bloomsbury Publishing : A virtuous flywheel - Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BEN.AX / BMY.N / BSX.N / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / F.N / GM.N / KO.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JKHY.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Motors Co / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Jack Henry & Associates Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / France / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for BMY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Model Update Post 3Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2516152 / 5671735 / 0989529 / 0925288 / 2126335 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">Eli Lilly and Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended October 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended October 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Bristol Myers Squibb Stock After Q3 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Merck's Q3?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Broad Domestic Declines Continue With No Signals of Seasonally Driven Wave, FDA Authorizes Moderna and JNJ Boosters</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AIN / MRK=US / BMY=US / HD=US / KO=US / MCD=US / PG=US / WEN=US / MDT=US / PD=US / T=US / DT=US / BLD=US / INCY=US / CPE=US / H=US / LOW=US / ENR=US / HSII=US / BRO=US / MAR=US / EXPE=US / LEG=US / VMC=US / HLT=US / NWL=US / MLM=US / FLO=US / STZ=US / KFY=US / SWIM=US / CBRL=US / CENT=US / CHD=US / CSTR=US / CCK=US / DRI=US / EPC=US / GFF=US / IBP=US / NOW=US / MAS=US / MHK=US / MCRI=US / TEAM=US / OI=US / REGI=US / SMG=US / TRIP=US / POST=US / SNOW=US / CGEN=US / BKNG=US / BDN=US / CNM=US / FB=US / GBCI=US / REG=US / BE=US / DIN=US / MGPI=US / MNST=US / NOMD=US / TPX=US / EXP=US / BECN=US / PLAY=US / BAH=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / SAIC=US / TAST=US / QSR=US / PRPL=US / NOG=US / JACK=US / RCUS=US / AAN=US / UTZ=US / TREX=US / RLJ=US / FBHS=US / MTDR=US / SPLK=US / TILE=US / IBTX=US / TMUS=US / NDLS=US / CNCE=US / QURE=US / GOOGL=US / 00770K202 / LOCO=US / NEWR=US / SHAK=US / WING=US / ARGX=US / 82982L103 / EVBG=US / TRVG=US / ANAB=US / JELD=US / AYX=US / PETQ=US / KDP=US / SITC=US / ESTC=US / APLT=US / FERG=US / DDOG=US / BRBR=US / GMAB=US / IMVT=US / REYN=US / AZEK=US / AZYO=US / ABNB=US / HYFM=US / 67421J108 / DNUT=US / SNPO=US / EWCZ=US / PKG=U / ROIV=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Bristol-Myers Squibb Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Procter & Gamble Co / Wendys Co / Medtronic PLC / PagerDuty Inc / AT&T Inc / Dynatrace Inc / TopBuild Corp / Incyte Corp / Callon Petroleum Co / Hyatt Hotels Corp / Lowe's Companies Inc / Energizer Holdings Inc / Heidrick & Struggles International Inc / Brown & Brown Inc / Marriott International Inc / Expedia Group Inc / Leggett & Platt Inc / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Constellation Brands Inc / Korn Ferry / Latham Group Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CapStar Financial Holdings Inc / Crown Holdings Inc / Darden Restaurants Inc / Edgewell Personal Care Co / Griffon Corp / Installed Building Products Inc / ServiceNow Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Atlassian Corporation PLC / O-I Glass Inc / Renewable Energy Group Inc / Scotts Miracle-Gro Co / Tripadvisor Inc / Post Holdings Inc / Snowflake Inc. / Compugen Ltd / Booking Holdings Inc / Brandywine Realty Trust / Core & Main Inc / Meta Platforms Inc / Glacier Bancorp Inc / Regency Centers Corp / Bloom Energy Corp / Dine Brands Global Inc / MGP Ingredients Inc / Monster Beverage Corp / Nomad Foods Ltd / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Booz Allen Hamilton Holding Corp / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Science Applications International Corp / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Arcus Biosciences Inc / Aaron's Company Inc / UTZ Brands Inc / Trex Company Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Matador Resources Co / Splunk Inc / Interface Inc / Independent Bank Group Inc / T-Mobile US Inc / Noodles & Co / Concert Pharmaceuticals Inc / Uniqure NV / Alphabet Inc / Aemetis Inc / El Pollo Loco Holdings Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Everbridge Inc / Trivago NV / AnaptysBio Inc / JELD-WEN Holding Inc / Alteryx Inc / PetIQ Inc / Keurig Dr Pepper Inc / Site Centers Corp / Elastic NV / Applied Therapeutics Inc / Ferguson PLC / Datadog Inc / Bellring Brands Inc / Genmab A/S / Immunovant Inc / Reynolds Consumer Products Inc / Azek Company Inc / Aziyo Biologics Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Oatly Group AB / Krispy Kreme Inc / Snap One Holdings Corp / European Wax Center Inc / Packaging Corp of America / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2026242 / 2270726 / 2542049 / 2317087 / 2100920 / 2455965 / 2684703 / 2799351 / 2503529 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / BVVN4Q8 / BQPVQZ6 / BD8DJ71 / BJFSR88 / BJ2Z0H2 / BJJMGL2 / BFXC911 / BKTNTR9 / BYY88Y7 / BFYVZ75 / BP96C52 / BMDTR28</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / FirstEnergy Corp / Biogen Inc / Pfizer Inc / Sinclair Broadcast Group Inc / World Wrestling Entertainment Inc / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / Horizon Therapeutics PLC / Snap Inc / Uniqure NV / Pinterest Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Alphabet Inc / Seelos Therapeutics Inc / Surrozen Inc / First Watch Restaurant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / SHW.N / GWW.N / JCI.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / PYPL.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / W W Grainger Inc / Johnson Controls International PLC / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / TMO / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / Thermo Fisher Scientific Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NEM.N / NSC.N / PFE.N / PNW.N / SO.N / TEL.PS / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / MTD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / APH.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / CHD.N / TWTR.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / ORLY.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / SWKS.O / CMCSA.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / MSCI.N / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / PLDT Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Mettler-Toledo International Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Amphenol Corp / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Twitter Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Skyworks Solutions Inc / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / MSCI Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (25 October-): Jul-Sep results announcements started with Chugai raising full-year guidance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4519.T / 4502.T / 4503.T / 4507.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Chugai Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（10月25日～）: 9月期決算始まる、中外薬の通期計画上方修正でスタート</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: China PD-(L)1 on the move: Picking long-term winners in a competitive race</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">BGNE.OQ / 1877.HK / BMY.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / 1177.HK / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / INCY.OQ / AGEN.OQ / 600276.SS / 0950.HK / 002437.SZ / 300003.SZ / MRTX.OQ / ZLAB.OQ / 6160.HK / 1801.HK</td><td class="leftalignment">Beigene Ltd / Shanghai Junshi Biosciences Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sino Biopharmaceutical Ltd / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Incyte Corp / Agenus Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Lee's Pharmaceutical Holdings Ltd / Harbin Gloria Pharmaceuticals Co Ltd / Lepu Medical Technology Beijing Co Ltd / Mirati Therapeutics Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.3% Above Pre-Pandemic Base- Week 81</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 570</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Navigating Project Optimus Recap: Shift to Earlier Dose-Randomization; Intelligent Trial Design Could Lessen Timeline Impacts</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / SLB.N / SO.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / ROP.N / CAT.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / HCA.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / FIS.N / STX.AX / ADP.PA / AON.N / MRNA.OQ / CME.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / Southern Co / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / HCA Healthcare Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Revisiting Our Core Thesis Following Recent Share Pullback</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / BMY=US / TWTR=US / EFX=US / AMZN=US / T=US / BLD=US / KMI=US / CMA=US / PEB=US / SLG=US / BC=US / H=US / TRU=US / CONE=US / V=US / MTN=US / VZ=US / CCI=US / THC=US / MAR=US / UMPQ=US / LSTR=US / TNL=US / HLT=US / WTFC=US / AIR=US / ELY=US / FUN=US / CHH=US / DRH=US / EEFT=US / HAS=US / IBP=US / HZO=US / MAS=US / MAT=US / PII=US / SNAP=US / THO=US / WW=US / WGO=US / GOLF=US / PYPL=US / FMBI=US / FB=US / FR=US / NLS=US / NFLX=US / STRO=US / BIIB=US / EXP=US / BECN=US / SHO=US / DENN=US / XM=US / GMS=US / HST=US / MA=US / SIX=US / AWI=US / OC=US / WH=US / SEAS=US / CWH=US / JACK=US / HGV=US / RLJ=US / VAC=US / MTDR=US / SPLK=US / RHP=US / TILE=US / FOXF=US / FATE=US / MBUU=US / GOOGL=US / AFMD=US / ANTM=US / BVH=US / MCFT=US / SQ=US / CRSP=US / PK=US / 50189K103 / PLYA=US / FNKO=US / LAZY=US / HWC=US / ALLO=US / TCRR=US / FERG=US / XAIR=US / ONEW=US / SQSP=US / HLLY=US / PKG=U</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Twitter Inc / Equifax Inc / Amazon.com Inc / AT&T Inc / TopBuild Corp / Kinder Morgan Inc / Comerica Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Brunswick Corp / Hyatt Hotels Corp / TransUnion / CyrusOne Inc / Visa Inc / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Tenet Healthcare Corp / Marriott International Inc / Umpqua Holdings Corp / Landstar System Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / AAR Corp / Callaway Golf Co / Cedar Fair LP / Choice Hotels International Inc / Diamondrock Hospitality Co / Euronet Worldwide Inc / Hasbro Inc / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mattel Inc / Polaris Inc / Snap Inc / Thor Industries Inc / WW International Inc / Winnebago Industries Inc / Acushnet Holdings Corp / PayPal Holdings Inc / First Midwest Bancorp Inc / Meta Platforms Inc / First Industrial Realty Trust Inc / Nautilus Inc / Netflix Inc / Sutro Biopharma Inc / Biogen Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Denny's Corp / Qualtrics International Inc / GMS Inc / Host Hotels & Resorts Inc / Mastercard Inc / Six Flags Entertainment Corp / Armstrong World Industries Inc / Owens Corning / Wyndham Hotels & Resorts Inc / SeaWorld Entertainment Inc / Camping World Holdings Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Matador Resources Co / Splunk Inc / Ryman Hospitality Properties Inc / Interface Inc / Fox Factory Holding Corp / Fate Therapeutics Inc / Malibu Boats Inc / Alphabet Inc / Affimed NV / Anthem Inc / Bluegreen Vacations Holding Corp / Mastercraft Boat Holdings Inc / Block Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / LCI Industries / Playa Hotels & Resorts NV / Funko Inc / Lazydays Holdings Inc / Hancock Whitney Corp / Allogene Therapeutics Inc / TCR2 Therapeutics Inc / Ferguson PLC / Beyond Air Inc / OneWater Marine Inc / Squarespace Inc / Holley Inc / Packaging Corp of America</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Engaging serial killer (NK) cells to target cancer - Initiating with a Buy, PT $10/sh</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">AFMD=US / MRK=US / BMY=US / STRO=US / FATE=US</td><td class="leftalignment">Affimed NV / Merck & Co Inc / Bristol-Myers Squibb Co / Sutro Biopharma Inc / Fate Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / ECL.N / EL.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / SLB.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / NUE.N / ROK.N / UHS.N / MET.N / ETN.N / DHR.N / GD.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / SYY.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / TSCO.OQ / O.N / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / IQV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / General Dynamics Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Sysco Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Bristol-Myers Squibb Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / PPG.N / SLB.N / T.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / ROK.N / UHS.N / ETN.N / DHR.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / CHTR.OQ / MTCH.OQ / ALGN.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / ANTM.N / TMUS.OQ / CSX.OQ / IQV.N / FB.PS / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / Charter Communications Inc / Match Group Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Anthem Inc / T-Mobile US Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 10 19</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">FFIV.OQ / HI.N / AES.N / BMY.N / PG.N / DELL.N / TGT.N / TJX.N / ACN.N / NCR.N / QCOM.OQ / INTU.OQ / SKT.N / ILMN.OQ / MA.N / KTOS.OQ / SQ.N / VREX.OQ / FND.N / ATGE.N / GO.OQ</td><td class="leftalignment">F5 Inc / Hillenbrand Inc / AES Corp / Bristol-Myers Squibb Co / Procter & Gamble Co / Dell Technologies Inc / Target Corp / TJX Companies Inc / Accenture PLC / NCR Corp / Qualcomm Inc / Intuit Inc / Tanger Factory Outlet Centers Inc / Illumina Inc / Mastercard Inc / Kratos Defense and Security Solutions Inc / Block Inc / Varex Imaging Corp / Floor & Decor Holdings Inc / Adtalem Global Education Inc / Grocery Outlet Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Aerospace / Defense / Education / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Machinery / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Utilities</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MOGa / HEI.N / FR0000054470 / BE0165385973 / US0079031078 / US0123481089 / US01741R1023 / US0311621009 / US0382221051 / US0463531089 / US0970231058 / US0997241064 / US1101221083 / US1442851036 / US2358511028 / US2855121099 / US3695501086 / US37733W1053 / US4228061093 / US4282911084 / US4385161066 / US4523271090 / US4781601046 / US5128071082 / US5324571083 / US5398301094 / US55306N1046 / US5949181045 / US6668071029 / US66987V1098 / US6701002056 / US7170811035 / US7475251036 / US7711951043 / US8356993076 / US8740541094 / US8835561023 / US8968181011 / US91307C1027 / US9807451037 / CA0977512007 / IL0010824113 / JP3435000009 / US92343X1000 / US80105N1054 / US1167941087 / US6098391054 / US8936411003 / US8485741099 / US00507V1098 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US34959E1091 / US1920051067 / US88160R1014 / US69404D1081 / US29082A1079 / US92839U2069 / US4464131063 / JE00B783TY65 / US03027X1000 / US98986T1088 / US29414B1044 / US00287Y1091 / US98978V1035 / US81762P1021 / US72919P2020 / US6974351057 / US63009R1095 / US29664W1053 / US60468T1051 / NL0010696654 / US9222801022 / US09062W2044 / US98936J1016 / US04523Y1055 / US22822V1017 / US30050B1017 / GB00BZ09BD16 / US98138J2069 / US07725L1026 / US90138F1021 / US78410G1040 / US23355L1061 / US03236M2008 / US98980G1022 / US92336X1090 / US2575541055 / US01671P1003 / US28414H1032 / US90184D1000 / IL0011571556 / US03828A1016 / US22788C1053 / US5024311095 / US88025U1097 / US18915M1071 / US85205L1070 / US1567271093 / US4432011082 / US75513E1010 / US6541101050 / GB00BMVP7Y09 / US75943R1023 / US8334451098 / US03044L1052 / US22041X1028 / US38246G1085 / US33813J1060 / US81578P1066 / US00810F1066 / US72815L1070 / US67080N1019 / LU2314763264 / US49926T1043 / US90089L1089 / US90364P1057 / US68622V1061 / US23954D1090 / US81730H1095 / US28489L1044 / US30049H1023 / IL0011786154 / US3696043013 / US75340L1044 / US00091E1091 / CA50202P1053 / US45254E1073 / IL0011794802 / US34631B1017 / US90240B1061 / IL0011796625 / US00152K1016 / US8852601090 / US1095041000 / US2297901009</td><td class="leftalignment">Moog Inc / HEICO Corp / Ubisoft Entertainment SA / Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Allegheny Technologies Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / Boeing Co / Borgwarner Inc / Bristol-Myers Squibb Co / Carpenter Technology Corp / Danaher Corp / Electronic Arts Inc / General Dynamics Corp / GlaxoSmithKline PLC / HEICO Corp / Hexcel Corp / Honeywell International Inc / Illumina Inc / Johnson & Johnson / Lam Research Corp / Eli Lilly and Co / Lockheed Martin Corp / MKS Instruments Inc / Microsoft Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Qualcomm Inc / Roche Holding AG / Sony Group Corp / Take-Two Interactive Software Inc / Thermo Fisher Scientific Inc / Triumph Group Inc / United Therapeutics Corp / Woodward Inc / Bombardier Inc / Check Point Software Technologies Ltd / Sony Group Corp / Verint Systems Inc / Sanofi SA / Bruker Corp / Monolithic Power Systems Inc / TransDigm Group Inc / Spirit AeroSystems Holdings Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Fortinet Inc / Codexis Inc / Tesla Inc / Pacific Biosciences of California Inc / Embraer SA / Visteon Corp / Huntington Ingalls Industries Inc / Aptiv PLC / American Tower Corp / Zynga Inc / Epam Systems Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / Plug Power Inc / Palo Alto Networks Inc / NanoString Technologies Inc / Esperion Therapeutics Inc / Mirati Therapeutics Inc / Uniqure NV / Varonis Systems Inc / BioLife Solutions Inc / Zendesk Inc / Aspen Aerogels Inc / Crown Castle International Corp / Evolent Health Inc / Atlassian Corporation PLC / Workhorse Group Inc / Beigene Ltd / Twilio Inc / SBA Communications Corp / DXC Technology Co / Amyris Inc / Zscaler Inc / Veoneer Inc / Domo Inc / Allakos Inc / Elanco Animal Health Inc / Twist Bioscience Corp / Tufin Software Technologies Ltd / Applied Therapeutics Inc / CrowdStrike Holdings Inc / L3harris Technologies Inc / 10X Genomics Inc / Cloudflare Inc / SpringWorks Therapeutics Inc / Cerence Inc / Howmet Aerospace Inc / Raytheon Technologies Corp / Nikola Corp / Royalty Pharma PLC / Relay Therapeutics Inc / Snowflake Inc. / American Well Corp / Corsair Gaming Inc / Goodrx Holdings Inc / Fisker Inc / Seer Inc / AerSale Corp / Playtika Holding Corp / Nuvation Bio Inc / Arrival SA / Knowbe4 Inc / TuSimple Holdings Inc / UiPath Inc / Organon & Co / Day One Biopharmaceuticals Inc / SentinelOne Inc / Electric Last Mile Solutions Inc / Evolv Technologies Holdings Inc / REE Automotive Ltd / General Electric Co / Rapid Micro Biosystems Inc / Absci Corp / Li-Cycle Holdings Corp / Immuneering Corp / Cellebrite DI Ltd / ForgeRock Inc / Tyra Biosciences Inc / Arbe Robotics Ltd / AKA Brands Holding Corp / Thorne Healthtech Inc / Brilliant Earth Group Inc / Cue Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Japan / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2550707 / 2486813 / 2778844 / 2050832 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2366799 / 2684703 / 2048804 / 2440637 / 2799351 / 2825933 / 2842255 / 2931034 / 7103065 / B01SD70 / 2857817 / B125XQ6 / B3D7K31 / B4N0JJ6 / B7TL820 / B783TY6 / BFLR866 / BNGY4Q0 / BD8DJ71 / BJLKVS6 / BKTHM05 / BYZR4X4 / BMYML02 / BJJMGL2 / BYXJQG9 / BYY88Y7 / BYNQ369 / BNTB3N8 / BMGGJK8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / McDonald's Corp / Kellogg Co / Merck & Co Inc / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Starbucks Corp / Vertex Pharmaceuticals Inc / Novartis AG / Domino's Pizza Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Visteon Corp / Meta Platforms Inc / Aptiv PLC / Twitter Inc / Nextera Energy Partners LP / Snap Inc / Phathom Pharmaceuticals Inc / Passage Bio Inc / Axsome Therapeutics Inc / DraftKings Inc / Fox Corp / Spire Inc / Alphabet Inc / Albertsons Companies Inc / Vizio Holding Corp / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BK.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / OMC.N / PM.N / PPG.N / SLB.N / T.N / TRV.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / UHS.N / HAL.N / DHR.N / DOV.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CVX.N / MCO.N / RF.N / INTC.OQ / AAPL.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / SYF.N / ANTM.N / KHC.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Danaher Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Chevron Corp / Moody's Corp / Regions Financial Corp / Intel Corp / Apple Inc / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Anthem Inc / Kraft Heinz Co / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">3Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAX.N / BK.N / BMY.N / BR.N / BSX.N / CB.N / CCI.N / CE.N / CL.N / CNC.N / COF.N / DD.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / NEM.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / SLB.N / T.N / TEL.PS / TRV.N / PG.N / DGX.N / WY.N / NUE.N / UHS.N / HAL.N / ADML.L / DHR.N / GD.N / DOV.N / ROP.N / CAT.N / UNP.N / GS.N / RCL.N / MCD.N / YUM.N / VLO.N / SYK.N / GLW.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / GWW.N / VZ.N / STT.N / HCA.N / VFC.N / APH.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / CHD.N / TWTR.N / MTB.N / GPC.N / CVX.N / MCO.N / RF.N / INTC.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / ZION.OQ / SBUX.OQ / ORLY.OQ / GILD.OQ / DFS.N / TSCO.OQ / POOL.OQ / AMZN.OQ / EBAY.OQ / CHTR.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / NVR.N / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / LYB.N / MSI.N / KEY.TO / BKR.N / PSX.N / NOW.N / ABBV.N / GOOGL.OQ / SYF.N / CFG.N / ANTM.N / KHC.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Baxter International Inc / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Broadridge Financial Solutions Inc / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / PLDT Inc / Travelers Companies Inc / Procter & Gamble Co / Quest Diagnostics Inc / Weyerhaeuser Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Danaher Corp / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Goldman Sachs Group Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Yum! Brands Inc / Valero Energy Corp / Stryker Corp / Corning Inc / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / W W Grainger Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / VF Corp / Amphenol Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / Twitter Inc / M&T Bank Corp / Genuine Parts Co / Chevron Corp / Moody's Corp / Regions Financial Corp / Intel Corp / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / O'Reilly Automotive Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Pool Corp / Amazon.com Inc / eBay Inc / Charter Communications Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / NVR Inc / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Baker Hughes Co / Phillips 66 / ServiceNow Inc / Abbvie Inc / Alphabet Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Kraft Heinz Co / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Jiangsu Hengrui Pharmaceuticals Co., Ltd.: First-ever R&D Day successfully highlights innovative R&D, but could have delivered more on early-stage pipeline. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">600276.SS / BMY.N / GSK.L</td><td class="leftalignment">Jiangsu Hengrui Pharmaceuticals Co Ltd / Bristol-Myers Squibb Co / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.1% Above Pre-Pandemic Base- Week 80</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/16/2021</td><td class="leftalignment">Allaria Ledesma y Cia SA</td><td class="leftalignment">RECOMENDACIONES INTERNACIONALES</td><td class="leftalignment">Spanish</td><td class="rightalignment">5</td><td class="leftalignment">AAPL / AMZN / BBD / BMY / CSCO / MDT / MSFT / TMO / TSM</td><td class="leftalignment">Apple Inc / Amazon.com Inc / Banco Bradesco SA / Bristol-Myers Squibb Co / Cisco Systems Inc / Medtronic PLC / Microsoft Corp / Thermo Fisher Scientific Inc / Taiwan Semiconductor Manufacturing Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Ireland / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 569</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/16/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">BMY - Embedded Expectations Analysis - 2021 10 15</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Navigating Project Optimus: Panel Discussion on FDA Initiative on Finding the Optimal Dose, October 21, 11:00 a.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">110122108 / 03116210 / 09062X103 / 45337C102 / 00847G705 / 268158201 / 04651310 / 00887A105 / 67022C106 / 720795103 / 49372L100 / 05280R100 / 717224109 / N5749R100 / 16961L106 / 192010106 / 13089P101 / 30315R107 / 45175G108</td><td class="leftalignment">Bristol-Myers Squibb Co / Amgen Inc / Biogen Inc / Incyte Corp / Agenus Inc / Dynavax Technologies Corp / Atara Biotherapeutics Inc / Aileron Therapeutics Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / PhaseBio Pharmaceuticals Inc / Merus NV / Chinook Therapeutics Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Hunter Rogers / Mr. Tim F. Lugo / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third Quarter 2021 Biotechnology Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">03116210 / 09062X103 / 64125C109 / 110122108 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 462222100 / 19459J104 / G11196105 / 69366J200 / 09609G100 / 37890U108 / 81181C104 / 91864C107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / bluebird bio Inc / Global Blood Therapeutics Inc / Seagen Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2437071 / 2280220 / 2270726 / 2317087 / 2576941 / 2455965 / 2471950 / 2623911 / 2632003 / 2048804 / 2730190 / 2825933 / 2931034 / 4595739 / B00FWN1 / B1F76F9 / B19FQ48 / 2713317 / B01SD70 / 2857817 / B3D7K31 / B7TL820 / BBFL7S1 / B8DPDT7 / BQPVQZ6 / BXDZ9Z0 / BZ1LFB2 / BD8DJ71 / BMQ5T49 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BZ05388 / BDFZSP1 / BK6N347 / BFWK4R7 / BYYWPW6 / BWY52P3 / BYY88Y7 / BDZ30Q0 / BYTJZL1 / BNRQM83 / BJ62Z18</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / New York Times Co / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Vertex Pharmaceuticals Inc / Genmab A/S / Alnylam Pharmaceuticals Inc / Western Union Co / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Domino's Pizza Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Horizon Therapeutics PLC / Shopify Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / Okta Inc / Uber Technologies Inc / PagSeguro Digital Ltd / Beigene Ltd / Blueprint Medicines Corp / Alphabet Inc / Arvinas Inc / Zogenix Inc / Petco Health and Wellness Company Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / France / United Kingdom / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech: RNA-Targeting Small Molecule Drugs? Non-Canonical Roles of Estrogen Receptor (ER) as an RNA Binding Protein</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2576941 / 2455965 / 2684703 / 2931034 / BMQ5T49 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Exelixis Inc / Biogen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Debjit Chattopadhyay, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">3Q21 Global Biopharma Preview: Lackluster 3Q Results Won’t Shake Deteriorating Investor Sentiment, but There’s Value Here</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">2126335 / 0989529 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAC.N / BK.N / BMY.N / BSX.N / C.N / CB.N / CCI.N / COF.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / NEM.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / RHI.N / SLB.N / T.N / TRV.N / PG.N / NUE.N / UHS.N / HAL.N / DHR.N / UNH.N / DOV.N / ROP.N / CAT.N / UNP.N / GS.N / MCD.N / VLO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / STT.N / HCA.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / MCO.N / TDY.N / RF.N / INTC.OQ / AAPL.OQ / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / BRO.N / SIVB.OQ / ZION.OQ / SBUX.OQ / GILD.OQ / DFS.N / TSCO.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / TFC.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / MS.N / CMG.N / STX.AX / ADP.PA / CME.OQ / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / KEY.TO / NOW.N / SYF.N / ANTM.N / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of America Corp / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Capital One Financial Corp / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Robert Half International Inc / Schlumberger NV / AT&T Inc / Travelers Companies Inc / Procter & Gamble Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Valero Energy Corp / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Moody's Corp / Teledyne Technologies Inc / Regions Financial Corp / Intel Corp / Apple Inc / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Brown & Brown Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Truist Financial Corp / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / CME Group Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Keyera Corp / ServiceNow Inc / Synchrony Financial / Anthem Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">BMY Seeks to Terminate Abraxane Supply Agreement with BGNE in China; PT to $414</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / 07725L10 / 11012210 / 6160.HK</td><td class="leftalignment">Bristol-Myers Squibb Co / Beigene Ltd / Bristol-Myers Squibb Co / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D. / Ken Shields</td></tr>
<tr class="even"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAC.N / BK.N / BMY.N / BSX.N / C.N / CB.N / CCI.N / CE.N / CNC.N / COF.N / DAL.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / JPM.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / RHI.N / SLB.N / T.N / TEL.PS / TRV.N / USB.N / WFC.N / PG.N / DGX.N / NUE.N / UHS.N / HAL.N / ADML.L / DHR.N / UNH.N / GD.N / DOV.N / ROP.N / IPG.N / UNP.N / GS.N / MCD.N / VLO.N / UPS.N / WM.N / MMM.N / SHW.N / PKG.N / VZ.N / STT.N / HCA.N / WST.N / VFC.N / APH.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / TWTR.N / MTB.N / GPC.N / BLK.N / TDY.N / RF.N / INTC.OQ / FRC.N / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / BRO.N / SIVB.OQ / ZION.OQ / ORLY.OQ / DFS.N / TSCO.OQ / POOL.OQ / EBAY.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / NFLX.OQ / TXN.OQ / BIIB.OQ / TFC.N / DPZ.N / DLR.N / NDAQ.OQ / CDNS.OQ / MS.N / CMG.N / STX.AX / ADP.PA / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / KEY.TO / BKR.N / NOW.N / SYF.N / CFG.N / ANTM.N / WBA.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / TER.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of America Corp / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Centene Corp / Capital One Financial Corp / Delta Air Lines Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Robert Half International Inc / Schlumberger NV / AT&T Inc / PLDT Inc / Travelers Companies Inc / US Bancorp / Wells Fargo & Co / Procter & Gamble Co / Quest Diagnostics Inc / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Danaher Corp / UnitedHealth Group Inc / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Valero Energy Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / West Pharmaceutical Services Inc / VF Corp / Amphenol Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Twitter Inc / M&T Bank Corp / Genuine Parts Co / BlackRock Inc / Teledyne Technologies Inc / Regions Financial Corp / Intel Corp / First Republic Bank / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / SVB Financial Group / Zions Bancorporation NA / O'Reilly Automotive Inc / Discover Financial Services / Tractor Supply Co / Pool Corp / eBay Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Netflix Inc / Texas Instruments Inc / Biogen Inc / Truist Financial Corp / Domino's Pizza Inc / Digital Realty Trust Inc / Nasdaq Inc / Cadence Design Systems Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Keyera Corp / Baker Hughes Co / ServiceNow Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Walgreens Boots Alliance Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Teradyne Inc / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2050832 / 2206657 / 2317087 / 2684703 / 2799351 / 2825933 / 2900335 / 7103065 / 2712013 / B121557 / 2857817 / 2598246 / B3SWPT2 / B7TL820 / BCZS820 / B7577T2 / BVVN4Q8 / BFZNYB7 / BDHF4K6 / BZ1LFB2 / BR4T3B3 / BZ8VJQ8 / BJFSR99 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BN4RD42 / BNTB3N8 / BMVBZF5 / 120483382</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Ameren Corp / Coca-Cola Co / Entergy Corp / Pfizer Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Tractor Supply Co / Novartis AG / Global Payments Inc / Mastercard Inc / Netflix Inc / Neogenomics Inc / Ameresco Inc / Meta Platforms Inc / Fate Therapeutics Inc / Renewable Energy Group Inc / Eversource Energy / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / HubSpot Inc / Vistra Corp / Revance Therapeutics Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / CureVac NV / Vizio Holding Corp / Immuneering Corp / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 01</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 1, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Renewed Optimism With Broad Domestic Declines, Oral Antiviral Success, and Near-Term Vaccine Authorization for Children</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EFTR: Addressing Large Markets with Novel Targets; Initiating with an Outperform Rating and a $20 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">EFTR.OQ / BMY.N / PFE.N / SASY.PA / ROG.S / AMGN.OQ / NKTR.OQ / SGEN.OQ / MRTX.OQ / ADXS.OQ / IOVA.OQ / MNK.N^J20 / BCAB.OQ</td><td class="leftalignment">eFFECTOR Therapeutics Inc / Bristol-Myers Squibb Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Amgen Inc / Nektar Therapeutics / Seagen Inc / Mirati Therapeutics Inc / Advaxis Inc / Iovance Biotherapeutics Inc / Mallinckrodt PLC / Bioatla Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb sheds $12 billion in MCap in 2021, steepest loss in Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (11 October-): Downward pressure on pharmaceutical sector added after Takeda suspends studies on new drug program</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 6501.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Hitachi Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（10月11日～）: 武田薬品の新薬候補試験の中止が医薬品セクターの下押し圧力となった</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 6501.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Hitachi Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.0% Above Pre-Pandemic Base- Week 79</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 568</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Bristol-Myers Squibb (BMY US) - The tide is high</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">October 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / BMY=US / BXP=US / AMZN=US / GL=US / SLG=US / BC=US / CRK=US / HSII=US / VRM=US / MAR=US / EXPE=US / TTWO=US / ATVI=US / CLI=US / CI=US / KFY=US / AIZ=US / EXEL=US / HZO=US / PDM=US / RARE=US / HOOK=US / REGN=US / SGMO=US / SHOP=US / STRA=US / SNAP=US / TRIP=US / VRTX=US / WIX=US / CGEN=US / HIW=US / BKNG=US / BDN=US / OFC=US / CUZ=US / EPR=US / FB=US / MTCH=US / PRA=US / VNO=US / WRE=US / AMSF=US / AUTL=US / MRNS=US / PTON=US / IGMS=US / JRVR=US / STRO=US / MOH=US / APP=US / EIG=US / APEI=US / TIL=US / NOG=US / KNSL=US / RLJ=US / ANGI=US / EA=US / ABBV=US / MBUU=US / GOOGL=US / BABA=US / CMPR=US / DEA=US / GDDY=US / MCFT=US / LOB=US / PEN=US / SQ=US / CVNA=US / IOVA=US / SFIX=US / FTDR=US / ALLO=US / ESTC=US / HARP=US / LYFT=US / UBER=US / TCRR=US / LSPD=US / PLMR=US / NXTC=US / GMAB=US / ONEW=US / VMEO=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Bristol-Myers Squibb Co / Boston Properties Inc / Amazon.com Inc / Globe Life Inc / SL Green Realty Corp / Brunswick Corp / Comstock Resources Inc / Heidrick & Struggles International Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Take-Two Interactive Software Inc / Activision Blizzard Inc / Veris Residential Inc / Cigna Corp / Korn Ferry / Assurant Inc / Exelixis Inc / MarineMax Inc / Piedmont Office Realty Trust Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Shopify Inc / Strategic Education Inc / Snap Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Compugen Ltd / Highwoods Properties Inc / Booking Holdings Inc / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / EPR Properties / Meta Platforms Inc / Match Group Inc / ProAssurance Corp / Vornado Realty Trust / Washington Real Estate Investment Trust / Amerisafe Inc / Autolus Therapeutics PLC / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / IGM Biosciences Inc / James River Group Holdings Ltd / Sutro Biopharma Inc / Molina Healthcare Inc / Applovin Corp / Employers Holdings Inc / American Public Education Inc / Instil Bio Inc / Northern Oil and Gas Inc / Kinsale Capital Group Inc / RLJ Lodging Trust / Angi Inc / Electronic Arts Inc / Abbvie Inc / Malibu Boats Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / Easterly Government Properties Inc / GoDaddy Inc / Mastercraft Boat Holdings Inc / Live Oak Bancshares Inc / Penumbra Inc / Block Inc / Carvana Co / Iovance Biotherapeutics Inc / Stitch Fix Inc / Frontdoor Inc / Allogene Therapeutics Inc / Elastic NV / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Lightspeed Commerce Inc / Palomar Holdings Inc / NextCure Inc / Genmab A/S / OneWater Marine Inc / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">0925288 / 2126335 / 2000019 / 2002305 / 2085878 / 2113434 / 2270726 / 2542049 / 2317087 / 2684703 / 2048804 / 2799351 / 2825933 / 2503529 / 2783815 / B121557 / 2857817 / B3D7K31 / 2390817 / B7TL820 / B7VD3F2 / BFLR866 / BTN1Y11 / BVVN4Q8 / BYW36M8 / BFZNYB7 / BD8DJ71 / BNFWR44 / BR4T3B3 / BJ2Z0H2 / BKVDFF7 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BJXBP30 / BHRWS81 / BZ1LFG7 / BYY88Y7 / BKC9SX3 / BZ0P3Z5 / BF3N4P3 / BM8MM05 / BMGGJK8 / BLF0CW7 / BM8NHS1 / BF0QTY9</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Abbott Laboratories / Bed Bath & Beyond Inc / Boston Scientific Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Pfizer Inc / Pinnacle West Capital Corp / Sinclair Broadcast Group Inc / South Jersey Industries Inc / World Wrestling Entertainment Inc / Zimmer Biomet Holdings Inc / Mastercard Inc / Netflix Inc / Discovery Inc / Gray Television Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Medtronic PLC / Eversource Energy / PayPal Holdings Inc / Allogene Therapeutics Inc / Snap Inc / Worldline SA / HubSpot Inc / Pinterest Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Levi Strauss & Co / Roku Inc / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Tegna Inc / Arena Pharmaceuticals Inc / Madison Square Garden Entertainment Corp / Valneva SE / Repare Therapeutics Inc / Adagio Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Hot or Not? Checking The Temperature of SMID Oncology Subgroups</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / BMY=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / AUTL=US / IGMS=US / STRO=US / TIL=US / IOVA=US / ALLO=US / HARP=US / TCRR=US / NXTC=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Autolus Therapeutics PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Instil Bio Inc / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biotechnology Fourth-Quarter Catalyst Watch Call: Monday, October 11, at 12:00 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: Deucravacitinib UC LATTICE Trial Disappoints but BMY Exploring Even Higher Doses; Signal of Efficacy in IBD Important for Allo TYK2 Class</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 3Q Earnings And Beyond – Inline Results But Several Major Launches On The Horizon</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">BMY.N / ABBV.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Abbvie Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Deucravacitinib Failure in Ulcerative Colitis a Setback to Tyk2 Opportunity; Company Reiterates Long-Term Revenue Guidance</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third-Quarter Grand Rounds: A Review of Financing, Regulatory, and Business Development Activity</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">03116210 / 09062X103 / 110122108 / 45337C102 / 31572Q80 / 76133010 / 00461U105 / G11196105 / 01671P100 / 501147102 / 77313F106 / 05464T104 / G10830100 / 16961L106 / 89422G107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Bristol-Myers Squibb Co / Incyte Corp / FibroGen Inc / Revance Therapeutics Inc / Aclaris Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Allakos Inc / Krystal Biotech Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Beyondspring Inc / Chinook Therapeutics Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2026242 / 2732635 / 2222631 / 2270726 / 2542049 / 2317087 / 2121352 / 2415204 / 2515030 / 2684703 / 2048804 / 2730190 / 2825933 / 2943523 / 2503529 / 2181334 / 2170473 / B00FWN1 / 2769796 / 2857817 / B5B2106 / B7TL820 / B7VD3F2 / B8DPDT7 / BVVN4Q8 / BYW36M8 / BFZNYB7 / BD8DJ71 / BQT3XY6 / BZ1HM42 / BNFWR44 / BR4T3B3 / BFZ1K46 / BZ1LFG7 / BYY88Y7 / BKC9SX3 / BZ0P3Z5 / BNTB3N8 / BMGGJK8 / BM8NHS1</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / American Electric Power Company Inc / AutoNation Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Group 1 Automotive Inc / Hawaiian Electric Industries Inc / Lithia Motors Inc / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Penske Automotive Group Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Constellation Brands Inc / Alnylam Pharmaceuticals Inc / Fidelity National Information Services Inc / Netflix Inc / Fortinet Inc / Meta Platforms Inc / Duke Energy Corp / Sarepta Therapeutics Inc / Eversource Energy / PayPal Holdings Inc / Allogene Therapeutics Inc / Snap Inc / Cyberark Software Ltd / Adyen NV / Worldline SA / HubSpot Inc / Spotify Technology SA / Roku Inc / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Tegna Inc / Vizio Holding Corp / Valneva SE / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY - EADV TYK2 Follow Up: With TYK2, It’s Increasingly Clear …Go ALLO or You’ll Get JAK’d</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ARNA: Bristol's TYK2 Deucravacitinib Misses in UC; Reiterate ARNA Outperform</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ARNA.OQ / BMY.N</td><td class="leftalignment">Arena Pharmaceuticals Inc / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">10/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Our SITC Planner Highlights 60+ Datapoints Not To Be Missed</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / BMY=US / GILD=US / EXEL=US / CGEN=US / TIL=US / RCUS=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / HARP=US / TCRR=US / NXTC=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Exelixis Inc / Compugen Ltd / Instil Bio Inc / Arcus Biosciences Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">10/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">31</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2486813 / 2778844 / 2280220 / 2270726 / 2542049 / 2317087 / 2630085 / 2657802 / 2684703 / 2048804 / 2730190 / 7103065 / B121557 / 2857817 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / B7577T2 / BFLR866 / BVVN4Q8 / BD8DJ71 / BJ2Z0H2 / BGCYWN8 / BYZM6C2 / BJJMGL2 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BD72R64 / BNTB3N8 / BMW5LX6</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Neogen Corp / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Mastercard Inc / Netflix Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Snap Inc / Pinterest Inc / Xencor Inc / Intellia Therapeutics Inc / Fox Corp / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Liberty Media Corp / Vizio Holding Corp / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: October 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIG.N / AIRP.PA / ALB.N / AN.N / AXP.N / BA.N / BAC.N / BMY.N / CB.N / CCI.N / CI.N / CL.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / JPM.N / KO.N / LLY.N / MMC.N / NEM.N / OXY.N / PFE.N / PHM.N / PPCJ.J / RHI.N / SC.N / T.N / TMO.N / WFC.N / WMT.N / ACI.N / AA.N / PG.N / HUM.N / NUE.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / DT.N / IPG.N / UNP.N / SPOT.N / GS.N / CLX.N / MCD.N / HD.N / LOW.N / MRO.N / UPS.N / MMM.N / XOM.N / DVN.N / NKE.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / PWR.N / V.N / ACN.N / WSM.N / JLL.N / HAE.N / SAM.N / CRL.N / CVX.N / COP.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / AGL.N / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / RGEN.OQ / SIVB.OQ / ZION.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / LNG.A / MRCY.OQ / NVDA.OQ / PACW.OQ / ISRG.OQ / ILMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / BIIB.OQ / TPX.N / TFC.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / CMG.N / FIS.N / STX.AX / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / PAG.N / TDC.N / TNDM.OQ / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / NLSN.N / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / ZNGA.OQ / EPAM.N / PSX.N / WDC.OQ / NOW.N / SRPT.OQ / PANW.N / FANG.OQ / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / OLLI.OQ / NVCR.OQ / PSTG.N / TMUS.OQ / IONS.OQ / TWLO.N / COUP.OQ / LW.N / ATUS.N / IOVA.OQ / ROKU.OQ / CBRE.N / FB.PS / STNE.OQ / CTRA.N / TER.OQ / NWL.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / LFG.AX / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">American International Group Inc / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / AutoNation Inc / American Express Co / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Marsh & McLennan Companies Inc / Newmont Corporation / Occidental Petroleum Corp / Pfizer Inc / Pultegroup Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Alcoa Corp / Procter & Gamble Co / Humana Inc / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / Dynatrace Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / 3M Co / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / Quanta Services Inc / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / agilon health Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Repligen Corp / SVB Financial Group / Zions Bancorporation NA / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / PacWest Bancorp / Intuitive Surgical Inc / Illumina Inc / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Biogen Inc / Tempur Sealy International Inc / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Penske Automotive Group Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Nielsen Holdings PLC / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Zynga Inc / Epam Systems Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Diamondback Energy Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Ollie's Bargain Outlet Holdings Inc / Novocure Ltd / Pure Storage Inc / T-Mobile US Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Altice USA Inc / Iovance Biotherapeutics Inc / Roku Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Coterra Energy Inc / Teradyne Inc / Newell Brands Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Liberty Financial Group Ltd / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">EADV Updates: Opzelura Stays TRUE in Phase III; OX40 Scratches the Itch for Non-JAK Targets; Deucrava PASI-s Durability Test</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">110122108 / 45337C102 / 03116210</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Merck Stock May Continue To Rise</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">With Acceleron Acquisition Merck Stock Is Likely To See A Multiple Revision</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">XNCR - BUY - JNJ Agreement De-Risks Upcoming Data, Re-Establishes Plamotamab as a Contender in Crowded CD20 Space; Increasing PT to $54</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGCYWN8 / 2126335 / BKS3SM8</td><td class="leftalignment">Xencor Inc / Bristol-Myers Squibb Co / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Many Positives, But Upcoming Patent Expirations Depress Growth</td><td class="leftalignment">English</td><td class="rightalignment">115</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Industrials Calendar : October-December 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.L / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / MT.AS / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / EVKn.DE / CSTM.N / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O / HON.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / ArcelorMittal SA / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Evonik Industries AG / Constellium SE / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Sep 24</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (4 October-): JCR Pharmaceuticals up sharply, Shionogi still gaining, sector outperformed TOPIX</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4502.T / 4507.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（10月4日～）: JCRファーマ急進、塩野義は続伸、医薬品セクターはTOPIX対比アウトパフォーム</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4507.T / 4552.T / 4502.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Shionogi & Co Ltd / JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.6% Above Pre-Pandemic Base- Week 78</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 567</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Allaria Ledesma y Cia SA</td><td class="leftalignment">RECOMENDACIONES INTERNACIONALES</td><td class="leftalignment">Spanish</td><td class="rightalignment">5</td><td class="leftalignment">AAPL / AMZN / BBD / BMY / CSCO / MDT / MSFT / TMO / TSM / UL / V / SQ</td><td class="leftalignment">Apple Inc / Amazon.com Inc / Banco Bradesco SA / Bristol-Myers Squibb Co / Cisco Systems Inc / Medtronic PLC / Microsoft Corp / Thermo Fisher Scientific Inc / Taiwan Semiconductor Manufacturing Co Ltd / Unilever PLC / Visa Inc / Block Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / United Kingdom / Ireland / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Allaria Ledesma y Cia SA</td><td class="leftalignment">RECOMENDACIONES INTERNACIONALES</td><td class="leftalignment">Spanish</td><td class="rightalignment">5</td><td class="leftalignment">AAPL / BBD / BMY / CSCO / MDT / MSFT / TMO / TSM / UL / V / SQ / BABA</td><td class="leftalignment">Apple Inc / Banco Bradesco SA / Bristol-Myers Squibb Co / Cisco Systems Inc / Medtronic PLC / Microsoft Corp / Thermo Fisher Scientific Inc / Taiwan Semiconductor Manufacturing Co Ltd / Unilever PLC / Visa Inc / Block Inc / Alibaba Group Holding Ltd</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Cayman Islands / United Kingdom / Ireland / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb plummets 10% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Euro Credit Pilot - Good news priced in (September 2021)</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">US88579Y1010 / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANZ.AX / APD.N / ASML.AS / ATCOA.ST / AXAF.PA / BAC.N / BARC.L / BKT.MC / BMWG.DE / BNPP.PA / BNS.TO / BOUY.PA / BP.L / BT.L / C.N / CAPP.PA / CARR.PA / CBA.AX / CBKG.DE / CCH.L / CM.TO / CNPP.PA / CRH.I / DANO.PA / DEO.N / DSMN.AS / EDP.LS / ENI.MI / ERICb.ST / ERST.VI / FREG.F / GASI.MI / GE.N / GM.N / HEIG.F / HEIN.AS / HSBA.L / IBE.MC / IBM.N / KPN.AS / LLOY.L / LVMH.PA / MAP.MC / MDBI.MI / MGA / MICP.PA / MRK.N / PRTP.PA / SAN.MC / T.N / CONG.DE / AZN.L / AMGN.O / FER.MC / AAL.L / GS.N / ACE.MI / DBKGn.DE / MCD.N / FMEG.DE / BZU.MI / ENEI.MI / MRCG.DE / DTEGn.F / BBVA.MC / BTI.N / IFXGn.DE / FR0000064578 / FR0000035081 / ISS.CO / CARLb.CO / ADEN.S / HNRGn.DE / DPWGn.DE / IG.MI / GSK.L / BAB.L / AMXL.MX / EUFI.PA / JCDX.PA / GB0008220112 / SE0000455057 / US1101221083 / US2987361092 / US3377381088 / US4943681035 / US5949181045 / JP3116000005 / CAGR.PA / AMA.MC / DANSKE.CO / CH0013841017 / ARLG.DE / ENAG.MC / AV.L / US20030N1019 / US02209S1033 / EBKG.DE / JYSK.CO / MAERSKb.CO / HRA.MI / CAIV.VI / US46625H1005 / INGA.AS / LXSG.DE / BTGGg.F / GB0033986497 / ELI.BR / EDF.PA / ETL.PA / GAZP.MM / US31620M1062 / AKE.PA / ISP.MI / DWNG.DE / DK0060079531 / AU000000GMG2 / SABE.MC / CNE1000001Z5 / CNE1000002H1 / FR0010690156 / BNRGN.DE / IREE.MI / CNE100000KC0 / CABK.MC / US03027X1000 / LEGN.DE / GYC.DE / 1COV.DE / IMB.L / SE0009922164 / BIRG.I / BMG2178K1009 / BAWG.VI / LU0251710041 / AT0000BAWAG2 / AIBG.I / AIG.A / NL00150006R6</td><td class="leftalignment">3M Co / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Australia and New Zealand Banking Group Ltd / Air Products and Chemicals Inc / ASML Holding NV / Atlas Copco AB / AXA SA / Bank of America Corp / Barclays PLC / Bankinter SA / Bayerische Motoren Werke AG / BNP Paribas SA / Bank of Nova Scotia / Bouygues SA / BP PLC / BT Group PLC / Citigroup Inc / Capgemini SE / Carrefour SA / Commonwealth Bank of Australia / Commerzbank AG / Coca Cola HBC AG / Canadian Imperial Bank of Commerce / CNP Assurances SA / CRH PLC / Danone SA / Diageo PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Fresenius SE & Co KGaA / Assicurazioni Generali SpA / General Electric Co / General Motors Co / HeidelbergCement AG / Heineken NV / HSBC Holdings PLC / Iberdrola SA / International Business Machines Corp / Koninklijke KPN NV / Lloyds Banking Group PLC / LVMH Moet Hennessy Louis Vuitton SE / Mapfre SA / Mediobanca Banca di Credito Finanziario SpA / Magna International Inc / Compagnie Generale des Etablissements Michelin SCA / Merck & Co Inc / Kering SA / Banco Santander SA / AT&T Inc / Continental AG / AstraZeneca PLC / Amgen Inc / Ferrovial SA / Anglo American PLC / Goldman Sachs Group Inc / Acea SpA / Deutsche Bank AG / McDonald's Corp / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / British American Tobacco PLC / Infineon Technologies AG / Covivio SA / Icade SA / Iss A/S / Carlsberg A/S / Adecco Group AG / Hannover Rueck SE / Deutsche Post AG / Italgas SpA / GlaxoSmithKline PLC / Babcock International Group PLC / America Movil SAB de CV / Eurofins Scientific SE / JCDecaux SA / DS Smith PLC / Fastighets AB Balder / Bristol-Myers Squibb Co / Euronet Worldwide Inc / Fiserv Inc / Kimberly-Clark Corp / Microsoft Corp / Asahi Group Holdings Ltd / Credit Agricole SA / Amadeus IT Group SA / Danske Bank A/S / Lonza Group AG / Aareal Bank AG / Enagas SA / Aviva PLC / Comcast Corp / Altria Group Inc / EnBW Energie Baden Wuerttemberg AG / Jyske Bank A/S / AP Moeller - Maersk A/S / Hera SpA / CA Immobilien Anlagen AG / JPMorgan Chase & Co / ING Groep NV / Lanxess AG / Bertelsmann SE & Co KGaA / ITV PLC / Elia Group SA / Electricite de France SA / Eutelsat Communications SA / Gazprom PAO / Fidelity National Information Services Inc / Arkema SA / Intesa Sanpaolo SpA / Deutsche Wohnen SE / DSV A/S / Goodman Group / Banco de Sabadell SA / Bank of China Ltd / China Construction Bank Corp / Aeroports de Paris SA / Brenntag SE / Iren SpA / China National Chemical Engineering Co Ltd / Caixabank SA / American Tower Corp / LEG Immobilien SE / Grand City Properties SA / Covestro AG / Imperial Brands PLC / Essity AB (publ) / Bank of Ireland Group PLC / CK Infrastructure Holdings Ltd / BAWAG Group AG / CPI Property Group SA / BAWAG Group AG / Aib Group PLC / American International Group Inc / Ctp NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Czech Republic / Germany / Denmark / Spain / Finland / France / United Kingdom / Greece / Hungary / Ireland / Italy / Japan / Luxembourg / Mexico / Netherlands / Norway / New Zealand / Poland / Portugal / Russian Federation / Slovakia / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MISCELLANEOUS / CHANGE IN RECOMMENDATION / MODELS / PORTFOLIO STRATEGY / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Research Digest / Equity</td><td class="leftalignment">Herr Gianfranco Arcovito / Herr Christian Aust / Herr Tobias Keller / Herr. Stefan Kolek / Herr Sven Kreitmair, CFA / Herr. Franz Rudolf / Herr Jonathan Schroer / Frau. Jana Schuler / Frau Silke Stegemann / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">2126335 / 2000019 / 2942605 / 2280220 / 2270726 / 2272476 / 2317087 / 2100920 / 2471950 / 2632003 / 2048804 / 2862532 / 2799351 / 2829601 / 2931034 / B121557 / B19FQ48 / 2857817 / B3D7K31 / B6197Q2 / 2390817 / B4MG4Z6 / B7VD3F2 / B8L2798 / BBGVT40 / B7577T2 / BVVN4Q8 / BQPVQZ6 / BYW36M8 / BD3W133 / BYNZGK1 / BDHF4K6 / BZ8FPH3 / BYZM6C2 / BLGJ610 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BZ0P3Z5 / BP84RX0 / BM8MM05 / BYQCZ35 / BYXR425 / BMV31Q4 / BJLV8T9 / BM8NHS1</td><td class="leftalignment">Bristol-Myers Squibb Co / Amazon.com Inc / Avista Corp / DTE Energy Co / Walt Disney Co / Dollar Tree Inc / Entergy Corp / FirstEnergy Corp / Incyte Corp / New York Times Co / Pinnacle West Capital Corp / E W Scripps Co / Sinclair Broadcast Group Inc / Southern Co / Vertex Pharmaceuticals Inc / Mastercard Inc / Amicus Therapeutics Inc / Netflix Inc / Discovery Inc / Generac Holdings Inc / Gray Television Inc / AMC Networks Inc / Duke Energy Corp / Hemisphere Media Group Inc / News Corp / Renewable Energy Group Inc / Eversource Energy / Horizon Therapeutics PLC / PayPal Holdings Inc / Keurig Dr Pepper Inc / Block Inc / CRISPR Therapeutics AG / Editas Medicine Inc / Intellia Therapeutics Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Tegna Inc / Townsquare Media Inc / Madison Square Garden Entertainment Corp / Madison Square Garden Sports Corp / RH / Audacy Inc / Celldex Therapeutics Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">JAKs in the Box - Are Allosteric Inhibitors the “TYK”et to a Clean Label?</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Mr. Yatin Suneja</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker - Wegovy launch insights: For The Week Ended Sep 17</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Bristol-Myers Squibb Company SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Bristol Myers Squibb Stock After An 11% Fall In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2094670 / 2778844 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2657802 / 2689560 / 2684703 / 2707677 / 2730190 / 2862532 / 2138158 / 2799351 / 2829601 / 7103065 / 2857817 / 2390817 / B7TL820 / B7JYSG3 / B8L2798 / B7577T2 / B8DPDT7 / BFLR866 / BVVN4Q8 / BK0VHF6 / BD8DJ71 / BGCYWN8 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BZ0P3Z5 / BP84RX0 / BGKG6M3 / BF3N4P3 / BMV31Q4 / BNNTQY0 / BJ62Z18</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Best Buy Co Inc / Merck & Co Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / E W Scripps Co / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / Novartis AG / Netflix Inc / Gray Television Inc / Meta Platforms Inc / Guidewire Software Inc / Hemisphere Media Group Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Twitter Inc / Eversource Energy / IDEAYA Biosciences Inc / Snap Inc / Xencor Inc / Spotify Technology SA / Fox Corp / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Tegna Inc / Townsquare Media Inc / StoneCo Ltd / Arena Pharmaceuticals Inc / Audacy Inc / Oatly Group AB / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3956</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch Fourth Quarter 2021</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">00444P108 / 654405109 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Acer Therapeutics Inc / 9 Meters Biopharma Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Boosters Approved for High Risk and Elderly, Cases in South and West Decline, 5- to 11-Year-Old Data Positive</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / John Boyle / Lachlan Hanbury-Brown / Sami Corwin, PHD / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 27 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / BE0165385973 / CH0012032048 / CH0012005267 / US0116591092 / US0234361089 / US0463531089 / US0997241064 / US1101221083 / US1264081035 / US22284P1057 / US23918K1088 / US3021301094 / US31428X1063 / US37733W1053 / US4433201062 / US4448591028 / US4456581077 / US4781601046 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8356993076 / US8447411088 / US9029251066 / US9078181081 / US9113121068 / US91324P1021 / US9139031002 / US9507551086 / CA1363751027 / JP3435000009 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US60855R1005 / US15135B1017 / US50187A1079 / US0491642056 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / NL0000687663 / US01748X1028 / US2473617023 / US00922R1059 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US92839U2069 / US40412C1018 / JE00B783TY65 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US72919P2020 / US00912X3026 / US00404A1097 / US8485771021 / US21240E1055 / US02376R1023 / DK0060534915 / US03937C1053 / CA0089118776 / US0367521038 / US86881A1007 / US98138J2069 / CA87241L1094 / US74967X1037 / US23753F1075 / US80689H1023 / US4990491049 / US92336X1090 / US5904791358 / US28414H1032 / US1255231003 / US1567271093 / US26142R1041 / US6541101050 / US67181A1079 / US33813J1060 / US18914F1030 / US55406W1036 / US6877931096 / US82671G1004 / US45784A1043 / LU2314763264 / US90089L1089 / US01625V1044 / US74276R1023 / US00857U1079 / US92337R1014 / US68622V1061 / US53228F1012 / US28489L1044 / US10920V1070 / US13781Y1038 / US28623U1016 / IL0011786154 / CA50202P1053 / US14171W1036</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Melexis NV / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amedisys Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / DaVita Inc / Expeditors International of Washington Inc / FedEx Corp / GlaxoSmithKline PLC / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Sony Group Corp / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / United Parcel Service Inc / UnitedHealth Group Inc / Universal Health Services Inc / Werner Enterprises Inc / Canadian National Railway Co / Sony Group Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Molina Healthcare Inc / Centene Corp / LHC Group Inc / Atlas Air Worldwide Holdings Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Air Transport Services Group Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Visteon Corp / HCA Healthcare Inc / Aptiv PLC / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Plug Power Inc / Air Lease Corp / Acadia Healthcare Company Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Novo Nordisk A/S / ArcBest Corp / Air Canada / Anthem Inc / Surgery Partners Inc / Workhorse Group Inc / TFI International Inc / RH / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Veoneer Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Cigna Corp / Cerence Inc / DraftKings Inc / Nikola Corp / Oak Street Health Inc / Fisker Inc / Clover Health Investments Corp / MYT Netherlands Parent BV / Oscar Health Inc / Signify Health Inc / InnovAge Holding Corp / Arrival SA / TuSimple Holdings Inc / Alignment Healthcare Inc / Privia Health Group Inc / agilon health Inc / Vera Therapeutics Inc / Organon & Co / Lifestance Health Group Inc / Electric Last Mile Solutions Inc / Bright Health Group Inc / Cano Health Inc / Elevation Oncology Inc / REE Automotive Ltd / Li-Cycle Holdings Corp / CareMax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Japan / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator: Advancing Targeted Neurology With Genetic Insights Into Neuroinflammation</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (27 September-): Pharma sector rally led by Daiichi Sankyo; medical device/testing names also solid</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4568.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 3333.HK / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Daiichi Sankyo Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / China Evergrande Group / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / INTERNAL REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（9月27日～）: 第一三共の先導で医薬品セクター浮上、医療機器・検査も堅調</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4568.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 3333.HK / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Daiichi Sankyo Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / China Evergrande Group / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">09/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.2% Above Pre-Pandemic Base- Week 77</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bloomsbury Publishing climbs 19% in 2021, outperforming 84% of its global peers</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 566</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ESMO Recap: Enchanting Data From Enhertu, CD73 Excitement, Ensuing KRAS Battle, and Emerging New Targets</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">110122108 / G10830100 / 03116210 / 09062X103 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 462222100 / 19459J104 / G11196105 / 00887A105 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 720795103 / 49372L100 / 05280R100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 37890U108 / 03836N103 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / 73730P108 / 81181C104 / 877619106 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Bristol-Myers Squibb Co / Beyondspring Inc / Amgen Inc / Biogen Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Aptinyx Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Poseida Therapeutics Inc / Seagen Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Tim F. Lugo / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / 2367026 / 2126335 / 2681511 / 2000019 / 2008154 / 2497406 / 2065955 / 2113434 / 2270726 / 2317087 / 2471950 / 2459020 / 2684703 / 2048804 / 2440637 / 2862532 / 2799351 / 2971029 / 2822019 / 2857817 / B03PGL4 / 2390817 / B65LWX6 / B7TL820 / BBFL7S1 / B8L2798 / BFDV8K0 / BBPK0J0 / B7577T2 / BVVN4Q8 / BYW36M8 / BYNZGK1 / BD9GVY0 / BZ1LFB2 / BFZ1K46 / BMYML02 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BJVR9Y9 / BJXBP30 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BKX9VD3 / BKC9SX3 / BYNQ369 / BZ0P3Z5 / BMG75B4 / BP84RX0 / BLBLMD5 / BMV31Q4 / BM8NHS1 / BMFKLL6</td><td class="leftalignment">American Express Co / General Mills Inc / Bristol-Myers Squibb Co / PepsiCo Inc / Amazon.com Inc / Adobe Inc / Kroger Co / Autozone Inc / Boston Scientific Corp / Walt Disney Co / Entergy Corp / Incyte Corp / Intuit Inc / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Sinclair Broadcast Group Inc / LKQ Corp / Advance Auto Parts Inc / Netflix Inc / NorthWestern Corp / Gray Television Inc / O'Reilly Automotive Inc / Meta Platforms Inc / bluebird bio Inc / Hemisphere Media Group Inc / MacroGenics Inc / Mirati Therapeutics Inc / Renewable Energy Group Inc / Eversource Energy / PayPal Holdings Inc / Block Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Evergy Inc / Vistra Corp / iHeartMedia Inc / Turning Point Therapeutics Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / Arcutis Biotherapeutics Inc / Arcturus Therapeutics Holdings Inc / Albertsons Companies Inc / Tegna Inc / Inventiva SA / Townsquare Media Inc / Array Technologies Inc / Audacy Inc / Adagio Therapeutics Inc / Aeye Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / France / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Merck Stock At $72?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2126335 / 2000019 / 2008154 / 2065955 / 2270726 / 2829515 / 2317087 / 2455965 / 2459020 / 2630085 / 2048804 / 2440637 / 7123870 / B1Y9TB3 / 2857817 / B02R1L6 / B4Y1MH7 / B03PGL4 / B7577T2 / BFLR866 / BVVN4Q8 / BJLKVS6 / BMYML02 / BLGJ610 / BFMXGR0 / BZ1LFG7 / BYY88Y7 / BZ0P3Z5 / BF3N4P3 / BN7K304 / BNG3RZ7 / BMFPJK6 / BMBP1Q0</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Adobe Inc / Autozone Inc / Walt Disney Co / Edison International / Entergy Corp / Biogen Inc / Intuit Inc / Neogen Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Nestle SA / Danone SA / Netflix Inc / ALLETE Inc / KAR Auction Services Inc / NorthWestern Corp / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Phathom Pharmaceuticals Inc / DraftKings Inc / Warner Music Group Corp / Evergy Inc / Roku Inc / Alphabet Inc / Tegna Inc / Arena Pharmaceuticals Inc / Academy Sports and Outdoors Inc / Leslie's Inc / ACV Auctions Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1073</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2100920 / 2689560 / 2684703 / 2730190 / 2842255 / 2098876 / 7103065 / B121557 / 2769796 / 2857817 / B7TL820 / B4MG4Z6 / BBPK0J0 / B7577T2 / B8DPDT7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BHC8X90 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Yum! Brands Inc / Novartis AG / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Mirati Therapeutics Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Novo Nordisk A/S / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 0989529 / 2126335 / 2681511 / 2000019 / 2023607 / 2640147 / 2778844 / 2270726 / 2542049 / 2829515 / 2317087 / 2576941 / 2689560 / 2684703 / 2440637 / B1F76F9 / B121557 / 2857817 / 2983563 / B5B2106 / 2982924 / BBPK0J0 / B95N910 / B7577T2 / BFLR866 / BVVN4Q8 / BYNZGK1 / BZ1LFB2 / BKS3SM8 / BNFWR44 / BMQ5T49 / BKVDFF7 / BLGJ610 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BD6JX35 / BN2R582 / BQXZP64 / BLF0CW7 / BMVBZF5</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Nike Inc / Merck & Co Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Entergy Corp / Exelixis Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Western Union Co / Mastercard Inc / Netflix Inc / Carmax Inc / Fortinet Inc / Spectrum Pharmaceuticals Inc / Mirati Therapeutics Inc / PTC Inc / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Block Inc / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Worldline SA / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Evergy Inc / Fox Corp / ViacomCBS Inc / Krystal Biotech Inc / Relay Therapeutics Inc / Wayfair Inc / Repare Therapeutics Inc / Immuneering Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: Mid-Quarter Model Update; Lowering PT from $82 to $73 as Sequential Cliff & COVID-Related Slowdown Warrant DCF Valuation Focus on 2030</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ESMO 2021 oral and late-breaking sessions (Part 1): Zai lab, BeiGene and Hutchmed</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">0013.HK / 6160.HK / ZLAB.OQ / 1093.HK / BMY.N / 1177.HK / 600276.SS / MRTX.OQ / BGNE.OQ / HCM.OQ / 1801.HK / 2142.HK</td><td class="leftalignment">HUTCHMED (China) Ltd / Beigene Ltd / Zai Lab Ltd / CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Sino Biopharmaceutical Ltd / Jiangsu Hengrui Pharmaceuticals Co Ltd / Mirati Therapeutics Inc / Beigene Ltd / HUTCHMED (China) Ltd / Innovent Biologics Inc / Hbm Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Hong Kong / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Remain Stable Amidst Delta - Week 76</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended September 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SUPN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">SUPN.O / ABT / BMY / JNJ / LLY / UTHR.O / ZGNX.O</td><td class="leftalignment">Supernus Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / United Therapeutics Corp / Zogenix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALGM=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Allegro Microsystems Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 565</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 17 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US00846U1016 / US0463531089 / US1101221083 / US2435371073 / US5324571083 / US6541061031 / US66987V1098 / US7170811035 / US7711951043 / US9418481035 / US3448491049 / US80105N1054 / US2533931026 / FI0009013296 / US9043111072 / US58933Y1055 / US5560991094 / US64104Y1064 / US30057T1051 / US89377M1099 / US0843101017</td><td class="leftalignment">Agilent Technologies Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Deckers Outdoor Corp / Eli Lilly and Co / Nike Inc / Novartis AG / Pfizer Inc / Roche Holding AG / Waters Corp / Foot Locker Inc / Sanofi SA / DICK'S Sporting Goods Inc / Neste Oyj / Under Armour Inc / Merck & Co Inc / MacroGenics Inc / Neste Oyj / Evoqua Water Technologies Corp / Transmedics Group Inc / Berkeley Lights Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Finland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Our Take On Data In ESMO Abstracts Ahead Of The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0463531089 / US1101221083 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AHT.L / BMY.N / CSL.AX / ELE.MC / HSX.L / IBE.MC / JD.L / JNJ.N / KOMN.S / KSP.I / PRTP.PA / SAN.MC / SAPJ.J / STM.PA / AZN.L / AAL.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / BAMI.MI / NOVN.S / FMEG.DE / ENEI.MI / MRCG.DE / BBVA.MC / BANB.S / GSK.L / ITX.MC / FLS.CO / PFIZ.NS / REGN.OQ / GILD.OQ / MAERSKB.CO / IFCN.S / BIIB.OQ / LXSG.DE / DRX.L / ISP.MI / ALM.MC / FXPO.L / SOON.S / GRLS.MC / SABE.MC / BAYGN.DE / 0486.HK / PHNX.L / OCDO.L / CABK.MC / CDR.WA / ABBV.N / OCI.AS / ELIOR.PA / SKIN.S / G24N.DE / LANDI.S / KAPQ.L / MOVE.S / GMAB.CO / JETJ.L / PPGN.S</td><td class="leftalignment">Ashtead Group PLC / Bristol-Myers Squibb Co / CSL Ltd / Endesa SA / Hiscox Ltd / Iberdrola SA / JD Sports Fashion PLC / Johnson & Johnson / Komax Holding AG / Kingspan Group PLC / Kering SA / Banco Santander SA / Sappi Ltd / STMicroelectronics NV / AstraZeneca PLC / Anglo American PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Banco BPM SpA / Novartis AG / Fresenius Medical Care AG & Co KGaA / Enel SpA / Merck KGaA / Banco Bilbao Vizcaya Argentaria SA / Bachem Holding AG / GlaxoSmithKline PLC / Industria de Diseno Textil SA / FLSmidth & Co A/S / Pfizer Ltd / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / AP Moeller - Maersk A/S / Inficon Holding AG / Biogen Inc / Lanxess AG / Drax Group PLC / Intesa Sanpaolo SpA / Almirall SA / Ferrexpo PLC / Sonova Holding AG / Grifols SA / Banco de Sabadell SA / Bayer AG / OK Rusal MKPAO / Phoenix Group Holdings PLC / Ocado Group PLC / Caixabank SA / CD Projekt SA / Abbvie Inc / OCI NV / Elior Group SA / Cassiopea SpA / Scout24 SE / Landis+Gyr Group AG / NAK Kazatomprom AO / Medacta Group SA / Genmab A/S / Just Eat Takeaway.com NV / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / India / Ireland / Italy / Kazakhstan / Netherlands / Norway / Poland / Russian Federation / Sweden / Turkey / United States / South Africa</td><td class="leftalignment">Apparel & Textiles / Banks / Biotechnology / Building & Building Materials / Chemicals / Consumer / Electronics / Energy / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Retailing / Semiconductors / Shipping & Shipbuilding / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Allaria Ledesma y Cia SA</td><td class="leftalignment">RECOMENDACIONES INTERNACIONALES RECOMENDACIONES INTERNACIONALES</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BBD / BMY / CSCO / MDT / TMO / TSM / BABA</td><td class="leftalignment">Banco Bradesco SA / Bristol-Myers Squibb Co / Cisco Systems Inc / Medtronic PLC / Thermo Fisher Scientific Inc / Taiwan Semiconductor Manufacturing Co Ltd / Alibaba Group Holding Ltd</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Cayman Islands / United Kingdom / India / Ireland / Japan / Mexico / Taiwan / United States</td><td class="leftalignment">Advertising / Apparel & Textiles / Appliances / Automotive / Broadcasting & Cable / Building & Building Materials / Consumer / Electronics / Healthcare / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Photography / Publishing / Retailing / Services / Technology / Tire & Rubber / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Merck Stock After A 5% Fall In A Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US02553E1064 / US1101221083 / US2855121099 / US5002551043 / US8168501018 / US87612E1064 / US9311421039 / US21036P1084 / US90384S3031 / US0995021062 / US30303M1027 / US90184L1026 / US00771V1089 / US0994061002 / US72703H1014 / US02079K1079 / US74967X1037 / US83304A1060 / US5024311095 / US92766K1060 / US69047Q1022 / US13123X5086 / US58406B1035 / US30322L1017</td><td class="leftalignment">American Eagle Outfitters Inc / Bristol-Myers Squibb Co / Electronic Arts Inc / Kohls Corp / Semtech Corp / Target Corp / Walmart Inc / Constellation Brands Inc / Ulta Beauty Inc / Booz Allen Hamilton Holding Corp / Meta Platforms Inc / Twitter Inc / Aerie Pharmaceuticals Inc / Boot Barn Holdings Inc / Planet Fitness Inc / Alphabet Inc / RH / Snap Inc / L3harris Technologies Inc / Virgin Galactic Holdings Inc / Ovintiv Inc / Callon Petroleum Co / MedAvail Holdings Inc / F45 Training Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Rethinking Revlimid OUS Clips Outlook</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / AMGN=US / BMY=US / HD=US / MDT=US / GILD=US / PEB=US / H=US / MTN=US / LOW=US / IGT=US / MAR=US / ADS=US / TTWO=US / TNL=US / ATVI=US / HLT=US / CLI=US / CHH=US / DRH=US / EXEL=US / MHK=US / HOOK=US / REGN=US / SGMO=US / TRIP=US / SGMS=US / CNM=US / MTCH=US / IGMS=US / STRO=US / APP=US / SHO=US / HST=US / WH=US / TIL=US / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / RHP=US / TILE=US / AERI=US / BWXT=US / PEN=US / IBEX=US / TTD=US / PK=US / PLYA=US / CVNA=US / NCNA=US / DCPH=US / GSKY=US / BTAI=US / TCRR=US / GMAB=US / RBLX=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Medtronic PLC / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Activision Blizzard Inc / Hilton Worldwide Holdings Inc / Veris Residential Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Exelixis Inc / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Scientific Games Corp / Core & Main Inc / Match Group Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Aerie Pharmaceuticals Inc / BWX Technologies Inc / Penumbra Inc / Ibex Ltd / Trade Desk Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / NuCana PLC / Deciphera Pharmaceuticals Inc / GreenSky Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S / Roblox Corp / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Is Bristol-Myers Squibb Co a Good Long-Term Investment?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ESMO Planner Highlights 130+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / LLY=US / AMGN=US / BMY=US / GILD=US / EXEL=US / HOOK=US / REGN=US / IGMS=US / STRO=US / TIL=US / NCNA=US / DCPH=US / BTAI=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Instil Bio Inc / NuCana PLC / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Billal Jahangiri / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ESMO Abstract Highlights and Virtual Conference Itinerary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">00887A105 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Aileron Therapeutics Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Tim F. Lugo / Mr. Raju Prasad, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Sep. 14, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Labor Day Holiday Clouds Preliminary Domestic Declines, Focus on Imminent Pfizer Adolescent Vaccine Data and Booster Debate</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2670519 / 2328915 / 2459020 / 2689560 / 2684703 / 2440637 / 7103065 / B121557 / 2212922 / 2857817 / 2982924 / B7VD3F2 / BFDV8K0 / BBPK0J0 / B95N910 / BVVN4Q8 / BYW36M8 / BZ1LFB2 / BJXBP30 / BYQHPK7 / BYYWPW6 / BZ1LFG7 / BJDX8Y8 / BWY4XV3 / BGT0PL8 / BNTB3N8 / BMGGJK8</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Intuit Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Spectrum Pharmaceuticals Inc / Duke Energy Corp / MacroGenics Inc / Mirati Therapeutics Inc / PTC Inc / Eversource Energy / PayPal Holdings Inc / Deciphera Pharmaceuticals Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Roku Inc / Mirum Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / DiaMedica Therapeutics Inc / Vizio Holding Corp / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US healthcare reform back in focus: Build Back Better includes direct negotiation</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / CSL.AX / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ESMO0 2021 first impression (Part 3): Zai lab, Alphamab, Akeso, and Hutchmed</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / AZN.L / MRCG.DE / 600276.SS / MGNX.OQ / HCM.OQ / ZLAB.OQ / 1801.HK / 1877.HK</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Merck KGaA / Jiangsu Hengrui Pharmaceuticals Co Ltd / MacroGenics Inc / HUTCHMED (China) Ltd / Zai Lab Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 03, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ESMO 2021 first impression (Part 1): BeiGene, HBM, and Innovent</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">1801.HK / 2142.HK / 6160.HK / 1093.HK / BMY.N / 1177.HK / NOVN.S / 600276.SS / MRTX.OQ / BGNE.OQ / HCM.OQ / ZLAB.OQ</td><td class="leftalignment">Innovent Biologics Inc / Hbm Holdings Ltd / Beigene Ltd / CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Sino Biopharmaceutical Ltd / Novartis AG / Jiangsu Hengrui Pharmaceuticals Co Ltd / Mirati Therapeutics Inc / Beigene Ltd / HUTCHMED (China) Ltd / Zai Lab Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Hong Kong / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 75</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALGM=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Allegro Microsystems Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 564</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - POSEIDON data at World Lung: Efficacy disappointing in already crowded market</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AZN.L / BMY.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 2126335 / 2516152 / 2732635 / 2437071 / 2208073 / 2270726 / 2317087 / 2670519 / 2328915 / 2457864 / 2515030 / 2689560 / 2684703 / B121557 / 2857817 / 2983563 / B3D7K31 / B23FN39 / B7TL820 / B7VD3F2 / BBGVT40 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYZLV46 / BJF8Q81 / BD8DJ71 / BJLKVS6 / BZB1XF2 / BYXJQG9 / BYY88Y7 / BMG75B4 / BYXR425 / BZ4CHH2 / BMDJ397 / BLR6S36 / BMFPJK6 / BNLYBF3</td><td class="leftalignment">Sanofi SA / Bristol-Myers Squibb Co / Eli Lilly and Co / AutoNation Inc / Biomarin Pharmaceutical Inc / Copart Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / ImmunoGen Inc / Lithia Motors Inc / PG&E Corp / Pfizer Inc / Mastercard Inc / Netflix Inc / Carmax Inc / Discovery Inc / Lululemon Athletica Inc / Meta Platforms Inc / Duke Energy Corp / News Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / InflaRx NV / IAA Inc / Snap Inc / Phathom Pharmaceuticals Inc / Tactile Systems Technology Inc / Spire Inc / Alphabet Inc / Inventiva SA / RH / Soleno Therapeutics Inc / Bolt Biotherapeutics Inc / Longboard Pharmaceuticals Inc / ACV Auctions Inc / Erasca Inc</td><td class="leftalignment"></td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: World Lung (WCLC) & ESMO cancer conference preview</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / JNJ.N / AZN.L / SASY.PA / ROG.S / NOVN.S / MRCG.DE / REGN.OQ / SGEN.OQ / 4568.T / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Regeneron Pharmaceuticals Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended September 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Invest Heroes</td><td class="leftalignment">Bristol-Myers Squibb Co – Initial coverage report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dmitrii Novichkov</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT (BUY) - Clinical Collaboration With BMY To Evaluate BDC-1001 With Opdivo; Trial Progress On Track As Guided; Reiterating BUY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / BMDJ397 / 2126335</td><td class="leftalignment">Bristol-Myers Squibb Co / Bolt Biotherapeutics Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2367026 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2270726 / 2317087 / 2670519 / 2328915 / 2689560 / 2684703 / 2048804 / 2829601 / 7103065 / B1F76F9 / 2857817 / B3D7K31 / BCZS820 / BFDV8K0 / BVVN4Q8 / BYW36M8 / BJLT387 / BD8DJ71 / BJ5FZ74 / BFZ1K46 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BWY4XV3 / BMG5660 / BMHR7K6 / BP0TJN7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / General Mills Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Novartis AG / Western Union Co / Netflix Inc / Discovery Inc / Fate Therapeutics Inc / MacroGenics Inc / Eversource Energy / PayPal Holdings Inc / Avantor Inc / Snap Inc / Adaptive Biotechnologies Corp / Spotify Technology SA / ViacomCBS Inc / Roku Inc / Alphabet Inc / Adaptimmune Therapeutics PLC / Joann Inc / Impel Neuropharma Inc / Xponential Fitness Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 27, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / FR0000054470 / GB0009252882 / DE0006969603 / US09061G1013 / CH0012032048 / CH0012005267 / US0116591092 / US0311621009 / US0463531089 / US1101221083 / US1311931042 / US14149Y1082 / US1985161066 / US2435371073 / US2855121099 / US3377381088 / US3755581036 / US37733W1053 / US45337C1027 / US5324571083 / US58155Q1031 / US6541061031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US7782961038 / US8305661055 / US8308791024 / US8447411088 / US8725401090 / US8740541094 / US9182041080 / US03073E1055 / US3448491049 / US37940X1028 / US4771431016 / US4198791018 / US80105N1054 / US2533931026 / US09062X1037 / US9043111072 / US31620M1062 / US1314761032 / US4103451021 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US6936561009 / US7512121010 / JE00B783TY65 / US98986T1088 / US00287Y1091 / US85916J4094 / US41068X1000 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / DK0060534915 / CA0089118776 / US83417M1045 / US00653A1079 / VGG312491084 / US5904791358 / US98585X1046 / US89377M1099 / US26142R1041 / US02875D1090 / US04271T1007 / US82489W1071 / US30320C1036 / US1241551027 / US30260D1037 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Ubisoft Entertainment SA / GlaxoSmithKline PLC / Puma SE / Biomarin Pharmaceutical Inc / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cardinal Health Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Electronic Arts Inc / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Eli Lilly and Co / Mckesson Corp / Nike Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Ross Stores Inc / Skechers USA Inc / SkyWest Inc / Southwest Airlines Co / TJX Companies Inc / Take-Two Interactive Software Inc / VF Corp / Amerisourcebergen Corp / Foot Locker Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / DICK'S Sporting Goods Inc / Biogen Inc / Under Armour Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / HanesBrands Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / PVH Corp / Ralph Lauren Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / Stereotaxis Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Solaredge Technologies Inc / Adaptimmune Therapeutics PLC / Establishment Labs Holdings Inc / Mesa Air Group Inc / Yeti Holdings Inc / Transmedics Group Inc / DraftKings Inc / American Outdoor Brands Inc / Array Technologies Inc / Shoals Technologies Group Inc / FTC Solar Inc / Butterfly Network Inc / Figs Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Panama / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">2126335 / 2000019 / 2486813 / 2973821 / 2050832 / 2942605 / 2270726 / 2317087 / 2328915 / 2369174 / 2048804 / 2138158 / 2829601 / 2853688 / B1F76F9 / B121557 / 2857817 / B03PGL4 / B7TL820 / BCBVTX1 / B4MG4Z6 / B7JYSG3 / B7577T2 / BFLR866 / BVVN4Q8 / BYY8XK8 / BP4GNK9 / BYW36M8 / BJLFHW7 / BZ8FPH3 / BFZ1K46 / BZ1LFG7 / BYY88Y7 / BN2R582 / BD72R64 / BMHR7K6 / BL53KF5 / BP2P6L0 / BMW5LX6</td><td class="leftalignment">Bristol-Myers Squibb Co / Amazon.com Inc / Kellogg Co / Alliant Energy Corp / Ameren Corp / Avista Corp / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Gilead Sciences Inc / Pinnacle West Capital Corp / Sempra Energy / Southern Co / Stryker Corp / Western Union Co / Mastercard Inc / Netflix Inc / NorthWestern Corp / Meta Platforms Inc / Agios Pharmaceuticals Inc / AMC Networks Inc / Guidewire Software Inc / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / WEC Energy Group Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Chewy Inc / Editas Medicine Inc / Spotify Technology SA / Roku Inc / Alphabet Inc / Relay Therapeutics Inc / Liberty Media Corp / Impel Neuropharma Inc / F45 Training Holdings Inc / Tango Therapeutics Inc / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / 4516.T / 4506.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">TNGX - The Next Innovative Player in "La Cumparsita" of Synthetic Lethality; Initiating Coverage of Tango Therapeutics with a BUY Rating and $16 PT</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BP2P6L0 / 0989529 / 0925288 / 2126335 / 2369174 / 2455965 / 2684703 / 7103065 / BCBVTX1 / BBPK0J0 / BK0VHF6 / BYYWPW6 / BL71K91 / BN2RM92 / BLF0CW7</td><td class="leftalignment">Tango Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / IDEAYA Biosciences Inc / Beigene Ltd / Revolution Medicines Inc / Rain Therapeutics Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Bristol Myers Squibb (Buy, TP=$85) - 12m target upgrade - Still a value favourite - J. Smith (5p)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Justin S. Smith / Florent Cespedes / Dinesh Choudhary</td></tr>
<tr class="even"><td class="leftalignment">09/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 74</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ALGM=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Allegro Microsystems Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: Eliquis Patent Decision Confirms April 2028 Expiry and Removes Overhang</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 563</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 2126335 / 2516152 / 2000019 / 2065159 / 2270726 / 2317087 / 2670519 / 2328915 / 2471950 / 2689560 / 2684703 / 2048804 / 2730190 / 7103065 / 2857817 / B0T7YX2 / B7VD3F2 / B85KFY9 / BFH3N85 / BVVN4Q8 / BZ1HM42 / BNFWR44 / BLGJ610 / BJJMGL2 / BKTNTR9 / BDFZSP1</td><td class="leftalignment">Sanofi SA / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Autodesk Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Incyte Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Netflix Inc / Live Nation Entertainment Inc / Duke Energy Corp / Five Below Inc / Veeva Systems Inc / Eversource Energy / Adyen NV / Worldline SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Okta Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">FDA Guidance Adds More Caution for JAKs Across Inflammatory Diseases</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108 / 45337C102</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">NUS RMI-CRI</td><td class="leftalignment">Weekly Credit Brief (Aug 24 - Aug 30)</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Abbvie Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CREDIT / BOND</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">NUS RMI-CRI</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Bristol Myers Squibb (BMY: $66.86) wipes off $2 billion in MCap in August, highest loser in Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Allaria Ledesma y Cia SA</td><td class="leftalignment">RECOMENDACIONES INTERNACIONALES RECOMENDACIONES INTERNACIONALES</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BBD / BMY / CSCO / MDT / TMO / TSM / BABA</td><td class="leftalignment">Banco Bradesco SA / Bristol-Myers Squibb Co / Cisco Systems Inc / Medtronic PLC / Thermo Fisher Scientific Inc / Taiwan Semiconductor Manufacturing Co Ltd / Alibaba Group Holding Ltd</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Cayman Islands / United Kingdom / India / Ireland / Japan / Mexico / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Bristol Myers Squibb Stock Rebound After A 4% Fall Last Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2000019 / 2778844 / 2002305 / 2026242 / 2113434 / 2216850 / 2270726 / 2829515 / 2317087 / 2670519 / 2328915 / 2100920 / 2689560 / 2684703 / 2048804 / 2138158 / 2799351 / 2829601 / 2503529 / 7103065 / 2212922 / 2857817 / BDZCRX3 / BFH3N85 / BVVN4Q8 / BJJMGL2 / BKTNTR9 / BZ1LFG7 / BGKG6M3 / BNTB3N8 / BP8GHT2 / BLF0CW7 / BM8NHS1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Merck & Co Inc / Abbott Laboratories / American Electric Power Company Inc / Boston Scientific Corp / Consolidated Edison Inc / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / NRG Energy Inc / Netflix Inc / RingCentral Inc / Veeva Systems Inc / Eversource Energy / Fox Corp / ViacomCBS Inc / Roku Inc / StoneCo Ltd / Vizio Holding Corp / Vascular Biogenics Ltd / Repare Therapeutics Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Preliminary Signs of Domestic Inflection, Awaiting Return to School Impact, Fall Seasonality, and Booster Rollout</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Happening With Merck Stock?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 20, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 30 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US0079731008 / US0116591092 / US0126531013 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US37733W1053 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / AU000000LYC6 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US00287Y1091 / NL0010273215 / US8485771021 / US21240E1055 / US02376R1023 / DK0060534915 / CA0089118776 / KYG4740B1059 / CA53680Q2071 / SE0009414576 / US5904791358 / US53814L1089 / US5533681012 / US58406B1035 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Advanced Energy Industries Inc / Alaska Air Group Inc / Albemarle Corp / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / GlaxoSmithKline PLC / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / Lynas Rare Earths Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Ichor Holdings Ltd / Lithium Americas Corp / Oncopeptides AB / Mesa Air Group Inc / Livent Corp / Mp Materials Corp / MedAvail Holdings Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">08/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 73</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRVI=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Bristol-Myers Squibb Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 562</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: Novartis: CANOPY-1 P3 topline readout in 1L NSCLC expected in late 3Q/early 4Q21</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NOVN.S / BMY.N / MRK.N / SASY.PA / ROG.S / REGN.OQ</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Merck & Co Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb strengthens 2.0% in past quarter; Institutional Ownership steady</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Is There Long-Term Value in Bloomsbury Publishing PLC?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Apparel & Textiles / Appliances / Automotive / Broadcasting & Cable / Building & Building Materials / Consumer / Electronics / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Photography / Publishing / Retailing / Services / Tire & Rubber / Internet / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Aug 13</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Bloomsbury Publishing Plc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EGRX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EGRX.O / BMY / JNJ / LLY / NVS / AMGN.O / GSK / TEVA.K</td><td class="leftalignment">Eagle Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2486813 / 2778844 / 2973821 / 2216850 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2459020 / 2680905 / 2684703 / 2048804 / 2503529 / 7103065 / B125XQ6 / B0T7YX2 / 2949758 / B7577T2 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYNZGK1 / BYZR4X4 / BMYML02 / BKTNTR9 / BD72R64 / 021513106 / BN4NJG4 / BKPGJQ1 / BMVBZF5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / World Wrestling Entertainment Inc / Novartis AG / Portland General Electric Co / Live Nation Entertainment Inc / Nexstar Media Group Inc / Renewable Energy Group Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Block Inc / Axsome Therapeutics Inc / DraftKings Inc / ViacomCBS Inc / Liberty Media Corp / Alto Ingredients Inc / Freeline Therapeutics Holdings PLC / Squarespace Inc / Immuneering Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 13, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CADL: A Later-Stage Oncolytic Viral Immunotherapy Platform; Initiating with an Outperform, $15 TP</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ABT.N / BMY.N / MRK.N / AZN.L / NOVN.S / GSK.L / 601607.SS / 2607.HK / ALXO.OQ / IKNA.OQ</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Shanghai Pharmaceuticals Holding Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / ALX Oncology Holdings Inc / Ikena Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.3% Above Pre-Pandemic Base- Week 72</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/21/2021</td><td class="leftalignment">Allaria Ledesma y Cia SA</td><td class="leftalignment">RECOMENDACIONES INTERNACIONALES</td><td class="leftalignment">Spanish</td><td class="rightalignment">5</td><td class="leftalignment">BBD / BMY / CSCO / MDT / TMO / TSM / BABA</td><td class="leftalignment">Banco Bradesco SA / Bristol-Myers Squibb Co / Cisco Systems Inc / Medtronic PLC / Thermo Fisher Scientific Inc / Taiwan Semiconductor Manufacturing Co Ltd / Alibaba Group Holding Ltd</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Cayman Islands / Ireland / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VNDA-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VNDA.O / BMY / JNJ / LLY / MRK / NVS / PFE / TTNP.O</td><td class="leftalignment">Vanda Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRVI=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 561</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LGND-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LGND.O / BAX / BMY / JNJ / LLY / MRK / PFE / AMGN.O / GSK / SPPI.O</td><td class="leftalignment">Ligand Pharmaceuticals Inc / Baxter International Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Spectrum Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">OPK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OPK.O / ABT / BMY / JNJ / LH / REGN.O / ALNY.O / ARDX.O / TEVA.K</td><td class="leftalignment">OPKO Health Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ardelyx Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2486813 / 2778844 / 2026242 / 2270726 / 2829515 / 2670519 / 2328915 / 2689560 / 2684703 / 2829601 / 2503529 / 7103065 / B17HG57 / B0T7YX2 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYNZGK1 / BK1KWF7 / BMYML02 / BLGJ610 / BYXJQG9 / BKTNTR9 / BD72R64 / BP8GHT2 / BMHR7K6 / BNNTQY0 / BP0TJN7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Cardiovascular Systems Inc / Live Nation Entertainment Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Block Inc / Grocery Outlet Holding Corp / DraftKings Inc / Warner Music Group Corp / Spire Inc / ViacomCBS Inc / Liberty Media Corp / Vascular Biogenics Ltd / Impel Neuropharma Inc / Oatly Group AB / Xponential Fitness Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Delta Continues to Drive Domestic and Global Growth; Early Signs From Back to School in Low Vaccination Areas Concerning</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Bloomsbury Publishing PLC</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Apparel & Textiles / Appliances / Automotive / Broadcasting & Cable / Building & Building Materials / Consumer / Electronics / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Photography / Publishing / Retailing / Services / Tire & Rubber / Internet / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 6, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ME: Sitting on a Genome Mine: Initiate with an Outperform Rating and $13 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">ME.OQ / BMY.N / MRK.N / ROG.S / LH.N / MRCG.DE / GSK.L / GILD.OQ / MYGN.OQ / ILMN.OQ / SGEN.OQ / ALM.MC / NVTA.N / NTRA.OQ / BGNE.OQ / 6160.HK</td><td class="leftalignment">23andMe Holding Co. / Bristol-Myers Squibb Co / Merck & Co Inc / Roche Holding AG / Laboratory Corporation of America Holdings / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Myriad Genetics Inc / Illumina Inc / Seagen Inc / Almirall SA / Invitae Corp / Natera Inc / Beigene Ltd / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Spain / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.5% Above Pre-Pandemic Base- Week 71</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRVI=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 560</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2126335 / 2293819 / 2486813 / 2026242 / 2270726 / 2670519 / 2328915 / 2630513 / 2684703 / 2707677 / 2829601 / 2503529 / B125XQ6 / B0T7YX2 / B3D7K31 / 2982924 / B7TL820 / B4MG4Z6 / BFLR866 / BFZCHN7 / B95WG16 / BYVY8G0 / B0SDJB4 / BMQ5T49 / BFZ1K46 / BMYML02 / BKTNTR9 / BFWK4R7 / BHZSB82 / BDH65C8 / BDZ30Q0 / BYP71H7 / BN2R582 / BG0Q4Y1 / BMC5RV6 / BGT0PL8 / BD72R64 / BMDJ397 / BMC8SQ7 / BNTB3N8 / BN2RM92 / BN2S6Y8 / BLF0CW7 / BNKGXX2 / BP7KZP7 / BMW5084 / BNLYJ60</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / eBay Inc / Kellogg Co / American Electric Power Company Inc / Walt Disney Co / Exelon Corp / Nextera Energy Inc / New Jersey Resources Corp / Pfizer Inc / Public Service Enterprise Group Inc / Southern Co / World Wrestling Entertainment Inc / Portland General Electric Co / Live Nation Entertainment Inc / Discovery Inc / Spectrum Pharmaceuticals Inc / Meta Platforms Inc / AMC Networks Inc / Twitter Inc / Wix.Com Ltd / Zoetis Inc / Alphabet Inc / Zealand Pharma A/S / Zentalis Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / ViacomCBS Inc / PagSeguro Digital Ltd / Covetrus Inc / PetIQ Inc / Arvinas Inc / National Vision Holdings Inc / Relay Therapeutics Inc / Exicure Inc / Adicet Bio Inc / DiaMedica Therapeutics Inc / Liberty Media Corp / Bolt Biotherapeutics Inc / BTRS Holdings Inc / Vizio Holding Corp / Rain Therapeutics Inc / Talaris Therapeutics Inc / Repare Therapeutics Inc / Verve Therapeutics Inc / Monte Rosa Therapeutics Inc / PMV Pharmaceuticals Inc / Imago BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Summer May Be Ending, but Things Are Heating Up for Innate Immunity Drug Development: Featuring Top 10 Hot Targets in Neuro/Immunology</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">0925288 / 2126335 / 2516152 / 2778844 / 2369174 / 2455965 / 7103065 / BGCYWN8 / BMPRZV5 / BJLV8T9</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Novartis AG / Xencor Inc / Kymera Therapeutics Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yatin Suneja / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PSON-GB Company reports financial results for the half-year ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PSON.L / DMGOa.L / ERM.L / BLPU.L</td><td class="leftalignment">Pearson PLC / Daily Mail and General Trust P L C / Euromoney Institutional Investor PLC / Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REL-GB Company reports financial results for the half-year ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REL.L / DMGOa.L / ERM.L / PSON.L / QRT.L / BLPU.L</td><td class="leftalignment">Relx PLC / Daily Mail and General Trust P L C / Euromoney Institutional Investor PLC / Pearson PLC / Quarto Group Inc / Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RPTX (BUY) - Mgmt Discussion Highlights Near-Term Clinical Data for RP-3500 in Early 4Q 2021; Earnings & Pipeline Progress in Line</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BLF0CW7 / 2126335</td><td class="leftalignment">Repare Therapeutics Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CACI=US / BMY=US / MCD=US / GBT=US / WEN=US / EBAY=US / GILD=US / PEB=US / H=US / MTN=US / DIOD=US / VRM=US / MAR=US / ADS=US / TNL=US / HLT=US / AVT=US / CBRL=US / CHH=US / DRI=US / DRH=US / MCHP=US / SGMO=US / BKNG=US / SIVB=US / DIN=US / FLT=US / APP=US / SHO=US / PLAY=US / DENN=US / CMG=US / TDG=US / HST=US / RPRX=US / TAST=US / QSR=US / WH=US / JACK=US / HGV=US / NXPI=US / APTS=US / RLJ=US / VAC=US / RHP=US / NDLS=US / LOCO=US / ANTM=US / SHAK=US / ON=US / WING=US / PK=US / PLYA=US / MBIN=US / FSK=US / GOCO=US / AVAH=US</td><td class="leftalignment">CACI International Inc / Bristol-Myers Squibb Co / McDonald's Corp / Global Blood Therapeutics Inc / Wendys Co / eBay Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Diodes Inc / Vroom Inc / Marriott International Inc / Alliance Data Systems Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Microchip Technology Inc / Sangamo Therapeutics Inc / Booking Holdings Inc / SVB Financial Group / Dine Brands Global Inc / Fleetcor Technologies Inc / Applovin Corp / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / TransDigm Group Inc / Host Hotels & Resorts Inc / Royalty Pharma PLC / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / Preferred Apartment Communities Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Noodles & Co / El Pollo Loco Holdings Inc / Anthem Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Merchants Bancorp / FS KKR Capital Corp / Gohealth Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Model Update</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 11 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0231351067 / US1101221083 / US1266501006 / US5719032022 / US7170811035 / US8552441094 / US8968181011 / US9021041085 / US9282981086 / US21036P1084 / US8936411003 / US7181721090 / US4485791028 / US30212P3038 / US8969452015 / US00287Y1091 / US85916J4094 / US87918A1051 / US00938A1043 / US89686D1054 / US43300A2033 / US83304A1060 / US02083G1004 / VGG273581030 / US09857L1089 / US80706P1030 / US03836N1037 / US05455M1009 / CA39342L1085 / US90353T1007 / US39874R1014 / US89677Q1076 / ACRGau.CD / US85209E1091 / US3441741077 / US68062P1066 / US0090661010 / US73739W1045 / US82489W1071 / US23954D1090 / US47103J1051 / US00109K1051</td><td class="leftalignment">Amazon.com Inc / Bristol-Myers Squibb Co / CVS Health Corp / Marriott International Inc / Pfizer Inc / Starbucks Corp / Triumph Group Inc / II-VI Inc / Vishay Intertechnology Inc / Constellation Brands Inc / TransDigm Group Inc / Philip Morris International Inc / Hyatt Hotels Corp / Expedia Group Inc / Tripadvisor Inc / Abbvie Inc / Stereotaxis Inc / Teladoc Health Inc / Airgain Inc / Trivago NV / Hilton Worldwide Holdings Inc / Snap Inc / Alpine Immune Sciences Inc / Despegar.com Corp / Booking Holdings Inc / Scholar Rock Holding Corp / Aptinyx Inc / AVROBIO Inc / Green Thumb Industries Inc / Uber Technologies Inc / Grocery Outlet Holding Corp / Trip.com Group Ltd / Acreage Holdings Inc / Spruce Biosciences Inc / Foghorn Therapeutics Inc. / Olema Pharmaceuticals Inc / Airbnb Inc / Poshmark Inc / Shoals Technologies Group Inc / Day One Biopharmaceuticals Inc / Janux Therapeutics Inc / AFC Gamma Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Highlights From Virtual Company Visits - Day 1</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US7170811035 / US00287Y1091</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2486813 / 2778844 / 2973821 / 2050832 / 2280220 / 2542049 / 2829515 / 2670519 / 2328915 / 2689560 / 2684703 / 2829601 / 2503529 / 7103065 / B0T7YX2 / B570P91 / BBFL7S1 / B7VD3F2 / B8L2798 / BFDV8K0 / BBPK0J0 / BQPVQZ6 / BYVY8G0 / BYW36M8 / BYQHP96 / BF5L3T2 / BYNZGK1 / BD9GVY0 / BKS3SM8 / BYZR4X4 / BYQNYR5 / BMYML02 / BLGJ610 / BYXJQG9 / BJXBP30 / BZ1LFG7 / BKC9SX3 / BD6JX35 / BDVLM39 / BZ0P3Z5 / BYSFJV8 / BYTJZL1 / BWY4XV3 / BDD1B07 / BDRW1L7 / BF3N4P3 / BJRFSB7 / BD72R64 / BLR6S36 / BNTB3N8 / BMV31Q4 / BKPGJQ1 / BFYVZ75 / BNLYJ60 / BNLYBF3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Ameren Corp / DTE Energy Co / Dominion Energy Inc / Edison International / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Live Nation Entertainment Inc / Lear Corp / bluebird bio Inc / Duke Energy Corp / Hemisphere Media Group Inc / MacroGenics Inc / Mirati Therapeutics Inc / Horizon Therapeutics PLC / Alphabet Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Elanco Animal Health Inc / Block Inc / Zai Lab Ltd / IGM Biosciences Inc / Axsome Therapeutics Inc / Senseonics Holdings Inc / DraftKings Inc / Warner Music Group Corp / Spire Inc / Turning Point Therapeutics Inc / Roku Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / argenx SE / Tegna Inc / Planet Fitness Inc / Zogenix Inc / Adaptimmune Therapeutics PLC / Rubius Therapeutics Inc / AnaptysBio Inc / Arena Pharmaceuticals Inc / Immunovant Inc / Liberty Media Corp / Longboard Pharmaceuticals Inc / Vizio Holding Corp / Audacy Inc / Squarespace Inc / Seelos Therapeutics Inc / Imago BioSciences Inc / Erasca Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ERAS (BUY) - ERASe CAncer with a Deep RAS/MAPK-Focused Pipeline - Initiating Coverage with a BUY Rating and $25 PT</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">BNLYBF3 / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / 2713317 / BBFL7S1 / BBPK0J0 / BD9GVY0 / BDHF4K6 / BZ1LFB2 / BZ8FPH3 / BWY52P3 / BL71K91 / BDZ30Q0 / BN2R582 / BMPRZV5 / BMDJ397 / BN2RM92 / BP7KZP7</td><td class="leftalignment">Erasca Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Mirati Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / Editas Medicine Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Relay Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Food for Thought : US healthcare in FY22 Budget Resolution bill & latest touted FDA Commissioner candidate tough views on pricing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / UCB.BR / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Bristol-Myers Squibb (BMY US) - Q2 second opinion: thesis intact</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 30</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.4% Above Pre-Pandemic Base- Week 70</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRVI=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended August 02,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, BMY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for BMY. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 559</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Forecast Of The Day: Bristol-Myers Squibb's Cardiovascular Drugs Revenue</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">BMY.N / PFE.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Bristol-Myers Squibb</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / T=US / DVN=US / CMA=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PB=US / MGY=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / MRO=US / TNL=US / KFRC=US / VMC=US / MGM=US / HLT=US / UNM=US / CVS=US / RCL=US / UNH=US / MAC=US / WTFC=US / AIZ=US / AMED=US / AMN=US / APH=US / FUN=US / CENT=US / KIDS=US / CHH=US / CSTR=US / CW=US / DRH=US / EEFT=US / MPLX=US / DOC=US / ASGN=US / OKE=US / PACW=US / RHI=US / SGMO=US / SMG=US / TGI=US / WAL=US / HTH=US / BXS=US / CCRN=US / FNF=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / DCP=US / FRT=US / FBK=US / JAZZ=US / MTCH=US / ASB=US / SSB=US / SPR=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / EVOP=US / UCBI=US / VICI=US / ECPG=US / MGP=US / PNFP=US / SBCF=US / BDSI=US / JRVR=US / RPD=US / BIIB=US / FLT=US / TCBI=US / FNB=US / FHN=US / KAR=US / BDC=US / SHO=US / RNST=US / LHCG=US / CHNG=US / HST=US / MA=US / GPRE=US / ELF=US / WU=US / TEL=US / CADE=US / WH=US / IAC=US / PSN=US / JACK=US / SWI=US / VRSK=US / OAS=US / HGV=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / EA=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / UPLD=US / GDDY=US / ETSY=US / LOB=US / EVRI=US / ACBI=US / EDIT=US / 82982L103 / VVV=US / PK=US / PVAC=US / TVTY=US / 50189K103 / PLYA=US / SBOW=US / PETQ=US / ROKU=US / MBIN=US / MAXR=US / EOLS=US / HWC=US / OZK=US / FTDR=US / ALLO=US / AMTB=US / UBER=US / RTLR=US / IMVT=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / AT&T Inc / Devon Energy Corp / Comerica Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Travel + Leisure Co / Kforce Inc / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Unum Group / CVS Health Corp / Royal Caribbean Cruises Ltd / UnitedHealth Group Inc / Macerich Co / Wintrust Financial Corp / Assurant Inc / Amedisys Inc / AMN Healthcare Services Inc / Amphenol Corp / Cedar Fair LP / Central Garden & Pet Co / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Euronet Worldwide Inc / MPLX LP / Physicians Realty Trust / ASGN Inc / ONEOK Inc / PacWest Bancorp / Robert Half International Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Triumph Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Cross Country Healthcare Inc / Fidelity National Financial Inc / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / DCP Midstream LP / Federal Realty Investment Trust / FB Financial Corp / Jazz Pharmaceuticals PLC / Match Group Inc / Associated Banc-Corp / SouthState Corp / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / EVO Payments Inc / United Community Banks Inc / VICI Properties Inc / Encore Capital Group Inc / MGM Growth Properties LLC / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / James River Group Holdings Ltd / Rapid7 Inc / Biogen Inc / Fleetcor Technologies Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / KAR Auction Services Inc / Belden Inc / Sunstone Hotel Investors Inc / Renasant Corp / LHC Group Inc / Change Healthcare Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / elf Beauty Inc / Western Union Co / TE Connectivity Ltd / Cadence Bank / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Parsons Corp / Jack in the Box Inc / SolarWinds Corp / Verisk Analytics Inc / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Electronic Arts Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / Upland Software Inc / GoDaddy Inc / ETSY Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Atlantic Capital Bancshares Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Valvoline Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / Tivity Health Inc / LCI Industries / Playa Hotels & Resorts NV / SilverBow Resources Inc / PetIQ Inc / Roku Inc / Merchants Bancorp / Maxar Technologies Inc / Evolus Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Amerant Bancorp Inc / Uber Technologies Inc / Rattler Midstream LP / Immunovant Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / France / Ireland / Liberia / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">XLRN: Q2 Earnings Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Bristol Myers Squibb sequential quarterly profits hit by 47.8% fall</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb climbs 10.4% in 2021</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: SMID-Cap Oncology Take-Aways From Big-Cap 2Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / GILD=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - 1Q results: Healthy earnings; guidance raised</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / BMY.N</td><td class="leftalignment">Eisai Co Ltd / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 1Q決算：業績好調、業績予想増額修正</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / BMY.N</td><td class="leftalignment">Eisai Co Ltd / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Bristol Myers Squibb - $86.15 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Delta Continues to Drive Domestic and Global Growth; Vaccines Continue to Show Efficacy Despite Breakthrough Infections</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2270726 / 2542049 / 2829515 / 2328915 / 2100920 / 2415204 / 2689560 / 2684703 / 2829601 / 7103065 / 2712013 / B1HMF22 / B125XQ6 / B3SWPT2 / BCZS820 / BDZCRX3 / BFLR866 / BVVN4Q8 / BQPVQZ6 / BYVY8G0 / BYNZGK1 / BJLT387 / BZB1XF2 / BR4T3B3 / BYXJQG9 / BGSP7M9 / BZ1LFG7 / BDVLM39 / BG0Q4Y1 / BJRFSB7 / BMZ9Z11 / BNTB3N8 / BWC52Q6 / BJ62Z18</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / PG&E Corp / Pfizer Inc / Southern Co / Novartis AG / Global Payments Inc / First Solar Inc / Portland General Electric Co / Ameresco Inc / Fate Therapeutics Inc / RingCentral Inc / Twitter Inc / Eversource Energy / Horizon Therapeutics PLC / Alphabet Inc / Block Inc / Avantor Inc / Tactile Systems Technology Inc / HubSpot Inc / Spire Inc / Zoom Video Communications Inc / Roku Inc / argenx SE / Exicure Inc / Immunovant Inc / Prometheus Biosciences Inc / Vizio Holding Corp / Solaredge Technologies Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for BMBYF</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">G1179Q132</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ROKU=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Roku Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">PMVP - Precision Oncology Against Mutant p53 - The Next KRAS? Initiating Coverage with a BUY Rating and $56 PT</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">BMW5084 / 0989529 / 2126335 / 2023607 / 2684703 / 7103065 / BCBVTX1 / BN2RM92</td><td class="leftalignment">PMV Pharmaceuticals Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Amgen Inc / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 69</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/31/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ROKU=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Roku Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Bristol Myers Squibb (BMY: $67.87) rises for a second consecutive month, a two-month rise of 4%</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">NL0000226223 / FR0000120578 / GB0009895292 / DE0006231004 / GB0009252882 / CH0012032048 / CH0012005267 / US0079031078 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1727551004 / US1985161066 / US2435371073 / US2546871060 / US37733W1053 / US4581401001 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US55306N1046 / US5719032022 / US5951121038 / US6541061031 / US6549022043 / US66987V1098 / US6701002056 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US8610121027 / US8807701029 / US9282981086 / US9581021055 / US83088M1027 / US80105N1054 / US1572101053 / US6098391054 / US9043111072 / US82706C1080 / US5500211090 / US25470F1049 / US58933Y1055 / US4485791028 / US25470F3029 / US00164V1035 / US30212P3038 / US8969452015 / US00287Y1091 / NL0010273215 / US55405Y1001 / KYG037AX1015 / DK0060534915 / US74736K1016 / KYG4740B1059 / LGFb / US89686D1054 / US43300A2033 / LGFa / VGG273581030 / US09857L1089 / US11135F1012 / US98585X1046 / US35137L1052 / US70614W1009 / US89677Q1076 / US92556H2067 / GB00BMVP7Y09 / US0090661010 / US5738741041 / IE00BKVD2N49 / US30260D1037 / US68622V1061 / US81730H1095 / US89142B1070 / US69120X1072 / US30049H1023</td><td class="leftalignment">STMicroelectronics NV / Sanofi SA / AstraZeneca PLC / Infineon Technologies AG / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Advanced Micro Devices Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cirrus Logic Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Walt Disney Co / GlaxoSmithKline PLC / Intel Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / Micron Technology Inc / Nike Inc / Nokia Oyj / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / STMicroelectronics NV / Teradyne Inc / Vishay Intertechnology Inc / Western Digital Corp / Skyworks Solutions Inc / Sanofi SA / CEVA Inc / Monolithic Power Systems Inc / Under Armour Inc / Silicon Motion Technology Corp / Lululemon Athletica Inc / Discovery Inc / Merck & Co Inc / Hyatt Hotels Corp / Discovery Inc / AMC Networks Inc / Expedia Group Inc / Tripadvisor Inc / Abbvie Inc / ASML Holding NV / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Novo Nordisk A/S / Qorvo Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Trivago NV / Hilton Worldwide Holdings Inc / Lions Gate Entertainment Corp / Despegar.com Corp / Booking Holdings Inc / Broadcom Inc / Yeti Holdings Inc / Fox Corp / Peloton Interactive Inc / Trip.com Group Ltd / ViacomCBS Inc / Royalty Pharma PLC / Airbnb Inc / Marvell Technology Inc / Seagate Technology Holdings PLC / Figs Inc / Organon & Co / SentinelOne Inc / Torrid Holdings Inc / Owlet Inc / Evolv Technologies Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 558</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Allaria Ledesma y Cia SA</td><td class="leftalignment">RECOMENDACIONES INTERNACIONALES RECOMENDACIONES INTERNACIONALES</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BBD / BMY / CSCO / DAL / MDT / TSM / BABA / KHC</td><td class="leftalignment">Banco Bradesco SA / Bristol-Myers Squibb Co / Cisco Systems Inc / Delta Air Lines Inc / Medtronic PLC / Taiwan Semiconductor Manufacturing Co Ltd / Alibaba Group Holding Ltd / Kraft Heinz Co</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Cayman Islands / United Kingdom / India / Ireland / Japan / Mexico / Turkey / Taiwan / United States</td><td class="leftalignment">Advertising / Agriculture / Apparel & Textiles / Appliances / Automotive / Beverages & Tobacco / Broadcasting & Cable / Building & Building Materials / Consumer / Cosmetics & Personal Care / Electronics / Food / Healthcare / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Photography / Publishing / Retailing / Services / Technology / Tire & Rubber / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: India - Sun Pharmaceutical Industries Limited: 1Q boosted by COVID-19; expect moderation in Ilumya ramp-up in 2H FY22. Maintain UNDERPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SUN.BO / BMY.N / TORP.BO / UCB.BR / SKIN.S / ERIS.BO / IQV.N</td><td class="leftalignment">Sun Pharmaceutical Industries Ltd / Bristol-Myers Squibb Co / Torrent Pharmaceuticals Ltd / Ucb SA / Cassiopea SpA / Eris Lifesciences Ltd / IQVIA Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / India / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4528.T: Ono Pharmaceutical - 1Q results solid, but company still tainted by bribery scandal</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4528.T / BMY.N / MRK.N</td><td class="leftalignment">Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4528.T: 小野薬品工業 - 1Q決算：好決算だが、みそぎが未達</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4528.T / BMY.N / MRK.N</td><td class="leftalignment">Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended July 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Bristol-Myers Squibb Co Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BMY=US / MCD=US / AMD=US / RRC=US / AVB=US / AMZN=US / DT=US / EBAY=US / PEB=US / H=US / CONE=US / V=US / MTN=US / IART=US / PB=US / XLNX=US / TRMK=US / MAR=US / TTMI=US / TNL=US / VMC=US / HLT=US / CLI=US / AKR=US / HUM=US / CI=US / MLM=US / WTFC=US / AMK=US / APH=US / BMRN=US / CHH=US / CYH=US / DRH=US / EQIX=US / EQT=US / EEFT=US / EXAS=US / NOW=US / MCRI=US / MNRO=US / ASGN=US / PDM=US / ST=US / STRA=US / VSEC=US / EPD=US / FNF=US / PYPL=US / FAF=US / R=US / EPR=US / FB=US / MAA=US / SSB=US / UDR=US / DRE=US / ENSG=US / AMSF=US / RRR=US / MOH=US / EXP=US / NUVA=US / SHO=US / RNST=US / HST=US / MA=US / SIX=US / XPO=US / TEL=US / OC=US / EHC=US / WH=US / EPRT=US / AR=US / HGV=US / NXPI=US / RLJ=US / VAC=US / FBHS=US / MTDR=US / RHP=US / GOOGL=US / BABA=US / VKTX=US / WING=US / SQ=US / PK=US / GDS=US / PLYA=US / GSKY=US / AMTB=US / LYFT=US / DDOG=US / OVV=US</td><td class="leftalignment">Bristol-Myers Squibb Co / McDonald's Corp / Advanced Micro Devices Inc / Range Resources Corp / Avalonbay Communities Inc / Amazon.com Inc / Dynatrace Inc / eBay Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / CyrusOne Inc / Visa Inc / Vail Resorts Inc / Integra Lifesciences Holdings Corp / Prosperity Bancshares Inc / Xilinx Inc / Trustmark Corp / Marriott International Inc / TTM Technologies Inc / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Veris Residential Inc / Acadia Realty Trust / Humana Inc / Cigna Corp / Martin Marietta Materials Inc / Wintrust Financial Corp / AssetMark Financial Holdings Inc / Amphenol Corp / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Community Health Systems Inc / Diamondrock Hospitality Co / Equinix Inc / EQT Corp / Euronet Worldwide Inc / Exact Sciences Corp / ServiceNow Inc / Monarch Casino & Resort Inc / Monro Inc / ASGN Inc / Piedmont Office Realty Trust Inc / Sensata Technologies Holding PLC / Strategic Education Inc / VSE Corp / Enterprise Products Partners LP / Fidelity National Financial Inc / PayPal Holdings Inc / First American Financial Corp / Ryder System Inc / EPR Properties / Meta Platforms Inc / Mid-America Apartment Communities Inc / SouthState Corp / UDR Inc / Duke Realty Corp / Ensign Group Inc / Amerisafe Inc / Red Rock Resorts Inc / Molina Healthcare Inc / Eagle Materials Inc / NuVasive Inc / Sunstone Hotel Investors Inc / Renasant Corp / Host Hotels & Resorts Inc / Mastercard Inc / Six Flags Entertainment Corp / XPO Logistics Inc / TE Connectivity Ltd / Owens Corning / Encompass Health Corp / Wyndham Hotels & Resorts Inc / Essential Properties Realty Trust Inc / Antero Resources Corp / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Matador Resources Co / Ryman Hospitality Properties Inc / Alphabet Inc / Alibaba Group Holding Ltd / Viking Therapeutics Inc / Wingstop Inc / Block Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / GreenSky Inc / Amerant Bancorp Inc / Lyft Inc / Datadog Inc / Ovintiv Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / V / 0989529 / 2126335 / 2550707 / 2437071 / 2280220 / 2270726 / 2542049 / 2829515 / 2328915 / 2342034 / 2369174 / 2600088 / 2689560 / 2684703 / 2730190 / 2829601 / 2943523 / 2931034 / 2769796 / B28TS42 / B5B2106 / B03PGL4 / B65LWX6 / B7TL820 / B95N910 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BYNZGK1 / BNFWR44 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BFXC911 / BYY88Y7 / BKS3RS7 / BMG75B4 / BMDCDP2 / BZ4CHH2 / BMZ9Z11</td><td class="leftalignment">American Express Co / Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / McDonald's Corp / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / Monro Inc / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Southern Co / Penske Automotive Group Inc / Vertex Pharmaceuticals Inc / Fidelity National Information Services Inc / Ulta Beauty Inc / Fortinet Inc / NorthWestern Corp / O'Reilly Automotive Inc / Meta Platforms Inc / PTC Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / Block Inc / Worldline SA / Spotify Technology SA / Fox Corp / Spire Inc / Guardant Health Inc / Alphabet Inc / 10X Genomics Inc / Inventiva SA / Bigcommerce Holdings Inc / Soleno Therapeutics Inc / Prometheus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY: 2Q21 Postview – beats (but no raise), lots of new product flow ahead</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : 2Q Takeaways - Solid Quarter with New Launch Portfolio and Pipeline Progression</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Solid 2Q21 results; clarity over next 12-18mos likely on how new launches/pipeline could offset LOEs</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 2Q21 (BSX, BMY, HUM, TMO, PFE) – What Mattered for Credit</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / BSX.N / HUM.N / TMO.N / BAX.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Humana Inc / Thermo Fisher Scientific Inc / Baxter International Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: 2Q Beat Driven By Sales Recovery, EPS Guidance Unchanged; Focus Remains on Pipeline & Launches</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">OPK-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OPK.O / ABT / BMY / JNJ / LH / REGN.O / ALNY.O / ARDX.O / TEVA.K</td><td class="leftalignment">OPKO Health Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ardelyx Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Strong Second Quarter With Opdivo and New Product Growth</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HP.N / AFL.N / BA.N / BMY.N / BP.L / F.N / HIG.N / IBM.N / IR.N / NSC.N / PFE.N / SLB.N / TMO.N / AVB.N / DRE.N / HUM.N / HAL.N / GD.N / URI.N / MCD.N / XOM.N / AVY.N / RE.N / APH.N / UDR.N / MAA.N / MCO.N / TEL.N / TDY.N / CTSH.OQ / AAPL.OQ / CINF.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / ROL.N / TYL.N / XLNX.OQ / SBUX.OQ / ODFL.OQ / QCOM.OQ / ORLY.OQ / AMZN.OQ / EQIX.OQ / GRMN.OQ / ALGN.OQ / 0700.HK / RDSA.L / HES.N / 9999.HK / CME.OQ / ADP.OQ / GNRC.N / BKR.N / FBHS.N / FB.OQ / NOW.N / PTC.OQ / PYPL.OQ / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Helmerich and Payne Inc / Aflac Inc / Boeing Co / Bristol-Myers Squibb Co / BP PLC / Ford Motor Co / Hartford Financial Services Group Inc / International Business Machines Corp / Ingersoll Rand Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Avalonbay Communities Inc / Duke Realty Corp / Humana Inc / Halliburton Co / General Dynamics Corp / United Rentals Inc / McDonald's Corp / Exxon Mobil Corp / Avery Dennison Corp / Everest Re Group Ltd / Amphenol Corp / UDR Inc / Mid-America Apartment Communities Inc / Moody's Corp / TE Connectivity Ltd / Teledyne Technologies Inc / Cognizant Technology Solutions Corp / Apple Inc / Cincinnati Financial Corp / Hologic Inc / Lam Research Corp / Microsoft Corp / Rollins Inc / Tyler Technologies Inc / Xilinx Inc / Starbucks Corp / Old Dominion Freight Line Inc / Qualcomm Inc / O'Reilly Automotive Inc / Amazon.com Inc / Equinix Inc / Garmin Ltd / Align Technology Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / Hess Corp / NetEase Inc / CME Group Inc / Automatic Data Processing Inc / Generac Holdings Inc / Baker Hughes Co / Fortune Brands Home & Security Inc / Meta Platforms Inc / ServiceNow Inc / PTC Inc / PayPal Holdings Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 EPS, Sales Beat; 2021 Guidance Reaffirmed</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : 2Q First Impressions: Solid Top-Line Beat Led by Eliquis; New Launches in Line</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2:21 EPS, Revenue Beat; 2021 Non-GAAP Guidance Reiterated</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Second-Quarter Quick Take: Opdivo Posts Best Quarter to Date and CAR-T Therapies Strong Out of the Gate; Guidance Reaffirmed</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Brief of Bristol-Myers Squibb Co conference call, Jul. 28, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Jul. 28, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Earnings Beat In Cards For Merck's Q2?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BE0165385973 / US0079031078 / US0123481089 / US0311621009 / US0323325045 / US0378331005 / US0382221051 / US0463531089 / US0997241064 / US1101221083 / US1265011056 / US1985161066 / US2435371073 / US37733W1053 / US45167R1041 / US4657411066 / US48203R1041 / US5128071082 / US5324571083 / US5370081045 / US55306N1046 / US5949181045 / US6541061031 / US66987V1098 / US6745991058 / US7170811035 / US7237871071 / US7711951043 / US8552441094 / US8636671013 / US8807701029 / US9113121068 / US9282981086 / US98956P1021 / US00508Y1029 / US4198791018 / US80105N1054 / US6098391054 / US6866881021 / US12541W2098 / US9043111072 / US42330P1075 / US3364331070 / US5500211090 / US92826C8394 / US00507V1098 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US13100M5094 / US88160R1014 / US92839U2069 / US8676524064 / JE00B783TY65 / US00287Y1091 / US72919P2020 / US5764852050 / US29355A1079 / US41068X1000 / IE00BLS09M33 / US83417M1045 / US89400J1079 / US87918A1051 / US02079K1079 / US98138J2069 / US87266J1043 / CH0371153492 / US92336X1090 / US0937121079 / US04206A1016 / KY30744W1070 / US98585X1046 / US35952H6018 / US76156B1070 / US86150R1077 / US88339P1012 / US70614W1009 / US1567271093 / US69047Q1022 / US75513E1010 / US6541101050 / US04271T1007 / US33813J1060 / US74767V1098 / US62955J1034 / US73739W1045 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036 / US83089J1088 / US30260D1037</td><td class="leftalignment">Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Amgen Inc / Amtech Systems Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / CTS Corp / Columbia Sportswear Co / Deckers Outdoor Corp / GlaxoSmithKline PLC / IDEX Corp / Itron Inc / Juniper Networks Inc / Lam Research Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Microsoft Corp / Nike Inc / Novartis AG / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / Starbucks Corp / Stryker Corp / Teradyne Inc / United Parcel Service Inc / Vishay Intertechnology Inc / Zimmer Biomet Holdings Inc / Acuity Brands Inc / Hawaiian Holdings Inc / Sanofi SA / Monolithic Power Systems Inc / Ormat Technologies Inc / CH Robinson Worldwide Inc / Under Armour Inc / Helix Energy Solutions Group Inc / First Solar Inc / Lululemon Athletica Inc / Visa Inc / Activision Blizzard Inc / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Calix Inc / Tesla Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Abbvie Inc / Plug Power Inc / Matador Resources Co / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Pentair PLC / Solaredge Technologies Inc / TransUnion / Teladoc Health Inc / Alphabet Inc / Workhorse Group Inc / TPI Composites Inc / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Arlo Technologies Inc / Farfetch Ltd / Yeti Holdings Inc / Fuelcell Energy Inc / Revolve Group Inc / Stoke Therapeutics Inc / RealReal Inc / Peloton Interactive Inc / Cerence Inc / Ovintiv Inc / Raytheon Technologies Corp / Nikola Corp / Array Technologies Inc / Fisker Inc / Quantumscape Corp / Nov Inc / Poshmark Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc / Skywater Technology Inc / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / STE.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / MCD.N / TSN.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / AON.N / ES.N / CME.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / STERIS plc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / CME Group Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for BMY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US00846U1016 / US1101221083 / US42222N1037 / US09062X1037 / US8162121045 / US7310941080 / US03753U1060</td><td class="leftalignment">Agilent Technologies Inc / Bristol-Myers Squibb Co / HealthStream Inc / Biogen Inc / Selecta Biosciences Inc / PolarityTE Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharma Pipelines: Number of Pharma Pipeline Candidates Up 15% YoY</td><td class="leftalignment">English</td><td class="rightalignment">129</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Bristol Myers Squibb Stock After Q2 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AIN / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / INTC=US / MCD=US / AMD=US / RRC=US / WEN=US / PD=US / AMZN=US / DT=US / BLD=US / TEVA=US / NVDA=US / PEB=US / LOW=US / CHKP=US / HSII=US / CHRS=US / BRO=US / SPOT=US / LEG=US / VMC=US / HLT=US / MLM=US / KFY=US / SWIM=US / BNL=US / CBRL=US / DRI=US / ENDP=US / AJG=US / GFF=US / HAS=US / HXL=US / IBP=US / TREE=US / NOW=US / MAS=US / MEDP=US / MHK=US / TEAM=US / NTST=US / PRGO=US / REGI=US / ROLL=US / SNOW=US / BXS=US / CFB=US / LCI=US / ADC=US / BDN=US / FB=US / SSB=US / CATY=US / GBCI=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / PRPL=US / LUMN=US / APEI=US / TIL=US / EPRT=US / JACK=US / ZTS=US / TREX=US / AR=US / RLJ=US / FBHS=US / SPLK=US / ABBV=US / TILE=US / NDLS=US / QURE=US / 00770K202 / LOCO=US / NEWR=US / SHAK=US / WING=US / ACBI=US / WLTW=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / AYX=US / IOVA=US / ARVN=US / ESTC=US / FERG=US / DDOG=US / AZEK=US / BALY=US / DBRG=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / PagerDuty Inc / Amazon.com Inc / Dynatrace Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / Pebblebrook Hotel Trust / Lowe's Companies Inc / Check Point Software Technologies Ltd / Heidrick & Struggles International Inc / Coherus BioSciences Inc / Brown & Brown Inc / Spotify Technology SA / Leggett & Platt Inc / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Korn Ferry / Latham Group Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Endo International PLC / Arthur J Gallagher & Co / Griffon Corp / Hasbro Inc / Hexcel Corp / Installed Building Products Inc / Lendingtree Inc / ServiceNow Inc / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / Perrigo Company PLC / Renewable Energy Group Inc / RBC Bearings Inc / Snowflake Inc. / Cadence Bank / Crossfirst Bankshares Inc / Lannett Company Inc / Agree Realty Corp / Brandywine Realty Trust / Meta Platforms Inc / SouthState Corp / Cathay General Bancorp / Glacier Bancorp Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lumen Technologies Inc / American Public Education Inc / Instil Bio Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Zoetis Inc / Trex Company Inc / Antero Resources Corp / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Splunk Inc / Abbvie Inc / Interface Inc / Noodles & Co / Uniqure NV / Aemetis Inc / El Pollo Loco Holdings Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / Atlantic Capital Bancshares Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Arvinas Inc / Elastic NV / Ferguson PLC / Datadog Inc / Azek Company Inc / Bally's Corp / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2681511 / 2550707 / 2778844 / 2973821 / 2026242 / 2270726 / 2829515 / 2328915 / 2100920 / 2344922 / 2689560 / 2684703 / 2829601 / 2842255 / 2098876 / 2181334 / 7103065 / 7123870 / B0X7DZ3 / B01SD70 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / BFLR866 / B3NXMJ9 / BNGY4Q0 / BYVY8G0 / BTF8CF0 / BXDZ9Z0 / BJLFHW7 / BD8DJ71 / BJFSR88 / BYXJQG9 / BKTNTR9 / BDH65C8 / BMH0MR7 / BYSFJV8 / BMBP1Q0 / BL98755</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / McDonald's Corp / Merck & Co Inc / Alliant Energy Corp / American Electric Power Company Inc / Walt Disney Co / Edison International / Nextera Energy Inc / FirstEnergy Corp / Jack in the Box Inc / PG&E Corp / Pfizer Inc / Southern Co / Starbucks Corp / Yum! Brands Inc / Check Point Software Technologies Ltd / Novartis AG / Nestle SA / Chipotle Mexican Grill Inc / Domino's Pizza Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Twitter Inc / Wendys Co / Nextera Energy Partners LP / Alphabet Inc / Restaurant Brands International Inc / Shopify Inc / Chewy Inc / Snap Inc / Uniqure NV / Spire Inc / ViacomCBS Inc / PetIQ Inc / Zendesk Inc / Planet Fitness Inc / Flywire Corp / Beachbody Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GE.N / GM.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / MCD.N / TSN.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / BLL.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Ball Corp / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 16: Focus on Almirall's US TRx trends</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ALM.MC / 4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Almirall SA / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-GB Company reports financial results for the half-year ended February 28,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BLPU.L / ERM.L / PSON.L / QRT.L / FUTR.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Euromoney Institutional Investor PLC / Pearson PLC / Quarto Group Inc / Future PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Alz Dis Pipeline – Future Lies Ahead with Increasingly Visible March Towards IND for Two Novel Candidates</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BMY.N / US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Assuming coverage of ABBV, BMY, LLY, MRK, and PFE</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY=US / ABBV=US / LLY.N / MRK.N / PFE.N / MRK=US / LLY=US / PFE=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Abbvie Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">R&D Pentathlon: Which Pharma's R&D Is Faster, Higher, Stronger?- Ahead of Curve</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / GB0009895292 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AES.N / AIG.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CB.N / CI.N / CL.N / CNC.N / CVS.N / DD.N / ECL.N / ED.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / OXY.N / PEG.N / PFE.N / SO.N / TEL.PS / TMO.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / K.N / CAT.N / MCD.N / IFF.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / CHD.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / CNP.N / HAYS.L / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / ZBRA.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / NOW.N / FANG.OQ / ABBV.N / ZTS.N / CDW.OQ / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / IQV.N / APTV.N / XEL.OQ / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Consolidated Edison Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Public Service Enterprise Group Inc / Pfizer Inc / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Kellogg Co / Caterpillar Inc / McDonald's Corp / International Flavors & Fragrances Inc / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Church & Dwight Co Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / CenterPoint Energy Inc / Hays PLC / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Zebra Technologies Corp / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / IQVIA Holdings Inc / Aptiv PLC / Xcel Energy Inc / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (26 July-): Results season begins; focus on Chugai, M3, Takeda</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4502.T / 4519.T / 4503.T / 4507.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">M3 Inc / Takeda Pharmaceutical Co Ltd / Chugai Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（7月26日～）: 決算発表スタート、注目は中外薬、M3、武田薬</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4519.T / 4502.T / 4503.T / 4507.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">M3 Inc / Chugai Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Zai Lab: Incyte's PD-1's regulatory setback not expected to significantly impact ZLAB materially. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">INCY.OQ / ZLAB.OQ / BMY.N / MRK.N / 1877.HK</td><td class="leftalignment">Incyte Corp / Zai Lab Ltd / Bristol-Myers Squibb Co / Merck & Co Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.7% Above Pre-Pandemic Base- Week 68</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 557</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AEE.N / AES.N / AIG.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CVS.N / DD.N / EOG.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / EOG Resources Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ROG.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0989529 / 2126335 / 2000019 / 2219224 / 2206657 / 2280220 / 2270726 / 2542049 / 2829515 / 2328915 / 2342034 / 2515030 / 2707677 / 2440637 / 2138158 / 2829601 / 2503529 / 4595739 / 7103065 / 2712013 / B121557 / 2769796 / 2857817 / B3D7K31 / B7TL820 / BBFL7S1 / B7577T2 / BFLR866 / BYW36M8 / BYNZGK1 / BD8DJ71 / BR4T3B3 / BJ2Z0H2 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BGSP7M9 / BFWK4R7 / BZ1LFG7 / BNTB3N8 / BD5GSZ4 / BJLV8T9</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Amazon.com Inc / CMS Energy Corp / Coca-Cola Co / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / Fiserv Inc / Lithia Motors Inc / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sempra Energy / Southern Co / World Wrestling Entertainment Inc / Genmab A/S / Novartis AG / Global Payments Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / bluebird bio Inc / Renewable Energy Group Inc / Twitter Inc / PayPal Holdings Inc / Block Inc / Snap Inc / HubSpot Inc / Pinterest Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Zoom Video Communications Inc / PagSeguro Digital Ltd / Roku Inc / Vizio Holding Corp / Infrastructure and Energy Alternatives Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / EOG.N / FCX.N / GE.N / GM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - BeiGene: Novartis unveiling a rich BLA filing plan for PD-1, further supporting BeiGene globalisation progress. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BGNE.OQ / 6160.HK / NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / ROG.S / UTHR.OQ / 1801.HK / 1877.HK</td><td class="leftalignment">Beigene Ltd / Beigene Ltd / Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Roche Holding AG / United Therapeutics Corp / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 21/07/2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BMY.L / CCC.L / ERM.L / NXT.L / INF.L / HBR.L / CAU.L / FUTR.L / TSTL.L / CBRO.L / EKF.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Computacenter PLC / Euromoney Institutional Investor PLC / Next PLC / Informa PLC / Harbour Energy PLC / Centaur Media PLC / Future PLC / Tristel PLC / Close Brothers Group PLC / EKF Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Alastair P. Reid / Alex Smith / Mr. Ben Hunt, CFA, CFA / Dr Jens Lindqvist / Mr. Ian Gordon / Mr. Julian R. Yates / Ms. Kate S. Calvert / Mr. Nathan G. Piper / Roger J. Phillips / Ross Broadfoot</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Second Quarter 2021 Biotechnology Earnings Preview: Sector Trading in Line as Earnings Kicks Off and New Products Approved</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">G11196105 / 09061G101 / 03116210 / 64125C109 / 110122108 / 09062X103 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 462222100 / 19459J104 / 69366J200 / 09609G100 / 37890U108 / 517125100 / 74006W108</td><td class="leftalignment">Biohaven Pharmaceutical Holding Company Ltd / Biomarin Pharmaceutical Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / PTC Therapeutics Inc / bluebird bio Inc / Global Blood Therapeutics Inc / Larimar Therapeutics Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Bloomsbury Publishing : Track record continues to build - Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / FCX.N / GE.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / PM.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / MTB.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ANTM.N / ZBH.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Freeport-McMoRan Inc / General Electric Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Philip Morris International Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Anthem Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SNY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SNY.O / ABT / BMY / JNJ / LLY / MRK / NVO / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Sanofi SA / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novo Nordisk A/S / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Delta, Now Dominant in the U.S., Is Driving Domestic and Global Growth; Regions With Low Vaccination Rates at Greatest Risk</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">2Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">NL0000226223 / DE0006231004 / DE0007164600 / US00724F1012 / US0079031078 / US0231351067 / US02553E1064 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1265011056 / US1266501006 / US14149Y1082 / US1727551004 / US17275R1023 / US1924461023 / US22160K1051 / US2545431015 / US2910111044 / US30226D1063 / US3156161024 / US3647601083 / US37733W1053 / US4456581077 / US45167R1041 / US4567881085 / US4581401001 / US48203R1041 / US4824801009 / US5002551043 / US5128071082 / US5184151042 / US5261071071 / US5324571083 / US5370081045 / US55306N1046 / US5719032022 / US58155Q1031 / US5949181045 / US5950171042 / US5951121038 / US6556641008 / US66987V1098 / US6701002056 / US67066G1040 / US6821891057 / US68389X1054 / US7170811035 / US7274931085 / US7392761034 / US7475251036 / US7711951043 / US7782961038 / US8030542042 / US8168501018 / US8269191024 / US8610121027 / US8725401090 / US87612E1064 / US9282981086 / US9311421039 / US9581021055 / US9839191015 / IL0010824113 / US03073E1055 / US83088M1027 / US80105N1054 / US21036P1084 / US1572101053 / US79466L3024 / US6098391054 / US82706C1080 / US55616P1049 / US88076W1036 / US90384S3031 / IE00B4BNMY34 / US58933Y1055 / US4485791028 / US34959E1091 / NL0009538784 / US03027X1000 / US30212P3038 / US8969452015 / US29414B1044 / US00287Y1091 / US98978V1035 / US5017971046 / US81762P1021 / US98138H1014 / US55405Y1001 / US8486371045 / US6974351057 / KYG037AX1015 / US9222801022 / US98936J1016 / US0404131064 / US0396971071 / LU0974299876 / IL0011334468 / US4435731009 / US0994061002 / US64829B1008 / US22822V1017 / US74736K1016 / US74624M1027 / GB00BZ09BD16 / US90138F1021 / IE00BY7QL619 / US89686D1054 / US43300A2033 / US78410G1040 / US02156B1035 / US23355L1061 / US6792951054 / US03782L1017 / US8760301072 / US76674Q1076 / VGG273581030 / US09354A1007 / US09857L1089 / US98980G1022 / US11135F1012 / US2575541055 / US29260V1052 / US28414H1032 / CA64079L1058 / KY30744W1070 / US69553P1003 / IL0011571556 / US22788C1053 / US39874R1014 / US18915M1071 / US89677Q1076 / IE00BK9ZQ967 / US39813G1094 / US14448C1045 / GB00BMVP7Y09 / US8334451098 / US07373B1098 / US86646P1030 / US74767V1098 / US0090661010 / US7761531083 / US55406W1036 / US15961R1059 / US49926T1043 / US90364P1057 / US5738741041 / US68622V1061 / IL0011762130 / US20717M1036 / US02080L1026 / IE000GID8VI0 / US28623U1016 / US38870X1046</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / SAP SE / Adobe Inc / Advanced Micro Devices Inc / Amazon.com Inc / American Eagle Outfitters Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / CTS Corp / CVS Health Corp / Cardinal Health Inc / Cirrus Logic Inc / Cisco Systems Inc / Cognizant Technology Solutions Corp / Costco Wholesale Corp / Diodes Inc / Emerson Electric Co / Extreme Networks Inc / F5 Inc / Gap Inc / GlaxoSmithKline PLC / J B Hunt Transport Services Inc / IDEX Corp / Infosys Ltd / Intel Corp / Juniper Networks Inc / KLA Corp / Kohls Corp / Lam Research Corp / Lattice Semiconductor Corp / Lennox International Inc / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / Mckesson Corp / Microsoft Corp / Microchip Technology Inc / Micron Technology Inc / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / ON Semiconductor Corp / Oracle Corp / Pfizer Inc / Plantronics Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Ross Stores Inc / SAP SE / Semtech Corp / Silicon Laboratories Inc / STMicroelectronics NV / TJX Companies Inc / Target Corp / Vishay Intertechnology Inc / Walmart Inc / Western Digital Corp / Xilinx Inc / Check Point Software Technologies Ltd / Amerisourcebergen Corp / Skyworks Solutions Inc / Sanofi SA / Constellation Brands Inc / CEVA Inc / Salesforce.Com Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Macy's Inc / Teradata Corp / Ulta Beauty Inc / Accenture PLC / Merck & Co Inc / Hyatt Hotels Corp / Fortinet Inc / NXP Semiconductors NV / American Tower Corp / Expedia Group Inc / Tripadvisor Inc / Epam Systems Inc / Abbvie Inc / Zoetis Inc / Bath & Body Works Inc / ServiceNow Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Splunk Inc / Palo Alto Networks Inc / Ambarella Inc / Varonis Systems Inc / Zendesk Inc / Arista Networks Inc / Ardelyx Inc / Globant SA / Cyberark Software Ltd / HubSpot Inc / Boot Barn Holdings Inc / New Relic Inc / Crown Castle International Corp / Qorvo Inc / Pure Storage Inc / Atlassian Corporation PLC / Twilio Inc / Johnson Controls International PLC / Trivago NV / Hilton Worldwide Holdings Inc / SBA Communications Corp / Alteryx Inc / DXC Technology Co / Okta Inc / Appian Corp / Tapestry Inc / Rimini Street Inc / Despegar.com Corp / Blink Charging Co / Booking Holdings Inc / Zscaler Inc / Broadcom Inc / Domo Inc / Endava PLC / Elanco Animal Health Inc / Neptune Wellness Solutions Inc / Farfetch Ltd / PagerDuty Inc / Tufin Software Technologies Ltd / CrowdStrike Holdings Inc / Grocery Outlet Holding Corp / Cloudflare Inc / Trip.com Group Ltd / Trane Technologies PLC / Grid Dynamics Holdings Inc / Carrier Global Corp / Royalty Pharma PLC / Snowflake Inc. / Beam Global / Sumo Logic Inc / Quantumscape Corp / Airbnb Inc / Romeo Power Inc / MYT Netherlands Parent BV / ChargePoint Holdings Inc / Knowbe4 Inc / UiPath Inc / Marvell Technology Inc / Organon & Co / Monday.Com Ltd / Confluent Inc / Alpha Teknova Inc / GH Research PLC / Elevation Oncology Inc / Graphite Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2732635 / 2942605 / 2219224 / 2270726 / 2829515 / 2328915 / 2684703 / 2829601 / 2900335 / 2980906 / 2503529 / 7103065 / B17HG57 / B121557 / 2857817 / B7TL820 / B4MG4Z6 / B7VD3F2 / BFLR866 / BYNZGK1 / BP7RS48 / BFMXGR0 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BDT5KT5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / AutoNation Inc / Avista Corp / CMS Energy Corp / Walt Disney Co / Edison International / Nextera Energy Inc / Pfizer Inc / Southern Co / Tractor Supply Co / Foot Locker Inc / World Wrestling Entertainment Inc / Novartis AG / Cardiovascular Systems Inc / Mastercard Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Twitter Inc / Block Inc / Intersect Ent Inc / Evergy Inc / Fox Corp / Spire Inc / ViacomCBS Inc / Inspire Medical Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma - 2Q21 Quarterly Prep Pack</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / LONN.S / GSK.L / UCB.BR / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Future Forecasts: July 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DOW.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / HAL.N / ETN.N / DHR.N / DOV.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / UAL.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dow Inc / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Halliburton Co / Eaton Corporation PLC / Danaher Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Event Analysis (1): Major patent cliffs looming from 2026</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / JNJ.N / 4516.T / 4506.T / 4536.T / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: イベントアナリシス①：特許期間‐2026年以降に一大クリフ</td><td class="leftalignment">Japanese</td><td class="rightalignment">12</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / JNJ.N / 4516.T / 4506.T / 4536.T / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Many Positives, But Upcoming Patent Expirations Depress Growth</td><td class="leftalignment">English</td><td class="rightalignment">115</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharmaceutical Industry Pulse</td><td class="leftalignment">English</td><td class="rightalignment">1205</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 09, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Key Takeaways From Day 2 of the 2021 William Blair Biotech Focus Conference</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">110122108 / 268158201 / 03116210 / 64125C109 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Bristol-Myers Squibb Co / Dynavax Technologies Corp / Amgen Inc / Neurocrine Biosciences Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">FR0000121014 / FR0000054470 / US0028241000 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1567821046 / US1925761066 / US22284P1057 / US2855121099 / US2944291051 / US3021301094 / US3377381088 / US37733W1053 / US4433201062 / US4456581077 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US5763231090 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US74762E1029 / US7711951043 / US8308791024 / US8447411088 / US8740541094 / US8807701029 / US9029251066 / US91347P1057 / US91913Y1001 / US92343V1044 / US9507551086 / US37940X1028 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US20030N1019 / US21036P1084 / US3463751087 / US90385V1070 / US12541W2098 / US00206R1023 / US31620M1062 / US1314761032 / US57636Q1040 / US78709Y1055 / PAP310761054 / US75025X1000 / US3364331070 / US01748X1028 / US2473617023 / US25470M1099 / US7181721090 / US92826C8394 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US39304D1028 / US9100471096 / US3390411052 / US4361061082 / US56585A1025 / US8676524064 / US98986T1088 / US7185461040 / US9837931008 / US96208T1043 / US69318G1067 / US00287Y1091 / NL0010273215 / US98978V1035 / US8725901040 / US29355A1079 / PR30040P1032 / US69366J2006 / US00847X1046 / US8485771021 / US21240E1055 / CH0210483332 / US90184L1026 / US02376R1023 / US03937C1053 / KYG8807B1068 / US69888T2078 / US94419L1017 / CA0089118776 / US83417M1045 / US09627Y1091 / US12685J1051 / US89400J1079 / US70450Y1038 / CA1380351009 / US8522341036 / US16119P1084 / KYG4740B1059 / CA87241L1094 / GB00BDSFG982 / US83304A1060 / US23753F1075 / US80689H1023 / US05722G1004 / US24665A1034 / US02156K1034 / US4990491049 / US26927E1047 / US46571Y1073 / US74275G1076 / US5904791358 / CA39342L1085 / US28414H1032 / KY30744W1070 / US26142R1041 / US22041X1028 / CA67079A1021 / US04271T1007 / US11778X1046 / US72815L1070 / US55406W1036 / US82489W1071 / US30320C1036 / BMG6964L1072 / US20717M1036 / US61225M1027</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Ubisoft Entertainment SA / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cerner Corp / Cohu Inc / Covenant Logistics Group Inc / Electronic Arts Inc / Equifax Inc / Expeditors International of Washington Inc / Fiserv Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / MasTec Inc / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Quanta Services Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Take-Two Interactive Software Inc / Teradyne Inc / USA Truck Inc / Universal Display Corp / Valero Energy Corp / Verizon Communications Inc / Werner Enterprises Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / Comcast Corp / Constellation Brands Inc / FormFactor Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / Mastercard Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / First Solar Inc / Allegiant Travel Co / Delta Air Lines Inc / DISH Network Corp / Philip Morris International Inc / Visa Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / Green Dot Corp / United Airlines Holdings Inc / Fleetcor Technologies Inc / HollyFrontier Corp / Marathon Petroleum Corp / SunPower Corp / Zynga Inc / Phillips 66 / XPO Logistics Inc / WEX Inc / PBF Energy Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / T-Mobile US Inc / Enphase Energy Inc / Evertec Inc / PTC Therapeutics Inc / Agios Pharmaceuticals Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / Twitter Inc / American Airlines Group Inc / ArcBest Corp / Theravance Biopharma Inc / Par Pacific Holdings Inc / Wayfair Inc / Air Canada / Solaredge Technologies Inc / Blueprint Medicines Corp / Cable One Inc / TransUnion / PayPal Holdings Inc / Canopy Growth Corp / Block Inc / Charter Communications Inc / Ichor Holdings Ltd / TFI International Inc / TechnipFMC PLC / Snap Inc / Daseke Inc / Schneider National Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / EVO Payments Inc / I3 Verticals Inc / Priority Technology Holdings Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Farfetch Ltd / DraftKings Inc / Corsair Gaming Inc / Nuvei Corp / Array Technologies Inc / BTRS Holdings Inc / Playtika Holding Corp / MYT Netherlands Parent BV / Shoals Technologies Group Inc / FTC Solar Inc / Paysafe Ltd / Confluent Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Puerto Rico / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2002305 / 2026242 / 2216850 / 2270726 / 2829515 / 2670519 / 2328915 / 2459020 / 2730190 / 2440637 / 2829601 / B067BM3 / 2857817 / B1XGNW4 / B0796X4 / B7TL820 / BTN1Y11 / BS7K7C9 / BYW36M8 / BZBY005 / BJ5FZ74 / BLGJ610 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BF3W461 / BDZ30Q0 / BMPRZV5 / BMC8SQ7 / BP7KZP7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Abbott Laboratories / American Electric Power Company Inc / Consolidated Edison Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / Intuit Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Molson Coors Beverage Co / Netflix Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / Medtronic PLC / Nevro Corp / PayPal Holdings Inc / Merus NV / Adaptive Biotechnologies Corp / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Tandem Diabetes Care Inc / Arvinas Inc / Kymera Therapeutics Inc / BTRS Holdings Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GLUE (BUY) - Molecular Glue - Differentiated Approach to Targeted Protein Degradation - Initiating Coverage with a BUY Rating and $30 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BP7KZP7 / 5671735 / 0989529 / 0925288 / 2126335 / 2023607 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / BBFL7S1 / BDHF4K6 / BZ8FPH3 / BWY52P3 / BDZ30Q0 / BN2R582 / BDD1B07 / BMPRZV5 / BMDJ397 / BN2RM92</td><td class="leftalignment">Monte Rosa Therapeutics Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amgen Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / bluebird bio Inc / CRISPR Therapeutics AG / Editas Medicine Inc / Blueprint Medicines Corp / Arvinas Inc / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAX.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / CNC.N / COF.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TEL.PS / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / NUE.N / UHS.N / HAL.N / ADML.L / ETN.N / DHR.N / FE.N / GD.N / DOV.N / ROP.N / CAT.N / IPG.N / UNP.N / MCD.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / WHR.N / LIN.N / SHW.N / PKG.N / GWW.N / VZ.N / STT.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / CHD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / ZION.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / POOL.OQ / AMZN.OQ / TTWO.OQ / VRSN.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ISRG.OQ / EQIX.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / LVS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / NVR.N / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / BKR.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / CSX.OQ / IQV.N / XEL.OQ / WELL.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / FirstEnergy Corp / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Interpublic Group of Companies Inc / Union Pacific Corp / McDonald's Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Whirlpool Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / W W Grainger Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Cerner Corp / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Pool Corp / Amazon.com Inc / Take-Two Interactive Software Inc / Verisign Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Intuitive Surgical Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / NVR Inc / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / Baker Hughes Co / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / CSX Corp / IQVIA Holdings Inc / Xcel Energy Inc / Welltower Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 67</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2Q21 Global Biopharma Preview: Group Fundamentals Solid & Valuations Improving but Don't Look for Big 2Q Beats</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">2126335 / 0989529 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 556</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Key Takeaways From the 11th Annual Cancer Immunotherapy Day of the 2021 William Blair Biotech Focus Conference</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">00847G705 / 05280R100 / 110122108 / 45337C102 / 720795103 / 019770106 / N5749R100 / 192010106 / 151205200 / 30315R107 / 45175G108</td><td class="leftalignment">Agenus Inc / Autolus Therapeutics PLC / Bristol-Myers Squibb Co / Incyte Corp / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Merus NV / Codiak BioSciences, Inc. / Celyad Oncology SA / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Hunter Rogers / Mr. Tim F. Lugo / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Jul. 14, 2021 / 8:55AM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Quantum Research Group, LLC</td><td class="leftalignment">Predictive Oncology: Unique, Valuable Assets and Recent Capitalization Present a Promising Opportunity in AI-Driven Drug Development</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">POAI=US / CAH=US / BMY=US / NVS=US / SYK=US / AZN=US / MMSI=US / NVAX=US / SDGR=US / GRPN=US / BTAI=US / THMO=US / TFFP=US / LTRN=US</td><td class="leftalignment">Predictive Oncology Inc / Cardinal Health Inc / Bristol-Myers Squibb Co / Novartis AG / Stryker Corp / AstraZeneca PLC / Merit Medical Systems Inc / Novavax Inc / Schrodinger Inc / Groupon Inc / BioXcel Therapeutics Inc / Thermogenesis Holdings Inc / TFF Pharmaceuticals Inc / Lantern Pharma Inc.</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">INITIATING COVERAGE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Karl Egeland</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 07 13</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">BLKB.OQ / CVS.N / BMY.N / CAH.N / GE.N / LLY.N / WMT.N / CPB.N / LOW.N / AMT.N / AMGN.OQ / AMAT.OQ / CASY.OQ / CGNX.OQ / SJM.N / INTU.OQ / AMZN.OQ / MTCH.OQ / SIX.N / VRSK.OQ / ZM.OQ</td><td class="leftalignment">Blackbaud Inc / CVS Health Corp / Bristol-Myers Squibb Co / Cardinal Health Inc / General Electric Co / Eli Lilly and Co / Walmart Inc / Campbell Soup Co / Lowe's Companies Inc / American Tower Corp / Amgen Inc / Applied Materials Inc / Caseys General Stores Inc / Cognex Corp / J M Smucker Co / Intuit Inc / Amazon.com Inc / Match Group Inc / Six Flags Entertainment Corp / Verisk Analytics Inc / Zoom Video Communications Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Conglomerates / Electronics / Food / Healthcare / Info. Tech./Software / Leisure & Entertainment / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Our Q&A With Management of Crescendo Biologics, a Novel Multispecific T-Cell Enhancer Biotherapeutic Company</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 110122108 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 15117K103 / 04651310 / 00887A105 / 816212104 / 09609G100 / 67022C106 / 603380106 / 720795103 / 49372L100 / 05280R100 / 019770106 / H17182108 / 74019P108 / N5749R100 / G10830100 / 81181C104 / 00507W206 / 03890D108 / 192010106 / 13089P101 / 151205200 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Cellectis SA / Atara Biotherapeutics Inc / Aileron Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Precision BioSciences Inc / Merus NV / Beyondspring Inc / Seagen Inc / Actinium Pharmaceuticals Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2026242 / 2219224 / 2270726 / 2542049 / 2829515 / 2100920 / 2455965 / 2684703 / 2048804 / 2707677 / 2138158 / 2825933 / 2829601 / 2503529 / 7103065 / B121557 / 2857817 / B125XQ6 / B02R1L6 / B7TL820 / BFLR866 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BD8DJ71 / BNFWR44 / BFZ1K46 / BKTNTR9 / BRJ3GY4 / BJ9N563 / BNKGXX2</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Edison International / FirstEnergy Corp / Biogen Inc / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Mastercard Inc / Netflix Inc / Portland General Electric Co / ALLETE Inc / Meta Platforms Inc / Twitter Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Snap Inc / Worldline SA / Spotify Technology SA / ViacomCBS Inc / Xenon Pharmaceuticals Inc / Sunnova Energy International Inc / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 2Q Earnings Preview - Easy Comps and Receding COVID-19 Headwinds</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">BMY.N / ABBV.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Abbvie Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ARBN.BO: Aurobindo Pharma Ltd - Higher growth trajectory and improving RoCE to drive re-rating</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">ARBN.BO / BMY.N / CIPL.BO / REDY.BO / SUN.BO / NOVN.S / WCKH.BO / CADI.BO / GLEN.BO / FREG.DE / LUPN.BO / SPPI.OQ / HIK.L / TEVA.N / ALEM.BO</td><td class="leftalignment">Aurobindo Pharma Ltd / Bristol-Myers Squibb Co / Cipla Ltd / Dr Reddy's Laboratories Ltd / Sun Pharmaceutical Industries Ltd / Novartis AG / Wockhardt Ltd / Cadila Healthcare Ltd / Glenmark Pharmaceuticals Ltd / Fresenius SE & Co KGaA / Lupin Ltd / Spectrum Pharmaceuticals Inc / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Alembic Pharmaceuticals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / India / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ATAI: A Diversified Platform Approach to NeuroPsych Drug Development; Initiate with an Outperform Rating</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">ATAI.OQ / 4503.T / BMY.N / JNJ.N / AZN.L / NOVN.S / 4768.T / NBIX.OQ / BIIB.OQ / JAZZ.OQ / ABBV.N / SAGE.OQ</td><td class="leftalignment">ATAI Life Sciences NV / Astellas Pharma Inc / Bristol-Myers Squibb Co / Johnson & Johnson / AstraZeneca PLC / Novartis AG / Otsuka Corp / Neurocrine Biosciences Inc / Biogen Inc / Jazz Pharmaceuticals PLC / Abbvie Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Mark Connolly / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 02, 2021: Focus on Shingrix trends</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare policy: new and updated democrat proposals: Biden drug proposals via EO; Pelosi & Wyden seek legislative approach</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 66</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 555</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">A / AIG / AJG / ALL / AON / AR / ASH / BIO / BMY / CB / CLR / CNI / CNX / COG / CP / CPE / CRL / DGX / DHR / DVN / EOG / EQT / HIG / JNJ / LH / LNC / MET / MGY / MMC / MRO / MTD / NSC / PGR / PKI / PPG / PRU / PXD / RE / RNR / RRC / SM / SWN / TMO / TRV / UNP / WAT / WLL / CMCSA.O / BRO / ENB.TO / ICLR.O / CHTR.O / ILMN.O / TECH.O / AXS / LPI / HOLX.O / PROG.O / BLUE.O / ACGL.O / EXAS.O / BRKR.O / NOG.A / WRB.N / TSLA.O / ESTE.K / MTDR.K / PDCE.O / FANG.O / UIHC.O / BCEI.K / VOYA.K / FATE.O / NVTA.N / CABO.N / NTRA.O / CYAD.O / CSX.O / WLTW.O / CRSP.O / CLLS.O / CDEV.O / ATUS.N / BHF.O / IQV / QGEN.K / EQH / AUTL.O / BRY.O / GH.O / AVTR.K / BRP.O / OAS.O / NTST.K / ROOT.O / GRCL.O / CHK.O</td><td class="leftalignment">Agilent Technologies Inc / American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / Aon PLC / Antero Resources Corp / Ashland Global Holdings Inc / Bio Rad Laboratories Inc / Bristol-Myers Squibb Co / Chubb Ltd / Continental Resources Inc / Canadian National Railway Co / CNX Resources Corp / Coterra Energy Inc / Canadian Pacific Railway Ltd / Callon Petroleum Co / Charles River Laboratories International Inc / Quest Diagnostics Inc / Danaher Corp / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Johnson & Johnson / Laboratory Corporation of America Holdings / Lincoln National Corp / MetLife Inc / Magnolia Oil & Gas Corp / Marsh & McLennan Companies Inc / Marathon Oil Corp / Mettler-Toledo International Inc / Norfolk Southern Corp / Progressive Corp / PerkinElmer Inc / PPG Industries Inc / Prudential Financial Inc / Pioneer Natural Resources Co / Everest Re Group Ltd / Renaissancere Holdings Ltd / Range Resources Corp / SM Energy Co / Southwestern Energy Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Union Pacific Corp / Waters Corp / Whiting Petroleum Corp / Comcast Corp / Brown & Brown Inc / Enbridge Inc / ICON PLC / Charter Communications Inc / Illumina Inc / Bio-Techne Corp / AXIS Capital Holdings Ltd / Laredo Petroleum Inc / Hologic Inc / Progenity Inc / bluebird bio Inc / Arch Capital Group Ltd / Exact Sciences Corp / Bruker Corp / Northern Oil and Gas Inc / W R Berkley Corp / Tesla Inc / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / United Insurance Holdings Corp / Civitas Resources Inc / Voya Financial Inc / Fate Therapeutics Inc / Invitae Corp / Cable One Inc / Natera Inc / Celyad Oncology SA / CSX Corp / Willis Towers Watson PLC / CRISPR Therapeutics AG / Cellectis SA / Centennial Resource Development Inc / Altice USA Inc / Brighthouse Financial Inc / IQVIA Holdings Inc / Qiagen NV / Equitable Holdings Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Guardant Health Inc / Avantor Inc / BRP Group Inc / Oasis Petroleum Inc / Netstreit Corp / Root Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Myeloma KOL Highlights Data for Ide-Cel (ABECMA) and Cilta-Cel, and Opportunities for Innovation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / BLUE.O / FATE.O / CYAD.O / CRSP.O / CLLS.O / AUTL.O / GRCL.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / bluebird bio Inc / Fate Therapeutics Inc / Celyad Oncology SA / CRISPR Therapeutics AG / Cellectis SA / Autolus Therapeutics PLC / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / France / United Kingdom / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Larry Biegelsen / Mr. Yanan Zhu</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended July 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2497406 / 2026242 / 2219224 / 2280220 / 2270726 / 2670519 / 2342034 / 2100920 / 2684703 / 2707677 / 2138158 / 2829601 / 7103065 / 2857817 / B3D7K31 / B6197Q2 / B7TL820 / BFLR866 / BYVY8G0 / BG31GH0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BZ4CHH2 / BKPGJQ1 / BFYVZ75</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kroger Co / American Electric Power Company Inc / CMS Energy Corp / DTE Energy Co / Walt Disney Co / Exelon Corp / Fiserv Inc / FirstEnergy Corp / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / Novartis AG / Netflix Inc / Discovery Inc / Generac Holdings Inc / Meta Platforms Inc / Twitter Inc / Alphabet Inc / Y-mAbs Therapeutics Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Soleno Therapeutics Inc / Squarespace Inc / Seelos Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Spread of Delta Variant Reverses Downward Trends in Regions With Low Vaccination, Global Spread Driving Broad Growth</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / 4516.T / 4506.T / ROG.S / 4151.T / BIIB.OQ / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Biogen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">33</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / 4516.T / 4506.T / ROG.S / 4151.T / BIIB.OQ / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Biogen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">BMY - Embedded Expectations Analysis - 2021 07 06</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 25, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/05/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: BMY - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">BMY</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">07/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (5 July ): Weak overall, Eisai and Astellas shares under pressure from profit-taking</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4503.T / 4523.T / 6869.T / 4502.T / 4507.T / 4519.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / 1833.HK / 4568.T / QGEN.N / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">M3 Inc / Astellas Pharma Inc / Eisai Co Ltd / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / Ping An Healthcare and Technology Co Ltd / Daiichi Sankyo Co Ltd / Qiagen NV / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（7月5日～）: 全般的には軟調、エーザイとアステラスは利益確定売りに押されたもよう</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4543.T / 6869.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / 1833.HK / 2413.T / 4568.T / QGEN.N / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Terumo Corp / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / Ping An Healthcare and Technology Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Qiagen NV / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.5% Above Pre-Pandemic Base- Week 65</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 554</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">2021 DC Day Review: Expect Incremental Policy Reform, Strong Support for Value-Based Care, Tech-Enabled Novel Delivery Models</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 09060J106 / 252131107 / 42222N103 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 90184D100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 30068X103 / 15912K100 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107 / 98985X100</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Mr. Raju Prasad, PHD / John C. Kreger, III / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / Brian D. Weinstein, CFA / Mr. Tim F. Lugo / Mr. Matt Larew / Matt Phipps, PHD / Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / BMY=US / OXY=US / RRC=US / GBT=US / DVN=US / TXN=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / H=US / MTN=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / MUR=US / MAR=US / MRO=US / TNL=US / HLT=US / W=US / STZ=US / AMED=US / CHH=US / CNX=US / DRH=US / EQT=US / MHK=US / RARE=US / TRIP=US / VRTX=US / CVX=US / SAGE=US / CGEN=US / VNO=US / COP=US / MRNS=US / PTON=US / BIIB=US / APTX=US / SHO=US / HST=US / CPRX=US / CLR=US / WH=US / NOG=US / RCUS=US / AR=US / OAS=US / HGV=US / NXPI=US / RLJ=US / ESTE=US / VAC=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / CNCE=US / VNOM=US / RLMD=US / VKTX=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CDEV=US / CRSP=US / PK=US / PVAC=US / ANAB=US / PLYA=US / VRNA=US / SBOW=US / ARVN=US / OVV=US / CRMD.US / TSHA / 96758W101</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Occidental Petroleum Corp / Range Resources Corp / Global Blood Therapeutics Inc / Devon Energy Corp / Texas Instruments Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wayfair Inc / Constellation Brands Inc / Amedisys Inc / Choice Hotels International Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / Mohawk Industries Inc / Ultragenyx Pharmaceutical Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Chevron Corp / SAGE Therapeutics Inc / Compugen Ltd / Vornado Realty Trust / Conocophillips / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Biogen Inc / Aptinyx Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Catalyst Pharmaceuticals Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Relmada Therapeutics Inc / Viking Therapeutics Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Ranger Oil Corp / AnaptysBio Inc / Playa Hotels & Resorts NV / Verona Pharma PLC / SilverBow Resources Inc / Arvinas Inc / Ovintiv Inc / CorMedix Inc / Taysha Gene Therapies Inc / WideOpenWest Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Deep Genomics, Inc.: Our Q&A With Management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 92247510 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 90184D100 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 000380204 / 89422G107 / 56600D107 / 65443P102 / 30315R107 / 45175G108 / 91864C107 / 98985X100</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Veeva Systems Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Twist Bioscience Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / 908 Devices Inc. / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">IO Nuggets: Insight Into The Expression & Function of PVRIG & TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CGEN=US / MRK=US / BMY=US / GILD=US / RCUS=US</td><td class="leftalignment">Compugen Ltd / Merck & Co Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb gains 6.4% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb gains 6.4% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 30 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0028241000 / US0463531089 / US1011371077 / US1101221083 / US37733W1053 / US4663671091 / US92343V1044 / US20030N1019 / US2533931026 / US00206R1023 / US25470M1099 / US58933Y1055 / US8725901040 / US12685J1051 / US16119P1084 / US02156K1034 / US4622601007 / US98980G1022 / US68570P1012 / US4432011082 / US03476J1079</td><td class="leftalignment">Abbott Laboratories / AstraZeneca PLC / Boston Scientific Corp / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Jack in the Box Inc / Verizon Communications Inc / Comcast Corp / DICK'S Sporting Goods Inc / AT&T Inc / DISH Network Corp / Merck & Co Inc / T-Mobile US Inc / Cable One Inc / Charter Communications Inc / Altice USA Inc / Iovance Biotherapeutics Inc / Zscaler Inc / Orchard Therapeutics PLC / Howmet Aerospace Inc / Angion Biomedica Corp</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Highlights From Cowen ADA 2021 KOL Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Bristol-Myers Squibb Company JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIN / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / LOW=US / LEG=US / LSTR=US / VMC=US / HUM=US / MLM=US / AMED=US / SWIM=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HXL=US / IBP=US / MAS=US / MHK=US / REGI=US / VRTX=US / SPR=US / DIN=US / OGN / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / LHCG=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / EHC=US / JACK=US / TREX=US / WWD=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / RLMD=US / ETSY=US / WING=US / EDIT=US / NTLA=US / 82982L103 / CRSP=US / JELD=US / FERG=US / PNTG=US / ARQT=US / AZEK=US / AVAH=US</td><td class="leftalignment">Albany International Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Lowe's Companies Inc / Leggett & Platt Inc / Landstar System Inc / Vulcan Materials Co / Humana Inc / Martin Marietta Materials Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Vertex Pharmaceuticals Inc / Spirit AeroSystems Holdings Inc / Dine Brands Global Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / LHC Group Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / Jack in the Box Inc / Trex Company Inc / Woodward Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Relmada Therapeutics Inc / ETSY Inc / Wingstop Inc / Editas Medicine Inc / Intellia Therapeutics Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / JELD-WEN Holding Inc / Ferguson PLC / Pennant Group Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2113393 / 2280220 / 2270726 / 2576941 / 2670519 / 2100920 / 2369174 / 2455965 / 2471950 / 2689560 / 2672689 / 2684703 / 2707677 / 2138158 / 2825933 / 2829601 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / B7VD3F2 / BCZS820 / BDZCRX3 / BYVY8G0 / BYW36M8 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BHC8X90 / BD8DJ71 / BMQ5T49 / BWFKZT2 / BJJMGL2 / BKTNTR9 / BGSP7M9</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Boston Beer Company Inc / DTE Energy Co / Walt Disney Co / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Gilead Sciences Inc / Biogen Inc / Incyte Corp / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Fate Therapeutics Inc / RingCentral Inc / Alphabet Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: Highlights from Guggenheim's BioPharma Strategy Series Discussion with Management</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 18, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Final Reminder: Virtual Washington, D.C. Day - This Wednesday, June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GILD (BUY) - Yescarta Improves Event-Free Survival by 60% in ZUMA-7; Results Consistent With Our Expectations; Also Positive for Cell Therapy Space</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.OQ / 2126335 / 2369174 / BCZS820 / BFZNYB7 / BDHF4K6 / BWFKZT2</td><td class="leftalignment">Gilead Sciences Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Fate Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Cellectis SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0116591092 / US02553E1064 / US0463531089 / US1101221083 / US1924221039 / US3695501086 / US37733W1053 / US4781601046 / US5002551043 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US87612E1064 / US8832031012 / CA0977512007 / US4771431016 / US4198791018 / US80105N1054 / US31620M1062 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US29082A1079 / US00287Y1091 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US70450Y1038 / US5588681057 / US8760301072 / US5904791358 / US28414H1032 / US76156B1070 / US88339P1012 / US26142R1041 / US12769G1004 / CA67079A1021 / US05875B1061 / US73739W1045 / BMG6964L1072</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cognex Corp / General Dynamics Corp / GlaxoSmithKline PLC / Johnson & Johnson / Kohls Corp / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Target Corp / Textron Inc / Bombardier Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Fidelity National Information Services Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Embraer SA / Abbvie Inc / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / PayPal Holdings Inc / Madrigal Pharmaceuticals Inc / Tapestry Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Revolve Group Inc / RealReal Inc / DraftKings Inc / Caesars Entertainment Inc / Nuvei Corp / Bally's Corp / Poshmark Inc / Paysafe Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Next-Gen Lipid Nanoparticle Drug Delivery Under the Microscope; Discussion With Dan Siegwart, Ph.D., June 29, 12:00 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 000380204 / 89422G107 / 56600D107 / 65443P102 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / 908 Devices Inc. / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Raju Prasad, PHD / Mr. Myles R. R. Minter / Mr. Matt Larew / Sami Corwin, PHD / Max Smock</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2126335 / 2516152 / 2000019 / 2973821 / 2065159 / 2437071 / 2280220 / 2270726 / 2829515 / 2455965 / 2459020 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 2895163 / B00FWN1 / B125XQ6 / 2983563 / B6197Q2 / B87ZMX0 / B95N910 / B424494 / BFZCHN7 / BYVY8G0 / BS7K7C9 / BF4VBS8 / BXDZ9Z0 / BK0VHF6 / BD8DJ71 / BLGJ610 / BGSP7M9 / BZ1LFG7 / BMDCDP2 / BMC8SQ7 / BNTB3N8 / BN2RM92 / BLF0CW7</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Alliant Energy Corp / Autodesk Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Edison International / Biogen Inc / Intuit Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / United Natural Foods Inc / Alnylam Pharmaceuticals Inc / Portland General Electric Co / Carmax Inc / Generac Holdings Inc / Palo Alto Networks Inc / PTC Inc / Splunk Inc / Wix.Com Ltd / Alphabet Inc / Nevro Corp / BioXcel Therapeutics Inc / Shopify Inc / IDEAYA Biosciences Inc / Snap Inc / Warner Music Group Corp / Zoom Video Communications Inc / Roku Inc / Bigcommerce Holdings Inc / BTRS Holdings Inc / Vizio Holding Corp / Rain Therapeutics Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Learn your ADC</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jun 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">DNA Damage "Repare" Primer: Targeting Cancer's Synthetic Lethal Vulnerabilities Around DNA Repair and Maintenance</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">0989529 / 0925288 / 2126335 / 7103065 / BK0VHF6 / BMQ5T49 / BN2RM92 / BLF0CW7</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Novartis AG / IDEAYA Biosciences Inc / Zentalis Pharmaceuticals Inc / Rain Therapeutics Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RPTX - Synthetic Lethal Targeting of DNA Damage "Repare"; Initiating Coverage with a BUY Rating and $46 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BLF0CW7 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2684703 / B6RS2B3 / BK0VHF6 / BMQ5T49 / BWY52P3</td><td class="leftalignment">Repare Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Clovis Oncology Inc / IDEAYA Biosciences Inc / Zentalis Pharmaceuticals Inc / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 64</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 553</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch Third Quarter 2021</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">54142F102 / 73730P108 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 04651310 / 462222100 / 01345P106 / 00887A105 / 69366J200 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 92686J106 / 37890U108 / 77313F106 / 717224109 / 05464T104 / 48576A100 / G10830100 / 81181C104 / 517125100 / 74006W108 / 92840H202 / 03890D108 / 192010106 / 13089P101 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">LogicBio Therapeutics Inc / Poseida Therapeutics Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Albireo Pharma Inc / Aileron Therapeutics Inc / PTC Therapeutics Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Viking Therapeutics Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / PhaseBio Pharmaceuticals Inc / Axsome Therapeutics Inc / Karuna Therapeutics Inc / Beyondspring Inc / Seagen Inc / Larimar Therapeutics Inc / Praxis Precision Medicines Inc / VistaGen Therapeutics Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: First CAR-T approval: A small step in commercialisation, a big step in advancing innovative pipeline. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2196.HK / 600196.SS / BMY.N / NOVN.S / GILD.OQ / BLUE.OQ</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Bristol-Myers Squibb Co / Novartis AG / Gilead Sciences Inc / bluebird bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: BMY - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">BMY</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / GILD=US / LOW=US / LEG=US / VMC=US / MLM=US / SWIM=US / CBRL=US / CW=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / CRTO=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / PGTI=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / RCUS=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / 00770K202 / LOCO=US / UPLD=US / SHAK=US / WING=US / EVRI=US / 82982L103 / JELD=US / FOCS=US / UBER=US / FERG=US / ARQT=US / AZEK=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Gilead Sciences Inc / Lowe's Companies Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Curtiss-Wright Corp / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Criteo SA / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / Aemetis Inc / El Pollo Loco Holdings Inc / Upland Software Inc / Shake Shack Inc / Wingstop Inc / Everi Holdings Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Focus Financial Partners Inc / Uber Technologies Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First-Dose Vaccinations Settle in at 500K Per Day, Domestic COVID-19 Metrics Continue to Improve Despite Spread of Variants</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2008154 / 2544960 / 2280220 / 2270726 / 2670519 / 2342034 / 2684703 / 2440637 / 2829601 / 7103065 / B121557 / 2769796 / B02R1L6 / B3D7K31 / B03PGL4 / B7VD3F2 / BYW36M8 / BXDZ9Z0 / BHC8X90 / BKDS4H5 / BMYML02 / BLGJ610 / BFNR303 / BKTNTR9 / BJVR9Y9 / BP3YM85 / BZ1LFG7 / BQXZP64 / BP8XZL1 / BMBP1Q0</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Adobe Inc / Beasley Broadcast Group Inc / DTE Energy Co / Walt Disney Co / Exelon Corp / Fiserv Inc / Pfizer Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Mastercard Inc / Fidelity National Information Services Inc / ALLETE Inc / Discovery Inc / NorthWestern Corp / Duke Energy Corp / PayPal Holdings Inc / Shopify Inc / Novo Nordisk A/S / Bill.com Holdings Inc / DraftKings Inc / Warner Music Group Corp / Northwest Natural Holding Co / ViacomCBS Inc / iHeartMedia Inc / Trupanion Inc / Roku Inc / Wayfair Inc / Healthequity Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - CS forecasts 2.2% CAGR Rev Growth to 2030 range of 0% to 6.4% based on R&D success</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GSK.L / BMY.N / CL.N / JNJ.N / LLY.N / MRK.N / OREP.PA / PFE.N / ULVR.L / PG.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / BEIG.DE / ABBV.N / RKT.L</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / L'Oreal SA / Pfizer Inc / Unilever PLC / Procter & Gamble Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Beiersdorf AG / Abbvie Inc / Reckitt Benckiser Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Ms Jo Walton / Elizabeth Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Reminder: Virtual Washington, D.C. Day - June 30, 2021; Updated Full Agenda</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb up 5.7% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 11, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US37733W1053 / US4523271090 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US34959E1091 / US9100471096 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US70438V1061 / CA0089118776 / US07725L1026 / KYG4740B1059 / US8760301072 / US5904791358 / US28414H1032 / US46583P1021 / US26142R1041 / US83089J1088 / US1241551027 / US30260D1037 / US82933R1005 / US23954D1090</td><td class="leftalignment">Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Fortinet Inc / United Airlines Holdings Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Paylocity Holding Corp / Air Canada / Beigene Ltd / Ichor Holdings Ltd / Tapestry Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Iveric Bio Inc / DraftKings Inc / Skywater Technology Inc / Butterfly Network Inc / Figs Inc / Singular Genomics Systems Inc / Day One Biopharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT® Healthcare: Value Creation in Healthcare - Tracking Profit Pools & Identifying Value Creators</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BMY.N / TMO.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Thermo Fisher Scientific Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">HOLT Americas / Steven Bock</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (21 June-): Expecting good returns from pharma stocks' defensive qualities</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4503.T / 4507.T / 4502.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / SAGE.OQ / 4887.T</td><td class="leftalignment">Astellas Pharma Inc / Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / SAGE Therapeutics Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（6月21日～）: 医薬品のディフェンシブ性に期待</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4503.T / 4507.T / 4502.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / SAGE.OQ / 4887.T</td><td class="leftalignment">Astellas Pharma Inc / Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / SAGE Therapeutics Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1076</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Does The Valuation Gap Between Merck Stock And Zoetis Make Sense?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.4% Above Pre-Pandemic Base- Week 63</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bloomsbury Publishing advances 18% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 552</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Euro Credit Pilot - Credit remains solid (June 2021)</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">US88579Y1010 / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANZ.AX / APD.N / ASML.AS / ATCOA.ST / AXAF.PA / BAC.N / BARC.L / BKT.MC / BMWG.DE / BNPP.PA / BNS.TO / BOUY.PA / BP.L / BT.L / C.N / CAPP.PA / CARR.PA / CBA.AX / CBKG.DE / CCH.L / CM.TO / CNPP.PA / CRH.I / DANO.PA / DEO.N / DSMN.AS / EDP.LS / ENI.MI / ERICb.ST / ERST.VI / FREG.F / GASI.MI / GE.N / GM.N / HEIG.F / HEIN.AS / HSBA.L / IBE.MC / IBM.N / KPN.AS / LLOY.L / LVMH.PA / MAP.MC / MDBI.MI / MGA / MICP.PA / MOLB.BU / MRK.N / MUVGn.DE / NAB.AX / PRTP.PA / SAN.MC / T.N / CONG.DE / AZN.L / AMGN.O / FER.MC / AAL.L / GS.N / ACE.MI / DBKGn.DE / MCD.N / FMEG.DE / BZU.MI / ENEI.MI / MRCG.DE / DTEGn.F / BBVA.MC / BTI.N / IFXGn.DE / FR0000064578 / FR0000035081 / ISS.CO / CARLb.CO / ADEN.S / HNRGn.DE / DPWGn.DE / IG.MI / GSK.L / BAB.L / AMXL.MX / EUFI.PA / JCDX.PA / GB0008220112 / SE0000455057 / US1101221083 / US2987361092 / US3377381088 / US4943681035 / US5949181045 / JP3116000005 / CAGR.PA / AMA.MC / DANSKE.CO / CH0013841017 / ARLG.DE / ENAG.MC / AV.L / US20030N1019 / US02209S1033 / EBKG.DE / JYSK.CO / MAERSKb.CO / HRA.MI / CAIV.VI / US46625H1005 / INGA.AS / LXSG.DE / BTGGg.F / GB0033986497 / JP3885780001 / MTXGn.DE / ELI.BR / EDF.PA / ETL.PA / MS.N / GAZP.MM / US31620M1062 / AKE.PA / ISP.MI / DWNG.DE / DK0060079531 / AU000000GMG2 / SABE.MC / CNE1000001Z5 / CNE1000002H1 / FR0010690156 / BNRGN.DE / IREE.MI / CNE100000KC0 / CABK.MC / US03027X1000 / MDLZ.OQ / LEGN.DE / GYC.DE / 1COV.DE / IMB.L / SE0009922164 / BIRG.I / BMG2178K1009 / BAWG.VI / LU0251710041 / AT0000BAWAG2 / AIBG.I / AIG.A / NL00150006R6</td><td class="leftalignment">3M Co / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Australia and New Zealand Banking Group Ltd / Air Products and Chemicals Inc / ASML Holding NV / Atlas Copco AB / AXA SA / Bank of America Corp / Barclays PLC / Bankinter SA / Bayerische Motoren Werke AG / BNP Paribas SA / Bank of Nova Scotia / Bouygues SA / BP PLC / BT Group PLC / Citigroup Inc / Capgemini SE / Carrefour SA / Commonwealth Bank of Australia / Commerzbank AG / Coca Cola HBC AG / Canadian Imperial Bank of Commerce / CNP Assurances SA / CRH PLC / Danone SA / Diageo PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Fresenius SE & Co KGaA / Assicurazioni Generali SpA / General Electric Co / General Motors Co / HeidelbergCement AG / Heineken NV / HSBC Holdings PLC / Iberdrola SA / International Business Machines Corp / Koninklijke KPN NV / Lloyds Banking Group PLC / LVMH Moet Hennessy Louis Vuitton SE / Mapfre SA / Mediobanca Banca di Credito Finanziario SpA / Magna International Inc / Compagnie Generale des Etablissements Michelin SCA / MOL Magyar Olajes Gazipari Nyrt / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Australia Bank Ltd / Kering SA / Banco Santander SA / AT&T Inc / Continental AG / AstraZeneca PLC / Amgen Inc / Ferrovial SA / Anglo American PLC / Goldman Sachs Group Inc / Acea SpA / Deutsche Bank AG / McDonald's Corp / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / British American Tobacco PLC / Infineon Technologies AG / Covivio SA / Icade SA / Iss A/S / Carlsberg A/S / Adecco Group AG / Hannover Rueck SE / Deutsche Post AG / Italgas SpA / GlaxoSmithKline PLC / Babcock International Group PLC / America Movil SAB de CV / Eurofins Scientific SE / JCDecaux SA / DS Smith PLC / Fastighets AB Balder / Bristol-Myers Squibb Co / Euronet Worldwide Inc / Fiserv Inc / Kimberly-Clark Corp / Microsoft Corp / Asahi Group Holdings Ltd / Credit Agricole SA / Amadeus IT Group SA / Danske Bank A/S / Lonza Group AG / Aareal Bank AG / Enagas SA / Aviva PLC / Comcast Corp / Altria Group Inc / EnBW Energie Baden Wuerttemberg AG / Jyske Bank A/S / AP Moeller - Maersk A/S / Hera SpA / CA Immobilien Anlagen AG / JPMorgan Chase & Co / ING Groep NV / Lanxess AG / Bertelsmann SE & Co KGaA / ITV PLC / Mizuho Financial Group Inc / MTU Aero Engines AG / Elia Group SA / Electricite de France SA / Eutelsat Communications SA / Morgan Stanley / Gazprom PAO / Fidelity National Information Services Inc / Arkema SA / Intesa Sanpaolo SpA / Deutsche Wohnen SE / DSV A/S / Goodman Group / Banco de Sabadell SA / Bank of China Ltd / China Construction Bank Corp / Aeroports de Paris SA / Brenntag SE / Iren SpA / China National Chemical Engineering Co Ltd / Caixabank SA / American Tower Corp / Mondelez International Inc / LEG Immobilien SE / Grand City Properties SA / Covestro AG / Imperial Brands PLC / Essity AB (publ) / Bank of Ireland Group PLC / CK Infrastructure Holdings Ltd / BAWAG Group AG / CPI Property Group SA / BAWAG Group AG / Aib Group PLC / American International Group Inc / Ctp NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Czech Republic / Germany / Denmark / Spain / Finland / France / United Kingdom / Greece / Hungary / Ireland / Italy / Japan / Luxembourg / Mexico / Netherlands / Norway / New Zealand / Poland / Portugal / Russian Federation / Slovakia / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MISCELLANEOUS / CHANGE IN RECOMMENDATION / MODELS / PORTFOLIO STRATEGY / CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Herr Gianfranco Arcovito / Herr Christian Aust / Herr Tobias Keller / Herr. Stefan Kolek / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GSK Licensing Deal Hugely Validating for EOS-448 and TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">11012210 / 45337C10 / 71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / M2572210 / 09062X10 / 478160104 / 640268108 / 771195104 / 58933Y10 / 92337C10 / 04651310 / 75046920 / 00287Y10 / 98401F10 / ITOS.OQ / 58949210 / 09627Y10 / 07725L10 / G3910J11 / 81181C10 / K3967W10 / 46565G10 / 61776010 / 03969F10 / F5548N10 / 48111610</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Compugen Ltd / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Verastem Inc / Atara Biotherapeutics Inc / Radius Health Inc / Abbvie Inc / Xencor Inc / Iteos Therapeutics Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Genmab A/S / Iteos Therapeutics Inc / MorphoSys AG / Arcus Biosciences Inc / Sanofi SA / Jounce Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Jeffrey La Rosa / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / MCD=US / OXY=US / RRC=US / WEN=US / DVN=US / INCY=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / PB=US / IGT=US / MGY=US / SWN=US / MUR=US / EWBC=US / BRO=US / BYD=US / UMPQ=US / MRO=US / EXPE=US / MGM=US / PENN=US / CBRL=US / CNX=US / DRI=US / EQIX=US / EQT=US / AJG=US / MCRI=US / PACW=US / REGI=US / TRIP=US / WAL=US / CVX=US / SGMS=US / BXS=US / BKNG=US / SNV=US / FBK=US / MKL=US / PRA=US / CATY=US / COP=US / DIN=US / PNFP=US / RRR=US / JRVR=US / BIIB=US / TCBI=US / FNB=US / CZR=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / GPRE=US / TAST=US / QSR=US / CLR=US / NMTR=US / NOG=US / JACK=US / KNSL=US / AR=US / ESTE=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / ABBV=US / NDLS=US / FATE=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / DEA=US / WING=US / ARGX=US / WLTW=US / CDEV=US / TRVG=US / PVAC=US / SBOW=US / HWC=US / OZK=US / RTLR=US / AHCO=US / OVV=US / ARQT=US / DKNG=US / ZI=US / BALY=US / ABNB=US / VMEO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Devon Energy Corp / Incyte Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / East West Bancorp Inc / Brown & Brown Inc / Boyd Gaming Corp / Umpqua Holdings Corp / Marathon Oil Corp / Expedia Group Inc / MGM Resorts International / Penn National Gaming Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / Equinix Inc / EQT Corp / Arthur J Gallagher & Co / Monarch Casino & Resort Inc / PacWest Bancorp / Renewable Energy Group Inc / Tripadvisor Inc / Western Alliance Bancorp / Chevron Corp / Scientific Games Corp / Cadence Bank / Booking Holdings Inc / Synovus Financial Corp / FB Financial Corp / Markel Corp / ProAssurance Corp / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Red Rock Resorts Inc / James River Group Holdings Ltd / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / Caesars Entertainment Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / 9 Meters Biopharma Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Easterly Government Properties Inc / Wingstop Inc / argenx SE / Willis Towers Watson PLC / Centennial Resource Development Inc / Trivago NV / Ranger Oil Corp / SilverBow Resources Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Adapthealth Corp / Ovintiv Inc / Arcutis Biotherapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Bally's Corp / Airbnb Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2008154 / 2050832 / 2026242 / 2216850 / 2280220 / 2270726 / 2328915 / 2100920 / 2680905 / 2684703 / 2707677 / 2829601 / 7103065 / B067BM3 / B125XQ6 / B02R1L6 / B3D7K31 / B03PGL4 / BVVN4Q8 / BJLFHW7 / BFZ1K46 / BMYML02 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BGKG6M3 / BN2S6Y8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Adobe Inc / Ameren Corp / American Electric Power Company Inc / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / PPL Corp / Pfizer Inc / Public Service Enterprise Group Inc / Southern Co / Novartis AG / Molson Coors Beverage Co / Portland General Electric Co / ALLETE Inc / Discovery Inc / NorthWestern Corp / Eversource Energy / Chewy Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / StoneCo Ltd / Talaris Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Pay for performance: CEO compensation</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 04, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 14 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US02553E1064 / US0463531089 / US09058V1035 / US1101221083 / US37733W1053 / US45337C1027 / US4663671091 / US4781601046 / US5002551043 / US5324571083 / US66987V1098 / US6701002056 / US7010941042 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9699041011 / US4771431016 / US4198791018 / US80105N1054 / PAP310761054 / US01748X1028 / US2473617023 / US90384S3031 / US58933Y1055 / US9100471096 / US00287Y1091 / US98978V1035 / IE00B4Q5ZN47 / US8485771021 / US21240E1055 / CA05156V1022 / US02376R1023 / IE00BQPVQZ61 / CA0089118776 / US07725L1026 / US74967X1037 / US5904791358 / US28414H1032 / US0144421072 / US98420X1037 / US26142R1041</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / AstraZeneca PLC / BioCryst Pharmaceuticals Inc / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Incyte Corp / Jack in the Box Inc / Johnson & Johnson / Kohls Corp / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Williams-Sonoma Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / Zoetis Inc / Jazz Pharmaceuticals PLC / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / Horizon Therapeutics PLC / Air Canada / Beigene Ltd / RH / Mesa Air Group Inc / Elanco Animal Health Inc / Alector Inc / X4 Pharmaceuticals Inc / DraftKings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 62</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">EHA Update: Wide Safety Margin for SLN124; GEMINI-II Data in Second Half With Indication Expansion Into PV in the Cards</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">BMY ASCO Call Highlights; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US1101221083 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Reminder: Virtual Washington, D.C. Day - June 30, 2021; Full Agenda Now Available</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 551</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ABCs of ASCO: Adjuvant Advances, BCMA CAR and Bispecific Bonanza, CD137 Comeback, Dual IO Developments, EGFR Exon20 Excites</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">00847G705 / 00887A105 / 03116210 / 110122108 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 15117K103 / 04651310 / 816212104 / 09609G100 / 67022C106 / 720795103 / 49372L100 / 05280R100 / 019770106 / H17182108 / 717224109 / 74019P108 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 03890D108 / 192010106 / 13089P101 / 151205200 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Agenus Inc / Aileron Therapeutics Inc / Amgen Inc / Bristol-Myers Squibb Co / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Cellectis SA / Atara Biotherapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / CRISPR Therapeutics AG / PhaseBio Pharmaceuticals Inc / Precision BioSciences Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sami Corwin, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">V / 2126335 / 2216850 / 2280220 / 2328915 / 2689560 / 2707677 / 2829601 / 2931034 / 2503529 / B121557 / 2857817 / B0T7YX2 / B02R1L6 / BCZS820 / BYVY8G0 / BFZNYB7 / BDHF4K6 / BWFKZT2 / BFZ1K46 / BLGJ610 / BFMXGR0 / BYY88Y7 / BNTB3N8 / BP8GHT2</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Consolidated Edison Inc / DTE Energy Co / Nextera Energy Inc / PG&E Corp / Public Service Enterprise Group Inc / Southern Co / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / Mastercard Inc / Netflix Inc / Live Nation Entertainment Inc / ALLETE Inc / Fate Therapeutics Inc / Alphabet Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Cellectis SA / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / Alphabet Inc / Vizio Holding Corp / Vascular Biogenics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HGEN: Bringing Calm to the (Cytokine) Storm; Initiate with an Outperform Rating and $28 TP</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">HGEN.OQ / BMY.N / SASY.PA / ROG.S / NOVN.S / GSK.L / REGN.OQ / GILD.OQ / IMAB.OQ</td><td class="leftalignment">Humanigen Inc / Bristol-Myers Squibb Co / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Tiago Fauth / Matthew Terwelp / Mr. Thomas Deal / Roger Xu / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">VBLT (BUY) - Takeaways from Our Virtual NDR; Focus on VB-111 First-In-Class Opportunities in Ovarian & Glioblastoma</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BP8GHT2 / 2126335</td><td class="leftalignment">Vascular Biogenics Ltd / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">TRANSFORM Meets Endpoint, Setting Potential to Leapfrog Competition to Earlier Lines for Aggressive Lymphoma</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Jun. 10, 2021 / 9:40AM ET</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ALLO, CLLS, CRSP, FATE - Positive Topline for Breyanzi in 2L LBCL Highlights Growth Opportunity for CAR-T Therapies</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ALLO.OQ / CRSP.BN / FATE.OQ / 2126335 / BCZS820 / BFZNYB7 / BDHF4K6 / BWFKZT2</td><td class="leftalignment">Allogene Therapeutics Inc / CRISPR Therapeutics AG / Fate Therapeutics Inc / Bristol-Myers Squibb Co / Fate Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Cellectis SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / AMGN=US / BMY=US / GBT=US / BLD=US / INCY=US / GL=US / GILD=US / PAA=US / CHRS=US / LEG=US / VMC=US / MLM=US / PATH=US / BNL=US / DRI=US / ENDP=US / IBP=US / MHK=US / NTST=US / REGN=US / THO=US / VRTX=US / HIW=US / BDN=US / PRI=US / EGP=US / KIM=US / MAA=US / UDR=US / DRE=US / AUTL=US / DIN=US / OGN / BCO=US / TPX=US / EXP=US / BECN=US / TXRH=US / BLDR=US / PGTI=US / OC=US / KTOS=US / TREX=US / OLO=US / APTS=US / MEIP=US / ABBV=US / TILE=US / HTRG=US / DEA=US / 82982L103 / CRSP=US / YEXT=US / COLD=US / EOLS=US / UBER=US / GMAB=US / AZEK=US / VTRS=US / DASH=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / TopBuild Corp / Incyte Corp / Globe Life Inc / Gilead Sciences Inc / Plains All American Pipeline LP / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / UiPath Inc / Bunzl plc / Darden Restaurants Inc / Endo International PLC / Installed Building Products Inc / Mohawk Industries Inc / Netstreit Corp / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Vertex Pharmaceuticals Inc / Highwoods Properties Inc / Brandywine Realty Trust / Primerica Inc / Eastgroup Properties Inc / Kimco Realty Corp / Mid-America Apartment Communities Inc / UDR Inc / Duke Realty Corp / Autolus Therapeutics PLC / Dine Brands Global Inc / Organon & Co / Brinks Co / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Builders FirstSource Inc / PGT Innovations Inc / Owens Corning / Kratos Defense and Security Solutions Inc / Trex Company Inc / Olo Inc / Preferred Apartment Communities Inc / MEI Pharma Inc / Abbvie Inc / Interface Inc / Heritage Insurance Holdings Inc / Easterly Government Properties Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Yext Inc / Americold Realty Trust / Evolus Inc / Uber Technologies Inc / Genmab A/S / Azek Company Inc / Viatris Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">V / 0989529 / 0925288 / 2126335 / 2000019 / 2023607 / 2778844 / 2973821 / 2026242 / 2219224 / 2270726 / 2829515 / 2317087 / 2342034 / 2455965 / 2471950 / 2689560 / 2680905 / 2684703 / 2705198 / 2707677 / 2829601 / 4595739 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / B7VD3F2 / BFLR866 / BYVY8G0 / BYZLV46 / BXDZ9Z0 / BNFWR44 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BN7K304 / BMHR7K6</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Edison International / Entergy Corp / Fiserv Inc / Biogen Inc / Incyte Corp / PG&E Corp / PPL Corp / Pfizer Inc / Progress Software Corp / Public Service Enterprise Group Inc / Southern Co / Genmab A/S / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / Duke Energy Corp / Twitter Inc / Alphabet Inc / InflaRx NV / Shopify Inc / Worldline SA / Evergy Inc / ViacomCBS Inc / Roku Inc / Academy Sports and Outdoors Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v2.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">State of the RCC: 1L Tug of War Could Continue Until Triplet Data; Keytruda’s Adjuvant Win May Be Deferred Until Mature OS</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">110122108 / 30161Q104</td><td class="leftalignment">Bristol-Myers Squibb Co / Exelixis Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US1101221083 / US1266501006 / US4448591028 / US75886F1075 / US09062X1037 / US0042251084 / US15135B1017 / US42226A1079 / US0367521038 / US05464T1043 / US0327973006 / US24823R1059 / US1255231003</td><td class="leftalignment">Bristol-Myers Squibb Co / CVS Health Corp / Humana Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Centene Corp / Healthequity Inc / Anthem Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Denali Therapeutics Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from BMY’s ASCO event</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REL-GB -  Dividend Quality Analysis, for the period ended June 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REL.L / DMGOa.L / ERM.L / PSON.L / QRT.L / BLPU.L</td><td class="leftalignment">Relx PLC / Daily Mail and General Trust P L C / Euromoney Institutional Investor PLC / Pearson PLC / Quarto Group Inc / Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BLUE, AMGN (NEUTRAL), GMAB.DC (BUY)- Read-through from ASCO MM Session Highlights Emerging Competition in Late Line; Darzalex Largely Shielded for Now</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.OQ / BLUE.OQ / 0925288 / 2126335 / 2023607 / 2475833 / 2684703 / 4595739 / BBFL7S1</td><td class="leftalignment">Amgen Inc / bluebird bio Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amgen Inc / Johnson & Johnson / Pfizer Inc / Genmab A/S / bluebird bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Jun. 08, 2021 / 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / INCY=US / TEVA=US / MTN=US / LOW=US / PB=US / CHRS=US / LEG=US / VMC=US / MLM=US / AIR=US / SWIM=US / CBRL=US / CSTR=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / REGN=US / REGI=US / FOUR=US / CGEN=US / FMBI=US / SNV=US / SIVB=US / ABCB=US / FBK=US / SSB=US / RF=US / FFIN=US / GBCI=US / DIN=US / PNFP=US / SBCF=US / BIIB=US / TPX=US / EXP=US / BDC=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / IBTX=US / NDLS=US / FATE=US / 00770K202 / COUP=US / LOCO=US / HQY=US / SHAK=US / WING=US / ARGX=US / ACBI=US / SQ=US / 82982L103 / TVTY=US / JELD=US / SFIX=US / HWC=US / BTAI=US / LSPD=US / FERG=US / OPCH=US / ARQT=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / AAR Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Shift4 Payments Inc / Compugen Ltd / First Midwest Bancorp Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / SouthState Corp / Regions Financial Corp / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Wingstop Inc / argenx SE / Atlantic Capital Bancshares Inc / Block Inc / SiteOne Landscape Supply Inc / Tivity Health Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Lightspeed Commerce Inc / Ferguson PLC / Option Care Health Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Adult Vaccinations Near 65% as Record Lows Extend Across Key COVID-19 Metrics Domestically; Broad Global Declines Continue</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2065159 / 2216850 / 2270726 / 2542049 / 2829515 / 2576941 / 2328915 / 2455965 / 2457864 / 2689560 / 2684703 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / BBGVT40 / BYVY8G0 / BP4GNK9 / BYNZGK1 / BJ2Z0H2 / BMQ5T49 / BFMXGR0 / BFNR303 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BDVLM39 / BP8XZL1 / BMG5660</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Autodesk Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / News Corp / Alphabet Inc / SAGE Therapeutics Inc / Block Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Evergy Inc / Northwest Natural Holding Co / ViacomCBS Inc / Roku Inc / Alphabet Inc / argenx SE / Healthequity Inc / Joann Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">4506.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / PFE.N / 4516.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">40</td><td class="leftalignment">4506.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / PFE.N / 4516.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ASCO 2021: Key takeaways (Part 4)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / MRK.N / ROG.S / NOVN.S / BAYGN.DE / 1801.HK / 1877.HK</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Roche Holding AG / Novartis AG / Bayer AG / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from MRK’s ASCO event</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK=US / BMY=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SNY-US -  Dividend Quality Analysis, for the period ended May 26,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SNY.O / ABT / BMY / JNJ / LLY / MRK / NVO / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Sanofi SA / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novo Nordisk A/S / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended June 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Disease-Modifying Therapy for Alz’s – End of the Beginning, with Several Cov’g Programs Gaining Traction</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / DNLI.O / BIIB.O / ACAD.O / PRTA.O / AVXL.O / AXSM.O / SAVA.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Denali Therapeutics Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Prothena Corporation PLC / Anavex Life Sciences Corp / Axsome Therapeutics Inc / Cassava Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 28, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Register: Virtual Washington, D.C. Day - June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BE0165385973 / US0091581068 / US00971T1016 / US0116591092 / US0311621009 / US0323325045 / US0463531089 / US0997241064 / US1101221083 / US17275R1023 / US2310211063 / US34354P1057 / US37733W1053 / US45167R1041 / US4523271090 / US45337C1027 / US4657411066 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7010941042 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8835561023 / US92343V1044 / US9427491025 / CA8265161064 / US30063P1057 / US00508Y1029 / US4771431016 / US4198791018 / US80105N1054 / US64111Q1040 / US1281261099 / US79466L3024 / US6866881021 / US2538681030 / US00206R1023 / US6247581084 / PAP310761054 / US16115Q3083 / US3364331070 / US01748X1028 / US2473617023 / US53261M1045 / US90384S3031 / US1940141062 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US69404D1081 / US92839U2069 / US8676524064 / JE00B783TY65 / US98419M1009 / US00287Y1091 / US98978V1035 / US8725901040 / US72919P2020 / US64051T1007 / US29355A1079 / US23283R1005 / US41068X1000 / US8485771021 / US21240E1055 / US5560991094 / US02376R1023 / IE00BLS09M33 / US0404131064 / CA0089118776 / US29444U7000 / US46185L1035 / US83417M1045 / US6323071042 / US98138J2069 / US45073V1089 / US34959J1088 / US87266J1043 / US36165L1089 / US45782B1044 / NL0012169213 / US87105L1044 / US8760301072 / US30057T1051 / US4622601007 / US05351X1019 / CH0371153492 / US92336X1090 / US0937121079 / US5904791358 / US28414H1032 / KY30744W1070 / US40131M1099 / US35952H6018 / US71535D1063 / US1567271093 / US23725P2092 / US92537N1081 / US26142R1041 / US6541101050 / US12233L1070 / US04271T1007 / KYG3902L1095 / US5502411037 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036</td><td class="leftalignment">Melexis NV / Air Products and Chemicals Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Amtech Systems Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / Cisco Systems Inc / Cummins Inc / Flowserve Corp / GlaxoSmithKline PLC / IDEX Corp / Illumina Inc / Incyte Corp / Itron Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Thermo Fisher Scientific Inc / Verizon Communications Inc / Watts Water Technologies Inc / Sierra Wireless Inc / Exact Sciences Corp / Acuity Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / NETGEAR Inc / CalAmp Corp / Salesforce.Com Inc / Ormat Technologies Inc / Digital Realty Trust Inc / AT&T Inc / Mueller Water Products Inc / Copa Holdings SA / Chart Industries Inc / First Solar Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Ulta Beauty Inc / Colfax Corp / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Xylem Inc / Abbvie Inc / Zoetis Inc / T-Mobile US Inc / Plug Power Inc / NeoPhotonics Corp / Enphase Energy Inc / CyrusOne Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / American Airlines Group Inc / Pentair PLC / Arista Networks Inc / Air Canada / Equinix Inc / Invitae Corp / Solaredge Technologies Inc / Natera Inc / Workhorse Group Inc / ITT Inc / Fortive Corp / TPI Composites Inc / GDS Holdings Ltd / Inseego Corp / Qiagen NV / Switch Inc / Tapestry Inc / Evoqua Water Technologies Corp / Iovance Biotherapeutics Inc / Avaya Holdings Corp / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Mesa Air Group Inc / Elanco Animal Health Inc / Farfetch Ltd / Guardant Health Inc / Fuelcell Energy Inc / Personalis Inc / Cerence Inc / DarioHealth Corp / Vertiv Holdings Co / DraftKings Inc / Nikola Corp / Burning Rock Biotech Ltd / Array Technologies Inc / GDS Holdings Ltd / Lumen Technologies Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO Highlights In Pharma From The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US1101221083 / US66987V1098 / US7711951043 / US58933Y1055</td><td class="leftalignment">Bristol-Myers Squibb Co / Novartis AG / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">CM648 to Add to Opdivo Growth Opportunity in GI and Rela Another String to the IO Bow; Cilta-cel Could Leave Abecma ide-ling</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (7 Jun-): Kyowa Kirin last week, Eisai this week</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4151.T / 4503.T / 4523.T / 2593.T / 4502.T / 4507.T / 4519.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Kyowa Kirin Co Ltd / Astellas Pharma Inc / Eisai Co Ltd / Ito En Ltd / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（6月7日～）: 先週は協和キリン、今週はエーザイ</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">2593.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Ito En Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - ASCO 2021: Tecentriq in adjuvant lung cancer likely practice changing in a limited population</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ROG.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - ASCO 2021 weekend takeaways</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - ASCO 2021 Weekend highlights</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ASCO 2021: Key takeaway from weekend presentations (Part 1)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">4502.T / BMY.N / MRK.N / AMGN.OQ / 600276.SS / ZLAB.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Merck & Co Inc / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Zai Lab Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 61</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 550</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 04/06/2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.L / SVT.L / UU.L / GLO.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Severn Trent PLC / United Utilities Group PLC / ContourGlobal PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Alastair P. Reid / Mr. Martin C. Young / Ross Broadfoot</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Bloomsbury Publishing (Add) - Success through diversity</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Malcolm Morgan / Ms. Jessica Pok</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 4 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">DE0006231004 / US0028241000 / US0079031078 / US0231351067 / US0382221051 / US0463531089 / US0530151036 / US1005571070 / US1101221083 / US1265011056 / US1727551004 / US1924461023 / US2545431015 / US4567881085 / US4581401001 / US4781601046 / US5012421013 / US5370081045 / US55306N1046 / US5950171042 / US66987V1098 / US67066G1040 / US6795801009 / US7043261079 / US8269191024 / US8610121027 / US91347P1057 / US9581021055 / US37940X1028 / US87157D1090 / US83088M1027 / US21036P1084 / US6098391054 / US60871R2094 / US31620M1062 / US82706C1080 / US78709Y1055 / US1717793095 / US3020811044 / US92932M1018 / US87874R1005 / BMG3922B1072 / US5500211090 / US64110D1046 / IE00B4BNMY34 / US58933Y1055 / US39304D1028 / US29414B1044 / US96208T1043 / NL0010273215 / US81762P1021 / US2908462037 / US55405Y1001 / KYG037AX1015 / US03823U1025 / US8086251076 / US70438V1061 / US70432V1026 / US03937C1053 / LU0974299876 / US94419L1017 / US40434L1052 / GB00BZ09BD16 / US98138J2069 / US2067871036 / US87968A1043 / US02156B1035 / US23355L1061 / US76674Q1076 / US7625441040 / US89854H1023 / US98980G1022 / US11135F1012 / US15677J1088 / US29260V1052 / US69553P1003 / US22788C1053 / US39813G1094 / US86646P1030 / CA67079A1021 / US8808811074 / US15961R1059 / US90364P1057 / US83089J1088 / US44891N2080 / US92719V1008</td><td class="leftalignment">Infineon Technologies AG / Abbott Laboratories / Advanced Micro Devices Inc / Amazon.com Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Boston Beer Company Inc / Bristol-Myers Squibb Co / CTS Corp / Cirrus Logic Inc / Cognizant Technology Solutions Corp / Diodes Inc / Infosys Ltd / Intel Corp / Johnson & Johnson / Kulicke and Soffa Industries Inc / Littelfuse Inc / MKS Instruments Inc / Microchip Technology Inc / Novartis AG / NVIDIA Corp / Old Dominion Freight Line Inc / Paychex Inc / Silicon Laboratories Inc / STMicroelectronics NV / Universal Display Corp / Western Digital Corp / Global Payments Inc / Synaptics Inc / Skyworks Solutions Inc / Constellation Brands Inc / Monolithic Power Systems Inc / Molson Coors Beverage Co / Fidelity National Information Services Inc / Silicon Motion Technology Corp / Saia Inc / Ciena Corp / Exlservice Holdings Inc / WNS (Holdings) Ltd / TechTarget Inc / Genpact Ltd / Lululemon Athletica Inc / NetApp Inc / Accenture PLC / Merck & Co Inc / Green Dot Corp / Epam Systems Inc / WEX Inc / ASML Holding NV / ServiceNow Inc / EMCORE Corp / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Applied Optoelectronics Inc / Science Applications International Corp / Paylocity Holding Corp / Paycom Software Inc / ArcBest Corp / Globant SA / Wayfair Inc / HP Inc / Atlassian Corporation PLC / Workhorse Group Inc / Conduent Inc / Tellurian Inc / Alteryx Inc / DXC Technology Co / Rimini Street Inc / Ribbon Communications Inc / TTEC Holdings Inc / Zscaler Inc / Broadcom Inc / Ceridian HCM Holding Inc / Endava PLC / PagerDuty Inc / CrowdStrike Holdings Inc / Grid Dynamics Holdings Inc / Sumo Logic Inc / Nuvei Corp / Terns Pharmaceuticals Inc / ChargePoint Holdings Inc / UiPath Inc / Skywater Technology Inc / IAC/Interactivecorp / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: Late-Breaking Pharma Abstracts And Our Take On The Data</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0463531089 / US1101221083 / US66987V1098 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Novartis AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2126335 / 2516152 / 2496113 / 2023607 / 2778844 / 2973821 / 2216850 / 2222631 / 2270726 / 2317087 / 2670519 / 2328915 / 2680905 / 2707677 / 2829601 / 7103065 / 2857817 / 2951452 / B0T7YX2 / B02R1L6 / B3D7K31 / B23FN39 / B7TL820 / B85KFY9 / B7JYSG3 / BBPK0J0 / BJ0KXV4 / B424494 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BKS3SM8 / BZ1HM42 / BFZ1K46 / BFMXGR0 / BJJMGL2 / BFWK4R7 / BL71K91 / BK71LY6 / BDRW1L7 / BKF9DQ8 / BNG3RZ7 / BMDJ085 / BMG5660 / BP8GHT2</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kohls Corp / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / Consolidated Edison Inc / Cooper Companies Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / PPL Corp / Public Service Enterprise Group Inc / Southern Co / Novartis AG / Netflix Inc / J M Smucker Co / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Lululemon Athletica Inc / Meta Platforms Inc / Five Below Inc / Guidewire Software Inc / Mirati Therapeutics Inc / ONE Gas Inc / Splunk Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / IGM Biosciences Inc / Adyen NV / Spotify Technology SA / Evergy Inc / Fox Corp / PagSeguro Digital Ltd / Revolution Medicines Inc / WW International Inc / AnaptysBio Inc / Phreesia Inc / Leslie's Inc / Shoals Technologies Group Inc / Joann Inc / Vascular Biogenics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ASCO 2021 Late-Breakers Highlight Practice Changing Adjuvant Results from MRK/AZN's Lynparza in BRCA+ Breast Cancer & MRK's Keytruda in Kidney Cancer</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.L / MRK.N / 0989529 / 2126335 / 2778844 / 7103065</td><td class="leftalignment">AstraZeneca PLC / Merck & Co Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Bloomsbury Publishing : A virtuous circle - Buy</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - ASCO 2021 late breaking abstract released: Junshi's toripalimab improves survival in 1L nasopharyngeal cancer</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / MRK.N / AZN.L / NOVN.S / 600276.SS / BGNE.OQ / 1877.HK</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC / Novartis AG / Jiangsu Hengrui Pharmaceuticals Co Ltd / Beigene Ltd / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 2126335 / 2973821 / 2216850 / 2270726 / 2542049 / 2829515 / 2670519 / 2328915 / 2471950 / 2689560 / 2684703 / 2707677 / 2138158 / 2829601 / 2980906 / 5531000 / 2822019 / 2969637 / B0T7YX2 / B02R1L6 / B3D7K31 / B6197Q2 / B7TL820 / B65SQW4 / B7VD3F2 / B7JYSG3 / B3V9F12 / BFLR866 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BYW36M8 / BD8DJ71 / BKDS4H5 / BJ2Z0H2 / BKVDFF7 / BFZ1K46 / BMYML02 / BFMXGR0 / BZ8VJQ8 / BGSP7M9 / BFWK4R7 / BGKG6M3 / BYXR425 / BZ4CHH2 / BYXB1Y8 / BMCC9R7 / BMDJ397 / BNTB3N8 / BWC52Q6 / BJ9N563</td><td class="leftalignment">American Express Co / Visa Inc / Bristol-Myers Squibb Co / Alliant Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Exelon Corp / Nextera Energy Inc / Incyte Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / Foot Locker Inc / MorphoSys AG / Advance Auto Parts Inc / DICK'S Sporting Goods Inc / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Generac Holdings Inc / Meta Platforms Inc / Enphase Energy Inc / Duke Energy Corp / Guidewire Software Inc / PVH Corp / Twitter Inc / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Snap Inc / Bill.com Holdings Inc / Pinterest Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Vistra Corp / Zoom Video Communications Inc / PagSeguro Digital Ltd / StoneCo Ltd / RH / Soleno Therapeutics Inc / Sunrun Inc / SCYNEXIS Inc / Bolt Biotherapeutics Inc / Vizio Holding Corp / Solaredge Technologies Inc / Sunnova Energy International Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - New report: ASCO 2021 calendar-China biotech presentations to watch</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1093.HK / BMY.N / JNJ.N / MRK.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / 600276.SS / 4568.T / MRTX.OQ / BGNE.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / IMAB.OQ</td><td class="leftalignment">CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Mirati Therapeutics Inc / Beigene Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: ASCO 2021 calendar: China biotech presentations to watch</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">1093.HK / BMY.N / JNJ.N / MRK.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / 600276.SS / 4568.T / MRTX.OQ / BGNE.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / IMAB.OQ</td><td class="leftalignment">CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Mirati Therapeutics Inc / Beigene Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 02/06/2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.L / GNC.L / CCR.L / HSP.L / PARA.L / IDHC.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Greencore Group PLC / C&C Group PLC / Hargreaves Services PLC / Paragon Banking Group PLC / Integrated Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Alastair P. Reid / Ms. Alicia A. Forry, CFA / Dr. Andrew M. Whitney / Mr. Ian Gordon / Mr. Michael Donnelly / Nicola V. Mallard / Ross Broadfoot / Tom Brookhouse</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Jun. 02, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Bloomsbury Publishing (Add) - Upgrades and special dividend</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Malcolm Morgan / Ms. Jessica Pok</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / KMI=US / V=US / LOW=US / HSII=US / LEG=US / KFRC=US / VMC=US / MLM=US / KFY=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAN=US / MAS=US / MRCY=US / MHK=US / ASGN=US / REGI=US / RHI=US / SMG=US / SHOP=US / TRIP=US / CGEN=US / CCRN=US / PYPL=US / AVTR=US / CRTO=US / NFLX=US / DIN=US / PTON=US / RNG=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / MA=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / KTOS=US / NXGN=US / JACK=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / PTCT=US / CEQP=US / FATE=US / VCYT=US / 00770K202 / LOCO=US / SHAK=US / BWXT=US / WING=US / 100095108 / 82982L103 / IRTC=US / JELD=US / ROKU=US / SYNH=US / MAXR=US / BTAI=US / FERG=US / LHX=US / IMVT=US / ARQT=US / SPCE=US / FBRX=US / AZEK=US / AFRM=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Kinder Morgan Inc / Visa Inc / Lowe's Companies Inc / Heidrick & Struggles International Inc / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Korn Ferry / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Robert Half International Inc / Scotts Miracle-Gro Co / Shopify Inc / Tripadvisor Inc / Compugen Ltd / Cross Country Healthcare Inc / PayPal Holdings Inc / Avantor Inc / Criteo SA / Netflix Inc / Dine Brands Global Inc / Peloton Interactive Inc / RingCentral Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Mastercard Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / NextGen Healthcare Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Crestwood Equity Partners LP / Fate Therapeutics Inc / Veracyte Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / BWX Technologies Inc / Wingstop Inc / Bank of America Corp / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Roku Inc / Syneos Health Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Ferguson PLC / L3harris Technologies Inc / Immunovant Inc / Arcutis Biotherapeutics Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2367026 / 2701271 / 2126335 / 2516152 / 2000019 / 2486813 / 2002305 / 2973821 / 2050832 / 2216850 / 2270726 / 2670519 / 2684703 / 2048804 / 2707677 / 2440637 / 2829601 / 7103065 / 2857817 / B02R1L6 / B2R3PV1 / B3D7K31 / BFLR866 / BYRY499 / BTN1Y11 / BQPVQZ6 / BYVY8G0 / BNFWR44 / BWFKZT2 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BYY88Y7 / BDVLM39 / BKWD3M9 / BGKG6M3 / BJRFSB7 / BMDJ085 / BMFPJK6</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / General Mills Inc / Costco Wholesale Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Abbott Laboratories / Alliant Energy Corp / Ameren Corp / Consolidated Edison Inc / Walt Disney Co / Exelon Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Twitter Inc / Kraft Heinz Co / Medtronic PLC / Horizon Therapeutics PLC / Alphabet Inc / Worldline SA / Cellectis SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Alphabet Inc / argenx SE / Progyny Inc / StoneCo Ltd / Immunovant Inc / Shoals Technologies Group Inc / ACV Auctions Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Bloomsbury Publishing : Strategy delivers returns - Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 21, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (31 May): Focus on Astellas, Eisai, Terumo</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4503.T / 4523.T / 4543.T / 4502.T / 4507.T / 4519.T / 4528.T / BMY.N / MRK.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Astellas Pharma Inc / Eisai Co Ltd / Terumo Corp / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Merck & Co Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（5月31日～）: アステラス製薬、エーザイ、テルモなどに注目したい</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4503.T / 4523.T / 4502.T / 4507.T / 4519.T / 4528.T / 4543.T / BMY.N / MRK.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Astellas Pharma Inc / Eisai Co Ltd / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Merck & Co Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">05/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 60</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Ford Motor Co / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Bristol Myers Squibb (BMY: $65.72) drops on high volatility in May 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 549</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Weekly Previews: Anpario, Biffa, Bloomsbury Publishing, Chemring, CMC Markets, discoverIE, Go-Ahead, Gooch & Housego, Mitie, NewRiver REIT, Oxford Instruments, Paragon Banking Group, Sirius Real Estate, SSP Group, Ted Baker, Wizz Air, Workspace</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GB0000055888 / GB0003753778 / GB0006650450 / GB0001048619 / GB0002259116 / GB0004657408 / GB0033147751 / GB00B2NGPM57 / GB00B3NWT178 / GB00B45C9X44 / GB00B67G5X01 / JE00BN574F90 / GB00BD7XPJ64 / GB00B14SKR37 / GB00BD8DR117 / GB00BGBN7C04</td><td class="leftalignment">Discoverie Group PLC / Go-Ahead Group PLC / Oxford Instruments PLC / Ted Baker PLC / Gooch & Housego PLC / Mitie Group PLC / Bloomsbury Publishing PLC / Paragon Banking Group PLC / Anpario PLC / Chemring Group PLC / Workspace Group PLC / Wizz Air Holdings PLC / Newriver Reit PLC / CMC Markets PLC / Biffa PLC / SSP Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Jersey</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Banks / Broadcasting & Cable / Conglomerates / Defense / Education / Electrical / Engineering & Construction / Environmental Services / Financial Services / Industrial Materials / Lodging & Restaurants / Machinery / Media / Publishing / Railroads / Real Estate / Retailing / Services / Shipping & Shipbuilding / Transportation / Wholesale / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: India - Sun Pharmaceuticals Industries Limited: Specialty sales missed estimates in 4Q, and should further decline in 1Q . Maintain UNDERPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SUN.BO / BMY.N / UCB.BR / IQV.N</td><td class="leftalignment">Sun Pharmaceutical Industries Ltd / Bristol-Myers Squibb Co / Ucb SA / IQVIA Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / India / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Save the Date - Washington, D.C. Day - June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / AMZN=US / T=US / INCY=US / GILD=US / VZ=US / CHRS=US / EWBC=US / MANH=US / MLM=US / DV=US / WTFC=US / AIZ=US / CBRL=US / ELY=US / EXEL=US / HEI=US / MAIN=US / OKE=US / HOOK=US / REGN=US / GOLF=US / CGEN=US / CFB=US / SNV=US / SIVB=US / ABCB=US / FB=US / FBK=US / SSB=US / GBCI=US / NLS=US / PNFP=US / SBCF=US / JRVR=US / STRO=US / RNG=US / IAC=US / RCUS=US / CLNY=US / KNSL=US / MEIP=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / ACBI=US / ZS=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / OZK=US / FTDR=US / ALLO=US / HARP=US / UBER=US / GMAB=US / AVAH=US / VMEO=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Amazon.com Inc / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / Coherus BioSciences Inc / East West Bancorp Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Wintrust Financial Corp / Assurant Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Exelixis Inc / HEICO Corp / Main Street Capital Corp / ONEOK Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Acushnet Holdings Corp / Compugen Ltd / Crossfirst Bankshares Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / Meta Platforms Inc / FB Financial Corp / SouthState Corp / Glacier Bancorp Inc / Nautilus Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / James River Group Holdings Ltd / Sutro Biopharma Inc / RingCentral Inc / IAC/Interactivecorp / Arcus Biosciences Inc / DigitalBridge Group Inc / Kinsale Capital Group Inc / MEI Pharma Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / Genmab A/S / Aveanna Healthcare Holdings Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">0925288 / 2577609 / 2126335 / 2000019 / 2973821 / 2065955 / 2219224 / 2280220 / 2270726 / 2328915 / 2459020 / 2515030 / 2641827 / 2707677 / 2138158 / 2829601 / B02R1L6 / B7TL820 / B7VD3F2 / BFLR866 / BYVY8G0 / BYW36M8 / BYNZGK1 / BD8DJ71 / BL2HYY7 / BGCYWN8 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJTJGC4 / BMDJ085 / BN2RM92</td><td class="leftalignment">GlaxoSmithKline PLC / CVS Health Corp / Bristol-Myers Squibb Co / Amazon.com Inc / Alliant Energy Corp / Autozone Inc / CMS Energy Corp / DTE Energy Co / Walt Disney Co / Nextera Energy Inc / Intuit Inc / Lithia Motors Inc / Nordstrom Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / ALLETE Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Alphabet Inc / PayPal Holdings Inc / Block Inc / Snap Inc / Casper Sleep Inc / Xencor Inc / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Kontoor Brands Inc / Shoals Technologies Group Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ASCO Planner v2.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ASCO 2021 Abstract Highlights and Virtual Conference Itinerary</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">00847G705 / 03116210 / 110122108 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 15117K103 / 04651310 / 462222100 / 00887A105 / 09609G100 / 67022C106 / 720795103 / 49372L100 / 05280R100 / 019770106 / H17182108 / 74019P108 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 03890D108 / 192010106 / 13089P101 / 151205200 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Agenus Inc / Amgen Inc / Bristol-Myers Squibb Co / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Aileron Therapeutics Inc / bluebird bio Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Precision BioSciences Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sami Corwin, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb gains 8.3% in past quarter; Institutional Ownership down 1%</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, BMY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, May 25, 2021 / 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / LSI=US / PFE=US / AMGN=US / BMY=US / MCD=US / WEN=US / INCY=US / CHKP=US / IART=US / MAC=US / BMRN=US / BNL=US / CBRL=US / CRL=US / DRI=US / EXEL=US / NOW=US / REGI=US / STOR=US / PSA=US / NET=US / OFC=US / SRC=US / NTRA=US / DIN=US / RPD=US / BIIB=US / EXR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / CMG=US / REX=US / GPRE=US / EHTH=US / OC=US / TAST=US / QSR=US / JACK=US / NEO=US / CUBE=US / PANW=US / ABBV=US / NDLS=US / FEYE=US / VRNS=US / 00770K202 / LOCO=US / SHAK=US / NSA=US / WING=US / LOB=US / ZS=US / LGF.B=US / OKTA=US / YEXT=US / SAIL=US / TENB=US / CRWD=US / ARQT=US / 96758W101 / VTRS=US / ABNB=US / HYFM=US / HIMS=US / KNBE=US</td><td class="leftalignment">Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Wendys Co / Incyte Corp / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Macerich Co / Biomarin Pharmaceutical Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Charles River Laboratories International Inc / Darden Restaurants Inc / Exelixis Inc / ServiceNow Inc / Renewable Energy Group Inc / STORE Capital Corp / Public Storage / Cloudflare Inc / Corporate Office Properties Trust / Spirit Realty Capital Inc / Natera Inc / Dine Brands Global Inc / Rapid7 Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / eHealth Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Neogenomics Inc / CubeSmart / Palo Alto Networks Inc / Abbvie Inc / Noodles & Co / Mandiant Inc / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / National Storage Affiliates Trust / Wingstop Inc / Live Oak Bancshares Inc / Zscaler Inc / Lions Gate Entertainment Corp / Okta Inc / Yext Inc / SailPoint Technologies Holdings Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Arcutis Biotherapeutics Inc / WideOpenWest Inc / Viatris Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Hims & Hers Health Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2973821 / 2942605 / 2317087 / 2576941 / 2100920 / 2459020 / 2657802 / 2684703 / 2048804 / 2440637 / 2138158 / 2829601 / 7103065 / B125XQ6 / B02R1L6 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / BK7Y2V9 / BD8DJ71 / BJ2Z0H2 / BFMXGR0 / BYY88Y7 / BK71LY6 / BMG75B4 / BKLCX50 / BMTVQT8 / BMDJ085</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Alliant Energy Corp / Avista Corp / Entergy Corp / Exelixis Inc / FirstEnergy Corp / Intuit Inc / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sempra Energy / Southern Co / Novartis AG / Portland General Electric Co / ALLETE Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Akero Therapeutics Inc / Snap Inc / Pinterest Inc / Evergy Inc / Alphabet Inc / WW International Inc / Inventiva SA / Health Catalyst Inc / Goodrx Holdings Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Record Lows Across Key COVID-19 Metrics as Vaccinations Near 50% in United States; Situation in India Continues to Improve</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 14, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 24 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079031078 / US0079731008 / US0116591092 / US0311001004 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1727551004 / US1925761066 / US37733W1053 / US4581401001 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US55306N1046 / US5951121038 / US66987V1098 / US6701002056 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US91347P1057 / US9282981086 / US9581021055 / US9699041011 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US3463751087 / US1572101053 / US90385V1070 / US79466L3024 / US6098391054 / US82706C1080 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US0995021062 / US7512121010 / US00287Y1091 / NL0010273215 / US98978V1035 / US98138H1014 / US55405Y1001 / US8486371045 / KYG037AX1015 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / CA0089118776 / US74736K1016 / IE00BTN1Y115 / CA1380351009 / US40434L1052 / KYG4740B1059 / US74967X1037 / US11135F1012 / US2575541055 / US5904791358 / US28414H1032 / US24703L2025 / US85205L1070 / US75943R1023 / US8334451098 / US5738741041 / US30320C1036 / US83089J1088 / IE00BKVD2N49</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Micro Devices Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / AMETEK Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cirrus Logic Inc / Cohu Inc / GlaxoSmithKline PLC / Intel Corp / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / Universal Display Corp / Vishay Intertechnology Inc / Western Digital Corp / Williams-Sonoma Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CEVA Inc / Ultra Clean Holdings Inc / Salesforce.Com Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / Ralph Lauren Corp / Abbvie Inc / ASML Holding NV / Zoetis Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Splunk Inc / Ambarella Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / Air Canada / Qorvo Inc / Medtronic PLC / Canopy Growth Corp / HP Inc / Ichor Holdings Ltd / RH / Broadcom Inc / Domo Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Dell Technologies Inc / SpringWorks Therapeutics Inc / Relay Therapeutics Inc / Snowflake Inc. / Marvell Technology Inc / FTC Solar Inc / Skywater Technology Inc / Seagate Technology Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2973821 / 2270726 / 2670519 / 2369174 / 2459020 / 2657802 / 2048804 / 2829601 / 2928683 / 2980906 / 7103065 / B125XQ6 / B0T7YX2 / B02R1L6 / B3D7K31 / 2949758 / B7TL820 / BCZS820 / B87ZMX0 / BYVY8G0 / BXDZ9Z0 / BYNZGK1 / BFZNYB7 / BDHF4K6 / BHC8X90 / BD8DJ71 / BWFKZT2 / BFMXGR0 / BKTNTR9 / BMDJ085</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Exelon Corp / Gilead Sciences Inc / Intuit Inc / OGE Energy Corp / Pinnacle West Capital Corp / Southern Co / VF Corp / Foot Locker Inc / Novartis AG / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Nexstar Media Group Inc / Meta Platforms Inc / Fate Therapeutics Inc / Palo Alto Networks Inc / Alphabet Inc / Shopify Inc / Block Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Cellectis SA / Evergy Inc / ViacomCBS Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Global Pharma Model Sweep: Reopening and Washington Headwinds Should Abate in 2H21 as Key Potential Catalysts Approach</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">2126335 / 0989529 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Pharma : Relative Valuation Finally Finding A Bottom?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N / LLY.N / ENDP.O / IDXX.O / HSKA.O / TEVA.N / HZNP.O / ABBV.N / ZTS.N / PRGO.N / AMRX.N / BHC.N / ELAN.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Endo International PLC / IDEXX Laboratories Inc / Heska Corp / Teva Pharmaceutical Industries Ltd / Horizon Therapeutics PLC / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Amneal Pharmaceuticals Inc / Bausch Health Companies Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova / Xiling Chen</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (from 24 May): Focus on stocks with strong earnings and themes, now that results releases are over</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / PFE.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / GKOS.N / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Glaukos Corp / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（5月24日～）: 決算発表一巡、好業績とテーマ性のある銘柄物色に注目</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / PFE.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / GKOS.N / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Glaukos Corp / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Level - Week 60</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : Updated Credit Views from the "USD HG Coverage and Rating Report"</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABC.N / AMGN.O / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CI.N / JNJ.N / LLY.N / MCK.N / MRK.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / BIIB.O / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amerisourcebergen Corp / Amgen Inc / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Biogen Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 548</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Weekly Previews: Avon Rubber, Biffa, Big Yellow, Bloomsbury Publishing, British Land, Charles Stanley, Chemring, discoverIE, Electrocomponents, Gooch & Housego, Greencore, Helical, Hill & Smith, Hilton Food, Impax Asset Management, LondonMetric Property,</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">GB0000055888 / GB0001367019 / GB0007995243 / IE0003864109 / GB0003096442 / GB0006556046 / GB0000163088 / GB0004270301 / GB0000667013 / GB0007990962 / GB0009896605 / GB0001048619 / GB0002259116 / GB0004905260 / GB0002869419 / GB0033147751 / GB00B0YG1K06 / GB00B0FYMT95 / GB00B1V9NW54 / GB00B4WFW713 / GB00B45C9X44 / GB00B0LCW208 / GB00B67G5X01 / JE00BN574F90 / GB00BD7XPJ64 / GB00BD8DR117 / GB00BD2NCM38</td><td class="leftalignment">Discoverie Group PLC / British Land Company PLC / Renewi PLC / Greencore Group PLC / Electrocomponents PLC / Charles Stanley Group PLC / Speedy Hire PLC / Hill & Smith Holdings PLC / Avon Protection PLC / Shaftesbury PLC / Zotefoams PLC / Ted Baker PLC / Gooch & Housego PLC / Impax Asset Management Group PLC / Big Yellow Group PLC / Bloomsbury Publishing PLC / Restaurant Group PLC / Helical PLC / Hilton Food Group PLC / Londonmetric Property PLC / Chemring Group PLC / Picton Property Income Ltd / Workspace Group PLC / Wizz Air Holdings PLC / Newriver Reit PLC / Biffa PLC / Warehouse REIT PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Jersey / Guernsey</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Banks / Broadcasting & Cable / Chemicals / Conglomerates / Defense / Education / Electrical / Engineering & Construction / Environmental Services / Financial Services / Food / Industrial Materials / Lodging & Restaurants / Machinery / Media / Publishing / Railroads / Real Estate / Retailing / Services / Shipping & Shipbuilding / Transportation / Wholesale / Marketing</td><td class="leftalignment">Euroland / Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: Key Abstracts And Our Take On The Data</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0463531089 / US1101221083 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN=US / BMY=US / HD=US / ADI=US / T=US / GILD=US / AMT=US / PEB=US / H=US / MTN=US / VZ=US / LOW=US / MAR=US / ADS=US / TTWO=US / TNL=US / HLT=US / BMRN=US / CHH=US / CPRT=US / DRH=US / RARE=US / REGN=US / STRO=US / EXP=US / AWH / SHO=US / NSP=US / HST=US / WH=US / TIL=US / JACK=US / RCUS=US / HGV=US / RLJ=US / VAC=US / MEIP=US / RHP=US / FATE=US / 00770K202 / UPLD=US / VVV=US / PK=US / GDS=US / PLYA=US / IOVA=US / BTAI=US / ALLO=US / FERG=US / SPCE=US / KNBE=US</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Analog Devices Inc / AT&T Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Lowe's Companies Inc / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Copart Inc / Diamondrock Hospitality Co / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sutro Biopharma Inc / Eagle Materials Inc / Aspira Women's Health Inc / Sunstone Hotel Investors Inc / Insperity Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Jack in the Box Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / MEI Pharma Inc / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Aemetis Inc / Upland Software Inc / Valvoline Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / Iovance Biotherapeutics Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Ferguson PLC / Virgin Galactic Holdings Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Four Highlights and Insights from ASCO Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">11012210 / 37555810 / 75886F10 / 03969F10 / F5548N10</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Arcus Biosciences Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2259101 / 2126335 / 2000019 / 2536763 / 2973821 / 2437071 / 2175672 / 2190750 / 2208073 / 2270726 / 2542049 / 2670519 / 2342034 / 2369174 / 2459202 / 2459020 / 2645409 / 2657802 / 2048804 / 2440637 / 2825933 / 2829601 / 2989301 / 2769796 / B02R1L6 / B3D7K31 / B1HJLW5 / B44C366 / B7TL820 / B7VD3F2 / B9M2WX3 / B87ZMX0 / B95WG16 / BVVN4Q8 / BYY8XK8 / BF4VBS8 / BF5L3T2 / BFZNYB7 / BK7Y2V9 / BFZ1K46 / BFMXGR0 / BFNR303 / BFWK4R7 / BHZSB82 / BP3YM85 / BL95N25 / BZ1LFG7 / BYY88Y7 / BKWD3M9 / BGKG6M3 / BLBLMD5 / BMDJ085 / BMC8SQ7 / BD5GSZ4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Target Corp / Bristol-Myers Squibb Co / Amazon.com Inc / Lowe's Companies Inc / Alliant Energy Corp / Biomarin Pharmaceutical Inc / Cardinal Health Inc / Chesapeake Utilities Corp / Copart Inc / Walt Disney Co / Dominion Energy Inc / Exelon Corp / Fiserv Inc / Gilead Sciences Inc / IDEXX Laboratories Inc / Intuit Inc / NiSource Inc / OGE Energy Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / South Jersey Industries Inc / Southern Co / TJX Companies Inc / Fidelity National Information Services Inc / ALLETE Inc / Discovery Inc / Emergent BioSolutions Inc / Heska Corp / Meta Platforms Inc / Duke Energy Corp / Bath & Body Works Inc / Palo Alto Networks Inc / Zoetis Inc / Eversource Energy / WEC Energy Group Inc / BioXcel Therapeutics Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Akero Therapeutics Inc / Spotify Technology SA / Evergy Inc / Northwest Natural Holding Co / PagSeguro Digital Ltd / Covetrus Inc / Trupanion Inc / Phibro Animal Health Corp / Roku Inc / Alphabet Inc / Progyny Inc / StoneCo Ltd / Array Technologies Inc / Shoals Technologies Group Inc / BTRS Holdings Inc / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Abstracts Review: Few Surprises Overall, but BMY's Relatlimab Looks Additive to Us</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Bristol-Myers Squibb Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Opdivo Plus Relatlimab Exceeds Expectations and Additional Data in ASCO Abstracts Supports LAG-3 Targeting</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108 / 09609G100 / 30315R107</td><td class="leftalignment">Bristol-Myers Squibb Co / bluebird bio Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Relatlimab (LAG-3) Abstract Data Highlights Compelling Profile in 1L Melanoma</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Relatlimab data appear compelling</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / INCY=US / AMT=US / LOW=US / SCOR=US / LEG=US / VMC=US / MANH=US / MLM=US / UNH=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / CVX=US / CCRN=US / NFLX=US / DIN=US / MGNI=US / MRNS=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / OLO=US / NLSN=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / VCYT=US / 00770K202 / LOCO=US / SHAK=US / WING=US / 82982L103 / LGF.B=US / JELD=US / ROKU=US / FERG=US / ARQT=US / ZI=US / AZEK=US / HIMS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Incyte Corp / American Tower Corp / Lowe's Companies Inc / Comscore Inc / Leggett & Platt Inc / Vulcan Materials Co / Manhattan Associates Inc / Martin Marietta Materials Inc / UnitedHealth Group Inc / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Chevron Corp / Cross Country Healthcare Inc / Netflix Inc / Dine Brands Global Inc / Magnite Inc / Marinus Pharmaceuticals Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Olo Inc / Nielsen Holdings PLC / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / Veracyte Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Lions Gate Entertainment Corp / JELD-WEN Holding Inc / Roku Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc / Hims & Hers Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Record Lows Across Key COVID-19 Metrics Signal New Phase of Pandemic in United States; Early Sign of Waning Outbreak in India</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2973821 / 2050832 / 2219224 / 2270726 / 2542049 / 2670519 / 2342034 / 2415204 / 2471950 / 2657802 / 2689560 / 2684703 / 2829601 / 7103065 / B121557 / B1Y9TB3 / 2857817 / B125XQ6 / B02R1L6 / B3D7K31 / B7TL820 / B7254K9 / BFLR866 / B95WG16 / BVVN4Q8 / BNGY4Q0 / BYVY8G0 / BYNZGK1 / BD8DJ71 / BKTHM05 / BZ1HM42 / BMQ5T49 / BFZ1K46 / BFMXGR0 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BKS3RS7 / BK71LV3 / BQXZP64 / BMC5RV6 / BGT0PL8 / BMCC9R7 / BMDJ085 / BNTB3N8 / BD9MK29 / BP8GHT2 / BMHR7K6 / BN2RM92</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Alliant Energy Corp / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Exelon Corp / Fiserv Inc / Hawaiian Electric Industries Inc / Incyte Corp / OGE Energy Corp / PG&E Corp / Pfizer Inc / Southern Co / Novartis AG / Mastercard Inc / Danone SA / Netflix Inc / Portland General Electric Co / ALLETE Inc / Discovery Inc / Meta Platforms Inc / AxoGen Inc / Twitter Inc / Zoetis Inc / Eversource Energy / Nextera Energy Partners LP / Alphabet Inc / Block Inc / Snap Inc / Passage Bio Inc / Adyen NV / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Evergy Inc / Vistra Corp / ViacomCBS Inc / Roku Inc / 10X Genomics Inc / Relmada Therapeutics Inc / Wayfair Inc / Adicet Bio Inc / DiaMedica Therapeutics Inc / SCYNEXIS Inc / Shoals Technologies Group Inc / Vizio Holding Corp / Onconova Therapeutics Inc / Vascular Biogenics Ltd / Impel Neuropharma Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 07, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 17 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1311931042 / US17275R1023 / US37733W1053 / US5324571083 / US5398301094 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US3448491049 / US4771431016 / US4198791018 / US80105N1054 / US00206R1023 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US25470F1049 / US58933Y1055 / US9100471096 / US00287Y1091 / US09609G1004 / US8485771021 / US21240E1055 / US02376R1023 / US70432V1026 / CA0089118776 / US23355L1061 / US81141R1005 / US5904791358 / US49926T1043 / US90364P1057 / US83089J1088 / US98985X1000</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cisco Systems Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Lockheed Martin Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Foot Locker Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / AT&T Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Discovery Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / bluebird bio Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Paycom Software Inc / Air Canada / DXC Technology Co / Sea Ltd / Mesa Air Group Inc / Knowbe4 Inc / UiPath Inc / Skywater Technology Inc / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / TWTR=US / GBT=US / CL=US / AMZN=US / T=US / EBAY=US / INCY=US / GILD=US / VZ=US / IGT=US / VRM=US / BYD=US / SPOT=US / EXPE=US / MGM=US / AKR=US / PENN=US / W=US / DV=US / AMK=US / PATH=US / COLL=US / TREE=US / NOW=US / MCRI=US / REGN=US / SNAP=US / TRIP=US / TRUE=US / VRTX=US / WIX=US / PSA=US / SNOW=US / SGMS=US / NET=US / HIW=US / PYPL=US / BKNG=US / EGP=US / FB=US / MTCH=US / AUTL=US / BDSI=US / RRR=US / PTON=US / BIIB=US / RNG=US / CZR=US / EXR=US / GMS=US / PGTI=US / WH=US / TIL=US / IAC=US / 45665G303 / OLO=US / NLSN=US / ANGI=US / MEIP=US / SSTK=US / ABBV=US / VOYA=US / PTCT=US / FATE=US / GOOGL=US / COUP=US / BABA=US / CMPR=US / VCEL=US / GDDY=US / ETSY=US / ARGX=US / ZG=US / SQ=US / WVE=US / MIME=US / TTD=US / CRSP=US / TRVG=US / GDS=US / CVNA=US / YEXT=US / IOVA=US / RDFN=US / ROKU=US / CARG=US / SFIX=US / ROOT=US / COLD=US / FTDR=US / SVMK=US / EB=US / SITC=US / AMTB=US / LYFT=US / UBER=US / GMAB=US / DKNG=US / CRMD.US / BALY=US / ABNB=US / DASH=US / NGMS=US / COUR-US / KNBE=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Twitter Inc / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / AT&T Inc / eBay Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / International Game Technology PLC / Vroom Inc / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / MGM Resorts International / Acadia Realty Trust / Penn National Gaming Inc / Wayfair Inc / DoubleVerify Holdings Inc / AssetMark Financial Holdings Inc / UiPath Inc / Collegium Pharmaceutical Inc / Lendingtree Inc / ServiceNow Inc / Monarch Casino & Resort Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / TrueCar Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Public Storage / Snowflake Inc. / Scientific Games Corp / Cloudflare Inc / Highwoods Properties Inc / PayPal Holdings Inc / Booking Holdings Inc / Eastgroup Properties Inc / Meta Platforms Inc / Match Group Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / Peloton Interactive Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / Extra Space Storage Inc / GMS Inc / PGT Innovations Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Olo Inc / Nielsen Holdings PLC / Angi Inc / MEI Pharma Inc / Shutterstock Inc / Abbvie Inc / Voya Financial Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Alphabet Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Cimpress PLC / Vericel Corp / GoDaddy Inc / ETSY Inc / argenx SE / Zillow Group Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / GDS Holdings Ltd / Carvana Co / Yext Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / CarGurus Inc / Stitch Fix Inc / Root Inc / Americold Realty Trust / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Site Centers Corp / Amerant Bancorp Inc / Lyft Inc / Uber Technologies Inc / Genmab A/S / DraftKings Inc / CorMedix Inc / Bally's Corp / Airbnb Inc / DoorDash Inc / NeoGames SA / Coursera Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : MRK / BMY – Our Latest Thoughts of PD-1 Landscape; Market Model Update</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N / MRK.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">05/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Level- Week 59</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Bristol-Myers Squibb Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 547</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v1.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: More Key Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US1101221083 / US66987V1098 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Novartis AG / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 14 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">FR0000121014 / US02553E1064 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1264081035 / US22160K1051 / US2546871060 / US3647601083 / US5002551043 / US6556641008 / US6558441084 / US66987V1098 / US7170811035 / US7274931085 / US7711951043 / US7782961038 / US8725401090 / US87612E1064 / US9078181081 / US9311421039 / CA1363751027 / CA13645T1003 / US21036P1084 / US19239V3024 / US55616P1049 / US90384S3031 / US58933Y1055 / US30212P3038 / US5017971046 / US60468T1051 / US09062W2044 / LU0974299876 / US0994061002 / US64829B1008 / US4622221004 / US74967X1037 / CA1350861060 / IL0011407140 / US8760301072 / US6085501095 / US09354A1007 / US09857L1089 / US4380831077 / US03836N1037 / US05455M1009 / KY30744W1070 / US7172241090 / CA89788C1041 / US39874R1014 / US24984K1051 / US85205L1070 / US1266541028 / US7602731025 / US05380C1027 / US65487U1088 / US75943R1023 / US38246G1085 / US0090661010 / US7761531083 / US55406W1036 / US8808811074 / US6877931096 / US35909R1086 / US45175G1085</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / American Eagle Outfitters Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / CSX Corp / Costco Wholesale Corp / Walt Disney Co / Gap Inc / Kohls Corp / Nordstrom Inc / Norfolk Southern Corp / Novartis AG / Pfizer Inc / Plantronics Inc / Roche Holding AG / Ross Stores Inc / TJX Companies Inc / Target Corp / Union Pacific Corp / Walmart Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Constellation Brands Inc / Cogent Communications Holdings Inc / Macy's Inc / Ulta Beauty Inc / Merck & Co Inc / Expedia Group Inc / Bath & Body Works Inc / Mirati Therapeutics Inc / BioLife Solutions Inc / Globant SA / Boot Barn Holdings Inc / New Relic Inc / Ionis Pharmaceuticals Inc / RH / Canada Goose Holdings Inc / Urogen Pharma Ltd / Tapestry Inc / Molecular Templates Inc / Blink Charging Co / Booking Holdings Inc / Homology Medicines Inc / Aptinyx Inc / AVROBIO Inc / Farfetch Ltd / PhaseBio Pharmaceuticals Inc / Trulieve Cannabis Corp / Grocery Outlet Holding Corp / DermTech Inc / SpringWorks Therapeutics Inc / CV Sciences Inc / Repare Therapeutics Inc / AVITA Medical Inc / Nkarta Inc / Relay Therapeutics Inc / Goodrx Holdings Inc / Airbnb Inc / Romeo Power Inc / MYT Netherlands Parent BV / Terns Pharmaceuticals Inc / Oscar Health Inc / Frontier Group Holdings Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BGNE (NEUTRAL) - Model Update Post 1Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BYYWPW6 / 2126335 / 2457864 / BBPK0J0</td><td class="leftalignment">Beigene Ltd / Bristol-Myers Squibb Co / ImmunoGen Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US1101221083 / US45773H2013 / US2312692005 / CA39342L1085 / CA23126M1023 / US38046W1053</td><td class="leftalignment">Bristol-Myers Squibb Co / Inovio Pharmaceuticals Inc / Curis Inc / Green Thumb Industries Inc / Curaleaf Holdings Inc / Gohealth Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Bloomsbury Publishing Plc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Preclinical Data at EHA Support Wide Therapeutic Range of SLN124 Ahead of GEMINI-1 Top-Line Data Expected First Half 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">110122108 / 45337C102</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Let's Talk About Who's Cooking Up A Storm At EHA This Year</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.N / US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">XLRN: Ph2 BEYOND Study of Reblozyl in NTD B-thal Hits Primary Endpoint</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">4151.T / 4506.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4568.T / 4578.T</td><td class="leftalignment">Kyowa Kirin Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">38</td><td class="leftalignment">4151.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / 4568.T / 4578.T</td><td class="leftalignment">Kyowa Kirin Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, May 11, 2021 / 5:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Cancer Immunotherapy Market: Current Analysis and Forecast (2021-2027)</td><td class="leftalignment">English</td><td class="rightalignment">261</td><td class="leftalignment">FACT=US / MRK=US / PFE=US / AMGN=US / BMY=US / A=US / NOVN=CH / AZN=GB / BLUE=US / null / 500680=IN / 506820=IN / ABBV=US / CNTO=US</td><td class="leftalignment">Freedom Acquisition I Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Novartis AG / AstraZeneca PLC / bluebird bio Inc / One 97 Communications Ltd / Pfizer Ltd / Astrazeneca Pharma India Ltd / Abbvie Inc / Centor Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Cayman Islands / Germany / Spain / France / United Kingdom / India / Italy / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Vaccinations Reach 46%, Adolescent Approval Likely to Reverse Downward Trend in Administrations; Outbreak in India Continues</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / John Boyle / Sami Corwin, PHD / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / ICLR=US / WEN=US / BLD=US / INCY=US / TEVA=US / KMI=US / CMA=US / REI=US / PLUG=US / CRM=US / LOW=US / ENR=US / FMS=US / VRM=US / CHRS=US / MAR=US / LEG=US / VMC=US / MLM=US / CBRL=US / ELY=US / CHH=US / CSGP=US / DRI=US / GFF=US / IBP=US / NOW=US / MAS=US / MPLX=US / MHK=US / SHOP=US / GOLF=US / SAGE=US / SPG=US / EPD=US / SGMS=US / BKNG=US / NLS=US / DIN=US / MGNI=US / PTON=US / RNG=US / TCBI=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / APEI=US / WH=US / JACK=US / TREX=US / APTS=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / NDLS=US / LOCO=US / OSH=US / VCEL=US / SHAK=US / GSBD=US / WING=US / SQ=US / AXSM=US / 82982L103 / TTD=US / EVBG=US / JELD=US / ATNX=US / SWCH=US / SAIL=US / EQH=US / BTAI=US / SVMK=US / PLMR=US / FERG=US / RPAY=US / ARQT=US / REYN=US / SPCE=US / FBRX=US / AZEK=US / BALY=US / VTRS=US / ABNB=US / AFRM=US / RBLX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / ICON PLC / Wendys Co / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Kinder Morgan Inc / Comerica Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Lowe's Companies Inc / Energizer Holdings Inc / Fresenius Medical Care AG & Co KGaA / Vroom Inc / Coherus BioSciences Inc / Marriott International Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Choice Hotels International Inc / CoStar Group Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ServiceNow Inc / Masco Corp / MPLX LP / Mohawk Industries Inc / Shopify Inc / Acushnet Holdings Corp / SAGE Therapeutics Inc / Simon Property Group Inc / Enterprise Products Partners LP / Scientific Games Corp / Booking Holdings Inc / Nautilus Inc / Dine Brands Global Inc / Magnite Inc / Peloton Interactive Inc / RingCentral Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / American Public Education Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Preferred Apartment Communities Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Oak Street Health Inc / Vericel Corp / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Block Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Everbridge Inc / JELD-WEN Holding Inc / Athenex Inc / Switch Inc / SailPoint Technologies Holdings Inc / Equitable Holdings Inc / BioXcel Therapeutics Inc / Momentive Global Inc / Palomar Holdings Inc / Ferguson PLC / Repay Holdings Corp / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Bally's Corp / Viatris Inc / Airbnb Inc / Affirm Holdings Inc / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2973821 / 2219224 / 2175672 / 2222631 / 2037170 / 2328915 / 2369174 / 2415204 / 2457864 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 4595739 / 7103065 / B1F76F9 / B121557 / B19FQ48 / B125XQ6 / B7TL820 / B4MG4Z6 / B7VD3F2 / BJ0XLZ3 / BDZCRX3 / BFH3N85 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYVFC94 / BF4VBS8 / BK0VHF6 / BD9GVY0 / BJXPS33 / BD8DJ71 / BJFSR88 / BYZR4X4 / BP7RS48 / BKVDFF7 / BYXJQG9 / BZ1LFG7 / BL71K91 / BD6JX35 / BZ0P3Z5 / BYTJZL1 / BDD1B07 / BKT6B38 / BF3N4P3 / BM8MM05 / BLBLMD5 / BNG3RZ7 / BMDJ085 / BLR6S36</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / CMS Energy Corp / Cardinal Health Inc / Cooper Companies Inc / 8x8 Inc / Nextera Energy Inc / Gilead Sciences Inc / Hawaiian Electric Industries Inc / ImmunoGen Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Genmab A/S / Novartis AG / Western Union Co / Mastercard Inc / Amicus Therapeutics Inc / Portland General Electric Co / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Heron Therapeutics Inc / RingCentral Inc / Veeva Systems Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / US Foods Holding Corp / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / BELLUS Health Inc / Snap Inc / Uniqure NV / Axsome Therapeutics Inc / Intersect Ent Inc / Oric Pharmaceuticals Inc / Spire Inc / Roku Inc / Revolution Medicines Inc / Krystal Biotech Inc / Tegna Inc / Zogenix Inc / Rubius Therapeutics Inc / SmileDirectClub Inc / Arena Pharmaceuticals Inc / Madison Square Garden Entertainment Corp / Array Technologies Inc / Leslie's Inc / Shoals Technologies Group Inc / Longboard Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) – Takeaways from Our Virtual NDR; Focus on GR antagonist, Early Pipeline of Potl. Best-in-Class Inhibitors Targeting EGFR, CD73, and PRC2</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PSON-GB -  Dividend Quality Analysis, for the period ended May 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PSON.L / DMGOa.L / ERM.L / BLPU.L</td><td class="leftalignment">Pearson PLC / Daily Mail and General Trust P L C / Euromoney Institutional Investor PLC / Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Transcript from our fireside chat with BMY</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 10 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US2371941053 / US37733W1053 / US4663671091 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US5801351017 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8552441094 / US8807701029 / US91347P1057 / US9884981013 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / US25754A2015 / US1696561059 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US95058W1009 / US00287Y1091 / NL0010273215 / LU0914713705 / US38046C1099 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / CA76131D1033 / US8190471016 / US9741551033 / US45782B1044 / KYG4740B1059 / CA35805P1071 / US05351X1019 / US68373M1071 / US5904791358 / IE00BZ12WP82 / US4833791035 / US92556H2067 / US92537N1081 / US26142R1041 / US38246G1085 / US90089L1089</td><td class="leftalignment">Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / Darden Restaurants Inc / GlaxoSmithKline PLC / Jack in the Box Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / McDonald's Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Teradyne Inc / Universal Display Corp / Yum! Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / Wendys Co / Abbvie Inc / ASML Holding NV / Intelsat SA / Gogo Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Restaurant Brands International Inc / Shake Shack Inc / Wingstop Inc / Inseego Corp / Ichor Holdings Ltd / Freshii Inc / Avaya Holdings Corp / Opera Ltd / Mesa Air Group Inc / Linde PLC / Kaleyra Inc / ViacomCBS Inc / Vertiv Holdings Co / DraftKings Inc / Goodrx Holdings Inc / TuSimple Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">4031976 / 2126335 / 2023607 / 2640147 / 2973821 / 2219224 / 2216850 / 2328915 / 2415204 / 2459202 / 2459020 / 2630513 / 2657802 / 2680905 / 2684703 / 2048804 / 2440637 / 2799351 / 2825933 / 2795393 / B121557 / 2212922 / 2769796 / B125XQ6 / B0T7YX2 / B02R1L6 / B2R3PV1 / B1HJLW5 / B3P93Y7 / B570P91 / B7TL820 / B4MG4Z6 / BCDWBX6 / BJ3V905 / BBPK0J0 / BBGVT40 / BCGCR79 / BFLR866 / BFZCHN7 / B95WG16 / BVVN4Q8 / BYY8XK8 / BYW36M8 / BYQHP96 / BFNF1D6 / BF5L3T2 / BYNZGK1 / BD8DJ71 / BKDS4H5 / BR4T3B3 / BKVDFF7 / BMYML02 / BFMXGR0 / BYXJQG9 / BG31GH0 / BKTNTR9 / BJVR9Y9 / BD6D4Y5 / BZ1LFG7 / BL71K91 / BN0XTW4 / BN7K304 / BLBLMD5 / BD8QGD5 / BNTB3N8</td><td class="leftalignment">Adidas AG / Bristol-Myers Squibb Co / Amgen Inc / Nike Inc / Alliant Energy Corp / CMS Energy Corp / Consolidated Edison Inc / Nextera Energy Inc / Hawaiian Electric Industries Inc / IDEXX Laboratories Inc / Intuit Inc / New Jersey Resources Corp / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Amerisourcebergen Corp / Mastercard Inc / NRG Energy Inc / Fidelity National Information Services Inc / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / American Water Works Company Inc / Emergent BioSolutions Inc / Anheuser Busch Inbev SA / Lear Corp / Meta Platforms Inc / AMC Networks Inc / ANI Pharmaceuticals Inc / Endo International PLC / Mirati Therapeutics Inc / News Corp / Sprouts Farmers Market Inc / Twitter Inc / Wix.Com Ltd / Zoetis Inc / Eversource Energy / WEC Energy Group Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Amneal Pharmaceuticals Inc / Elanco Animal Health Inc / Block Inc / Snap Inc / Bill.com Holdings Inc / HubSpot Inc / Oric Pharmaceuticals Inc / DraftKings Inc / Evergy Inc / Spire Inc / Y-mAbs Therapeutics Inc / ViacomCBS Inc / iHeartMedia Inc / Altair Engineering Inc / Roku Inc / Revolution Medicines Inc / Orphazyme A/S / Academy Sports and Outdoors Inc / Array Technologies Inc / Liberty Media Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Germany / Denmark / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics: Top Questions for Management Teams</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">4502.T / BMY.N / CI.N / CVS.N / GE.N / MCK.N / MRK.N / PFE.N / TMO.N / WMT.N / DGX.N / AZN.L / ROG.S / DHR.N / UNH.N / LH.N / MMM.N / CRL.N / IDXX.OQ / XRAY.OQ / HSIC.OQ / AMZN.OQ / ALGN.OQ / STMN.S / PETS.OQ / ICLR.OQ / QGEN.N / BAYGN.DE / ZTS.N / PAHC.OQ / LNTH.OQ / ANTM.N / WBA.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / General Electric Co / Mckesson Corp / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Walmart Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / 3M Co / Charles River Laboratories International Inc / IDEXX Laboratories Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Amazon.com Inc / Align Technology Inc / Straumann Holding AG / Petmed Express Inc / ICON PLC / Qiagen NV / Bayer AG / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">05/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Holding Steady - Week 58</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 546</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) - Positive Competitor Data Provides External Clinical Validation For ORIC's GR Antagonist ORIC-101</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">1Q21: Model Update; Plenty of Catalysts in 2H21; PT $641</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">75886F10 / 11012210 / F5548N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Bristol-Myers Squibb Co / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - POSEIDON: Imfinzi + treme + chemo triplet show survival benefit in 1L lung cancer</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AZN.L / BMY.N / MRK.N / SASY.PA / ROG.S / REGN.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) – 1Q21 Recap; ORIC-101 Updates at ASCO While 3 Addl. Programs Move Towards IND in 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Re-Accelerating Growth Continues with Strong 1Q Cabo Sales Beat and Momentum Exiting the Quarter; Maintain BUY, $32 PT</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2576941 / 2126335</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Bristol-Myers Squibb</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Bristol-Myers Squibb (BMY US) - Q1 second opinion: replacement power builds</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">DNB / WMB=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / RUN=US / AMT=US / PEB=US / APA=US / BR=US / CPE=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PXD=US / MGY=US / MAR=US / MRO=US / TNL=US / VMC=US / HLT=US / BKI=US / MLM=US / AMK=US / AIZ=US / AMN=US / FUN=US / CENT=US / CHH=US / CSGP=US / CW=US / DRH=US / EQT=US / DOC=US / SMG=US / WW=US / WIX=US / CCRN=US / MANT=US / PYPL=US / BKNG=US / DCP=US / EPR=US / FRT=US / JAZZ=US / MTCH=US / SRC=US / SPR=US / CRTO=US / AUTL=US / DIN=US / ECPG=US / MGPI=US / PTON=US / IGMS=US / FLT=US / CZR=US / NUVA=US / KAR=US / BDC=US / HURN=US / SHO=US / LHCG=US / AAWW=US / SPWR=US / HST=US / MA=US / LUMN=US / KTOS=US / WH=US / ATSG=US / IAC=US / PSN=US / RCUS=US / VRSK=US / HTA=US / HGV=US / GDOT=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ZNGA=US / ENPH=US / PDCE=US / RHP=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / GDDY=US / ETSY=US / EVRI=US / EDIT=US / 82982L103 / CRSP=US / PK=US / TVTY=US / ANAB=US / PLYA=US / SBOW=US / IOVA=US / RDFN=US / PETQ=US / DCPH=US / ROOT=US / GSKY=US / HARP=US / UBER=US / TCRR=US / PLMR=US / NXTC=US / GMAB=US / ARQT=US / REYN=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Williams Companies Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Sunrun Inc / American Tower Corp / Pebblebrook Hotel Trust / APA Corp (US) / Broadridge Financial Solutions Inc / Callon Petroleum Co / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Marriott International Inc / Marathon Oil Corp / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Black Knight Inc / Martin Marietta Materials Inc / AssetMark Financial Holdings Inc / Assurant Inc / AMN Healthcare Services Inc / Cedar Fair LP / Central Garden & Pet Co / Choice Hotels International Inc / CoStar Group Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / EQT Corp / Physicians Realty Trust / Scotts Miracle-Gro Co / WW International Inc / Wix.Com Ltd / Cross Country Healthcare Inc / ManTech International Corp / PayPal Holdings Inc / Booking Holdings Inc / DCP Midstream LP / EPR Properties / Federal Realty Investment Trust / Jazz Pharmaceuticals PLC / Match Group Inc / Spirit Realty Capital Inc / Spirit AeroSystems Holdings Inc / Criteo SA / Autolus Therapeutics PLC / Dine Brands Global Inc / Encore Capital Group Inc / MGP Ingredients Inc / Peloton Interactive Inc / IGM Biosciences Inc / Fleetcor Technologies Inc / Caesars Entertainment Inc / NuVasive Inc / KAR Auction Services Inc / Belden Inc / Huron Consulting Group Inc / Sunstone Hotel Investors Inc / LHC Group Inc / Atlas Air Worldwide Holdings Inc / SunPower Corp / Host Hotels & Resorts Inc / Mastercard Inc / Lumen Technologies Inc / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Parsons Corp / Arcus Biosciences Inc / Verisk Analytics Inc / Healthcare Trust Of America Inc / Hilton Grand Vacations Inc / Green Dot Corp / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Zynga Inc / Enphase Energy Inc / PDC Energy Inc / Ryman Hospitality Properties Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / GoDaddy Inc / ETSY Inc / Everi Holdings Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Tivity Health Inc / AnaptysBio Inc / Playa Hotels & Resorts NV / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Redfin Corp / PetIQ Inc / Deciphera Pharmaceuticals Inc / Root Inc / GreenSky Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Palomar Holdings Inc / NextCure Inc / Genmab A/S / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Today's NeuroNavigator Calls: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech Fireside Highlights: HARP, TCRR, IOVA, AUTL @ The Truist Life Sciences Summit (May 5)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AUTL.OQ / HARP.OQ / IOVA.OQ / TCRR.OQ / PFE=US / AMGN=US / BMY=US / AUTL=US / IOVA=US / HARP=US / TCRR=US / NXTC=US</td><td class="leftalignment">Autolus Therapeutics PLC / Harpoon Therapeutics Inc / Iovance Biotherapeutics Inc / TCR2 Therapeutics Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Autolus Therapeutics PLC / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from fireside chat with ARQT</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ARQT=US / BMY=US / INCY=US</td><td class="leftalignment">Arcutis Biotherapeutics Inc / Bristol-Myers Squibb Co / Incyte Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended May 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended April 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from fireside chat with BMY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Bristol-Myers Squibb - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, May 05, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ARNA: Q1 Earnings Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ARNA.OQ / BMY.N</td><td class="leftalignment">Arena Pharmaceuticals Inc / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, May 04, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First-Dose Vaccinations Continue to Decline; Outbreak in India Continues, Showing Initial Signs of Slowing Growth</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / MDT=US / BLD=US / DVN=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / CHRS=US / MRO=US / LEG=US / KFRC=US / VMC=US / MLM=US / CBRL=US / CNX=US / DRI=US / EQT=US / EXEL=US / GFF=US / IBP=US / HZO=US / MAS=US / MHK=US / HOOK=US / REGN=US / REGI=US / RHI=US / WIX=US / CVX=US / SAGE=US / PSA=US / EPD=US / CGEN=US / BXS=US / SNV=US / ADC=US / CUZ=US / OHI=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / STRO=US / TPX=US / EXP=US / FHN=US / CDLX=US / BECN=US / SHO=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / KBR=US / CMG=US / REX=US / CCOI=US / XPO=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / EPRT=US / JACK=US / RCUS=US / CLNY=US / TREX=US / AR=US / NLSN=US / WWD=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / TILE=US / NDLS=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / SEDG=US / BWXT=US / WING=US / SPNE=US / CABO=US / ACBI=US / AXSM=US / 82982L103 / CDEV=US / CRSP=US / PVAC=US / JELD=US / CVNA=US / SBOW=US / IOVA=US / ATNX=US / ROKU=US / SWCH=US / DCPH=US / MAXR=US / BTAI=US / FTDR=US / SVMK=US / ALLO=US / KOD=US / HARP=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / ZI=US / AZEK=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Coherus BioSciences Inc / Marathon Oil Corp / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Griffon Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / Wix.Com Ltd / Chevron Corp / SAGE Therapeutics Inc / Public Storage / Enterprise Products Partners LP / Compugen Ltd / Cadence Bank / Synovus Financial Corp / Agree Realty Corp / Cousins Properties Inc / Omega Healthcare Investors Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Sutro Biopharma Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Cardlytics Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / XPO Logistics Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / DigitalBridge Group Inc / Trex Company Inc / Antero Resources Corp / Nielsen Holdings PLC / Woodward Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Solaredge Technologies Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Carvana Co / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Athenex Inc / Roku Inc / Switch Inc / Deciphera Pharmaceuticals Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Kodiak Sciences Inc / Harpoon Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2050832 / 2045623 / 2437071 / 2219224 / 2542049 / 2670519 / 2613990 / 2501578 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 7103065 / B1F76F9 / B125XQ6 / 2679204 / 2390817 / B7TL820 / BDZCRX3 / B8DPDT7 / BFLR866 / B76LYJ2 / BYY8XK8 / BJLT387 / BZBY005 / BZB1XF2 / BR4T3B3 / BMQ5T49 / BFMXGR0 / BYQRFY1 / BKT6B38 / BMPRZV5 / BLBLMD5 / BNTB3N8 / BD5GSZ4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / ANSYS Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Dominion Energy Inc / Exelon Corp / Illumina Inc / Ligand Pharmaceuticals Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Novartis AG / Western Union Co / Portland General Electric Co / Align Technology Inc / Gray Television Inc / Meta Platforms Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / Vocera Communications Inc / WEC Energy Group Inc / Avantor Inc / Merus NV / Tactile Systems Technology Inc / HubSpot Inc / Zentalis Pharmaceuticals Inc / Evergy Inc / Teladoc Health Inc / SmileDirectClub Inc / Kymera Therapeutics Inc / Array Technologies Inc / Vizio Holding Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / SUN.BO / NOVOB.CO / NOVN.S / 4768.T / GSK.L / UCB.BR / AMGN.OQ / ALKS.OQ / GILD.OQ / UTHR.OQ / BIIB.OQ / 4568.T / TEVA.N / ALM.MC / BAYGN.DE / 4578.T / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Alkermes Plc / Gilead Sciences Inc / United Therapeutics Corp / Biogen Inc / Daiichi Sankyo Co Ltd / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Otsuka Holdings Co Ltd / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What Bristol Myers Squibb's Q1 Results Say About Its Stock</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What?s Next For Merck Stock After A 5% Drop Following Q1 Miss?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist ASCO Planner v1.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 3 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MOGa / US0116591092 / US0231351067 / US0463531089 / US0758871091 / US1101221083 / US14149Y1082 / US37733W1053 / US4234521015 / US5324571083 / US58155Q1031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US03073E1055 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US5380341090 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US7185461040 / US69318G1067 / US00287Y1091 / US55345K1034 / US8485771021 / US21240E1055 / US02376R1023 / US94419L1017 / US0465131078 / CA0089118776 / US00653A1079 / US05464T1043 / US00773U1088 / GB00BDSFG982 / US7493971052 / US02156B1035 / US5904791358 / US0197701065 / US0144421072 / US5024311095 / US70614W1009 / US09203E1055 / US26142R1041 / CH0499880968 / US15872M1045 / US44891N1090 / US69353Y1038 / US62955J1034</td><td class="leftalignment">Moog Inc / Alaska Air Group Inc / Amazon.com Inc / AstraZeneca PLC / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Eli Lilly and Co / Mckesson Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Amerisourcebergen Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Live Nation Entertainment Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Phillips 66 / PBF Energy Inc / Abbvie Inc / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Wayfair Inc / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / TechnipFMC PLC / R1 RCM Inc / Alteryx Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / L3harris Technologies Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / ChampionX Corp / IAC/Interactivecorp / PMV Pharmaceuticals Inc / Nov Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GBT=US / CL=US / AMZN=US / DVN=US / GILD=US / EOG=US / REI=US / CHTR=US / XOM=US / WLL=US / PXD=US / HSII=US / SWN=US / VRM=US / MRO=US / EXPE=US / KFRC=US / MANH=US / NWL=US / W=US / DISH=US / KFY=US / AMN=US / B=US / BMRN=US / COLL=US / EXPO=US / GFF=US / LH=US / TREE=US / MAN=US / HZO=US / MHK=US / ASGN=US / RARE=US / RHI=US / SGMO=US / STRA=US / SNAP=US / THO=US / TRIP=US / VRTX=US / WIX=US / WGO=US / CVX=US / SAGE=US / CCRN=US / BKNG=US / CFR=US / FB=US / ENSG=US / AMSF=US / VICI=US / MGP=US / BDSI=US / MRNS=US / PTON=US / PRG=US / BIIB=US / MOG.A=US / APTX=US / NUVA=US / WMG=US / AAWW=US / NSP=US / CPRX=US / EIG=US / QSR=US / CLR=US / TIL=US / NOG=US / CWH=US / RCUS=US / KNSL=US / OLO=US / ESTE=US / ANGI=US / FANG=US / ABBV=US / GLPI=US / CNCE=US / GOOGL=US / FIVN=US / HTRG=US / BABA=US / CMPR=US / WK=US / RLMD=US / GDDY=US / ETSY=US / VKTX=US / ARGX=US / NVCR=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / EVBG=US / CRSP=US / PVAC=US / ANAB=US / JELD=US / CVNA=US / VRNA=US / SBOW=US / IOVA=US / SFIX=US / LAZY=US / FTDR=US / SVMK=US / ARVN=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / LHX=US / OVV=US / ONEW=US / CRMD.US / DASH=US / COUR-US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / Devon Energy Corp / Gilead Sciences Inc / EOG Resources Inc / Ring Energy Inc / Charter Communications Inc / Exxon Mobil Corp / Whiting Petroleum Corp / Pioneer Natural Resources Co / Heidrick & Struggles International Inc / Southwestern Energy Co / Vroom Inc / Marathon Oil Corp / Expedia Group Inc / Kforce Inc / Manhattan Associates Inc / Newell Brands Inc / Wayfair Inc / DISH Network Corp / Korn Ferry / AMN Healthcare Services Inc / Barnes Group Inc / Biomarin Pharmaceutical Inc / Collegium Pharmaceutical Inc / Exponent Inc / Griffon Corp / Laboratory Corporation of America Holdings / Lendingtree Inc / ManpowerGroup Inc / MarineMax Inc / Mohawk Industries Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / Robert Half International Inc / Sangamo Therapeutics Inc / Strategic Education Inc / Snap Inc / Thor Industries Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Winnebago Industries Inc / Chevron Corp / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / Meta Platforms Inc / Ensign Group Inc / Amerisafe Inc / VICI Properties Inc / MGM Growth Properties LLC / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / PROG Holdings Inc / Biogen Inc / Moog Inc / Aptinyx Inc / NuVasive Inc / Warner Music Group Corp / Atlas Air Worldwide Holdings Inc / Insperity Inc / Catalyst Pharmaceuticals Inc / Employers Holdings Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Camping World Holdings Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Olo Inc / Earthstone Energy Inc / Angi Inc / Diamondback Energy Inc / Abbvie Inc / Gaming and Leisure Properties Inc / Concert Pharmaceuticals Inc / Alphabet Inc / Five9 Inc / Heritage Insurance Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / Relmada Therapeutics Inc / GoDaddy Inc / ETSY Inc / Viking Therapeutics Inc / argenx SE / Novocure Ltd / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Everbridge Inc / CRISPR Therapeutics AG / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Carvana Co / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Stitch Fix Inc / Lazydays Holdings Inc / Frontdoor Inc / Momentive Global Inc / Arvinas Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / L3harris Technologies Inc / Ovintiv Inc / OneWater Marine Inc / CorMedix Inc / DoorDash Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator REMINDER: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Preview and Planner – Key Updates Across Our Global Pharma / Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Initiating on Iovance Biotherapeutics (IOVA) with a Buy Rating and $50 PT</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">IOVA=US / BMY=US / TIL=US / ABBV=US / ALLO=US / TCRR=US</td><td class="leftalignment">Iovance Biotherapeutics Inc / Bristol-Myers Squibb Co / Instil Bio Inc / Abbvie Inc / Allogene Therapeutics Inc / TCR2 Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Major Pharmaceuticals : Thoughts As We Wrap Up A Difficult 1Q Earnings Season</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Activity Remains Positive - Week 57</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY: 1Q21 Postview – miss on revs/EPS, catalyst path intact</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MRVL=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / Marvell Technology Inc / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Bristol Myers Squibb - $80.01 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bloomsbury Publishing increases 2.4% in 2021, but lagging Media sector</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Bristol Myers Squibb (BMY:$62.42) decreases, trailing 86% of stocks</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 545</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for BMY. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / BMY=US / MCD=US / TWTR=US / ICLR=US / AMZN=US / GILD=US / AMT=US / PEB=US / BC=US / CONE=US / V=US / IGT=US / SWN=US / TRMK=US / TNL=US / MDRX=US / AKR=US / AFL=US / HUM=US / CMCSA=US / RCL=US / AMED=US / BMRN=US / CHD=US / CNX=US / DRI=US / DVA=US / EEFT=US / EXPO=US / FCN=US / AJG=US / TREE=US / MHK=US / TEAM=US / NTST=US / OKE=US / SMG=US / VSEC=US / VRTX=US / WEX=US / OPT=US / SGMS=US / ADC=US / AVTR=US / CPT=US / OFC=US / CUZ=US / KIM=US / MKL=US / SSB=US / ENSG=US / AMSF=US / MMP=US / MOH=US / TPX=US / TXRH=US / DLR=US / MPW=US / KBR=US / CCOI=US / MA=US / GPRE=US / WU=US / PAG=US / EHTH=US / CLR=US / LLNW=US / WH=US / AGS=US / SWI=US / KNSL=US / AR=US / HGV=US / CUBE=US / FBHS=US / MTDR=US / SPLK=US / LKQ=US / ABBV=US / NDLS=US / FIVN=US / 00770K202 / CMPR=US / ZG=US / EVRI=US / WLTW=US / ADVM=US / VVV=US / VRNA=US / RDFN=US / MBIN=US / SYNH=US / KDP=US / SITC=US / OVV=US / ONEW=US / AIRC=US / HYFM=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / McDonald's Corp / Twitter Inc / ICON PLC / Amazon.com Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / CyrusOne Inc / Visa Inc / International Game Technology PLC / Southwestern Energy Co / Trustmark Corp / Travel + Leisure Co / Allscripts Healthcare Solutions Inc / Acadia Realty Trust / Aflac Inc / Humana Inc / Comcast Corp / Royal Caribbean Cruises Ltd / Amedisys Inc / Biomarin Pharmaceutical Inc / Church & Dwight Co Inc / CNX Resources Corp / Darden Restaurants Inc / DaVita Inc / Euronet Worldwide Inc / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Lendingtree Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / ONEOK Inc / Scotts Miracle-Gro Co / VSE Corp / Vertex Pharmaceuticals Inc / WEX Inc / Opthea Ltd / Scientific Games Corp / Agree Realty Corp / Avantor Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Kimco Realty Corp / Markel Corp / SouthState Corp / Ensign Group Inc / Amerisafe Inc / Magellan Midstream Partners LP / Molina Healthcare Inc / Tempur Sealy International Inc / Texas Roadhouse Inc / Digital Realty Trust Inc / Medical Properties Trust Inc / KBR Inc / Cogent Communications Holdings Inc / Mastercard Inc / Green Plains Inc / Western Union Co / Penske Automotive Group Inc / eHealth Inc / Continental Resources Inc / Limelight Networks Inc / Wyndham Hotels & Resorts Inc / PlayAGS Inc / SolarWinds Corp / Kinsale Capital Group Inc / Antero Resources Corp / Hilton Grand Vacations Inc / CubeSmart / Fortune Brands Home & Security Inc / Matador Resources Co / Splunk Inc / LKQ Corp / Abbvie Inc / Noodles & Co / Five9 Inc / Aemetis Inc / Cimpress PLC / Zillow Group Inc / Everi Holdings Inc / Willis Towers Watson PLC / Adverum Biotechnologies Inc / Valvoline Inc / Verona Pharma PLC / Redfin Corp / Merchants Bancorp / Syneos Health Inc / Keurig Dr Pepper Inc / Site Centers Corp / Ovintiv Inc / OneWater Marine Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / United Kingdom / Ireland / Liberia / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">V / 2126335 / 2000019 / 2486813 / 2778844 / 2003698 / 2026242 / 2437071 / 2219224 / 2229126 / 2317087 / 2345022 / 2369174 / 2459020 / 2689560 / 2440637 / 2138158 / 2829601 / 2931034 / 2971029 / B00FWN1 / B121557 / B067BM3 / 2769796 / 2216991 / 2857817 / B125XQ6 / B3D7K31 / B1HJLW5 / B5B2106 / B0796X4 / B65LWX6 / B4N0JJ6 / B7TL820 / BCBVTX1 / BFDV8K0 / B95N910 / BFLR866 / B76LYJ2 / BYRY499 / BVVN4Q8 / BF4VBS8 / BD3W133 / BXDZ9Z0 / BYNZGK1 / BJLKVS6 / BFZ1K46 / BMYML02 / BP3YM85 / BWY52P3 / BMH0MR7 / BM8MM05 / BYXR425 / BLBLMD5 / 021513106</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / ABIOMED Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Columbia Sportswear Co / Entergy Corp / Macy's Inc / Gilead Sciences Inc / Intuit Inc / PG&E Corp / CenterPoint Energy Inc / Sempra Energy / Southern Co / Vertex Pharmaceuticals Inc / LKQ Corp / Alnylam Pharmaceuticals Inc / Mastercard Inc / Molson Coors Beverage Co / Fidelity National Information Services Inc / Tempur Sealy International Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Emergent BioSolutions Inc / Fortinet Inc / Dexcom Inc / O'Reilly Automotive Inc / Visteon Corp / Meta Platforms Inc / Agios Pharmaceuticals Inc / MacroGenics Inc / PTC Inc / Twitter Inc / Vocera Communications Inc / Kraft Heinz Co / Eversource Energy / BioXcel Therapeutics Inc / Keurig Dr Pepper Inc / Shopify Inc / Block Inc / Phathom Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Trupanion Inc / Blueprint Medicines Corp / Zendesk Inc / Madison Square Garden Entertainment Corp / RH / Array Technologies Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 1Q21 Earnings Highlights — What Mattered for Credit (BAX, BMY, GILD, LH, MRK, TMO)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / BAX.N / GILD.OQ / LH.N / MRK.N / TMO.N / GILD.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Baxter International Inc / Gilead Sciences Inc / Laboratory Corporation of America Holdings / Merck & Co Inc / Thermo Fisher Scientific Inc / Gilead Sciences Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Minor model tweaks post-1Q; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Still Waiting for Opdivo Positive Trials to Translate Into Sales Growth; 2021 EPS and Sales Guidance Maintained</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN (BUY) - Small 1Q Revenue Miss, But Early Stage Pipeline Starts to Emerge as Key Growth Driver With SEA-CD40 Data Guided for 2H21</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">0989529 / 2126335 / 2778844 / 2684703</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : 1Q Takeaways / Model Update – Outlook Largely Unchanged Despite Today’s Selloff</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY 1Q21 - They said what? Highlights from conference call that just ended</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Good start to 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : 1Q First Impressions: Eliquis Strength Offset By Revlimid/Opdivo Weakness; Guidance Maintained</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1:21 EPS Light On In-Line Revenue; 2021 Guidance Reiterated</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 EPS Missed, Sales In Line With Forecasts; 2021 Guidance Reaffirmed</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Apr 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMZN.OQ / BAX.N / BMY.N / CMS.N / EMN.N / IP.N / METR.KL / MO.N / MRK.N / NEM.N / NOC.N / SO.N / TAP.N / TMO.N / TXT.N / TFX.N / PH.N / WAB.N / CAT.N / MCD.N / LH.N / HSY.N / AMT.N / WST.N / DVA.N / COG.N / CHD.N / TWTR.N / AJG.N / MHK.N / AOS.N / ABMD.OQ / KLAC.OQ / TROW.OQ / GILD.OQ / DISH.OQ / CTXS.OQ / PTEN.OQ / VRTX.OQ / SWKS.OQ / CMCSA.OQ / DPZ.N / DXCM.OQ / RDSa.L / ICE.N / MA.N / BIO.N / FTNT.OQ / GNRC.N / FBHS.N / LKQ.OQ / WDC.OQ / KHC.OQ / WLTW.OQ / SPGI.N / FTV.N / XEL.OQ / CBRE.N / CARR.N / MCDG.MU</td><td class="leftalignment">Amazon.com Inc / Baxter International Inc / Bristol-Myers Squibb Co / CMS Energy Corp / Eastman Chemical Co / International Paper Co / MKH Bhd / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Northrop Grumman Corp / Southern Co / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Textron Inc / Teleflex Inc / Parker-Hannifin Corp / Westinghouse Air Brake Technologies Corp / Caterpillar Inc / McDonald's Corp / Laboratory Corporation of America Holdings / Hershey Co / American Tower Corp / West Pharmaceutical Services Inc / DaVita Inc / Coterra Energy Inc / Church & Dwight Co Inc / Twitter Inc / Arthur J Gallagher & Co / Mohawk Industries Inc / A O Smith Corp / ABIOMED Inc / KLA Corp / T Rowe Price Group Inc / Gilead Sciences Inc / DISH Network Corp / Citrix Systems Inc / Patterson-UTI Energy Inc / Vertex Pharmaceuticals Inc / Skyworks Solutions Inc / Comcast Corp / Domino's Pizza Inc / Dexcom Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / Mastercard Inc / Bio Rad Laboratories Inc / Fortinet Inc / Generac Holdings Inc / Fortune Brands Home & Security Inc / LKQ Corp / Western Digital Corp / Kraft Heinz Co / Willis Towers Watson PLC / S&P Global Inc / Fortive Corp / Xcel Energy Inc / CBRE Group Inc / Carrier Global Corp / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / Malaysia / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First Patient in for GEMINI-II Ahead of GEMINI-I SLN124 Data Expected First Half 2021; 3 Clinical Readouts in 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">110122108 / 462222100</td><td class="leftalignment">Bristol-Myers Squibb Co / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: 1Q21 Revenue In-Line but Mix and Fx a Drag on GM Despite Anticipated Reduced Sprycel Royalty Burden; 2021 Guidance Affirmed</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Brief of Bristol-Myers Squibb Co conference call, Apr. 29, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Apr. 29, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First-Quarter Quick Take: Weakness in Oncology Broadly but Full-Year Guidance Reaffirmed</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 29 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">DE0006969603 / US0378331005 / US0382221051 / US0463531089 / US0530151036 / US0970231058 / US1011371077 / US1101221083 / US2254471012 / US2786421030 / US30226D1063 / US3695501086 / US4364401012 / US4824801009 / US5128071082 / US5951121038 / US66987V1098 / US7170811035 / US7475251036 / US7711951043 / US7766961061 / US8168501018 / US8269191024 / US9021041085 / US91347P1057 / US9507551086 / US9581021055 / CA1363751027 / US89151E1091 / CA13645T1003 / US9884981013 / US83088M1027 / US88031M1099 / US3463751087 / US90385V1070 / FI0009013296 / US19239V3024 / RDSa.AS / US9043111072 / US82706C1080 / US78709Y1055 / US1717793095 / US48242W1062 / NL0000687663 / US64110D1046 / US2120151012 / US58933Y1055 / US13100M5094 / IE00B58JVZ52 / US30303M1027 / US75972A3014 / NL0010273215 / US81762P1021 / US5764852050 / US23283R1005 / US03674X1063 / CA89620X5064 / US74736K1016 / US29444U7000 / US87918A1051 / US74624M1027 / US00773U1088 / US90138F1021 / US64104Y1064 / KYG4740B1059 / US02156K1034 / US03753U1060 / US05351X1019 / US05352A1007 / US88339P1012 / US69047Q1022 / US92537N1081 / US15872M1045 / US03044L1052 / US5738741041</td><td class="leftalignment">Puma SE / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Boeing Co / Boston Scientific Corp / Bristol-Myers Squibb Co / Wolfspeed Inc / eBay Inc / Extreme Networks Inc / General Dynamics Corp / Hologic Inc / KLA Corp / Lam Research Corp / Micron Technology Inc / Novartis AG / Pfizer Inc / Qualcomm Inc / Roche Holding AG / Roper Technologies Inc / Semtech Corp / Silicon Laboratories Inc / II-VI Inc / Universal Display Corp / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / TotalEnergies SE / Canadian Pacific Railway Ltd / Yum! Brands Inc / Skyworks Solutions Inc / Tenaris SA / FormFactor Inc / Ultra Clean Holdings Inc / Neste Oyj / Cogent Communications Holdings Inc / Royal Dutch Shell PLC / Under Armour Inc / Silicon Motion Technology Corp / Saia Inc / Ciena Corp / KBR Inc / AerCap Holdings NV / NetApp Inc / Continental Resources Inc / Merck & Co Inc / Calix Inc / Seagate Technology Holdings PLC / Meta Platforms Inc / Renewable Energy Group Inc / ASML Holding NV / ServiceNow Inc / Matador Resources Co / CyrusOne Inc / Antero Resources Corp / Pfizer Inc / Qorvo Inc / Equinix Inc / Teladoc Health Inc / Pure Storage Inc / Adverum Biotechnologies Inc / Twilio Inc / Neste Oyj / Ichor Holdings Ltd / Altice USA Inc / Apellis Pharmaceuticals Inc / Avaya Holdings Corp / Avantor Inc / RealReal Inc / Ovintiv Inc / Vertiv Holdings Co / ChampionX Corp / American Well Corp / Marvell Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Finland / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: Key Abstract Titles And What To Watch For</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0463531089 / US1101221083 / US66987V1098 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Novartis AG / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for BMY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Earnings Beat In Cards For Merck's Q1?</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Bristol-Myers Squibb Co Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY 1Q21 earnings preview</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb increases 6.3% in 2021, tracking Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Peer Group Analytics - Q4 FY2020</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / CL=US / WEN=US / PLD=US / AMZN=US / BLD=US / DVN=US / INCY=US / KMI=US / APA=US / CPE=US / EOG=US / DGX=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / CHKP=US / PXD=US / ENR=US / HSII=US / MGY=US / SWN=US / MUR=US / BRO=US / BYD=US / MRO=US / LEG=US / HCA=US / VMC=US / MGM=US / PENN=US / NWL=US / MLM=US / FLO=US / KFY=US / ARCC=US / CBRL=US / CENT=US / CHD=US / CNX=US / DRI=US / EPC=US / EQT=US / GFF=US / HAIN=US / IBP=US / SAFE=US / TREE=US / MAIN=US / MAS=US / MEDP=US / MHK=US / MCRI=US / ORCC=US / PACW=US / REGN=US / REGI=US / SBAC=US / SMG=US / SSNC=US / SNAP=US / VRTX=US / CVX=US / POST=US / BXS=US / BKNG=US / FBK=US / FR=US / FFIN=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / MNST=US / RRR=US / NOMD=US / TPX=US / FNB=US / EXP=US / CZR=US / NUVA=US / AINV=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / NOG=US / JACK=US / AAN=US / TREX=US / AR=US / NXPI=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / NDLS=US / GLPI=US / TSLX=US / 00770K202 / VNOM=US / 70806A106 / LOCO=US / ANTM=US / SHAK=US / AJRD=US / GSBD=US / WING=US / ARGX=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / PETQ=US / ROKU=US / CARG=US / COLD=US / EOLS=US / KDP=US / OZK=US / FSK=US / LYFT=US / RTLR=US / FERG=US / BRBR=US / OVV=US / ARQT=US / REYN=US / DKNG=US / FSKR=US / AZEK=US / BALY=US / HYFM=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Colgate-Palmolive Co / Wendys Co / Prologis Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Kinder Morgan Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Pioneer Natural Resources Co / Energizer Holdings Inc / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Brown & Brown Inc / Boyd Gaming Corp / Marathon Oil Corp / Leggett & Platt Inc / HCA Healthcare Inc / Vulcan Materials Co / MGM Resorts International / Penn National Gaming Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Korn Ferry / Ares Capital Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CNX Resources Corp / Darden Restaurants Inc / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Hain Celestial Group Inc / Installed Building Products Inc / Safehold Inc / Lendingtree Inc / Main Street Capital Corp / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Monarch Casino & Resort Inc / Owl Rock Capital Corp / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / Scotts Miracle-Gro Co / SS&C Technologies Holdings Inc / Snap Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Post Holdings Inc / Cadence Bank / Booking Holdings Inc / FB Financial Corp / First Industrial Realty Trust Inc / First Financial Bankshares Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Red Rock Resorts Inc / Nomad Foods Ltd / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / Caesars Entertainment Inc / NuVasive Inc / Apollo Investment Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Aaron's Company Inc / Trex Company Inc / Antero Resources Corp / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Gaming and Leisure Properties Inc / Sixth Street Specialty Lending Inc / Aemetis Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Anthem Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / PetIQ Inc / Roku Inc / CarGurus Inc / Americold Realty Trust / Evolus Inc / Keurig Dr Pepper Inc / Bank Ozk / FS KKR Capital Corp / Lyft Inc / Rattler Midstream LP / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / DraftKings Inc / FS KKR Capital Corp / Azek Company Inc / Bally's Corp / Hydrofarm Holdings Group Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Bloomsbury Publishing (Add) - It’s a small world – Red Globe Press</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Malcolm Morgan</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2778844 / 2219224 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2613990 / 2630513 / 2689560 / 2684703 / 2440637 / 2825933 / 2829601 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / BH65L93 / BYVY8G0 / BJFSR88 / BNFWR44 / BYZR4X4 / BFZ1K46 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BJ9NFQ3 / BYNQ369 / BMH0MR7 / BQXZP64 / BLBLMD5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Illumina Inc / New Jersey Resources Corp / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / South Jersey Industries Inc / Southern Co / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Seacoast Banking Corporation of Florida / Alphabet Inc / Uniqure NV / Worldline SA / Axsome Therapeutics Inc / Spotify Technology SA / Fox Corp / Vistra Corp / ViacomCBS Inc / Neoleukin Therapeutics Inc / Albertsons Companies Inc / Zendesk Inc / Wayfair Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Transcript from Expert call on LAG-3 inhibitors and BMY’s relatlimab</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY=US / MRK=US / AMGN=US / INCY=US / REGN=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 26/04/2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AVON.L / BMY.L / CHG.L / ERM.L / IMI.L / MGGT.L / RR.L / SNR.L / TATE.L / ULE.L / INF.L / REL.L / CAU.L / TSTL.L / HSP.L / QQ.L / CHRT.L / BAES.L</td><td class="leftalignment">Avon Protection PLC / Bloomsbury Publishing PLC / Chemring Group PLC / Euromoney Institutional Investor PLC / IMI PLC / Meggitt PLC / Rolls-Royce Holdings PLC / Senior PLC / Tate & Lyle PLC / Ultra Electronics Holdings PLC / Informa PLC / Relx PLC / Centaur Media PLC / Tristel PLC / Hargreaves Services PLC / Qinetiq Group PLC / Cohort PLC / BAE Systems PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Alastair P. Reid / Ms. Alicia A. Forry, CFA / Mr. Ben C. Bourne / Dr Jens Lindqvist / Mr. Michael Donnelly / Ross Broadfoot / Mr. Scott K. Cagehin</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000054470 / US00971T1016 / US0116591092 / US0311621009 / US0378331005 / US0463531089 / US0718131099 / US1101221083 / US1266501006 / US2855121099 / US37733W1053 / US45337C1027 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US8636671013 / US8740541094 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US2538681030 / US0491642056 / PAP310761054 / NL0000687663 / US01748X1028 / US2473617023 / US53261M1045 / US00922R1059 / US00507V1098 / US58933Y1055 / US9100471096 / US98986T1088 / US00287Y1091 / US00912X3026 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US29444U7000 / US20717E1010 / US36165L1089 / US87105L1044 / US8760301072 / US19626G1085 / US5904791358 / CH0499880968 / US22041X1028 / US72815L1070 / US35909R1086</td><td class="leftalignment">Ubisoft Entertainment SA / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / AstraZeneca PLC / Baxter International Inc / Bristol-Myers Squibb Co / CVS Health Corp / Electronic Arts Inc / GlaxoSmithKline PLC / Incyte Corp / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Stryker Corp / Take-Two Interactive Software Inc / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Digital Realty Trust Inc / Atlas Air Worldwide Holdings Inc / Copa Holdings SA / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Air Transport Services Group Inc / Activision Blizzard Inc / Merck & Co Inc / United Airlines Holdings Inc / Zynga Inc / Abbvie Inc / Air Lease Corp / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Equinix Inc / Conformis Inc / GDS Holdings Ltd / Switch Inc / Tapestry Inc / DigitalBridge Group Inc / Mesa Air Group Inc / ADC Therapeutics SA / Corsair Gaming Inc / Playtika Holding Corp / Frontier Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PEP=US / AMGN=US / BMY=US / CAG=US / DIS=US / KO=US / OXY=US / RRC=US / CL=US / PG=US / AMZN=US / DVN=US / EBAY=US / INCY=US / U=US / APA=US / CPE=US / EOG=US / DGX=US / SLG=US / REI=US / MTN=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / MUR=US / SPOT=US / MRO=US / ATVI=US / MANH=US / NWL=US / FLO=US / STZ=US / AIR=US / ATRO=US / CENT=US / CHD=US / CSTR=US / COLL=US / CNX=US / DCO=US / EPC=US / EQT=US / HAIN=US / HEI=US / HXL=US / MAN=US / SMG=US / SHOP=US / TGI=US / CVX=US / POST=US / NET=US / SIVB=US / ABCB=US / BOKF=US / BDN=US / FB=US / SPR=US / RF=US / NLS=US / NFLX=US / COP=US / MGPI=US / SBCF=US / BDSI=US / MNST=US / PTON=US / NOMD=US / BIIB=US / RNG=US / NUVA=US / FRPT=US / THS=US / TDG=US / ELF=US / EIG=US / CLR=US / NOG=US / AAN=US / UTZ=US / OLO=US / AR=US / ESTE=US / BCEI=US / EA=US / MTDR=US / PDCE=US / FANG=US / GOOGL=US / FIVN=US / COUP=US / HUBS=US / ARGX=US / ACBI=US / AXSM=US / CDEV=US / PVAC=US / VRNA=US / SBOW=US / PETQ=US / ROKU=US / IQV=US / KDP=US / OZK=US / ARVN=US / BRBR=US / OVV=US / ARQT=US / REYN=US / DASH=US / HYFM=US / COUR-US</td><td class="leftalignment">PepsiCo Inc / Amgen Inc / Bristol-Myers Squibb Co / Conagra Brands Inc / Walt Disney Co / Coca-Cola Co / Occidental Petroleum Corp / Range Resources Corp / Colgate-Palmolive Co / Procter & Gamble Co / Amazon.com Inc / Devon Energy Corp / eBay Inc / Incyte Corp / Unity Software Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / SL Green Realty Corp / Ring Energy Inc / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Spotify Technology SA / Marathon Oil Corp / Activision Blizzard Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / AAR Corp / Astronics Corp / Central Garden & Pet Co / Church & Dwight Co Inc / CapStar Financial Holdings Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Ducommun Inc / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / ManpowerGroup Inc / Scotts Miracle-Gro Co / Shopify Inc / Triumph Group Inc / Chevron Corp / Post Holdings Inc / Cloudflare Inc / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / Brandywine Realty Trust / Meta Platforms Inc / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Nautilus Inc / Netflix Inc / Conocophillips / MGP Ingredients Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / Monster Beverage Corp / Peloton Interactive Inc / Nomad Foods Ltd / Biogen Inc / RingCentral Inc / NuVasive Inc / Freshpet Inc / TreeHouse Foods Inc / TransDigm Group Inc / elf Beauty Inc / Employers Holdings Inc / Continental Resources Inc / Northern Oil and Gas Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / Antero Resources Corp / Earthstone Energy Inc / Civitas Resources Inc / Electronic Arts Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Alphabet Inc / Five9 Inc / Coupa Software Inc / HubSpot Inc / argenx SE / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / Centennial Resource Development Inc / Ranger Oil Corp / Verona Pharma PLC / SilverBow Resources Inc / PetIQ Inc / Roku Inc / IQVIA Holdings Inc / Keurig Dr Pepper Inc / Bank Ozk / Arvinas Inc / Bellring Brands Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / DoorDash Inc / Hydrofarm Holdings Group Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator Call Miniseries: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator: DSM-VI Beta? Looking at Upstream Targets to Improve Neuropsychiatric Treatments</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Bloomsbury Publishing : Academic opportunities - Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Centaur Media : Metamorphosis - Buy</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CAU.L / BMY.L / ERM.L / INF.L / REL.L</td><td class="leftalignment">Centaur Media PLC / Bloomsbury Publishing PLC / Euromoney Institutional Investor PLC / Informa PLC / Relx PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Phase III POETYK Data at AAD Tyks All the Right Boxes to Support Deucravacitinib as Best-in-Class Oral Therapy for Psoriasis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (Apr 26-): Ono uptick on positive news, amid overall wait-and-see stance ahead of results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2413.T / 4528.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4543.T / BMY.N / CSL.AX / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 4568.T / 3626.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">M3 Inc / Ono Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / CSL Ltd / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Daiichi Sankyo Co Ltd / TIS Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（4月26日～）: 決算前で様子見の中、小野薬は好材料に反応</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4528.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4543.T / BMY.N / CSL.AX / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 4568.T / 3626.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">M3 Inc / Ono Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / CSL Ltd / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Daiichi Sankyo Co Ltd / TIS Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">No Surprises In Otezla’s ADVANCE Mild/Mod PSO Data - TYK2 A Real Threat</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Deucravacitinib Efficacy Solid But FDA's Ultimate View Of Safety Uncertain</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma 1Q Earnings Season : What to Watch for the Week Ahead (LLY, BMY, MRK, ABBV)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / ABBV.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Abbvie Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Xiling Chen / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Maintain Momentum - Week 56</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Maintaining Buy post-deucra data and our Expert call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY=US / AMGN=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : TYK-2 Phase 3 Results Point to a Best-in-Class Oral Psoriasis Profile, Should Address Lingering Safety Concerns</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Scratching the surface on the psoriasis competitive landscape for Otezla</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN=US / BMY=US / ARQT=US</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 544</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Apr. 23, 2021 / 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 23/04/2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.L / CNE.L / SNR.L / TLW.L / HBR.L / IOG.L / SQZ.L / IGAS.L / HUR.L / SEPL.L / DGOC.L / KOS.L / ENOG.L / PHARP.L / LUNE.ST</td><td class="leftalignment">Bloomsbury Publishing PLC / Capricorn Energy PLC / Senior PLC / Tullow Oil PLC / Harbour Energy PLC / Iog PLC / Serica Energy PLC / IGas Energy PLC / Hurricane Energy PLC / Seplat Energy PLC / Diversified Energy Company PLC / Kosmos Energy Ltd / Energean PLC / Pharos Energy PLC / Lundin Energy AB</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Nigeria / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Alastair P. Reid / Alex Smith / Mr. Ben C. Bourne / Mr. Nathan G. Piper / Mr. Rory Smith / Ross Broadfoot</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Bloomsbury Publishing (Add) - Acquisition of Red Global Press assets</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Malcolm Morgan / Ms. Jessica Pok</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / LLY=US / PFE=US / BMY=US / INTC=US / AMD=US / RRC=US / EFX=US / AMZN=US / T=US / GL=US / NVDA=US / DGX=US / TRU=US / MTN=US / VZ=US / CCI=US / VRM=US / EWBC=US / BRO=US / EXPE=US / LSTR=US / HCA=US / CVS=US / UNH=US / AVGO=US / AJG=US / SAFE=US / HZO=US / MAT=US / RARE=US / SNAP=US / TRIP=US / WIX=US / BXS=US / BKNG=US / FAF=US / FB=US / MKL=US / PTON=US / JRVR=US / BIIB=US / NUVA=US / KAR=US / CADE=US / EIG=US / KNSL=US / AR=US / ANGI=US / TMUS=US / GOOGL=US / ASMB=US / BABA=US / CMPR=US / ANTM=US / GDDY=US / LOB=US / WLTW=US / ANAB=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / SITC=US / LYFT=US / UBER=US / PLMR=US</td><td class="leftalignment">CACI International Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Amazon.com Inc / AT&T Inc / Globe Life Inc / NVIDIA Corp / Quest Diagnostics Inc / TransUnion / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Vroom Inc / East West Bancorp Inc / Brown & Brown Inc / Expedia Group Inc / Landstar System Inc / HCA Healthcare Inc / CVS Health Corp / UnitedHealth Group Inc / Broadcom Inc / Arthur J Gallagher & Co / Safehold Inc / MarineMax Inc / Mattel Inc / Ultragenyx Pharmaceutical Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Cadence Bank / Booking Holdings Inc / First American Financial Corp / Meta Platforms Inc / Markel Corp / Peloton Interactive Inc / James River Group Holdings Ltd / Biogen Inc / NuVasive Inc / KAR Auction Services Inc / Cadence Bank / Employers Holdings Inc / Kinsale Capital Group Inc / Antero Resources Corp / Angi Inc / T-Mobile US Inc / Alphabet Inc / Assembly Biosciences Inc / Alibaba Group Holding Ltd / Cimpress PLC / Anthem Inc / GoDaddy Inc / Live Oak Bancshares Inc / Willis Towers Watson PLC / AnaptysBio Inc / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Site Centers Corp / Lyft Inc / Uber Technologies Inc / Palomar Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AAN 2021 Recap: Oral CGRPs Promising; Waiting for Adu PDUFA Decision; Innovation in Rare Disease; Talent Show Extraordinary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Hunter Rogers / Mr. Tim F. Lugo / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">First Take: Bloomsbury Publishing - Expanding the footprint</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global ESG Research: Sustainable Investing: is it 'Dot.com' in disguise?</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">0257.HK / 0551.HK / 0895.HK / 1038.HK / 1093.HK / ABT.N / ACC.BO / AES.N / AHT.L / AIRP.PA / ALSO.PA / ALVG.DE / ANA.MC / APD.N / ARDS.AS / ASMI.AS / ASML.AS / BH.BK / BMWG.DE / BMY.N / BOUY.PA / CCK.N / CRH.I / DSMN.AS / ECL.N / ED.N / EL.N / ELUXB.ST / EMG.L / ERICB.ST / FLS.N / HEXAB.ST / IMI.L / IP.N / KPJH.KL / LLY.N / NIBEB.ST / PNW.N / PSON.L / ROR.L / SCC.BK / SCHN.PA / SGEF.PA / SMDS.L / SN.L / T.TO / TOM.OL / TOTF.PA / UU.L / VERB.VI / VLOF.PA / VNT.N / WPL.AX / 0371.HK / CONG.DE / OHL.MC / ETN.N / AMAR.BO / BWA.N / URI.N / WCC.N / PH.N / REE.MC / TRP.TO / CAT.N / ABBN.S / SIEGN.DE / ACE.MI / ROCKB.CO / HON.N / MFC.TO / VOPA.AS / EMR.N / ENEI.MI / MGA.N / DTEGN.F / IFXGN.DE / LIN.N / BLL.N / EXID.BO / GBFG.DE / VIE.PA / APA.AX / NZYMB.CO / KMI.N / PWR.N / MTZ.N / EPD.N / AXL.N / PCAR3.SA / FLR.N / KRC.N / NDXG.DE / DOW.AX / BLDP.TO / AMS.S / 600690.SS / NLS.N / BSL.AX / WG.L / 1211.HK / CNP.N / 600008.SS / 600009.SS / 000651.SZ / CGNX.OQ / FAST.OQ / TROW.OQ / REGN.OQ / TRMB.OQ / YORW.OQ / TTEK.OQ / SCHL.OQ / AZPN.OQ / BRKS.OQ / GRMN.OQ / MNST.OQ / UMI.BR / 012330.KS / 012630.KS / STMN.S / 0451.HK / 2628.HK / TRQ.TO / 600170.SS / 0981.HK / YAR.OL / 2338.HK / 2318.HK / 2331.HK / CPFE3.SA / 600820.SS / 600884.SS / 002008.SZ / 3311.HK / EDF.PA / 600491.SS / PFC.L / SGM.AX / SPWR.OQ / 600835.SS / 600845.SS / CSMG3.SA / ZUMV.VI / CPX.TO / 3899.HK / ERIC.OQ / ASHM.L / 1800.HK / 2006.HK / 3898.HK / 601628.SS / 601318.SS / SKG.I / 000338.SZ / ACM.N / DAIGN.DE / PGRD.BO / GL9.I / APEI.OQ / 3800.HK / FLUI.MC / 601390.SS / 0806.HK / 0390.HK / 601601.SS / 601186.SS / BIP.N / WRT1V.HE / LABB.MX / ERII.OQ / SEVI.PA / HOLI.OQ / AIPJ.J / 2009.HK / LOPE.OQ / 601727.SS / 1313.HK / 601888.SS / 002294.SZ / AQN.TO / 2601.HK / GNRC.N / 002431.SZ / 300073.SZ / 300024.SZ / LHCJ.J / TSLA.OQ / BASFN.DE / 002527.SZ / 1590.TW / KEY.TO / APAM.AS / WWD.OQ / FHI.N / 601992.SS / 002594.SZ / QUAL3.SA / UNFI.N / REGI.OQ / WETF.OQ / VAC.N / ENPH.OQ / 601800.SS / 002672.SZ / TAEE11.SA / SIIC.SI / BFAM.N / WSKT.JK / COTY.N / CAV1V.HE / CORB.AS / CHGG.N / ARMK.N / LNTAQ.L / APPS.MC / 2186.HK / MDLY.N / XXLA.OL / 1317.HK / SEDG.OQ / CLNX.MC / WRK.N / PLNT.N / IEL.AX / 1565.HK / MDCM.L / LHN.S / BFIT.AS / BEDU.N / SGREN.MC / REDU.OQ / ORSTED.CO / 0807.HK / DWSG.DE / EQNR.OL / 300750.SZ / ARCE.OQ / LTHM.N / 1797.HK / COGN3.SA / BRBR.N / DQ.ZY / J.N / 688339.SS / ENR1N.DE / ALGM.OQ / 6690.HK</td><td class="leftalignment">China Everbright Environment Group Ltd / Yue Yuen Industrial (Holdings) Ltd / Dongjiang Environmental Co Ltd / CK Infrastructure Holdings Ltd / CSPC Pharmaceutical Group Ltd / Abbott Laboratories / ACC Ltd / AES Corp / Ashtead Group PLC / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Alstom SA / Allianz SE / Acciona SA / Air Products and Chemicals Inc / Arcadis NV / ASM International NV / ASML Holding NV / Bumrungrad Hospital PCL / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Bouygues SA / Crown Holdings Inc / CRH PLC / Koninklijke DSM NV / Ecolab Inc / Consolidated Edison Inc / Estee Lauder Companies Inc / Electrolux AB / Man Group PLC / Telefonaktiebolaget LM Ericsson / Flowserve Corp / Hexagon AB / IMI PLC / International Paper Co / KPJ Healthcare Bhd / Eli Lilly and Co / Nibe Industrier AB / Pinnacle West Capital Corp / Pearson PLC / Rotork PLC / Siam Cement PCL / Schneider Electric SE / Vinci SA / DS Smith PLC / Smith & Nephew PLC / Telus Corp / Tomra Systems ASA / TotalEnergies SE / United Utilities Group PLC / Verbund AG / Valeo SE / Vontier Corp / Woodside Petroleum Ltd / Beijing Enterprises Water Group Ltd / Continental AG / Obrascon Huarte Lain SA / Eaton Corporation PLC / Amara Raja Batteries Ltd / Borgwarner Inc / United Rentals Inc / Wesco International Inc / Parker-Hannifin Corp / Red Electrica Corporacion SA / TC Energy Corp / Caterpillar Inc / Abb Ltd / Siemens AG / Acea SpA / Rockwool International A/S / Honeywell International Inc / Manulife Financial Corp / Koninklijke Vopak NV / Emerson Electric Co / Enel SpA / Magna International Inc / Deutsche Telekom AG / Infineon Technologies AG / Linde PLC / Ball Corp / Exide Industries Ltd / Bilfinger SE / Veolia Environnement SA / APA Group / Novozymes A/S / Kinder Morgan Inc / Quanta Services Inc / MasTec Inc / Enterprise Products Partners LP / American Axle & Manufacturing Holdings Inc / Companhia Brasileira de Distribuicao / Fluor Corp / Kilroy Realty Corp / Nordex SE / Downer EDI Ltd / Ballard Power Systems Inc / ams AG / Haier Smart Home Co Ltd / Nautilus Inc / BlueScope Steel Ltd / John Wood Group PLC / BYD Co Ltd / CenterPoint Energy Inc / Beijing Capital Eco-Environment Protection Group Co Ltd / Shanghai International Airport Co Ltd / Gree Electric Appliances Inc of Zhuhai / Cognex Corp / Fastenal Co / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trimble Inc / York Water Co / Tetra Tech Inc / Scholastic Corp / Aspen Technology Inc / Azenta Inc / Garmin Ltd / Monster Beverage Corp / Umicore SA / Hyundai Mobis Co Ltd / HDC Holdings Co Ltd / Straumann Holding AG / GCL New Energy Holdings Ltd / China Life Insurance Co Ltd / Turquoise Hill Resources Ltd / Shanghai Construction Group Co Ltd / Semiconductor Manufacturing International Corp / Yara International ASA / Weichai Power Co Ltd / Ping An Insurance Group Co of China Ltd / Li Ning Co Ltd / CPFL Energia SA / Shanghai Tunnel Engineering Co Ltd / Ningbo Shanshan Co Ltd / Han's Laser Technology Industry Group Co Ltd / China State Construction International Holdings Ltd / Electricite de France SA / Long Yuan Construction Group Co Ltd / Petrofac Ltd / Sims Ltd / SunPower Corp / Shanghai Mechanical & Electrical Industry Co Ltd / Shanghai Baosight Software Co Ltd / Companhia de Saneamento de Minas Gerais Copasa MG / Zumtobel Group AG / Capital Power Corp / CIMC Enric Holdings Ltd / Telefonaktiebolaget LM Ericsson / Ashmore Group PLC / China Communications Construction Co Ltd / Shanghai Jin Jiang Capital Co Ltd / Zhuzhou CRRC Times Electric Co Ltd / China Life Insurance Co Ltd / Ping An Insurance Group Co of China Ltd / Smurfit Kappa Group PLC / Weichai Power Co Ltd / AECOM / Daimler AG / Power Grid Corporation of India Ltd / Glanbia PLC / American Public Education Inc / GCL-Poly Energy Holdings Ltd / Fluidra SA / China Railway Group Ltd / Value Partners Group Ltd / China Railway Group Ltd / China Pacific Insurance Group Co Ltd / China Railway Construction Corp Ltd / Brookfield Infrastructure Partners LP / Wartsila Oyj Abp / Genomma Lab Internacional SAB de CV / Energy Recovery Inc / Suez SA / Hollysys Automation Technologies Ltd / Adcock Ingram Holdings Ltd / BBMG Corp / Grand Canyon Education Inc / Shanghai Electric Group Co Ltd / China Resources Cement Holdings Ltd / China Tourism Group Duty Free Corp Ltd / Shenzhen Salubris Pharmaceuticals Co Ltd / Algonquin Power & Utilities Corp / China Pacific Insurance Group Co Ltd / Generac Holdings Inc / Palm Eco-Town Development Co Ltd / Beijing Easpring Material Technology CO LTD / SIASUN Robot & Automation Co Ltd / Life Healthcare Group Holdings Ltd / Tesla Inc / BASF SE / Shanghai STEP Electric Corp / Airtac International Group / Keyera Corp / Aperam SA / Woodward Inc / Federated Hermes Inc / BBMG Corp / BYD Co Ltd / Qualicorp Consultoria e Corretora de Seguros SA / United Natural Foods Inc / Renewable Energy Group Inc / Wisdom Tree Investments Inc / Marriott Vacations Worldwide Corp / Enphase Energy Inc / China Communications Construction Co Ltd / Dongjiang Environmental Co Ltd / Transmissora Alianca de Energia Eletrica SA / SIIC Environment Holdings Ltd / Bright Horizons Family Solutions Inc / Waskita Karya (Persero) Tbk PT / Coty Inc / Caverion Oyj / Corbion NV / Chegg Inc / Aramark / Lenta Plc / Applus Services SA / Luye Pharma Group Ltd / Medley Management Inc / XXL ASA / China Maple Leaf Educational Systems Ltd / Solaredge Technologies Inc / Cellnex Telecom SA / Westrock Co / Planet Fitness Inc / IDP Education Ltd / Virscend Education Company Ltd / Mediclinic International PLC / Holcim AG / Basic Fit NV / Bright Scholar Education Holdings Ltd / Siemens Gamesa Renewable Energy SA / Rise Education Cayman Ltd / Orsted A/S / SIIC Environment Holdings Ltd / DWS Group GmbH & Co KgaA / Equinor ASA / Contemporary Amperex Technology Co Ltd / Arco Platform Ltd / Livent Corp / Koolearn Technology Holding Ltd / Cogna Educacao SA / Bellring Brands Inc / Daqo New Energy Corp / Jacobs Engineering Group Inc / Beijing SinoHytec Co Ltd / Siemens Energy AG / Allegro Microsystems Inc / Haier Smart Home Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Brazil / Canada / Switzerland / China / Cayman Islands / Cyprus / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / Indonesia / India / Ireland / Italy / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / Norway / New Zealand / Singapore / Sweden / Thailand / United States / Virgin Islands, British / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Environmental, Social, Governance</td><td class="leftalignment">Global ESG Team / Eugene Klerk / Bahar Sezer Longworth / Ms. Betty Jiang / Phineas Glover</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from our Expert call on BMY’s LAG-3 inhibitor relatlimab</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY=US / LLY=US / PFE=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech - Pharma Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / GSK.L / AMGN.OQ / CVM.A / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / UTHR.OQ / BMRN.OQ / ESPR.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / MNKD.OQ / RPRX.OQ / JAZZ.OQ / INO.OQ / MRNA.OQ / OMER.OQ / CYDY.PK / ABBV.N / ZTS.N / SRNE.OQ / HRTX.OQ / NVTA.N / IONS.OQ / EDIT.OQ / MDGL.OQ / KALA.OQ / VXRT.OQ / TLRY.OQ / 6160.HK / IGMS.OQ / OCGN.OQ / BEAM.OQ / PGEN.OQ / NRIX.OQ / 22UAy.DE / IBRX.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / CEL-SCI Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / MannKind Corp / Royalty Pharma PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Moderna Inc / Omeros Corp / Cytodyn Inc / Abbvie Inc / Zoetis Inc / Sorrento Therapeutics Inc / Heron Therapeutics Inc / Invitae Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / Kala Pharmaceuticals Inc / Vaxart Inc / Tilray Brands Inc / Beigene Ltd / IGM Biosciences Inc / Ocugen Inc / Beam Therapeutics Inc / Precigen Inc / Nurix Therapeutics Inc / BioNTech SE / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Short Term Headwind - The FTC's Flawed Assumptions About Biopharma M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE=US / AMGN=US / BMY=US / GILD=US / AZN=US / GSK=US / JNJ=US / ILMN=US / VRTX=US / SNY=US / ABBV=US</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Illumina Inc / Vertex Pharmaceuticals Inc / Sanofi SA / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Thoughts Ahead of Deucravacitinib (TYK-2) Data at AAD</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Bracketing Exposure Of Big Cap Pharma To Biden Tax Reform Proposal</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">ECONOMIC REPORTS / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0028241000 / US02553E1064 / US0378331005 / US0463531089 / US1101221083 / US1264081035 / US2435371073 / US25179M1036 / US28176E1082 / US2944291051 / US3377381088 / US37733W1053 / US4282911084 / US4781601046 / US5324571083 / US5398301094 / US6541061031 / US6558441084 / US66987V1098 / US6701002056 / US7170811035 / US7237871071 / US7711951043 / US87612E1064 / US9078181081 / US92532F1003 / US9311421039 / CA1363751027 / CA13645T1003 / US37940X1028 / US64110L1061 / US80105N1054 / US2533931026 / US31620M1062 / US82706C1080 / US57636Q1040 / US4103451021 / US92826C8394 / US58933Y1055 / US78454L1008 / US39304D1028 / US3390411052 / US96208T1043 / US00287Y1091 / NL0010273215 / US69327R1014 / US5764852050 / PR30040P1032 / US89400J1079 / US70450Y1038 / US8522341036 / US15136A1025 / US8760301072 / US2997341035 / US26927E1047 / US46571Y1073 / VGG312491084 / US74275G1076 / US98585X1046 / US69047Q1022 / US13123X5086 / CA67079A1021</td><td class="leftalignment">Abbott Laboratories / American Eagle Outfitters Inc / Apple Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Deckers Outdoor Corp / Devon Energy Corp / Edwards Lifesciences Corp / Equifax Inc / Fiserv Inc / GlaxoSmithKline PLC / Hexcel Corp / Johnson & Johnson / Eli Lilly and Co / Lockheed Martin Corp / Nike Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / Target Corp / Union Pacific Corp / Vertex Pharmaceuticals Inc / Walmart Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Global Payments Inc / Netflix Inc / Sanofi SA / DICK'S Sporting Goods Inc / Fidelity National Information Services Inc / Silicon Motion Technology Corp / Mastercard Inc / HanesBrands Inc / Visa Inc / Merck & Co Inc / SM Energy Co / Green Dot Corp / Fleetcor Technologies Inc / WEX Inc / Abbvie Inc / ASML Holding NV / PDC Energy Inc / Matador Resources Co / Evertec Inc / TransUnion / PayPal Holdings Inc / Block Inc / Centennial Resource Development Inc / Tapestry Inc / Evelo Biosciences Inc / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Priority Technology Holdings Inc / Yeti Holdings Inc / Ovintiv Inc / Callon Petroleum Co / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Netherlands / Puerto Rico / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AN=US / AMGN=US / BMY=US / DIS=US / PG=US / T=US / INCY=US / GILD=US / AMT=US / PEB=US / AKAM=US / CHTR=US / H=US / CONE=US / MTN=US / VZ=US / CCI=US / MGY=US / THC=US / MAR=US / SPOT=US / MRO=US / LEG=US / TNL=US / HLT=US / CMCSA=US / UNH=US / DISH=US / WTFC=US / BMRN=US / CHH=US / DRH=US / EQIX=US / HXL=US / MAN=US / PRGO=US / REGN=US / SBAC=US / VRTX=US / SNV=US / JAZZ=US / NFLX=US / PNFP=US / BIIB=US / TPX=US / EXP=US / SHO=US / DLR=US / PLAY=US / GMS=US / CCOI=US / HST=US / RPRX=US / LLNW=US / PRPL=US / LUMN=US / WH=US / CLNY=US / HGV=US / PCRX=US / RLJ=US / VAC=US / BCEI=US / RHP=US / ABBV=US / TMUS=US / SPNE=US / CABO=US / CRSP=US / PK=US / GDS=US / PLYA=US / SBOW=US / ROKU=US / SWCH=US / BHC=US / ARVN=US / AXNX=US / GMAB=US / 96758W101 / HIMS=US</td><td class="leftalignment">AutoNation Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Akamai Technologies Inc / Charter Communications Inc / Hyatt Hotels Corp / CyrusOne Inc / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Magnolia Oil & Gas Corp / Tenet Healthcare Corp / Marriott International Inc / Spotify Technology SA / Marathon Oil Corp / Leggett & Platt Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Wintrust Financial Corp / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Equinix Inc / Hexcel Corp / ManpowerGroup Inc / Perrigo Company PLC / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vertex Pharmaceuticals Inc / Synovus Financial Corp / Jazz Pharmaceuticals PLC / Netflix Inc / Pinnacle Financial Partners Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / GMS Inc / Cogent Communications Holdings Inc / Host Hotels & Resorts Inc / Royalty Pharma PLC / Limelight Networks Inc / Purple Innovation Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / DigitalBridge Group Inc / Hilton Grand Vacations Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Ryman Hospitality Properties Inc / Abbvie Inc / T-Mobile US Inc / SeaSpine Holdings Corp / Cable One Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / SilverBow Resources Inc / Roku Inc / Switch Inc / Bausch Health Companies Inc / Arvinas Inc / Axonics Inc / Genmab A/S / WideOpenWest Inc / Hims & Hers Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Keenly Watched Deucravacitinib Data at AAD Should Cement Psoriasis Opportunity Size and Possibly Highlight Potential Beyond</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">N=54 prescriber poll on JAK inhibitors in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : April - June 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Plateau Holds as First Dose Vaccinations Reach ~40% Overall and Breaking 50% in Adults; Outbreak in India Concerning</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IKNA: Targeted Oncology Company with Attractive Novel Therapy Candidates; Initiating with an Outperform Rating and a $30 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">IKNA.OQ / 4502.T / 4528.T / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / AMGN.OQ / INCY.OQ / A2.MI / BAYGN.DE / MRTX.OQ</td><td class="leftalignment">Ikena Oncology Inc / Takeda Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Incyte Corp / A2A SpA / Bayer AG / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Italy / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09061G1013 / US0028241000 / US0079731008 / US0116591092 / US0311621009 / US0382221051 / US0463531089 / US0556221044 / US1101221083 / US1924461023 / US1925761066 / US30161Q1040 / US30231G1022 / US3755581036 / US37733W1053 / US45337C1027 / US4567881085 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US64125C1099 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91307C1027 / US91347P1057 / US92532F1003 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / RDSa.AS / PAP310761054 / US16115Q3083 / US3020811044 / US29089Q1058 / US92932M1018 / US01748X1028 / US2473617023 / US87874R1005 / US03152W1099 / BMG3922B1072 / CH0102993182 / IE00B4BNMY34 / US58933Y1055 / US46333X1081 / US9100471096 / US03027X1000 / US29414B1044 / US00287Y1091 / NL0010273215 / US98978V1035 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US8485771021 / US21240E1055 / US02376R1023 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / CA0089118776 / US2681582019 / US31572Q8087 / US22822V1017 / IE00BTN1Y115 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / KYG4740B1059 / US2067871036 / US78410G1040 / US23355L1061 / IL0011407140 / US76243J1051 / US89854H1023 / US05351X1019 / US05455M1009 / US29260V1052 / US5904791358 / CA39342L1085 / US28414H1032 / US61775R1059 / US92537N1081 / US39813G1094 / US44891N1090 / US12769G1004 / US81181C1045 / US05875B1061</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Cognizant Technology Solutions Corp / Cohu Inc / Exelixis Inc / Exxon Mobil Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Infosys Ltd / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Neurocrine Biosciences Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / United Therapeutics Corp / Universal Display Corp / Vertex Pharmaceuticals Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Copa Holdings SA / Chart Industries Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / TechTarget Inc / Amicus Therapeutics Inc / Genpact Ltd / TE Connectivity Ltd / Accenture PLC / Merck & Co Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / American Tower Corp / Epam Systems Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Air Canada / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Medtronic PLC / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Conduent Inc / SBA Communications Corp / DXC Technology Co / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / TTEC Holdings Inc / Avaya Holdings Corp / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Morphic Holding Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / IAC/Interactivecorp / Caesars Entertainment Inc / Seagen Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Mexico / Netherlands / Panama / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">PD-(L)1 Market Model: Potential Price Erosion Offset By Adjuvant Visibility</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">US1101221083 / US0463531089 / US37733W1053 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US80105N1054 / US58933Y1055 / US07725L1026</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Zooming in: pharma out of favour, not out of mind</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / CH0013841017 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Lonza Group AG / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Xian Deng</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (19 Apr-): Results season kick-off; focus this week (Thu/Fri) on Chugai Pharmaceutical and M3</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">M3 Inc / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 5% Above Pre-Pandemic Level - Week 55</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 543</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">FSTX=US / GANX=US / MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / NVS=US / AZN=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / UCB=BE / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CHE=US / CYH=US / EW=US / ISEE=US / GEN=US / ISRG=US / PHG=US / LH=US / PRVL=US / REGN=US / USPH=US / UHS=US / VRTX=US / SGEN=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / IGMS=US / BIIB=US / ISR=US / SLP=US / MRNA=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / OSCR=US / FOLD=US / EHC=US / TMDI=US / ADXN=US / SWAV=US / ADUS=US / SRNE=US / RGNX=US / ANVS=US / ACHC=US / PRTA=US / MRTX=US / MGNX=US / AERI=US / XNCR=US / TRVN=US / FLXN=US / CTRE=US / VBIV=US / WBA=US / NVTA=US / EVH=US / TDOC=US / NVCR=US / VYGR=US / MRUS=US / APVO=US / IRTC=US / CRSP=US / IOVA=US / MTEM=US / SYBX=US / NCNA=US / MDNA=US / ALLO=US / IDYA=US / BCYC=US / PSNL=US / ONCT=US / NBSE=US / DMTK=US / BNTX=US / PNTG=US / PASG=US / LYS=US / ORIC=US / INBX=US / TSHA=US / KDNY=US / SIOX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Gain Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Ucb SA / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Iveric Bio Inc / General Electric Co / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Porvair PLC / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / IGM Biosciences Inc / Biogen Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Oscar Health Inc / Amicus Therapeutics Inc / Encompass Health Corp / Titan Medical Inc / Addex Therapeutics Ltd / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Regenxbio Inc / Annovis Bio Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Xencor Inc / Trevena Inc / Pacira Biosciences Inc / CareTrust REIT Inc / VBI Vaccines Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Merus NV / Aptevo Therapeutics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Molecular Templates Inc / Synlogic Inc / NuCana PLC / Medicenna Therapeutics Corp / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Personalis Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / DermTech Inc / BioNTech SE / Pennant Group Inc / Passage Bio Inc / Lysogene SA / Oric Pharmaceuticals Inc / Inhibrx Inc / Taysha Gene Therapies Inc / Chinook Therapeutics Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AACR Recap: Clinical and Preclinical Highlights Across Our Coverage and Beyond</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">110122108 / 30315R107 / 03116210 / 45253H101 / 00847G705 / 462222100 / 67022C106 / 49372L100 / 019770106 / H17182108 / 81181C104</td><td class="leftalignment">Bristol-Myers Squibb Co / F-Star Therapeutics Inc / Amgen Inc / ImmunoGen Inc / Agenus Inc / Ionis Pharmaceuticals Inc / NuCana PLC / Kezar Life Sciences Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Seagen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">April 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">171</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACI=US / FSTX=US / AAPL=US / IBM=US / MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / INTC=US / MSFT=US / C=US / GLW=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / INCY=US / BAC=US / USB=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / NVS=US / VZ=US / URI=US / TSM=US / CCI=US / UPS=US / AZN=US / GSK=US / JNJ=US / TTWO=US / ATVI=US / PNC=US / CMCSA=US / UNH=US / DISH=US / INTU=US / NUAN=US / APPS=US / HRB=US / CTL=US / CME=US / EGAN=US / EGHT=US / EQIX=US / HEAR=US / QUIK=US / REGN=US / SBAC=US / VG=US / WSC=US / RDWR=US / SNOW=US / NET=US / CRNT=US / RHHBY=US / GME=US / FB=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / IGMS=US / RNG=US / CEVA=US / MRNA=US / GOOG=US / DLR=US / VIAC=US / INO=US / HSBC=US / DISCA=US / PDD=US / CCOI=US / LLNW=US / LUMN=US / BBVA=US / 700-HK=US / UBI-PAR=US / TSLA=US / ZNGA=US / EA=US / TMUS=US / MGNX=US / GTT=US / XNCR=US / AVYA=US / GOOGL=US / TSLX=US / FIVN=US / BABA=US / NVTA=US / MRUS=US / APVO=US / DZSI=US / TEUM=US / ATUS=US / BILI=US / HUYA=US / ZM=US / FSLY=US / ONCT=US / CMBM=US / DMTK=US / BNTX=US / DKNG=US / INBX=US / KDNY=US / CRSR=US / RXT=US / ONDS=US / PLTK=US / DOCN=US</td><td class="leftalignment">Albertsons Companies Inc / F-Star Therapeutics Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Microsoft Corp / Citigroup Inc / Corning Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Incyte Corp / Bank of America Corp / US Bancorp / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / Novartis AG / Verizon Communications Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Crown Castle International Corp / United Parcel Service Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Activision Blizzard Inc / PNC Financial Services Group Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Digital Turbine Inc / H & R Block Inc / Lumen Technologies Inc / CME Group Inc / eGain Corp / 8x8 Inc / Equinix Inc / Turtle Beach Corp / QuickLogic Corp / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vonage Holdings Corp / Willscot Mobile Mini Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Roche Holding AG / GameStop Corp / Meta Platforms Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / IGM Biosciences Inc / RingCentral Inc / CEVA Inc / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Inovio Pharmaceuticals Inc / HSBC Holdings PLC / Discovery Inc / Pinduoduo Inc / Cogent Communications Holdings Inc / Limelight Networks Inc / Lumen Technologies Inc / Banco Bilbao Vizcaya Argentaria SA / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tesla Inc / Zynga Inc / Electronic Arts Inc / T-Mobile US Inc / MacroGenics Inc / GTT Communications Inc / Xencor Inc / Avaya Holdings Corp / Alphabet Inc / Sixth Street Specialty Lending Inc / Five9 Inc / Alibaba Group Holding Ltd / Invitae Corp / Merus NV / Aptevo Therapeutics Inc / DZS Inc / Pareteum Corp / Altice USA Inc / Bilibili Inc / HUYA Inc / Zoom Video Communications Inc / Fastly Inc / Oncternal Therapeutics Inc / Cambium Networks Corp / DermTech Inc / BioNTech SE / DraftKings Inc / Inhibrx Inc / Chinook Therapeutics Inc / Corsair Gaming Inc / Rackspace Technology Inc / Ondas Holdings Inc / Playtika Holding Corp / DigitalOcean Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Germany / Spain / United Kingdom / Israel / Netherlands / Sweden / Taiwan / United States / Guernsey</td><td class="leftalignment">Banks / Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1264081035 / US1265011056 / US22284P1057 / US2254471012 / US2371941053 / US28176E1082 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US4663671091 / US5150981018 / US5324571083 / US5370081045 / US5801351017 / US5951121038 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7134481081 / US7170811035 / US7392761034 / US7711951043 / US7782961038 / US8168501018 / US8308791024 / US8447411088 / US8552441094 / US8725401090 / US9029251066 / US9078181081 / US91324P1021 / US92343V1044 / US9282981086 / US9507551086 / US9581021055 / CA1363751027 / CA13645T1003 / US87157D1090 / US9884981013 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US25754A2015 / US12541W2098 / US00206R1023 / US1696561059 / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US64110D1046 / US58933Y1055 / IE00B58JVZ52 / US9100471096 / US95058W1009 / US9837931008 / US00287Y1091 / US98978V1035 / US8725901040 / US55405Y1001 / US69366J2006 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / US03937C1053 / CA76131D1033 / US74736K1016 / US8190471016 / US9741551033 / CA1380351009 / US74624M1027 / US00938A1043 / CA87241L1094 / CA35805P1071 / CA22717L1013 / US23753F1075 / US80689H1023 / US4990491049 / US09354A1007 / CA88105E1088 / US88688T1007 / US5904791358 / CA39342L1085 / US28414H1032 / CA22587M1068 / CA89788C1041 / CA23126M1023 / CA86730L1094 / US24984K1051 / CA1973091079 / CA05156X8843 / GB00BMVP7Y09 / US07373B1098 / US56854Q2003 / ACRGau.CD / US3441741077 / US74767V1098 / US7761531083 / US03743Q1085 / US15961R1059</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / CTS Corp / Covenant Logistics Group Inc / Wolfspeed Inc / Darden Restaurants Inc / Edwards Lifesciences Corp / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Jack in the Box Inc / Landstar System Inc / Eli Lilly and Co / Littelfuse Inc / McDonald's Corp / Micron Technology Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / PepsiCo Inc / Pfizer Inc / Power Integrations Inc / Roche Holding AG / Ross Stores Inc / Semtech Corp / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / TJX Companies Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Verizon Communications Inc / Vishay Intertechnology Inc / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / Synaptics Inc / Yum! Brands Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Domino's Pizza Inc / CH Robinson Worldwide Inc / AT&T Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / NetApp Inc / Merck & Co Inc / Seagate Technology Holdings PLC / United Airlines Holdings Inc / Wendys Co / XPO Logistics Inc / Abbvie Inc / Zoetis Inc / T-Mobile US Inc / MACOM Technology Solutions Holdings Inc / PTC Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / ArcBest Corp / Restaurant Brands International Inc / Qorvo Inc / Shake Shack Inc / Wingstop Inc / Canopy Growth Corp / Pure Storage Inc / Airgain Inc / TFI International Inc / Freshii Inc / Cronos Group Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Blink Charging Co / Terrascend Corp / Tilray Brands Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Cresco Labs Inc / Trulieve Cannabis Corp / Curaleaf Holdings Inc / Sundial Growers Inc / DermTech Inc / Columbia Care Inc / Aurora Cannabis Inc / Royalty Pharma PLC / Beam Global / Marinus Pharmaceuticals Inc / Acreage Holdings Inc / Foghorn Therapeutics Inc. / Quantumscape Corp / Romeo Power Inc / APA Corp (US) / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / PEP=US / AMGN=US / BMY=US / DIS=US / PLD=US / AMZN=US / CPE=US / VRM=US / BRO=US / EXPE=US / UNH=US / KIDS=US / AJG=US / MAN=US / REGN=US / SNAP=US / TRIP=US / WIX=US / BKNG=US / FB=US / KIM=US / PTON=US / STRO=US / BIIB=US / AAWW=US / CLNY=US / GDOT=US / PCRX=US / ANGI=US / SPLK=US / PTCT=US / VCYT=US / QURE=US / GOOGL=US / BABA=US / CMPR=US / GDDY=US / WLTW=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / HARP=US / LYFT=US / UBER=US / TCRR=US / GMAB=US / CRMD.US</td><td class="leftalignment">Merck & Co Inc / PepsiCo Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Prologis Inc / Amazon.com Inc / Callon Petroleum Co / Vroom Inc / Brown & Brown Inc / Expedia Group Inc / UnitedHealth Group Inc / OrthoPediatrics Corp / Arthur J Gallagher & Co / ManpowerGroup Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Booking Holdings Inc / Meta Platforms Inc / Kimco Realty Corp / Peloton Interactive Inc / Sutro Biopharma Inc / Biogen Inc / Atlas Air Worldwide Holdings Inc / DigitalBridge Group Inc / Green Dot Corp / Pacira Biosciences Inc / Angi Inc / Splunk Inc / PTC Therapeutics Inc / Veracyte Inc / Uniqure NV / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Willis Towers Watson PLC / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Genmab A/S / CorMedix Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / MRNA.OQ / ACRX.OQ / ABBV.N / MGNX.OQ / SAGE.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / MacroGenics Inc / SAGE Therapeutics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended April 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A Potential North Star of Bispecific Antibody Engineering; Initiate at Outperform & $30 PT</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">FSTX=US / MRK=US / AMGN=US / BMY=US / INCY=US / NVS=US / GSK=US / REGN=US / RHHBY=US / IGMS=US / MGNX=US / XNCR=US / MRUS=US / APVO=US / INBX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Merck & Co Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Roche Holding AG / IGM Biosciences Inc / MacroGenics Inc / Xencor Inc / Merus NV / Aptevo Therapeutics Inc / Inhibrx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Model Update</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 02, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - TP cut from £14 to £13 on Fx driven EPS cut & lower than consensus dividend expectations</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / HIK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Hikma Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2778844 / 2026242 / 2219224 / 2270726 / 2542049 / 2317087 / 2369174 / 2515030 / 2645409 / 2689560 / 2707677 / 2440637 / 2138158 / 2980906 / 2857817 / B125XQ6 / B3D7K31 / B1HJLW5 / B7TL820 / B7VD3F2 / BJ3V905 / BJ0XLZ3 / BFLR866 / BFZCHN7 / BVVN4Q8 / BQPVQZ6 / BYVY8G0 / BFNF1D6 / BD9GVY0 / BFMXGR0 / BYXJQG9 / BZ1LFG7 / BK71LY6 / BFFVVC1 / BLBLMD5 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Gilead Sciences Inc / Lithia Motors Inc / NiSource Inc / PG&E Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sempra Energy / Foot Locker Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Emergent BioSolutions Inc / Meta Platforms Inc / Duke Energy Corp / Endo International PLC / Heron Therapeutics Inc / Twitter Inc / Wix.Com Ltd / Eversource Energy / Horizon Therapeutics PLC / Alphabet Inc / Amneal Pharmaceuticals Inc / Zai Lab Ltd / Evergy Inc / Spire Inc / Roku Inc / WW International Inc / Bausch Health Companies Inc / Array Technologies Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">1Q21 Global Biopharma Preview: Drug Pricing & Macro Remain Overhangs; Group Fundamentals Solid & Unchanged</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">2126335 / 0989529 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Michigan Hospitalizations Surge, Confirming We Are Not in the Clear Despite Strong Vaccination Pace; Global Cases Still Grow</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / BLD=US / DVN=US / INCY=US / TEVA=US / AMT=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / CCI=US / MGY=US / SWN=US / MUR=US / CHRS=US / BRO=US / MRO=US / LEG=US / DISH=US / CBRL=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / SBAC=US / CVX=US / SAGE=US / BXS=US / MKL=US / COP=US / DIN=US / JRVR=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / CLR=US / PRPL=US / NMTR=US / TIL=US / NOG=US / IAC=US / JACK=US / TREX=US / KNSL=US / AR=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / 82982L103 / CDEV=US / IRTC=US / CRSP=US / PVAC=US / JELD=US / SBOW=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / FBRX=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Crown Castle International Corp / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Marathon Oil Corp / Leggett & Platt Inc / DISH Network Corp / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / SBA Communications Corp / Chevron Corp / SAGE Therapeutics Inc / Cadence Bank / Markel Corp / Conocophillips / Dine Brands Global Inc / James River Group Holdings Ltd / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / Instil Bio Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Assessing Pipeline Value</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2050832 / 2026242 / 2219224 / 2270726 / 2455965 / 2471950 / 2689560 / 2680905 / 2684703 / 2440637 / 7103065 / B00FWN1 / B125XQ6 / B3D7K31 / B3D7KG4 / B7TL820 / B3V9F12 / BYVY8G0 / BP4GNK9 / BJLT387 / BMQ5T49 / BKVDFF7 / BFMXGR0 / BYXJQG9 / BKTNTR9 / BJDX8Y8 / BJNQGL0 / BLBLMD5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Ameren Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Biogen Inc / Incyte Corp / PG&E Corp / PPL Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Portland General Electric Co / Discovery Inc / Discovery Inc / Meta Platforms Inc / PVH Corp / Alphabet Inc / SAGE Therapeutics Inc / Avantor Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Evergy Inc / Spire Inc / ViacomCBS Inc / Mirum Pharmaceuticals Inc / Rite Aid Corp / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Upgrading to Buy, PT to $74</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Initiating on Instil Bio (TIL) with a Buy and $32/sh PT</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">TIL=US / BMY=US</td><td class="leftalignment">Instil Bio Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Mr. Asthika Goonewardene / Ms. Srikripa Devarakonda, PHD / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">US Major Pharma – Assessing pipeline value and optionality</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / BMY=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma  : 1Q Earnings Preview – Many Moving Pieces But Underlying Trends Remain Healthy</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">BMY.N / ABBV.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Abbvie Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ARNA: IBD Market Deep-Dive Reinforces Opportunity for Etrasimod and the S1P Class in IBD; Increasing TP to $102</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ARNA.OQ / BMY.N</td><td class="leftalignment">Arena Pharmaceuticals Inc / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mr. Tiago Fauth / Mark Connolly / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US -  Dividend Quality Analysis, for the period ended April 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 12/04/2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.L / ERM.L / VTC.L / INF.L / GLO.L / TET.L / REL.L / SNNS.L / HYVE.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Euromoney Institutional Investor PLC / Vitec Group Plc / Informa PLC / ContourGlobal PLC / Treatt PLC / Relx PLC / Sanne Group PLC / Hyve Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Alastair P. Reid / Mr. Ben C. Bourne / Mr. Ian Gordon / Mr. Martin C. Young / Mr. Michael Donnelly / Nicola V. Mallard / Ross Broadfoot / Mr. Scott K. Cagehin</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0116591092 / US0231351067 / US0463531089 / US1101221083 / US37733W1053 / US45253H1014 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US37940X1028 / US4771431016 / US64110L1061 / US4198791018 / US80105N1054 / US31620M1062 / US1696561059 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US3390411052 / US30303M1027 / US96208T1043 / US00287Y1091 / US8485771021 / US60468T1051 / US21240E1055 / US5560991094 / US02376R1023 / US38000Q1022 / JE00BLG2ZQ72 / CA0089118776 / US8190471016 / US02079K1079 / US07725L1026 / IE00BY7QL619 / US83304A1060 / US8760301072 / US67022C1062 / US6085501095 / US59045L1061 / US5904791358 / KY30744W1070 / US76156B1070 / US70614W1009 / US76155X1000 / US44891N1090 / US5015751044 / US55406W1036 / 120404208</td><td class="leftalignment">Alaska Air Group Inc / Amazon.com Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / ImmunoGen Inc / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Global Payments Inc / JetBlue Airways Corp / Netflix Inc / Hawaiian Holdings Inc / Sanofi SA / Fidelity National Information Services Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Fleetcor Technologies Inc / Meta Platforms Inc / WEX Inc / Abbvie Inc / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / American Airlines Group Inc / GlycoMimetics Inc / Quotient Ltd / Air Canada / Shake Shack Inc / Alphabet Inc / Beigene Ltd / Johnson Controls International PLC / Snap Inc / Tapestry Inc / NuCana PLC / Molecular Templates Inc / Mersana Therapeutics Inc / Mesa Air Group Inc / Farfetch Ltd / Revolve Group Inc / Peloton Interactive Inc / Revolution Medicines Inc / IAC/Interactivecorp / Kymera Therapeutics Inc / MYT Netherlands Parent BV / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Informa : A brighter future - Buy</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">INF.L / BMY.L / ERM.L / REL.L / HYVE.L</td><td class="leftalignment">Informa PLC / Bloomsbury Publishing PLC / Euromoney Institutional Investor PLC / Relx PLC / Hyve Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biopharma: Latest Short Interest for US Biopharma: Large Caps Stable; ACRX and NBIX See Moderate Increases Among SMid Caps</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">AACR: BMY/Opdivo Impress In NeoAdj NSCLC; SNY/THOR-707 Early Data Encouraging</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US1101221083 / US80105N1054</td><td class="leftalignment">Bristol-Myers Squibb Co / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 5% Above Pre-Pandemic Level - Week 54</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 542</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Apr 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMAC=US / ONCT=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / ADCT=US / WMT=US / INCY=US / CMS=US / GILD=US / DGX=US / NVS=US / AZN=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / LH=US / LIFE=US / RKT=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / BIIB=US / ACAD=US / GOOG=US / LHCG=US / CHNG=US / BNGO=US / TPTX=US / EHC=US / ATHX=US / TMDI=US / SWAV=US / ADUS=US / SRNE=US / IRWD=US / SLRX=US / ACHC=US / CCXI=US / TGTX=US / ABBV=US / CTRE=US / OTIC=US / VBLT=US / CLRB=US / WBA=US / SNPHY=US / NVTA=US / EVH=US / GKOS=US / BGNE=US / RETA=US / APVO=US / FLGT=US / IRTC=US / PLXP=US / CYCN=US / TMDX=US / KRTX=US / PNTG=US / NNOX=US / KDNY=US / TVTX=US / EVAX=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Oncternal Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / ADC Therapeutics SA / Walmart Inc / Incyte Corp / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / General Electric Co / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Rocket Companies Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Bionano Genomics Inc / Turning Point Therapeutics Inc / Encompass Health Corp / Athersys Inc / Titan Medical Inc / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Ironwood Pharmaceuticals Inc / Salarius Pharmaceuticals Inc / Acadia Healthcare Company Inc / ChemoCentryx Inc / TG Therapeutics Inc / Abbvie Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Invitae Corp / Evolent Health Inc / Glaukos Corp / Beigene Ltd / Reata Pharmaceuticals Inc / Aptevo Therapeutics Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / PLx Pharma Inc / Cyclerion Therapeutics Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Pennant Group Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Travere Therapeutics Inc / Evaxion Biotech A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMAC=US / FTNT=US / AAPL=US / IBM=US / CSII=US / ALL=US / BMY=US / COST=US / DIS=US / INTC=US / MO=US / AMD=US / MSFT=US / CL=US / GLW=US / K=US / AMZN=US / QCOM=US / T=US / ORCL=US / A=US / WMT=US / TXN=US / RUN=US / CG=US / CSR=US / D=US / ED=US / NTRS=US / AMT=US / DOX=US / GS=US / AKAM=US / MPWR=US / JPM=US / PLUG=US / CHTR=US / NICE=US / V=US / NVS=US / VZ=US / PBR=US / EL=US / SMTC=US / VRTS=US / CHKP=US / SAP=US / URI=US / CCI=US / UPS=US / ENR=US / GSK=US / CTAS=US / CSL=US / TTWO=US / LEG=US / LRCX=US / ATVI=US / CMCSA=US / SRCL=US / CI=US / W=US / UNH=US / DISH=US / INTU=US / NUAN=US / AAII=US / ABMD=US / ALB=US / AMED=US / APPS=US / APLS=US / AVGO=US / BOX=US / B=US / BETA=US / HRB=US / CALM=US / CSV=US / KMX=US / CME=US / CRVL=US / CSGP=US / CYBR=US / DHI=US / EW=US / EGAN=US / EGHT=US / EQIX=US / EXAS=US / FIVE=US / ISRG=US / ITRI=US / LIFE=US / MS=US / MCO=US / TEAM=US / PZZA=US / QUIK=US / QDEL=US / ROK=US / ROP=US / SBAC=US / POOL=US / HSIC=US / SNAP=US / UTL=US / VG=US / WDFC=US / WSC=US / WIX=US / ALGN=US / OSUR=US / PDFS=US / RDWR=US / SNOW=US / PRVB=US / NET=US / CRNT=US / GME=US / ARE=US / FB=US / HR=US / MGRC=US / NEP=US / PRA=US / BIO=US / O=US / SWKS=US / NFLX=US / VRNT=US / ENSG=US / AMSF=US / TWLO=US / ERIC=US / NDAQ=US / PTON=US / RPD=US / BIIB=US / RNG=US / CRI=US / OPEN=US / CEVA=US / MRNA=US / DPZ=US / GOOG=US / DLR=US / OLED=US / VIAC=US / FRPT=US / MORN=US / DISCA=US / FIS=US / CCOI=US / ATNI=US / BIG=US / TEL=US / CSIQ=US / RSI=US / QSR=US / BX=US / LLNW=US / LULU=US / VMW=US / LUMN=US / SPGI=US / TBK=US / SWI=US / ADUS=US / GNRC=US / TCEHY=US / NEE=US / TSLA=US / MSCI=US / AMRC=US / HZNP=US / ZNGA=US / EA=US / SVB=US / CCXI=US / ENPH=US / SPLK=US / PANW=US / QLYS=US / WDAY=US / TMUS=US / FEYE=US / GTT=US / AVYA=US / TME=US / QURE=US / COUP=US / LOVE=US / QRVO=US / BILL=US / ETSY=US / WING=US / ZS=US / SQ=US / MIME=US / RETA=US / DZSI=US / TTD=US / CRSP=US / UAA=US / OKTA=US / CVNA=US / ATUS=US / IOVA=US / RDFN=US / ROKU=US / MDB=US / SAIL=US / PLXP=US / BILI=US / HUYA=US / FOCS=US / FTDR=US / ESTC=US / UBER=US / ZM=US / CYCN=US / TUFN=US / FSLY=US / CRWD=US / CMBM=US / FVRR=US / PING=US / NLOK=US / DKNG=US / KDNY=US / RXT=US / ONDS=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Fortinet Inc / Apple Inc / International Business Machines Corp / Cardiovascular Systems Inc / Allstate Corp / Bristol-Myers Squibb Co / Costco Wholesale Corp / Walt Disney Co / Intel Corp / Altria Group Inc / Advanced Micro Devices Inc / Microsoft Corp / Colgate-Palmolive Co / Corning Inc / Kellogg Co / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Agilent Technologies Inc / Walmart Inc / Texas Instruments Inc / Sunrun Inc / Carlyle Group Inc / Centerspace / Dominion Energy Inc / Consolidated Edison Inc / Northern Trust Corp / American Tower Corp / Amdocs Ltd / Goldman Sachs Group Inc / Akamai Technologies Inc / Monolithic Power Systems Inc / JPMorgan Chase & Co / Plug Power Inc / Charter Communications Inc / Nice Ltd / Visa Inc / Novartis AG / Verizon Communications Inc / Petroleo Brasileiro SA Petrobras / Estee Lauder Companies Inc / Semtech Corp / Virtus Investment Partners Inc / Check Point Software Technologies Ltd / SAP SE / United Rentals Inc / Crown Castle International Corp / United Parcel Service Inc / Energizer Holdings Inc / GlaxoSmithKline PLC / Cintas Corp / Carlisle Companies Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Lam Research Corp / Activision Blizzard Inc / Comcast Corp / Stericycle Inc / Cigna Corp / Wayfair Inc / UnitedHealth Group Inc / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Alabama Aircraft Industries Inc / ABIOMED Inc / Albemarle Corp / Amedisys Inc / Digital Turbine Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / Box Inc / Barnes Group Inc / Beta Drugs Ltd / H & R Block Inc / Cal-Maine Foods Inc / Carriage Services Inc / Carmax Inc / CME Group Inc / CorVel Corp / CoStar Group Inc / Cyberark Software Ltd / D R Horton Inc / Edwards Lifesciences Corp / eGain Corp / 8x8 Inc / Equinix Inc / Exact Sciences Corp / Five Below Inc / Intuitive Surgical Inc / Itron Inc / aTyr Pharma Inc / Morgan Stanley / Moody's Corp / Atlassian Corporation PLC / Papa John's International Inc / QuickLogic Corp / Quidel Corp / Rockwell Automation Inc / Roper Technologies Inc / SBA Communications Corp / Pool Corp / Henry Schein Inc / Snap Inc / Unitil Corp / Vonage Holdings Corp / WD-40 Co / Willscot Mobile Mini Holdings Corp / Wix.Com Ltd / Align Technology Inc / OraSure Technologies Inc / PDF Solutions Inc / Radware Ltd / Snowflake Inc. / Provention Bio Inc / Cloudflare Inc / Ceragon Networks Ltd / GameStop Corp / Alexandria Real Estate Equities Inc / Meta Platforms Inc / Healthcare Realty Trust Inc / McGrath RentCorp / Nextera Energy Partners LP / ProAssurance Corp / Bio Rad Laboratories Inc / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Verint Systems Inc / Ensign Group Inc / Amerisafe Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / Nasdaq Inc / Peloton Interactive Inc / Rapid7 Inc / Biogen Inc / RingCentral Inc / Carter's Inc / Opendoor Technologies Inc / CEVA Inc / Moderna Inc / Domino's Pizza Inc / Alphabet Inc / Digital Realty Trust Inc / Universal Display Corp / ViacomCBS Inc / Freshpet Inc / Morningstar Inc / Discovery Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / ATN International Inc / Big Lots Inc / TE Connectivity Ltd / Canadian Solar Inc / Rush Street Interactive Inc / Restaurant Brands International Inc / Blackstone Inc / Limelight Networks Inc / Lululemon Athletica Inc / VMware Inc / Lumen Technologies Inc / S&P Global Inc / Triumph Bancorp Inc / SolarWinds Corp / Addus Homecare Corp / Generac Holdings Inc / Tencent Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Ameresco Inc / Horizon Therapeutics PLC / Zynga Inc / Electronic Arts Inc / SilverBridge Holdings Ltd / ChemoCentryx Inc / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Qualys Inc / Workday Inc / T-Mobile US Inc / Mandiant Inc / GTT Communications Inc / Avaya Holdings Corp / Tencent Music Entertainment Group / Uniqure NV / Coupa Software Inc / Lovesac Co / Qorvo Inc / Bill.com Holdings Inc / ETSY Inc / Wingstop Inc / Zscaler Inc / Block Inc / Mimecast Ltd / Reata Pharmaceuticals Inc / DZS Inc / Trade Desk Inc / CRISPR Therapeutics AG / Under Armour Inc / Okta Inc / Carvana Co / Altice USA Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / MongoDB Inc / SailPoint Technologies Holdings Inc / PLx Pharma Inc / Bilibili Inc / HUYA Inc / Focus Financial Partners Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / Zoom Video Communications Inc / Cyclerion Therapeutics Inc / Tufin Software Technologies Ltd / Fastly Inc / CrowdStrike Holdings Inc / Cambium Networks Corp / Fiverr International Ltd / Ping Identity Holding Corp / NortonLifeLock Inc / DraftKings Inc / Chinook Therapeutics Inc / Rackspace Technology Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Israel / Netherlands / Sweden / United States / South Africa / Jersey / Guernsey</td><td class="leftalignment">Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Authoring a New Chapter in the Aspirin Wars; Initiate with Outperform, $20 PT</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PLXP=US / BMY=US / RKT=US</td><td class="leftalignment">PLx Pharma Inc / Bristol-Myers Squibb Co / Rocket Companies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Northland Securities</td><td class="leftalignment">Investor Event Provides Valuable Details on RP-6306; Reiterate OP</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">RPTX=US / BMY=US / AZN=US / BAY=US / IDYA=US</td><td class="leftalignment">Repare Therapeutics Inc / Bristol-Myers Squibb Co / AstraZeneca PLC / Bayer AG / IDEAYA Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Timothy Chiang</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">The Great Inflation Equity Duration</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALLY.N / UHAL.OQ / AXP.N / BMY.N / CAH.N / CE.N / COF.N / IBM.N / KEY.N / BEN.N / UHS.N / HAL.N / KR.N / WHR.N / UBS.N / AMP.N / VFC.N / DVA.N / TJX.N / ABC.N / MHK.N / IRM.N / INTC.OQ / PCAR.OQ / RJF.N / ROST.OQ / XLNX.OQ / DFS.N / NTAP.OQ / TPR.N / EWBC.OQ / ILMN.OQ / SGEN.OQ / TFC.N / VIAC.OQ / DISCA.OQ / IVZ.N / LYB.N / APO.N / BKR.N / ENPH.OQ / ZNGA.OQ / CDW.OQ / FOXA.OQ / ALLE.N / SYF.N / FTV.N / LW.N / PFG.OQ / DBX.OQ</td><td class="leftalignment">Ally Financial Inc / Amerco / American Express Co / Bristol-Myers Squibb Co / Cardinal Health Inc / Celanese Corp / Capital One Financial Corp / International Business Machines Corp / KeyCorp / Franklin Resources Inc / Universal Health Services Inc / Halliburton Co / Kroger Co / Whirlpool Corp / UBS Group AG / Ameriprise Financial Inc / VF Corp / DaVita Inc / TJX Companies Inc / Amerisourcebergen Corp / Mohawk Industries Inc / Iron Mountain Inc / Intel Corp / Paccar Inc / Raymond James Financial Inc / Ross Stores Inc / Xilinx Inc / Discover Financial Services / NetApp Inc / Tapestry Inc / East West Bancorp Inc / Illumina Inc / Seagen Inc / Truist Financial Corp / ViacomCBS Inc / Discovery Inc / Invesco Ltd / LyondellBasell Industries NV / Apollo Global Management Inc / Baker Hughes Co / Enphase Energy Inc / Zynga Inc / CDW Corp / Fox Corp / Allegion PLC / Synchrony Financial / Fortive Corp / Lamb Weston Holdings Inc / Principal Financial Group Inc / Dropbox Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Apparel & Textiles / Appliances / Banks / Broadcasting & Cable / Building & Building Materials / Chemicals / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Machinery / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Transportation / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Kailash Capital Kailash Capital</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">DMAC May Have Unlocked Synthetic KLK1's Potential in Stroke and Chronic Kidney Disease; Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">DMAC=US / PFE=US / BMY=US / NVS=US / BIIB=US / ATHX=US / IRWD=US / CCXI=US / RETA=US / CYCN=US / KDNY=US / TVTX=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Pfizer Inc / Bristol-Myers Squibb Co / Novartis AG / Biogen Inc / Athersys Inc / Ironwood Pharmaceuticals Inc / ChemoCentryx Inc / Reata Pharmaceuticals Inc / Cyclerion Therapeutics Inc / Chinook Therapeutics Inc / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Positive Top-Line Data From CheckMate-648 Trial Marks Another Win for Opdivo in Its Return to Growth</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / PEB=US / H=US / MTN=US / PXD=US / BRO=US / MAR=US / TNL=US / HLT=US / AIR=US / ATRO=US / CCL=US / CHH=US / DRH=US / DCO=US / EQT=US / AJG=US / HEI=US / HXL=US / TRIP=US / TGI=US / MKL=US / SPR=US / NFLX=US / JRVR=US / SHO=US / REX=US / TDG=US / HST=US / GPRE=US / LUMN=US / WH=US / KNSL=US / HGV=US / RLJ=US / VAC=US / RHP=US / FANG=US / ABBV=US / 00770K202 / GDDY=US / EVBG=US / PK=US / PLYA=US / OKTA=US / PLMR=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Pioneer Natural Resources Co / Brown & Brown Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / AAR Corp / Astronics Corp / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Ducommun Inc / EQT Corp / Arthur J Gallagher & Co / HEICO Corp / Hexcel Corp / Tripadvisor Inc / Triumph Group Inc / Markel Corp / Spirit AeroSystems Holdings Inc / Netflix Inc / James River Group Holdings Ltd / Sunstone Hotel Investors Inc / REX American Resources Corp / TransDigm Group Inc / Host Hotels & Resorts Inc / Green Plains Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Aemetis Inc / GoDaddy Inc / Everbridge Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Palomar Holdings Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ONCT=US / TMDI=US / MRK=US / NKE=US / BMY=US / INTC=US / AMD=US / MSFT=US / MDT=US / ADCT=US / INCY=US / GILD=US / NVDA=US / NVS=US / AZN=US / JNJ=US / TTWO=US / ATVI=US / PENN=US / HEAR=US / ISRG=US / GME=US / DKS=US / TH=US / BNGO=US / RSI=US / 700-HK=US / UBI-PAR=US / SRNE=US / SLRX=US / 2454-TW=US / ZNGA=US / EA=US / TGTX=US / ABBV=US / OTIC=US / CLRB=US / BGNE=US / APVO=US / FLGT=US / BILI=US / HUYA=US / ESTC=US / TMDX=US / DKNG=US / CRSR=US / PLTK=US / EVAX=US</td><td class="leftalignment">Oncternal Therapeutics Inc / Titan Medical Inc / Merck & Co Inc / Nike Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Microsoft Corp / Medtronic PLC / ADC Therapeutics SA / Incyte Corp / Gilead Sciences Inc / NVIDIA Corp / Novartis AG / AstraZeneca PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Activision Blizzard Inc / Penn National Gaming Inc / Turtle Beach Corp / Intuitive Surgical Inc / GameStop Corp / DICK'S Sporting Goods Inc / Target Hospitality Corp / Bionano Genomics Inc / Rush Street Interactive Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / Sorrento Therapeutics Inc / Salarius Pharmaceuticals Inc / MediaTek Inc / Zynga Inc / Electronic Arts Inc / TG Therapeutics Inc / Abbvie Inc / Otonomy Inc / Cellectar Biosciences Inc / Beigene Ltd / Aptevo Therapeutics Inc / Fulgent Genetics Inc / Bilibili Inc / HUYA Inc / Elastic NV / Transmedics Group Inc / DraftKings Inc / Corsair Gaming Inc / Playtika Holding Corp / Evaxion Biotech A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Consumer / Healthcare / Info. Tech./Computers / Info. Tech./Software / Retailing / Semiconductors / Services</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Portfolio Manager's Guide to ESG - April 2021</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">A.N / AAP.N / ABT.N / AIG.N / ALB.N / ALK.N / APD.N / BA.N / BAC.N / BAX.N / BBY.N / BDX.N / BMY.N / BSX.N / CAH.N / CCL.N / CE.N / CF.N / CI.N / CL.N / CNC.N / CVS.N / DAL.N / DD.N / DOW.N / ECL.N / EL.N / EMN.N / EOG.N / F.N / FCX.N / FDX.N / FLS.N / FMC.N / GE.N / GM.N / GPS.N / HLT.N / IP.N / IR.N / KMB.N / KO.N / LMT.N / LUV.N / MAS.N / MO.N / NEM.N / NOC.N / NSC.N / OXY.N / PHM.N / PM.N / PPG.N / RHI.N / RL.N / SEE.N / SGEF.PA / SLB.N / SWK.N / TAP.N / TXT.N / WMB.N / WMT.N / PG.N / DGX.N / PXD.N / NUE.N / ROK.N / CPB.N / HAL.N / AAL.L / ADML.L / ETN.N / DHR.N / BWA.N / CMI.N / GD.N / URI.N / DE.N / DOV.N / IEX.N / PH.N / ROP.N / K.N / WAB.N / CAT.N / MGM.N / LEN.N / UNP.N / RCL.N / CLX.N / MCD.N / CAG.N / TSN.N / SYY.N / YUM.N / VLO.N / HD.N / LOW.N / MRO.N / UPS.N / WM.N / KR.N / ITW.N / MMM.N / GIS.N / EMR.N / VMC.N / XOM.N / HSY.N / DVN.N / WHR.N / NKE.N / LIN.N / TGT.N / AVY.N / SHW.N / PKG.N / BLL.N / GWW.N / PKI.N / MLM.N / HCA.N / JCI.N / COO.N / DHI.N / STZ.N / VFC.N / DVA.N / TJX.N / KMI.N / AZO.N / KMX.N / PWR.N / COG.N / EFX.N / EW.N / OKE.N / HWM.N / LEG.N / RSG.N / SNA.N / CHD.N / AME.N / GPC.N / MKC.N / HRL.N / PVH.N / LB.TO / ABC.N / CVX.N / MHK.N / TDY.N / COP.N / HAYS.L / AOS.N / ABMD.OQ / AMGN.OQ / CERN.OQ / CTAS.OQ / EXPD.OQ / FAST.OQ / HOLX.OQ / JBHT.OQ / PCAR.OQ / PNR.N / ROL.N / ROST.OQ / SJM.N / TT.N / SBUX.OQ / ODFL.OQ / ORLY.OQ / GILD.OQ / COST.OQ / TSCO.OQ / CPRT.OQ / PENN.OQ / DLTR.OQ / HSIC.OQ / POOL.OQ / TPR.N / AMZN.OQ / CHRW.OQ / EBAY.OQ / EXPE.OQ / GRMN.OQ / ALGN.OQ / WYNN.OQ / MNST.OQ / BIIB.OQ / DPZ.N / MOS.N / LVS.N / NDAQ.OQ / NOV.N / DXCM.OQ / CMG.N / TDG.N / HES.N / HBI.N / ULTA.OQ / NVR.N / BIO.N / VRSK.OQ / GNRC.N / TSLA.OQ / LYB.N / CZR.OQ / NLSN.N / HII.N / HFC.N / BKR.N / FBHS.N / XYL.N / PSX.N / LKQ.OQ / MDLZ.OQ / FANG.OQ / ABBV.N / LDOS.N / MAR.OQ / ALLE.N / NCLH.N / CTLT.N / ANTM.N / WBA.OQ / ETSY.OQ / WRK.N / KHC.OQ / CSX.OQ / FTV.N / LW.N / UAA.N / APTV.N / PEP.OQ / BKNG.OQ / UAL.OQ / NWL.OQ / CTVA.N / LHX.N / J.N / RTX.N / CARR.N / OTIS.N / APA.OQ / HON.OQ / 1U1.DE</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Abbott Laboratories / American International Group Inc / Albemarle Corp / Alaska Air Group Inc / Air Products and Chemicals Inc / Boeing Co / Bank of America Corp / Baxter International Inc / Best Buy Co Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Carnival Corp / Celanese Corp / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Eastman Chemical Co / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Flowserve Corp / FMC Corp / General Electric Co / General Motors Co / Gap Inc / Hilton Worldwide Holdings Inc / International Paper Co / Ingersoll Rand Inc / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Masco Corp / Altria Group Inc / Newmont Corporation / Northrop Grumman Corp / Norfolk Southern Corp / Occidental Petroleum Corp / Pultegroup Inc / Philip Morris International Inc / PPG Industries Inc / Robert Half International Inc / Ralph Lauren Corp / Sealed Air Corp / Vinci SA / Schlumberger NV / Stanley Black & Decker Inc / Molson Coors Beverage Co / Textron Inc / Williams Companies Inc / Walmart Inc / Procter & Gamble Co / Quest Diagnostics Inc / Pioneer Natural Resources Co / Nucor Corp / Rockwell Automation Inc / Campbell Soup Co / Halliburton Co / Anglo American PLC / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / Borgwarner Inc / Cummins Inc / General Dynamics Corp / United Rentals Inc / Deere & Co / Dover Corp / IDEX Corp / Parker-Hannifin Corp / Roper Technologies Inc / Kellogg Co / Westinghouse Air Brake Technologies Corp / Caterpillar Inc / MGM Resorts International / Lennar Corp / Union Pacific Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Conagra Brands Inc / Tyson Foods Inc / Sysco Corp / Yum! Brands Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / Waste Management Inc / Kroger Co / Illinois Tool Works Inc / 3M Co / General Mills Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / Hershey Co / Devon Energy Corp / Whirlpool Corp / Nike Inc / Linde PLC / Target Corp / Avery Dennison Corp / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / PerkinElmer Inc / Martin Marietta Materials Inc / HCA Healthcare Inc / Johnson Controls International PLC / Cooper Companies Inc / D R Horton Inc / Constellation Brands Inc / VF Corp / DaVita Inc / TJX Companies Inc / Kinder Morgan Inc / Autozone Inc / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Edwards Lifesciences Corp / ONEOK Inc / Howmet Aerospace Inc / Leggett & Platt Inc / Republic Services Inc / Snap-On Inc / Church & Dwight Co Inc / AMETEK Inc / Genuine Parts Co / McCormick & Company Inc / Hormel Foods Corp / PVH Corp / Laurentian Bank of Canada / Amerisourcebergen Corp / Chevron Corp / Mohawk Industries Inc / Teledyne Technologies Inc / Conocophillips / Hays PLC / A O Smith Corp / ABIOMED Inc / Amgen Inc / Cerner Corp / Cintas Corp / Expeditors International of Washington Inc / Fastenal Co / Hologic Inc / J B Hunt Transport Services Inc / Paccar Inc / Pentair PLC / Rollins Inc / Ross Stores Inc / J M Smucker Co / Trane Technologies PLC / Starbucks Corp / Old Dominion Freight Line Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Costco Wholesale Corp / Tractor Supply Co / Copart Inc / Penn National Gaming Inc / Dollar Tree Inc / Henry Schein Inc / Pool Corp / Tapestry Inc / Amazon.com Inc / CH Robinson Worldwide Inc / eBay Inc / Expedia Group Inc / Garmin Ltd / Align Technology Inc / Wynn Resorts Ltd / Monster Beverage Corp / Biogen Inc / Domino's Pizza Inc / Mosaic Co / Las Vegas Sands Corp / Nasdaq Inc / Nov Inc / Dexcom Inc / Chipotle Mexican Grill Inc / TransDigm Group Inc / Hess Corp / HanesBrands Inc / Ulta Beauty Inc / NVR Inc / Bio Rad Laboratories Inc / Verisk Analytics Inc / Generac Holdings Inc / Tesla Inc / LyondellBasell Industries NV / Caesars Entertainment Inc / Nielsen Holdings PLC / Huntington Ingalls Industries Inc / HollyFrontier Corp / Baker Hughes Co / Fortune Brands Home & Security Inc / Xylem Inc / Phillips 66 / LKQ Corp / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Leidos Holdings Inc / Marriott International Inc / Allegion PLC / Norwegian Cruise Line Holdings Ltd / Catalent Inc / Anthem Inc / Walgreens Boots Alliance Inc / ETSY Inc / Westrock Co / Kraft Heinz Co / CSX Corp / Fortive Corp / Lamb Weston Holdings Inc / Under Armour Inc / Aptiv PLC / PepsiCo Inc / Booking Holdings Inc / United Airlines Holdings Inc / Newell Brands Inc / Corteva Inc / L3harris Technologies Inc / Jacobs Engineering Group Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / APA Corp (US) / Honeywell International Inc / 1&1 AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Panama / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Kiwoom Securities</td><td class="leftalignment">브리스톨-마이어스 스큅-블룸버그 투자의견 컨센서스-04/07/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">10</td><td class="leftalignment">BMY</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Won Ju Lee</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-GB -  Dividend Quality Analysis, for the period ended December 04,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BLPU.L / ERM.L / PSON.L / QRT.L / FUTR.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Euromoney Institutional Investor PLC / Pearson PLC / Quarto Group Inc / Future PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Michigan Surge Highlights Race Between Variants and Vaccines; Global Case Growth Continues</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 6 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MOGa / US0378331005 / US0463531089 / US1101221083 / US1570851014 / US1985161066 / US37733W1053 / US4523271090 / US5324571083 / US92343V1044 / US20030N1019 / US2533931026 / US00206R1023 / US25470M1099 / US58933Y1055 / US6936561009 / US7512121010 / US00287Y1091 / US8725901040 / US6951271005 / US4277461020 / JE00BLG2ZQ72 / US12685J1051 / US4622221004 / US16119P1084 / US02156K1034 / US1010441053 / US05351X1019 / US98585X1046 / US18453H1068 / US02875D1090 / US07373B1098 / US15961R1059 / 120248964</td><td class="leftalignment">Moog Inc / Apple Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cerus Corp / Columbia Sportswear Co / GlaxoSmithKline PLC / Illumina Inc / Eli Lilly and Co / Verizon Communications Inc / Comcast Corp / DICK'S Sporting Goods Inc / AT&T Inc / DISH Network Corp / Merck & Co Inc / PVH Corp / Ralph Lauren Corp / Abbvie Inc / T-Mobile US Inc / Pacira Biosciences Inc / Heron Therapeutics Inc / Quotient Ltd / Cable One Inc / Ionis Pharmaceuticals Inc / Charter Communications Inc / Altice USA Inc / Boston Omaha Corp / Avaya Holdings Corp / Yeti Holdings Inc / Clear Channel Outdoor Holdings Inc / American Outdoor Brands Inc / Beam Global / ChargePoint Holdings Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Bracketing Risk Of Drug Price Reform On Pharma; Stage Setting For PE Re-Rating?</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2942605 / 2270726 / 2542049 / 2317087 / 2100920 / 2613990 / 2459020 / 2632003 / 2689560 / 2684703 / 2048804 / 2138158 / 7103065 / B121557 / 2713317 / B1HJLW5 / B614LY3 / B7TL820 / B4MG4Z6 / BDZCRX3 / B8DPDT7 / BFLR866 / BVVN4Q8 / BYNZGK1 / BK0VHF6 / BJFSR88 / BJ2Z0H2 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BJXBP30 / BWY52P3 / BYTJZL1 / BF3N4P3 / BKF9DQ8 / BMZ9Z11 / BLR6S36 / BMG5660</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Avista Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / FirstEnergy Corp / Illumina Inc / Intuit Inc / New York Times Co / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sempra Energy / Novartis AG / Mastercard Inc / ACADIA Pharmaceuticals Inc / Emergent BioSolutions Inc / Cielo SA / Meta Platforms Inc / AMC Networks Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / Eversource Energy / Block Inc / IDEAYA Biosciences Inc / Uniqure NV / Pinterest Inc / Evergy Inc / Spire Inc / Vistra Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Zogenix Inc / Arena Pharmaceuticals Inc / Phreesia Inc / Prometheus Biosciences Inc / Longboard Pharmaceuticals Inc / Joann Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA (BUY) - Takeaways from Virtual NDRs: Investor Focus on Synthetic Lethal Platform and Near-Term MAT2A, PKC Inhibitor Data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BK0VHF6 / 2126335 / 2684703 / 7103065 / BCBVTX1 / BBPK0J0 / BFXC911 / BDD1B07</td><td class="leftalignment">IDEAYA Biosciences Inc / Bristol-Myers Squibb Co / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Guardant Health Inc / Rubius Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / 4516.T / 4506.T / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">33</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / 4516.T / 4506.T / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 5 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0126531013 / US01741R1023 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7237871071 / US7711951043 / US8308791024 / US8447411088 / US4771431016 / US4198791018 / US80105N1054 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US88160R1014 / US9100471096 / US00287Y1091 / US00912X3026 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US4622221004 / US26856L1035 / CA53680Q2071 / US74275G1076 / US5904791358 / US53814L1089 / US89377M1099 / US4432011082 / LU2314763264 / 120404208</td><td class="leftalignment">Alaska Air Group Inc / Albemarle Corp / Allegheny Technologies Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Tesla Inc / United Airlines Holdings Inc / Abbvie Inc / Air Lease Corp / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Ionis Pharmaceuticals Inc / elf Beauty Inc / Lithium Americas Corp / Priority Technology Holdings Inc / Mesa Air Group Inc / Livent Corp / Transmedics Group Inc / Howmet Aerospace Inc / Arrival SA / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Luxembourg / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (5 Apr-): Focus shifts forward with start of new fiscal year</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / SASY.PA / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / BX.N / BAYGN.DE / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Blackstone Inc / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">04/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SUN.BO: Sun Pharmaceuticals Industries Limited - Quick Take - Teva gets approval as generic in Absorica; market share shift to LD version still low at 20-25%</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">SUN.BO / TEVA.TA / BMY.N / UCB.BR / TEVA.N / IQV.N</td><td class="leftalignment">Sun Pharmaceutical Industries Ltd / Teva Pharmaceutical Industries Ltd / Bristol-Myers Squibb Co / Ucb SA / Teva Pharmaceutical Industries Ltd / IQVIA Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / India / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXLS=US / JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Exlservice Holdings Inc / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 541</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Bristol Myers Squibb (Buy, TP=$80) - ESG integration - Executing well on ‘S’, not so much on ‘G’ - J. Smith (1p)</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Justin S. Smith / Florent Cespedes / Dinesh Choudhary</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended March 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb strengthens 1.8% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb strengthens 1.8% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: BMY - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">BMY</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Euro Credit Pilot - Technical factors sitting in the driver’s seat (March 2021)</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">US88579Y1010 / AEGN.AS / AIRP.PA / AKZO.AS / ALSO.PA / ALV.N / ALVG.DE / ANZ.AX / APD.N / ASML.AS / ATCOA.ST / AXAF.PA / BAC.N / BARC.L / BKT.MC / BMWG.DE / BNPP.PA / BNS.TO / BOUY.PA / BP.L / BT.L / C.N / CAPP.PA / CARR.PA / CBA.AX / CBKG.DE / CCH.L / CM.TO / CNPP.PA / CRH.I / DANO.PA / DEO.N / DSMN.AS / EDP.LS / ENI.MI / ERICb.ST / ERST.VI / FREG.F / GASI.MI / GE.N / GM.N / HEIG.F / HEIN.AS / HSBA.L / IBE.MC / IBM.N / KPN.AS / LLOY.L / LVMH.PA / MAP.MC / MDBI.MI / MGA / MICP.PA / MOLB.BU / MRK.N / MUVGn.DE / PRTP.PA / SAN.MC / T.N / CONG.DE / AZN.L / AMGN.O / FER.MC / AAL.L / GS.N / ACE.MI / DBKGn.DE / MCD.N / FMEG.DE / BZU.MI / ENEI.MI / MRCG.DE / DTEGn.F / BBVA.MC / BTI.N / IFXGn.DE / FR0000064578 / FR0000035081 / ISS.CO / CARLb.CO / ADEN.S / HNRGn.DE / DPWGn.DE / IG.MI / GSK.L / BAB.L / AMXL.MX / EUFI.PA / JCDX.PA / GB0008220112 / SE0000455057 / US1101221083 / US2987361092 / US3377381088 / US4943681035 / US5949181045 / JP3116000005 / CAGR.PA / AMA.MC / DANSKE.CO / CH0013841017 / ARLG.DE / ENAG.MC / AV.L / US20030N1019 / US02209S1033 / EBKG.DE / JYSK.CO / MAERSKb.CO / HRA.MI / CAIV.VI / US46625H1005 / INGA.AS / LXSG.DE / BTGGg.F / GB0033986497 / JP3885780001 / MTXGn.DE / ELI.BR / EDF.PA / ETL.PA / MS.N / GAZP.MM / US31620M1062 / AKE.PA / ISP.MI / DWNG.DE / DK0060079531 / AU000000GMG2 / SABE.MC / CNE1000001Z5 / CNE1000002H1 / FR0010690156 / BNRGN.DE / IREE.MI / CNE100000KC0 / CABK.MC / US03027X1000 / MDLZ.OQ / LEGN.DE / GYC.DE / 1COV.DE / IMB.L / SE0009922164 / BIRG.I / BMG2178K1009 / BAWG.VI / LU0251710041 / AT0000BAWAG2 / AIBG.I / AIG.A</td><td class="leftalignment">3M Co / Aegon NV / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Akzo Nobel NV / Alstom SA / Autoliv Inc / Allianz SE / Australia and New Zealand Banking Group Ltd / Air Products and Chemicals Inc / ASML Holding NV / Atlas Copco AB / AXA SA / Bank of America Corp / Barclays PLC / Bankinter SA / Bayerische Motoren Werke AG / BNP Paribas SA / Bank of Nova Scotia / Bouygues SA / BP PLC / BT Group PLC / Citigroup Inc / Capgemini SE / Carrefour SA / Commonwealth Bank of Australia / Commerzbank AG / Coca Cola HBC AG / Canadian Imperial Bank of Commerce / CNP Assurances SA / CRH PLC / Danone SA / Diageo PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Eni SpA / Telefonaktiebolaget LM Ericsson / Erste Group Bank AG / Fresenius SE & Co KGaA / Assicurazioni Generali SpA / General Electric Co / General Motors Co / HeidelbergCement AG / Heineken NV / HSBC Holdings PLC / Iberdrola SA / International Business Machines Corp / Koninklijke KPN NV / Lloyds Banking Group PLC / LVMH Moet Hennessy Louis Vuitton SE / Mapfre SA / Mediobanca Banca di Credito Finanziario SpA / Magna International Inc / Compagnie Generale des Etablissements Michelin SCA / MOL Magyar Olajes Gazipari Nyrt / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Kering SA / Banco Santander SA / AT&T Inc / Continental AG / AstraZeneca PLC / Amgen Inc / Ferrovial SA / Anglo American PLC / Goldman Sachs Group Inc / Acea SpA / Deutsche Bank AG / McDonald's Corp / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Enel SpA / Merck KGaA / Deutsche Telekom AG / Banco Bilbao Vizcaya Argentaria SA / British American Tobacco PLC / Infineon Technologies AG / Covivio SA / Icade SA / Iss A/S / Carlsberg A/S / Adecco Group AG / Hannover Rueck SE / Deutsche Post AG / Italgas SpA / GlaxoSmithKline PLC / Babcock International Group PLC / America Movil SAB de CV / Eurofins Scientific SE / JCDecaux SA / DS Smith PLC / Fastighets AB Balder / Bristol-Myers Squibb Co / Euronet Worldwide Inc / Fiserv Inc / Kimberly-Clark Corp / Microsoft Corp / Asahi Group Holdings Ltd / Credit Agricole SA / Amadeus IT Group SA / Danske Bank A/S / Lonza Group AG / Aareal Bank AG / Enagas SA / Aviva PLC / Comcast Corp / Altria Group Inc / EnBW Energie Baden Wuerttemberg AG / Jyske Bank A/S / AP Moeller - Maersk A/S / Hera SpA / CA Immobilien Anlagen AG / JPMorgan Chase & Co / ING Groep NV / Lanxess AG / Bertelsmann SE & Co KGaA / ITV PLC / Mizuho Financial Group Inc / MTU Aero Engines AG / Elia Group SA / Electricite de France SA / Eutelsat Communications SA / Morgan Stanley / Gazprom PAO / Fidelity National Information Services Inc / Arkema SA / Intesa Sanpaolo SpA / Deutsche Wohnen SE / DSV A/S / Goodman Group / Banco de Sabadell SA / Bank of China Ltd / China Construction Bank Corp / Aeroports de Paris SA / Brenntag SE / Iren SpA / China National Chemical Engineering Co Ltd / Caixabank SA / American Tower Corp / Mondelez International Inc / LEG Immobilien SE / Grand City Properties SA / Covestro AG / Imperial Brands PLC / Essity AB (publ) / Bank of Ireland Group PLC / CK Infrastructure Holdings Ltd / BAWAG Group AG / CPI Property Group SA / BAWAG Group AG / Aib Group PLC / American International Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Canada / Switzerland / China / Czech Republic / Germany / Denmark / Spain / Finland / France / United Kingdom / Greece / Hungary / Ireland / Italy / Japan / Luxembourg / Mexico / Netherlands / Norway / New Zealand / Poland / Portugal / Russian Federation / Slovakia / Sweden / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">MISCELLANEOUS / CHANGE IN RECOMMENDATION / MODELS / PORTFOLIO STRATEGY / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Equity</td><td class="leftalignment">Herr Gianfranco Arcovito / Herr Christian Aust / Herr Tobias Keller / Herr. Stefan Kolek / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Northland Securities</td><td class="leftalignment">Upcoming April 8 Investor Day to Highlight CCNE-1 SL Target</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">RPTX=US / BMY=US / AZN=US / BAY=US / IDYA=US</td><td class="leftalignment">Repare Therapeutics Inc / Bristol-Myers Squibb Co / AstraZeneca PLC / Bayer AG / IDEAYA Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Timothy Chiang</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY=US / CAG=US / KO=US / MCD=US / CL=US / WEN=US / CONE=US / ENR=US / TNL=US / VMC=US / NWL=US / W=US / MLM=US / MAC=US / STZ=US / CBRL=US / CENT=US / DRI=US / EPC=US / EQIX=US / EXEL=US / SMG=US / POST=US / EPR=US / REG=US / DIN=US / MGPI=US / IGMS=US / EXP=US / EXR=US / DLR=US / PLAY=US / FRPT=US / DENN=US / THS=US / SIBN=US / CMG=US / ELF=US / TAST=US / JACK=US / HGV=US / VAC=US / NDLS=US / LOCO=US / HQY=US / NEWR=US / SHAK=US / WING=US / GDS=US / PETQ=US / SWCH=US / KDP=US / SITC=US / OSMT=US / BRBR=US / CRMD.US / HYFM=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Conagra Brands Inc / Coca-Cola Co / McDonald's Corp / Colgate-Palmolive Co / Wendys Co / CyrusOne Inc / Energizer Holdings Inc / Travel + Leisure Co / Vulcan Materials Co / Newell Brands Inc / Wayfair Inc / Martin Marietta Materials Inc / Macerich Co / Constellation Brands Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Darden Restaurants Inc / Edgewell Personal Care Co / Equinix Inc / Exelixis Inc / Scotts Miracle-Gro Co / Post Holdings Inc / EPR Properties / Regency Centers Corp / Dine Brands Global Inc / MGP Ingredients Inc / IGM Biosciences Inc / Eagle Materials Inc / Extra Space Storage Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / elf Beauty Inc / Carrols Restaurant Group Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / Marriott Vacations Worldwide Corp / Noodles & Co / El Pollo Loco Holdings Inc / Healthequity Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / GDS Holdings Ltd / PetIQ Inc / Switch Inc / Keurig Dr Pepper Inc / Site Centers Corp / Osmotica Pharmaceuticals PLC / Bellring Brands Inc / CorMedix Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Bristol-Myers Squibb Company MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Bristol Myers Squibb Stock At $63?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Our Cosmic-313 Read-Throughs: Data in Mid-2022; CONTACTs May Be Recruiting Rapidly As Well</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">EXEL=US / BMY=US</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Vaccination Ramp-Up Continues to Accelerate as Spring Wave Driven by Variants Likely</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2434209 / 2126335 / 2516152 / 2000019 / 2640147 / 2026242 / 2270726 / 2689560 / 2684703 / 2440637 / 7103065 / B121557 / 2857817 / B02R1L6 / B7VD3F2 / BBGVT40 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BD8DJ71 / BJFSR88 / BZ1HM42 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BJDX8Y8 / BP8XZL1 / BN0XTW4 / BMCC9R7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Nike Inc / American Electric Power Company Inc / Walt Disney Co / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Mastercard Inc / Netflix Inc / ALLETE Inc / Duke Energy Corp / News Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Snap Inc / Uniqure NV / Adyen NV / Spire Inc / Vistra Corp / ViacomCBS Inc / Mirum Pharmaceuticals Inc / Healthequity Inc / Orphazyme A/S / SCYNEXIS Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Introducing Berenberg DrugBank</td><td class="leftalignment">English</td><td class="rightalignment">123</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EXEL: 1L RCC Stalemate Averted; Initiate with an Outperform Rating, $30 TP</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">EXEL.OQ / 4523.T / BMY.N / LLY.N / MRK.N / PFE.N / ROG.S / SGEN.OQ / BAYGN.DE / ZYME.N / GMAB.CO</td><td class="leftalignment">Exelixis Inc / Eisai Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Roche Holding AG / Seagen Inc / Bayer AG / Zymeworks Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ZYME: Zymeworks - OppHER2nities High and Low; Initiate with an Outperform Rating, $55 TP</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">ZYME.N / BMY.N / JNJ.N / LLY.N / MRK.N / GSK.L / EXEL.OQ / 4568.T / BGNE.OQ / 6160.HK</td><td class="leftalignment">Zymeworks Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / GlaxoSmithKline PLC / Exelixis Inc / Daiichi Sankyo Co Ltd / Beigene Ltd / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AFMD: Affimed - It's Time to Get Engaged; Initiating with an Outperform Rating, $15 TP</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">AFMD.OQ / BMY.N / MRK.N / AZN.L / ROG.S / SGEN.OQ</td><td class="leftalignment">Affimed NV / Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EPZM: Margin of Safety (for Drug and Stock); Initiate with an Outperform Rating, $13 TP</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">EPZM.OQ / BMY.N / ROG.S / NOVN.S / REGN.OQ / GILD.OQ / INCY.OQ / EXEL.OQ / SGEN.OQ / BAYGN.DE / ABBV.N / TGTX.OQ / MGNX.OQ / BPMC.OQ / PBYI.OQ / ZLAB.OQ / DCPH.OQ / GMAB.CO</td><td class="leftalignment">Epizyme Inc / Bristol-Myers Squibb Co / Roche Holding AG / Novartis AG / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Exelixis Inc / Seagen Inc / Bayer AG / Abbvie Inc / TG Therapeutics Inc / MacroGenics Inc / Blueprint Medicines Corp / Puma Biotechnology Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Biotechnology: What's an Oncology Drug Worth? Data from a Decade of Oncology M&A</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">4502.T / 4503.T / BMY.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVN.S / MRCG.DE / 4768.T / GSK.L / AMGN.OQ / GILD.OQ / SGEN.OQ / 4568.T / JAZZ.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Jazz Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EGRX-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EGRX.O / BMY / JNJ / LLY / NVS / AMGN.O / GSK / TEVA.K</td><td class="leftalignment">Eagle Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 29 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1264081035 / US22284P1057 / US3021301094 / US3695501086 / US37733W1053 / US4433201062 / US4456581077 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US25754A2015 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US9837931008 / US00287Y1091 / US09609G1004 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / CA0089118776 / US9314271084 / CA87241L1094 / US23753F1075 / US80689H1023 / US4990491049 / US80706P1030 / US5904791358 / US89377M1099 / CA23126M1023 / US65487U1088 / US75943R1023 / US6877931096</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Domino's Pizza Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / XPO Logistics Inc / Abbvie Inc / bluebird bio Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Air Canada / Walgreens Boots Alliance Inc / TFI International Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Scholar Rock Holding Corp / Mesa Air Group Inc / Transmedics Group Inc / Curaleaf Holdings Inc / Nkarta Inc / Relay Therapeutics Inc / Oscar Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Abecma (ide-cel) Approved as First BCMA CAR-T, Fifth-Line Treatment for Multiple Myeloma</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">110122108 / 09609G100</td><td class="leftalignment">Bristol-Myers Squibb Co / bluebird bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Raju Prasad, PHD / Matt Phipps, PHD / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch Second Quarter 2021</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">00847G705 / 00887A105 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Agenus Inc / Aileron Therapeutics Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AXP / 2126335 / 2023607 / 2026242 / 2270726 / 2829515 / 2037170 / 2328915 / 2342034 / 2459020 / 2689560 / 2680905 / 2138158 / 2857817 / B7TL820 / BBFL7S1 / BFDV8K0 / BBGVT40 / BDZCRX3 / BFLR866 / BYVY8G0 / BF5L3T2 / BFZNYB7 / BDHF4K6 / BZBY005 / BKS3SM8 / BGCYWN8 / BLGJ610 / BYXJQG9 / BZ8VJQ8 / BG31GH0 / BKTNTR9 / BYQHPK7 / BG0Q4Y1 / BM8MM05</td><td class="leftalignment">American Express Co / Bristol-Myers Squibb Co / Amgen Inc / American Electric Power Company Inc / Walt Disney Co / Edison International / 8x8 Inc / Nextera Energy Inc / Fiserv Inc / Intuit Inc / PG&E Corp / PPL Corp / Sempra Energy / Netflix Inc / Meta Platforms Inc / bluebird bio Inc / MacroGenics Inc / News Corp / RingCentral Inc / Twitter Inc / Alphabet Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Xencor Inc / Warner Music Group Corp / Spire Inc / Vistra Corp / Y-mAbs Therapeutics Inc / ViacomCBS Inc / Zymeworks Inc / Exicure Inc / Madison Square Garden Entertainment Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Bristol Myers Squibb Stock Is Undervalued At $63</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（3月29日～）: 新年度相場入りで業績シフトとイベント注視</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4540.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 6869.T / 4541.T / 2318.HK / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">Tsumura & Co / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Ping An Insurance Group Co of China Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (29 Mar-): Focusing on earnings shifts and events as market moves into new fiscal year</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4503.T / 4540.T / 4502.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 6869.T / 4541.T / 2318.HK / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">Astellas Pharma Inc / Tsumura & Co / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Ping An Insurance Group Co of China Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Continue Upward Trend-Week 52</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">OPK-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OPK.O / ABT / BMY / JNJ / LH / REGN.O / ALNY.O / ARDX.O / TEVA.K</td><td class="leftalignment">OPKO Health Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ardelyx Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 540</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / CACI=US / BMY=US / BXP=US / AMZN=US / SLG=US / VZ=US / CCI=US / HSII=US / VRM=US / EXPE=US / KFRC=US / MGM=US / CLI=US / DISH=US / KFY=US / AMN=US / DRI=US / MAN=US / MRCY=US / ASGN=US / PDM=US / HOOK=US / RHI=US / SNAP=US / TRIP=US / WIX=US / CGEN=US / HIW=US / CCRN=US / BKNG=US / BDN=US / OFC=US / CUZ=US / FB=US / VNO=US / WRE=US / PTON=US / IGMS=US / CZR=US / KBR=US / REX=US / SAIC=US / KTOS=US / ANGI=US / ABBV=US / TMUS=US / CEQP=US / FATE=US / GOOGL=US / BABA=US / CMPR=US / DEA=US / GDDY=US / AJRD=US / BWXT=US / OKTA=US / CVNA=US / SFIX=US / MAXR=US / EOLS=US / FTDR=US / SVMK=US / ALLO=US / HARP=US / LYFT=US / UBER=US / TCRR=US / NXTC=US / LHX=US / GMAB=US / SPCE=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Bristol-Myers Squibb Co / Boston Properties Inc / Amazon.com Inc / SL Green Realty Corp / Verizon Communications Inc / Crown Castle International Corp / Heidrick & Struggles International Inc / Vroom Inc / Expedia Group Inc / Kforce Inc / MGM Resorts International / Veris Residential Inc / DISH Network Corp / Korn Ferry / AMN Healthcare Services Inc / Darden Restaurants Inc / ManpowerGroup Inc / Mercury Systems Inc / ASGN Inc / Piedmont Office Realty Trust Inc / HOOKIPA Pharma Inc / Robert Half International Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Compugen Ltd / Highwoods Properties Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / Meta Platforms Inc / Vornado Realty Trust / Washington Real Estate Investment Trust / Peloton Interactive Inc / IGM Biosciences Inc / Caesars Entertainment Inc / KBR Inc / REX American Resources Corp / Science Applications International Corp / Kratos Defense and Security Solutions Inc / Angi Inc / Abbvie Inc / T-Mobile US Inc / Crestwood Equity Partners LP / Fate Therapeutics Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / Easterly Government Properties Inc / GoDaddy Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Okta Inc / Carvana Co / Stitch Fix Inc / Maxar Technologies Inc / Evolus Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / NextCure Inc / L3harris Technologies Inc / Genmab A/S / Virgin Galactic Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2113393 / 2216850 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2632003 / 2680905 / 2684703 / 2730190 / 2829601 / 2883878 / B121557 / B7TL820 / BFDV8K0 / BBGVT40 / BYVY8G0 / BYVYD43 / BYZLV46 / BMQ5T49 / BGCYWN8 / BFZ1K46 / BZ8VJQ8 / BJ9NFQ3 / BN2R582 / BN7K304</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / New York Times Co / PPL Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Southern Co / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Meta Platforms Inc / MacroGenics Inc / News Corp / Alphabet Inc / Performance Food Group Co / InflaRx NV / Zentalis Pharmaceuticals Inc / Xencor Inc / Spotify Technology SA / Vistra Corp / Neoleukin Therapeutics Inc / Relay Therapeutics Inc / Academy Sports and Outdoors Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / BMY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Bristol-Myers Squibb Company</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CTIC-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CTIC.O / BAX / BMY / LLY / NVS / AMGN.O / INCY.O / TEVA.K</td><td class="leftalignment">CTI Biopharma Corp / Baxter International Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Amgen Inc / Incyte Corp / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : Relatlimab (LAG-3) Hits on PFS - Incremental Positive for the Story</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY: Anti-LAG3 – could it be the next TIGIT?!</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First Positive Late-Stage Readout for LAG-3 Combination Paves the Way for Lifecycle Management Plans</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Intriguing first Phase 3 readout for LAG-3 inhibitor relatlimab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY=US / MRK=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY's LAG-3 Combo with Opdivo Opens Another Door for PD-1 Combos; Is It Time to at Least Consider a Softer Landing for the PD-1 Cliff?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.N / 2126335 / BFDV8K0 / BGCYWN8</td><td class="leftalignment">Bristol-Myers Squibb Co / Bristol-Myers Squibb Co / MacroGenics Inc / Xencor Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Under the Microscope: Examining the Growing Toolbox in Next-Generation Cellular Therapeutics</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">110122108 / 15117K103 / 04651310 / 09609G100 / 05280R100 / 019770106 / H17182108 / 07373V105 / 74019P108 / 73730P108 / 151205200</td><td class="leftalignment">Bristol-Myers Squibb Co / Cellectis SA / Atara Biotherapeutics Inc / bluebird bio Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Beam Therapeutics Inc / Precision BioSciences Inc / Poseida Therapeutics Inc / Celyad Oncology SA</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Raju Prasad, PHD / Matt Phipps, PHD / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Bloomsbury Publishing (Add) - Confirming revised numbers</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Malcolm Morgan</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 24/03/2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BMY.L / HLMA.L / HASE.L / KWS.L / SCTS.L / BOWL.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Halma PLC / Hargreaves Services PLC / Keywords Studios PLC / Softcat PLC / Hollywood Bowl Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bahamas / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Alastair P. Reid / Alex Smith / Mr. Ben C. Bourne / Mr. Julian R. Yates / Ms. Kate S. Calvert / Mr. Michael Donnelly / Mr. Nathan G. Piper / Roger J. Phillips / Ross Broadfoot / Mr. Scott K. Cagehin</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Bloomsbury Publishing (Add) - Strong end to the year drives further upgrades</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Malcolm Morgan</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Bloomsbury Publishing : What a year! - Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Bloomsbury Publishing Plc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) – 4Q Recap; ORIC-101 Ph I on Track for 2Q; 3 Addl. INDs in 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">With an End in Sight, Variants and Eagerness to Open Set Up for U.S. Spring Wave as Race to Ramp Up Vaccinations Continues</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2026242 / 2317087 / 2670519 / 2100920 / 2455965 / 2680905 / 2684703 / 2707677 / 2440637 / 2573083 / 2138158 / 7103065 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BK7Y2V9 / B0SDJB4 / BJFSR88 / BKVDFF7 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BMG75B4</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / American Electric Power Company Inc / Entergy Corp / Exelon Corp / FirstEnergy Corp / Biogen Inc / PPL Corp / Pfizer Inc / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sangamo Therapeutics Inc / Sempra Energy / Novartis AG / Duke Energy Corp / Eversource Energy / Alphabet Inc / Akero Therapeutics Inc / Zealand Pharma A/S / Uniqure NV / Oric Pharmaceuticals Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Roku Inc / Inventiva SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) - Previewing Upcoming ORIC-101 (GR Inhibitor) Phase I Data in 1H21</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Mar 12, 2021: Focus on 1Q21 trends for EU Majors</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Bristol Myers Squibb (Buy, TP=$80) - 12m target upgrade - Our highest conviction ‘value’ call - J. Smith (5p)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Justin S. Smith / Florent Cespedes / Dinesh Choudhary</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Merck Stock Remains Significantly Undervalued At $77</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / PEP=US / BMY=US / CAG=US / DIS=US / KO=US / CL=US / PG=US / MDT=US / INCY=US / RUN=US / GILD=US / PEB=US / H=US / V=US / MTN=US / ENR=US / MAR=US / EXPE=US / TTWO=US / TNL=US / HLT=US / AKR=US / NWL=US / EQR=US / W=US / FLO=US / MAC=US / STZ=US / AIR=US / CENT=US / CHH=US / CHD=US / COLL=US / DRH=US / EPC=US / HAIN=US / NTST=US / SMG=US / TRIP=US / POST=US / BKNG=US / OFC=US / FRT=US / SRC=US / REG=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / STRO=US / SHO=US / FRPT=US / THS=US / SPWR=US / SCPL=US / HST=US / MA=US / ELF=US / WH=US / RCUS=US / AAN=US / 45665G303 / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / ENPH=US / MEIP=US / RHP=US / PINC=US / GOOGL=US / COUP=US / ETSY=US / SEDG=US / NSA=US / TRVG=US / PK=US / PLYA=US / PETQ=US / ROKU=US / SMAR=US / KDP=US / BTAI=US / APLT=US / BRBR=US / REYN=US / ABNB=US / HYFM=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / PepsiCo Inc / Bristol-Myers Squibb Co / Conagra Brands Inc / Walt Disney Co / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / Medtronic PLC / Incyte Corp / Sunrun Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Energizer Holdings Inc / Marriott International Inc / Expedia Group Inc / Take-Two Interactive Software Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Newell Brands Inc / Equity Residential / Wayfair Inc / Flowers Foods Inc / Macerich Co / Constellation Brands Inc / AAR Corp / Central Garden & Pet Co / Choice Hotels International Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Hain Celestial Group Inc / Netstreit Corp / Scotts Miracle-Gro Co / Tripadvisor Inc / Post Holdings Inc / Booking Holdings Inc / Corporate Office Properties Trust / Federal Realty Investment Trust / Spirit Realty Capital Inc / Regency Centers Corp / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Sutro Biopharma Inc / Sunstone Hotel Investors Inc / Freshpet Inc / TreeHouse Foods Inc / SunPower Corp / Sciplay Corp / Host Hotels & Resorts Inc / Mastercard Inc / elf Beauty Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Aaron's Company Inc / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / MEI Pharma Inc / Ryman Hospitality Properties Inc / Premier Inc / Alphabet Inc / Coupa Software Inc / ETSY Inc / Solaredge Technologies Inc / National Storage Affiliates Trust / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / PetIQ Inc / Roku Inc / Smartsheet Inc / Keurig Dr Pepper Inc / BioXcel Therapeutics Inc / Applied Therapeutics Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US0126531013 / US0311621009 / US0463531089 / US1101221083 / US1264081035 / US22284P1057 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US4581401001 / US4781601046 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / AU000000LYC6 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US45784P1012 / US58933Y1055 / US9100471096 / US92335C1062 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / CA0089118776 / US00653A1079 / CA87241L1094 / US23753F1075 / US80689H1023 / US04016X1019 / US4990491049 / CA53680Q2071 / US02083G1004 / US09354A1007 / US5904791358 / US28414H1032 / US0197701065 / US53814L1089 / US07373B1098 / US5533681012 / US74767V1098 / US7761531083 / US15961R1059</td><td class="leftalignment">Alaska Air Group Inc / Albemarle Corp / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Intel Corp / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Lynas Rare Earths Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Insulet Corp / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Air Canada / Adaptimmune Therapeutics PLC / TFI International Inc / Daseke Inc / Schneider National Inc / argenx SE / Knight-Swift Transportation Holdings Inc / Lithium Americas Corp / Alpine Immune Sciences Inc / Blink Charging Co / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Livent Corp / Beam Global / Mp Materials Corp / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - Follow up on positive adjuvant lung Tecentriq data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ROG.S / BMY.N / MRK.N / AZN.L</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">FULC: Fulcrum: Seeking Novel Solutions for Genetic Diseases; Initiate with an Outperform Rating and $26 TP</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">FULC.OQ / 4502.T / BMY.N / CSL.AX / PFE.N / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BLUE.OQ / VRTX.OQ / ABBV.N / AGIO.OQ / MRTX.OQ / GBT.OQ / NTLA.OQ / IMRA.OQ / FMTX.OQ</td><td class="leftalignment">Fulcrum Therapeutics Inc / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Pfizer Inc / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / bluebird bio Inc / Vertex Pharmaceuticals Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Global Blood Therapeutics Inc / Intellia Therapeutics Inc / Imara Inc / Forma Therapeutics Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mark Connolly / Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Bristol Myers Squibb - $80.00 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Key Metrics Remain Above Pre-Pandemic Levels-Week 51</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 539</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Sutro is Well Poised to Grow Into $37 PT. Execution Will Support Product-Defines-Platform Thesis</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">STRO=US / MRK=US / BMY=US</td><td class="leftalignment">Sutro Biopharma Inc / Merck & Co Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">BNGO=US / NBSE=US / MRK=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BAX=US / GSK=US / CRY=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / ATRC=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / EXEL=US / GEN=US / ICPT=US / LH=US / LIFE=US / NBIX=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / PRVB=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / ALPN=US / MIST=US / MD=US / SLF=US / ISR=US / SLP=US / MRNA=US / ACAD=US / MBRX=US / MNKD=US / GOOG=US / INO=US / LHCG=US / AGRX=US / CBAY=US / CHNG=US / INFI=US / TPTX=US / ORTX=US / PODD=US / EHC=US / NMTR=US / TNDM=US / SWAV=US / ASND=US / ADUS=US / ALPMY=US / ACHC=US / PRTA=US / ENTA=US / AGIO=US / FATE=US / AERI=US / TRVN=US / FLXN=US / MDWD=US / CTRE=US / ALDX=US / VBIV=US / XENT=US / AUPH=US / OTIC=US / VCEL=US / WBA=US / SNPHY=US / RLMD=US / EVH=US / GKOS=US / CFMS=US / CATB=US / IONS=US / VRAY=US / TCMD=US / AVDL=US / SRRA=US / SVRA=US / SLNO=US / URGN=US / VREX=US / IOVA=US / MTEM=US / VERU=US / KALA=US / MBIO=US / MDNA=US / MOTS=US / VCNX=US / CUE=US / MRKR=US / ORGO=US / PDSB=US / IDYA=US / BCYC=US / KRTX=US / XAIR=US / DMTK=US / ETNB=US / VERO=US / PNTG=US / AYLA=US / FMTX=US / NNOX=US / KDNY=US / VRDN=US / EVAX=US / SOBE=US</td><td class="leftalignment">Bionano Genomics Inc / NeuBase Therapeutics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Baxter International Inc / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Neurocrine Biosciences Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / Alpine Immune Sciences Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Sun Life Financial Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Moleculin Biotech Inc / MannKind Corp / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Agile Therapeutics Inc / Cymabay Therapeutics Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Insulet Corp / Encompass Health Corp / 9 Meters Biopharma Inc / Tandem Diabetes Care Inc / Shockwave Medical Inc / Ascendis Pharma A/S / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Pacira Biosciences Inc / Mediwound Ltd / CareTrust REIT Inc / Aldeyra Therapeutics Inc / VBI Vaccines Inc / Intersect Ent Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Vericel Corp / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Relmada Therapeutics Inc / Evolent Health Inc / Glaukos Corp / Conformis Inc / Astria Therapeutics Inc / Ionis Pharmaceuticals Inc / ViewRay Inc / Tactile Systems Technology Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Savara Inc / Soleno Therapeutics Inc / Urogen Pharma Ltd / Varex Imaging Corp / Iovance Biotherapeutics Inc / Molecular Templates Inc / Veru Inc / Kala Pharmaceuticals Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Motus GI Holdings Inc / Vaccinex Inc / Cue Biopharma Inc / Marker Therapeutics Inc / Organogenesis Holdings Inc / PDS Biotechnology Corp / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / Beyond Air Inc / DermTech Inc / 89Bio Inc / Venus Concept Inc / Pennant Group Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Viridian Therapeutics Inc / Evaxion Biotech A/S / AT&T Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Denmark / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Mavacamten Accepted for Standard FDA Review; Will Add New Blockbuster to CV Franchise</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1051</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call Starting in 15 mins: The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on March 18th (Today): The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">MTEM: OPCO Healthcare Conference Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MTEM=US / BMY=US / VRTX=US</td><td class="leftalignment">Molecular Templates Inc / Bristol-Myers Squibb Co / Vertex Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on March 18th (Tomorrow): The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on 18th March: The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US -  Dividend Quality Analysis, for the period ended March 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BPTH-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BPTH.O / BAX / BMY / SPPI.O / SGEN.O / TLOG.PK</td><td class="leftalignment">Bio Path Holdings Inc / Baxter International Inc / Bristol-Myers Squibb Co / Spectrum Pharmaceuticals Inc / Seagen Inc / TetraLogic Pharmaceuticals Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ONCY-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ONCY.O / BMY / LLY / HBP.TO / AEZS.O / AVEO.O / MRTX.O / TEVA.K / SPHS.PK</td><td class="leftalignment">Oncolytics Biotech Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Helix Biopharma Corp / Aeterna Zentaris Inc / Aveo Pharmaceuticals Inc / Mirati Therapeutics Inc / Teva Pharmaceutical Industries Ltd / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US3755581036 / US09062X1037 / US0042251084 / US42226A1079 / US05464T1043 / US0327973006 / US24823R1059</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Healthequity Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Improvements Continue, Though Signs of Deceleration as Variants Spread; IHME Warns of Easing Restrictions Too Early</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2026242 / 2942605 / 2317087 / 2328915 / 2342034 / 2369174 / 2630513 / 2684703 / 2048804 / 2980906 / 7103065 / B121557 / B1Y9TB3 / 2857817 / B2R3PV1 / B28TS42 / B7TL820 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BF4VBS8 / BP7RS48 / BFZ1K46 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BKTNTR9 / BDD1B07 / BP8XZL1 / BFY7DC4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / American Electric Power Company Inc / Avista Corp / Entergy Corp / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / New Jersey Resources Corp / Pfizer Inc / Pinnacle West Capital Corp / Foot Locker Inc / Novartis AG / Mastercard Inc / Danone SA / Netflix Inc / American Water Works Company Inc / Ulta Beauty Inc / Meta Platforms Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / BioXcel Therapeutics Inc / Intersect Ent Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / Vistra Corp / ViacomCBS Inc / Rubius Therapeutics Inc / Healthequity Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">First Few Waves of Innovation Tsunami During 2021 in Alz/Park’s Disease - Post AD/PD’21</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY.N / US1101221083 / BIIB.OQ / US0042251084 / PRTA.OQ / US05464T1043 / US0327973006 / US24823R1059 / SAVA.OQ</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Biogen Inc / ACADIA Pharmaceuticals Inc / Prothena Corporation PLC / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Denali Therapeutics Inc / Cassava Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Resounding themes from Chardan's Microbiome Medicines Summit (CMMS 2021)</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / BMY=US / GSK=US / JNJ=US / BMRN=US / EXAS=US / NESN=US / KLDO=US / DDDD=GB / MCRB=US / SYBX=US / FIXX=US / PHGE=US / FBRX=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / Exact Sciences Corp / Nestle SA / Kaleido Biosciences Inc / 4D Pharma PLC / Seres Therapeutics Inc / Synlogic Inc / Homology Medicines Inc / Biomx Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">EVLO=US / ADAP=US / MRK=US / LLY=US / PFE=US / BMY=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / JNJ=US / BMRN=US / BLUE=US / ISEE=US / EXAS=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NESN=US / KLDO=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / DDDD=GB / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / MCRB=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PHGE=US / PASG=US / SIGHT:FP=FR / FBRX=US / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Evelo Biosciences Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Exact Sciences Corp / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Nestle SA / Kaleido Biosciences Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / 4D Pharma PLC / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Seres Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Biomx Inc / Passage Bio Inc / Gensight Biologics SA / Forte Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 15 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000054470 / BE0165385973 / US0079731008 / US0116591092 / US0320951017 / US0382221051 / US0463531089 / US0997241064 / US1101221083 / US1925761066 / US2371941053 / US2855121099 / US37733W1053 / US45167R1041 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US6284641098 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8740541094 / US8793601050 / US8807701029 / US9021041085 / US91347P1057 / US4771431016 / US4198791018 / US80105N1054 / US0003752047 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US92839U2069 / JE00B783TY65 / US98986T1088 / US00287Y1091 / NL0010273215 / US72919P2020 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US98138J2069 / US45073V1089 / KYG4740B1059 / US05351X1019 / US92336X1090 / US5904791358 / US1567271093 / US92537N1081 / US22041X1028 / US33813J1060 / US72815L1070</td><td class="leftalignment">Ubisoft Entertainment SA / Melexis NV / Advanced Energy Industries Inc / Alaska Air Group Inc / Amphenol Corp / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / Cohu Inc / Darden Restaurants Inc / Electronic Arts Inc / GlaxoSmithKline PLC / IDEX Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Myers Industries Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Take-Two Interactive Software Inc / Teledyne Technologies Inc / Teradyne Inc / II-VI Inc / Universal Display Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Abb Ltd / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Visteon Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / ASML Holding NV / Plug Power Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Workhorse Group Inc / ITT Inc / Ichor Holdings Ltd / Avaya Holdings Corp / Veoneer Inc / Mesa Air Group Inc / Cerence Inc / Vertiv Holdings Co / Corsair Gaming Inc / Fisker Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SVRA=US / TRVN=US / MRK=US / BSX=US / CSII=US / FDX=US / ABT=US / AMGN=US / BMY=US / CAT=US / WM=US / BWA=US / MDT=US / QCOM=US / T=US / DT=US / INCY=US / RUN=US / CG=US / BAC=US / GILD=US / FRC=US / MPWR=US / JPM=US / FCEL=US / PLUG=US / NVS=US / TROW=US / CRY=US / JCI=US / JNJ=US / DE=US / RSG=US / ALB=US / AMSC=US / ARNA=US / ARRY=US / ATRC=US / AVNT=US / CMI=US / CREE=US / DRI=US / DRRX=US / EW=US / INSM=US / ITRI=US / MS=US / ROK=US / TER=US / TRMB=US / RHHBY=US / SIVB=US / NEP=US / SWKS=US / ICAD=US / BE=US / CLH=US / WCN=US / BIIB=US / ISR=US / ENS=US / GOOG=US / TWIN=US / ORA=US / AMRS=US / PDD=US / SPWR=US / CSIQ=US / FSLR=US / ARAY=US / BX=US / DAN=US / WPRT=US / SWAV=US / AGCO=US / CPIX=US / TSLA=US / DANA=US / AMRC=US / PCRX=US / ENPH=US / SPLK=US / HASI=US / CNHI=US / HRTX=US / BABA=US / EKTAY=US / NEWR=US / SEDG=US / LIVN=US / AQMS=US / CERC=US / VRAY=US / WKHS=US / IRTC=US / VERU=US / ATXI=US / APTV=US / VOW3-DE=US / CWEN=US / ESTC=US / DDOG=US / BXRX=US / TARA=US / SUMO=US / VLDR=US / SHLS=US / CHPT=US / GOEV=US</td><td class="leftalignment">Savara Inc / Trevena Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / FedEx Corp / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Caterpillar Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Qualcomm Inc / AT&T Inc / Dynatrace Inc / Incyte Corp / Sunrun Inc / Carlyle Group Inc / Bank of America Corp / Gilead Sciences Inc / First Republic Bank / Monolithic Power Systems Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Novartis AG / T Rowe Price Group Inc / CryoLife Inc / Johnson Controls International PLC / Johnson & Johnson / Deere & Co / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Arena Pharmaceuticals Inc / Array Technologies Inc / AtriCure Inc / Avient Corp / Cummins Inc / Wolfspeed Inc / Darden Restaurants Inc / DURECT Corp / Edwards Lifesciences Corp / Insmed Inc / Itron Inc / Morgan Stanley / Rockwell Automation Inc / Teradyne Inc / Trimble Inc / Roche Holding AG / SVB Financial Group / Nextera Energy Partners LP / Skyworks Solutions Inc / ICAD Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Biogen Inc / IsoRay Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / Pinduoduo Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Accuray Inc / Blackstone Inc / Dana Inc / Westport Fuel Systems Inc / Shockwave Medical Inc / AGCO Corp / Cumberland Pharmaceuticals Inc / Tesla Inc / Dana Gas PJSC / Ameresco Inc / Pacira Biosciences Inc / Enphase Energy Inc / Splunk Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Heron Therapeutics Inc / Alibaba Group Holding Ltd / Elekta AB (publ) / New Relic Inc / Solaredge Technologies Inc / LivaNova PLC / Aqua Metals Inc / Avalo Therapeutics Inc / ViewRay Inc / Workhorse Group Inc / iRhythm Technologies Inc / Veru Inc / Avenue Therapeutics Inc / Aptiv PLC / Volkswagen AG / Clearway Energy Inc / Elastic NV / Datadog Inc / Baudax Bio Inc / Protara Therapeutics Inc / Sumo Logic Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Canoo Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Arab Emirates / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Olinvyk . . . We Have Liftoff; Initiate at Perform</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">TRVN=US / MRK=US / BMY=US / NVS=US / JNJ=US / ARNA=US / DRRX=US / RHHBY=US / CPIX=US / PCRX=US / HRTX=US / CERC=US / VERU=US / ATXI=US / BXRX=US</td><td class="leftalignment">Trevena Inc / Merck & Co Inc / Bristol-Myers Squibb Co / Novartis AG / Johnson & Johnson / Arena Pharmaceuticals Inc / DURECT Corp / Roche Holding AG / Cumberland Pharmaceuticals Inc / Pacira Biosciences Inc / Heron Therapeutics Inc / Avalo Therapeutics Inc / Veru Inc / Avenue Therapeutics Inc / Baudax Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Lessons Learned; Late Stage De-Risked Asset in an Orphan Lung Disease-Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">SVRA=US / BMY=US / JNJ=US / INSM=US</td><td class="leftalignment">Savara Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Insmed Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RNA: Q4 Earnings Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RNA.OQ / BMY.N / LLY.N</td><td class="leftalignment">Avidity Biosciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mark Connolly / Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PSON-GB Company reports financial results for the half-year ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PSON.L / DMGOa.L / ERM.L / BLPU.L</td><td class="leftalignment">Pearson PLC / Daily Mail and General Trust P L C / Euromoney Institutional Investor PLC / Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: New Trial Starts Continue to Increase - Week 50</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/13/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Global Gene Therapy Market: Current Analysis and Forecast (2020-2027)</td><td class="leftalignment">English</td><td class="rightalignment">302</td><td class="leftalignment">BGT=AU / BMY=US / GILD=US / NOVN=CH / BMRN=US / BLUE=US / null / BIIB=US / ORTX=US / RGNX=US / QURE=US</td><td class="leftalignment">Bio-Gene Technology Ltd / Bristol-Myers Squibb Co / Gilead Sciences Inc / Novartis AG / Biomarin Pharmaceutical Inc / bluebird bio Inc / One 97 Communications Ltd / Biogen Inc / Orchard Therapeutics PLC / Regenxbio Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Germany / Spain / France / United Kingdom / India / Italy / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">OPT=US / VBIV=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / BMY=US / MDT=US / AMZN=US / WMT=US / INSP=US / CMS=US / GILD=US / DGX=US / BBI=US / RMD=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ISRG=US / LH=US / PHAR=US / REGN=US / USPH=US / UHS=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MRNS=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / EHC=US / NMTR=US / TMDI=US / SPRO=US / ASND=US / ADUS=US / ACHC=US / PRTA=US / OM=US / FLXN=US / CTRE=US / ALDX=US / XENT=US / WBA=US / EVH=US / ZBH=US / CATB=US / LIVN=US / CERC=US / AVDL=US / SRRA=US / SLNO=US / SYNH=US / FIXX=US / MRKR=US / GMDA=US / PDSB=US / TMDX=US / BCYC=US / KRTX=US / BNTX=US / PNTG=US</td><td class="leftalignment">Opthea Ltd / VBI Vaccines Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Amazon.com Inc / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Brickell Biotech Inc / Resmed Inc / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / Pharming Group NV / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Titan Medical Inc / Spero Therapeutics Inc / Ascendis Pharma A/S / Addus Homecare Corp / Acadia Healthcare Company Inc / Prothena Corporation PLC / Outset Medical Inc / Pacira Biosciences Inc / CareTrust REIT Inc / Aldeyra Therapeutics Inc / Intersect Ent Inc / Walgreens Boots Alliance Inc / Evolent Health Inc / Zimmer Biomet Holdings Inc / Astria Therapeutics Inc / LivaNova PLC / Avalo Therapeutics Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Soleno Therapeutics Inc / Syneos Health Inc / Homology Medicines Inc / Marker Therapeutics Inc / Gamida Cell Ltd / PDS Biotechnology Corp / Transmedics Group Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / BioNTech SE / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FR0000121014 / US0028241000 / US00738A1060 / US00846U1016 / US0126531013 / US02553E1064 / US0311621009 / US0463531089 / US1101221083 / US17275R1023 / US22160K1051 / US2358511028 / US30226D1063 / US3156161024 / US3377381088 / US3647601083 / US3755581036 / US37733W1053 / US4364401012 / US4523271090 / US4781601046 / US48203R1041 / US5002551043 / US5324571083 / US6245801062 / US62855J1043 / US6549022043 / US6556641008 / US66987V1098 / US6701002056 / US7140461093 / US7170811035 / US75886F1075 / US87612E1064 / US8835561023 / US9021041085 / US91307C1027 / US9311421039 / US9418481035 / US30063P1057 / US37940X1028 / AU000000LYC6 / US2948216088 / US1167941087 / US31620M1062 / US57636Q1040 / US1717793095 / US79546E1047 / US55616P1049 / US90384S3031 / US92826C8394 / US58933Y1055 / US13100M5094 / US1920051067 / US9100471096 / US69404D1081 / US92335C1062 / US98978V1035 / US5017971046 / US64051T1007 / US45845P1084 / US69366J2006 / US63009R1095 / US03823U1025 / CH0210483332 / US09062W2044 / US0404131064 / US78667J1088 / US0994061002 / IE00BTN1Y115 / US46185L1035 / US6323071042 / US70450Y1038 / US72703H1014 / US8522341036 / US26856L1035 / US74967X1037 / NL0012169213 / CA1350861060 / US03236M2008 / US8760301072 / CA53680Q2071 / US74766Q1013 / US7625441040 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / KY30744W1070 / US40131M1099 / US53814L1089 / US90184D1000 / VGG1890L1076 / US05352A1007 / US76156B1070 / US71535D1063 / US39874R1014 / US00650F1093 / US88339P1012 / US24984K1051 / US88025U1097 / US30068X1037 / US92766K1060 / US14448C1045 / US12233L1070 / US57667L1070 / US0843101017 / US07373B1098 / CA67079A1021 / US5533681012 / US74767V1098 / US81578P1066 / US65443P1021 / US7761531083 / US73739W1045 / US55406W1036 / US12047B1052 / US15961R1059</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abbott Laboratories / ADTRAN Inc / Agilent Technologies Inc / Albemarle Corp / American Eagle Outfitters Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cisco Systems Inc / Costco Wholesale Corp / Danaher Corp / Extreme Networks Inc / F5 Inc / Fiserv Inc / Gap Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Hologic Inc / Illumina Inc / Johnson & Johnson / Juniper Networks Inc / Kohls Corp / Eli Lilly and Co / Movado Group Inc / Myriad Genetics Inc / Nokia Oyj / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PerkinElmer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / Thermo Fisher Scientific Inc / II-VI Inc / United Therapeutics Corp / Walmart Inc / Waters Corp / Exact Sciences Corp / Global Payments Inc / Lynas Rare Earths Ltd / Telefonaktiebolaget LM Ericsson / Bruker Corp / Fidelity National Information Services Inc / Mastercard Inc / Ciena Corp / Sally Beauty Holdings Inc / Macy's Inc / Ulta Beauty Inc / Visa Inc / Merck & Co Inc / Calix Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Vera Bradley Inc / Zoetis Inc / Bath & Body Works Inc / NeoPhotonics Corp / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Applied Optoelectronics Inc / Compagnie Financiere Richemont SA / BioLife Solutions Inc / Arista Networks Inc / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Medtronic PLC / Invitae Corp / Natera Inc / PayPal Holdings Inc / Planet Fitness Inc / Block Inc / elf Beauty Inc / RH / Qiagen NV / Canada Goose Holdings Inc / Amyris Inc / Tapestry Inc / Lithium Americas Corp / Quanterix Corp / Ribbon Communications Inc / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Farfetch Ltd / Guardant Health Inc / Livent Corp / Twist Bioscience Corp / Capri Holdings Ltd / Avantor Inc / Revolve Group Inc / Personalis Inc / Grocery Outlet Holding Corp / Adaptive Biotechnologies Corp / RealReal Inc / DermTech Inc / 10X Genomics Inc / Exagen Inc / Virgin Galactic Holdings Inc / Carrier Global Corp / Burning Rock Biotech Ltd / Match Group Inc / Berkeley Lights Inc / Beam Global / Nuvei Corp / Mp Materials Corp / Quantumscape Corp / Seer Inc / 908 Devices Inc. / Romeo Power Inc / Poshmark Inc / MYT Netherlands Parent BV / Bumble Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 538</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">CSL=US / INTU=US / AAPL=US / IBM=US / CSCO=US / BMY=US / DIS=US / INTC=US / ADI=US / AMD=US / MSFT=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / TXN=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / MPWR=US / CHTR=US / NICE=US / VZ=US / SMTC=US / CCI=US / UPS=US / EXPE=US / CMCSA=US / W=US / DISH=US / NUAN=US / APPS=US / HRB=US / CTL=US / CRUS=US / CME=US / EGAN=US / EGHT=US / EQIX=US / FIVE=US / QUIK=US / SBAC=US / TRIP=US / VG=US / RDWR=US / SNOW=US / NET=US / CRNT=US / RHHBY=US / BKNG=US / FB=US / MTCH=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / BIIB=US / RNG=US / FTCH=US / CEVA=US / GOOG=US / DLR=US / VIAC=US / DISCA=US / CCOI=US / TRIT=US / LLNW=US / PRPL=US / LUMN=US / ULTA=US / SPRO=US / CDXC=US / 005930-KR=US / TCEHY=US / MXL=US / TSLA=US / NXPI=US / YY=US / PRTA=US / TMUS=US / GTT=US / AVYA=US / TME=US / GOOGL=US / FIVN=US / ALDX=US / LOVE=US / ETSY=US / DZSI=US / TEUM=US / CVNA=US / ATUS=US / FIXX=US / HUYA=US / GRWG=US / REZI=US / PDSB=US / ZM=US / FSLY=US / BCYC=US / CMBM=US / DKNG=US / YALA=US / RXT=US / ABNB=US / ONDS=US / CHPT=US</td><td class="leftalignment">Carlisle Companies Inc / Intuit Inc / Apple Inc / International Business Machines Corp / Cisco Systems Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Texas Instruments Inc / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Monolithic Power Systems Inc / Charter Communications Inc / Nice Ltd / Verizon Communications Inc / Semtech Corp / Crown Castle International Corp / United Parcel Service Inc / Expedia Group Inc / Comcast Corp / Wayfair Inc / DISH Network Corp / Nuance Communications Inc / Digital Turbine Inc / H & R Block Inc / Lumen Technologies Inc / Cirrus Logic Inc / CME Group Inc / eGain Corp / 8x8 Inc / Equinix Inc / Five Below Inc / QuickLogic Corp / SBA Communications Corp / Tripadvisor Inc / Vonage Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Roche Holding AG / Booking Holdings Inc / Meta Platforms Inc / Match Group Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / Biogen Inc / RingCentral Inc / Farfetch Ltd / CEVA Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Discovery Inc / Cogent Communications Holdings Inc / Triterras Inc / Limelight Networks Inc / Purple Innovation Inc / Lumen Technologies Inc / Ulta Beauty Inc / Spero Therapeutics Inc / Chromadex Corp / Farfetch Ltd / Tencent Holdings Ltd / Maxlinear Inc / Tesla Inc / NXP Semiconductors NV / JOYY Inc / Prothena Corporation PLC / T-Mobile US Inc / GTT Communications Inc / Avaya Holdings Corp / Tencent Music Entertainment Group / Alphabet Inc / Five9 Inc / Aldeyra Therapeutics Inc / Lovesac Co / ETSY Inc / DZS Inc / Pareteum Corp / Carvana Co / Altice USA Inc / Homology Medicines Inc / HUYA Inc / GrowGeneration Corp / Resideo Technologies Inc / PDS Biotechnology Corp / Zoom Video Communications Inc / Fastly Inc / Bicycle Therapeutics PLC / Cambium Networks Corp / DraftKings Inc / Yalla Group Ltd / Rackspace Technology Inc / Airbnb Inc / Ondas Holdings Inc / ChargePoint Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Guernsey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Household Products / Leisure & Entertainment / Machinery / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 2021 Catalysts - How We Are Thinking About Key Updates From Here</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: FDA Advisory committee to review accelerated approvals in cancer</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N / MRK.N / AZN.L / ROG.S / FGEN.PS</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / AstraZeneca PLC / Roche Holding AG / First Gen Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Philippines / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">AD/PD Presentations Reflect Leading Platform</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PRTA=US / BMY=US / RHHBY=US / BIIB=US</td><td class="leftalignment">Prothena Corporation PLC / Bristol-Myers Squibb Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Paragon Intel</td><td class="leftalignment">CEO Jackie Fouse Amongst Top Alpha Generators on MT</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">US1101221406 / AGIO.OQ / BG.N / ALC.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Agios Pharmaceuticals Inc / Bunge Ltd / Alcon AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United States</td><td class="leftalignment">Agriculture / Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / CAPITALIZATION / MISCELLANEOUS / INDEX</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paragon Intel</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ReCode Therapeutics, Inc.: Our Q&A With Management</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Synthetic Lethality Primer - A Prelude to Innovative IDEAYAs in DNA Damage Repare and Next-Generation Targeted Oncology</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2576941 / 2369174 / 2457864 / 2471950 / 2730190 / 5531000 / 7103065 / 2982924 / BCBVTX1 / BBFL7S1 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BYWVTY5 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BF3NP05 / BMDJ397</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / MorphoSys AG / Novartis AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / CytomX Therapeutics Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Mali / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA - Promising & Underappreciated Synthetic Lethality Platform; Initiating Coverage with a BUY Rating and $32 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">BK0VHF6 / 0989529 / 0925288 / 2126335 / 2684703 / 7103065 / BCBVTX1 / BBPK0J0</td><td class="leftalignment">IDEAYA Biosciences Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">4503.T / 4502.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / 4151.T / SGEN.OQ / 4568.T / 4578.T</td><td class="leftalignment">Astellas Pharma Inc / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Seagen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">34</td><td class="leftalignment">4503.T / 4502.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / 4516.T / 4506.T / 4151.T / SGEN.OQ / 4568.T / 4578.T</td><td class="leftalignment">Astellas Pharma Inc / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Seagen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended March 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Mar. 09, 2021 / 3:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Progress on Oral Antivirals as Domestic Improvements Continue and Declines in Global New Cases Plateau</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0028241000 / US0231351067 / US0311621009 / US0463531089 / US1101221083 / US2358511028 / US3377381088 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US87612E1064 / US9021041085 / US91307C1027 / US9311421039 / US37940X1028 / US0042251084 / US0491642056 / US31620M1062 / US57636Q1040 / US92826C8394 / US00922R1059 / US58933Y1055 / US69404D1081 / US30303M1027 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US90184L1026 / US0396971071 / US78667J1088 / IE00BTN1Y115 / US81750R1023 / US6323071042 / US70450Y1038 / US8522341036 / US87164F1057 / US03236M2008 / US8760301072 / US05351X1019 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / US68373M1071 / US90184D1000 / US1255231003 / US62921N1054 / US05352A1007 / US92537N1081 / US68902V1070 / US07373B1098 / US56854Q2003 / CA67079A1021 / US74767V1098 / US21077C1071 / US7761531083 / US73739W1045 / US15961R1059</td><td class="leftalignment">Abbott Laboratories / Amazon.com Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Danaher Corp / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / II-VI Inc / United Therapeutics Corp / Walmart Inc / Global Payments Inc / ACADIA Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / Fidelity National Information Services Inc / Mastercard Inc / Visa Inc / Air Transport Services Group Inc / Merck & Co Inc / Pacific Biosciences of California Inc / Meta Platforms Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Twitter Inc / Ardelyx Inc / SAGE Therapeutics Inc / Medtronic PLC / Seres Therapeutics Inc / Natera Inc / PayPal Holdings Inc / Block Inc / Syndax Pharmaceuticals Inc / Amyris Inc / Tapestry Inc / Avaya Holdings Corp / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Opera Ltd / Twist Bioscience Corp / Cigna Corp / NGM Biopharmaceuticals Inc / Avantor Inc / Vertiv Holdings Co / Otis Worldwide Corp / Beam Global / Marinus Pharmaceuticals Inc / Nuvei Corp / Quantumscape Corp / ContextLogic Inc / Romeo Power Inc / Poshmark Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2050832 / 2026242 / 2270726 / 2328915 / 2100920 / 2369174 / 2689560 / 2672689 / 2684703 / 2048804 / 2402121 / 2980906 / 7103065 / B1F76F9 / B121557 / 2769796 / B2R3PV1 / BCZS820 / BFZNYB7 / BDHF4K6 / BMQ5T49 / BWFKZT2 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BDRW1L7 / BZ4CHH2 / BNG3RZ7 / BMC8SQ7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Pinnacle West Capital Corp / Nuance Communications Inc / Foot Locker Inc / Novartis AG / Western Union Co / Mastercard Inc / Fidelity National Information Services Inc / American Water Works Company Inc / Fate Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Zentalis Pharmaceuticals Inc / Cellectis SA / Evergy Inc / Spire Inc / Vistra Corp / AnaptysBio Inc / Soleno Therapeutics Inc / Leslie's Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Bloomsbury Publishing (Add from Hold) - Unmerited share price fall prompts upgrade to Add</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Malcolm Morgan / Ms. Jessica Pok</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Topical Panel Wrap-Up</td><td class="leftalignment">English</td><td class="rightalignment">217</td><td class="leftalignment">US0028241000 / US0311621009 / US0463531089 / US1101221083 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US91307C1027 / US58933Y1055 / US69404D1081 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US78667J1088 / IE00BTN1Y115 / US03236M2008 / VGG312491084 / US90184D1000</td><td class="leftalignment">Abbott Laboratories / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Merck & Co Inc / Pacific Biosciences of California Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / SAGE Therapeutics Inc / Medtronic PLC / Amyris Inc / Establishment Labs Holdings Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Health Care Team / Cowen Washington Research</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Bloomsbury Publishing PLC Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Apparel & Textiles / Appliances / Automotive / Broadcasting & Cable / Building & Building Materials / Consumer / Electronics / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Photography / Publishing / Retailing / Services / Tire & Rubber / Internet / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 08 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0079731008 / US00846U1016 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US1925761066 / US22284P1057 / US2358511028 / US3021301094 / US37733W1053 / US4364401012 / US4433201062 / US4456581077 / US4523271090 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US62855J1043 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US68389X1054 / US7140461093 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US8835561023 / US9029251066 / US9078181081 / US91347P1057 / US9418481035 / US9507551086 / CA1363751027 / US30063P1057 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US1167941087 / US3463751087 / US2533931026 / US90385V1070 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US1920051067 / US9100471096 / US69404D1081 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US09609G1004 / US63009R1095 / US8485771021 / US21240E1055 / US02376R1023 / US09062W2044 / US03937C1053 / CA0089118776 / US46185L1035 / US6323071042 / KYG4740B1059 / CA87241L1094 / NL0012169213 / US23753F1075 / US80689H1023 / US6904691010 / US03236M2008 / US4990491049 / US74766Q1013 / US2575541055 / US5904791358 / US28414H1032 / US40131M1099 / US90184D1000 / US05352A1007 / US71535D1063 / US00650F1093 / US24984K1051 / US88025U1097 / US30068X1037 / US75513E1010 / US12233L1070 / US7602731025 / GB00BMVP7Y09 / US57667L1070 / US0843101017 / US86646P1030 / US6873051022 / US81578P1066 / US65443P1021 / US03783T1034 / US12047B1052 / US67080N1019</td><td class="leftalignment">Advanced Energy Industries Inc / Agilent Technologies Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cohu Inc / Covenant Logistics Group Inc / Danaher Corp / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hologic Inc / Hub Group Inc / J B Hunt Transport Services Inc / Illumina Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Myriad Genetics Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Oracle Corp / PerkinElmer Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Thermo Fisher Scientific Inc / USA Truck Inc / Union Pacific Corp / Universal Display Corp / Waters Corp / Werner Enterprises Inc / Canadian National Railway Co / Exact Sciences Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Bruker Corp / FormFactor Inc / DICK'S Sporting Goods Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / bluebird bio Inc / NanoString Technologies Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / BioLife Solutions Inc / ArcBest Corp / Air Canada / Invitae Corp / Natera Inc / Ichor Holdings Ltd / TFI International Inc / Qiagen NV / Daseke Inc / Schneider National Inc / Ovid Therapeutics Inc / Amyris Inc / Knight-Swift Transportation Holdings Inc / Quanterix Corp / Domo Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Personalis Inc / Adaptive Biotechnologies Corp / DermTech Inc / 10X Genomics Inc / Exagen Inc / Raytheon Technologies Corp / Burning Rock Biotech Ltd / Repare Therapeutics Inc / Royalty Pharma PLC / Match Group Inc / Berkeley Lights Inc / Sumo Logic Inc / Orphazyme A/S / Seer Inc / 908 Devices Inc. / AppHarvest Inc / Bumble Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics: Top Questions for Management Teams</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">4502.T / BMY.N / CI.N / CVS.N / GE.N / JPM.N / MCK.N / MRK.N / PFE.N / TMO.N / WMT.N / DGX.N / AZN.L / ROG.S / DHR.N / UNH.N / LH.N / MMM.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / AMZN.OQ / ALGN.OQ / STMN.S / PETS.OQ / ICLR.OQ / QGEN.N / BAYGN.DE / ZTS.N / PAHC.OQ / LNTH.OQ / ANTM.N / WBA.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / General Electric Co / JPMorgan Chase & Co / Mckesson Corp / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Walmart Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / 3M Co / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Amazon.com Inc / Align Technology Inc / Straumann Holding AG / Petmed Express Inc / ICON PLC / Qiagen NV / Bayer AG / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (8 Mar-): NHI drug price revisions mixed; removes risk factor</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4151.T / 4552.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / OVID.OQ</td><td class="leftalignment">Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Ovid Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（3月8日～）: 薬価改定率公表で明暗、イベント一巡で刺抜きも</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4151.T / 4552.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 26, 2021: Focus on Novo GLP-1s</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Big Cap Pharma Highlights From Cowen's 41st Annual Health Care Conference</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Emerging Markets Q4 update – China roars back, but EM growth still lags other geographies</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">00287Y109 / 0989529 / 5671735 / 0925288 / 7103065 / 7110388 / 717081103 / 110122108 / 532457108 / 58933Y105</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Most Key Metrics Continue To Move Favorably - Week 49</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JKHY=US / NKE=US / LLY=US / ABT=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Abbott Laboratories / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 537</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">EVAX=US / SNSE=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INSP=US / CMS=US / DGX=US / CRIS=US / AZN=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / BCRX=US / BMRN=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / GRTS=US / GEN=US / ICPT=US / PHG=US / LH=US / NBIX=US / PHAR=US / HOOK=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CMPI=US / SLF=US / ONCR=US / BIIB=US / MRNA=US / ACAD=US / GOOG=US / INO=US / LHCG=US / SNSS=US / AGRX=US / CHNG=US / TPTX=US / ORTX=US / EHC=US / CLDX=US / CVAC=US / ADUS=US / ACHC=US / SRPT=US / PRTA=US / MRTX=US / GNCA=US / CTRE=US / EKTAY=US / CLRB=US / WBA=US / NVTA=US / EVH=US / MCRB=US / CFMS=US / LIVN=US / CERC=US / IONS=US / SSKN=US / VRAY=US / SYRS=US / MDGL=US / FLGT=US / IRTC=US / AVDL=US / SLNO=US / VREX=US / ATNX=US / NCNA=US / RCKT=US / FIXX=US / ARVN=US / MRKR=US / XFOR=US / TMDX=US / BCYC=US / NEXI=US / KRTX=US / DMTK=US / BNTX=US / RCEL=US / PNTG=US / NNOX=US / TSHA=US / VIRX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Sensei Biotherapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Curis Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Gritstone bio Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / HOOKIPA Pharma Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Checkmate Pharmaceuticals Inc / Sun Life Financial Inc / Oncorus Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Viracta Therapeutics Inc / Agile Therapeutics Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Encompass Health Corp / Celldex Therapeutics Inc / CureVac NV / Addus Homecare Corp / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Genocea Biosciences Inc / CareTrust REIT Inc / Elekta AB (publ) / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Seres Therapeutics Inc / Conformis Inc / LivaNova PLC / Avalo Therapeutics Inc / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / ViewRay Inc / Syros Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Avadel Pharmaceuticals PLC / Soleno Therapeutics Inc / Varex Imaging Corp / Athenex Inc / NuCana PLC / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Arvinas Inc / Marker Therapeutics Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Bicycle Therapeutics PLC / Neximmune Inc / Karuna Therapeutics Inc / DermTech Inc / BioNTech SE / AVITA Medical Inc / Pennant Group Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Viracta Therapeutics Inc / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / A=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Northland Securities</td><td class="leftalignment">April 8 Investor Day; RP-6306 Entering Phase 1 in 2Q</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">RPTX=US / BMY=US / AZN=US / BAY=US / IDYA=US</td><td class="leftalignment">Repare Therapeutics Inc / Bristol-Myers Squibb Co / AstraZeneca PLC / Bayer AG / IDEAYA Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Timothy Chiang</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">China-sourced PD1s coming to a market near you!</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 4 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US02553E1064 / US1101221083 / US1156372096 / US45337C1027 / US4698141078 / US4781601046 / US87612E1064 / US1314761032 / US5380341090 / US1940141062 / US58933Y1055 / US4464131063 / US95058W1009 / US00287Y1091 / US98978V1035 / US8486371045 / KYG8807B1068 / US98936J1016 / US23283X2062 / US09627Y1091 / US30050B1017 / US9741551033 / US20717E1010 / US72703H1014 / US50127T1097 / US87164F1057 / US6301041074 / US90138F1021 / US7493971052 / US76674Q1076 / US55910K1088 / US2575541055 / US28414H1032 / US89377M1099 / CA16106R1091 / US39874R1014 / US09203E1055 / US76155X1000 / US8334451098</td><td class="leftalignment">American Eagle Outfitters Inc / Bristol-Myers Squibb Co / Brown-Forman Corp / Incyte Corp / Jacobs Engineering Group Inc / Johnson & Johnson / Target Corp / Calumet Specialty Products Partners LP / Live Nation Entertainment Inc / Colfax Corp / Merck & Co Inc / Huntington Ingalls Industries Inc / Wendys Co / Abbvie Inc / Zoetis Inc / Splunk Inc / Theravance Biopharma Inc / Zendesk Inc / Cytosorbents Corp / Blueprint Medicines Corp / Evolent Health Inc / Wingstop Inc / Conformis Inc / Planet Fitness Inc / Kura Oncology Inc / Syndax Pharmaceuticals Inc / NantHealth Inc / Twilio Inc / R1 RCM Inc / Rimini Street Inc / Magenta Therapeutics Inc / Domo Inc / Elanco Animal Health Inc / Transmedics Group Inc / Charlotte's Web Holdings Inc / Grocery Outlet Holding Corp / Black Diamond Therapeutics Inc / Revolution Medicines Inc / Snowflake Inc.</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Big Cap Pharma Highlights - Day 3</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US1101221083 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Africa / Europe / Middle East</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Mar. 03, 2021 / 10:20AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended January 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb strengthens 4.8% in past year; Institutional Ownership down 2%</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Paragon Intel</td><td class="leftalignment">Pharmaceuticals: Where does your CEO's MT Score rank?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / CTLT.N / JNJ.N / LLY.N / NKTR.OQ / JAZZ.OQ / HZNP.OQ / ZTS.N / PRGO.N / ELAN.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Catalent Inc / Johnson & Johnson / Eli Lilly and Co / Nektar Therapeutics / Jazz Pharmaceuticals PLC / Horizon Therapeutics PLC / Zoetis Inc / Perrigo Company PLC / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / CAPITALIZATION / MISCELLANEOUS / INDEX</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paragon Intel</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Bristol-Myers Squibb - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third Vaccine EUA Should Expand Access, New Variant Boosters Developed, Domestic and Global Improvements Slowing</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Mar. 02, 2021 / 8:20AM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">EVAX=US / SRCL=US / AAPL=US / MRK=US / BSX=US / PFE=US / AMGN=US / BMY=US / AMD=US / TSM=US / AZN=US / GSK=US / ETN=US / ANGN=US / ACI=US / AZO=US / BCRX=US / KMX=US / GRTS=US / ICPT=US / PHG=US / ORLY=US / PHAR=US / WSC=US / RHHBY=US / BIIB=US / MRNA=US / INO=US / AGRX=US / TPTX=US / PRPL=US / CVAC=US / AMRC=US / 2454-TW=US / PRTA=US / GNCA=US / IONS=US / MDGL=US / IRTC=US / UAA=US / AVDL=US / CVNA=US / CSPR=US / ATNX=US / ZM=US / TMDX=US / BNTX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Stericycle Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Advanced Micro Devices Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / GlaxoSmithKline PLC / Eaton Corporation PLC / Angion Biomedica Corp / Albertsons Companies Inc / Autozone Inc / BioCryst Pharmaceuticals Inc / Carmax Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / O'Reilly Automotive Inc / Pharming Group NV / Willscot Mobile Mini Holdings Corp / Roche Holding AG / Biogen Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Agile Therapeutics Inc / Turning Point Therapeutics Inc / Purple Innovation Inc / CureVac NV / Ameresco Inc / MediaTek Inc / Prothena Corporation PLC / Genocea Biosciences Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / Under Armour Inc / Avadel Pharmaceuticals PLC / Carvana Co / Casper Sleep Inc / Athenex Inc / Zoom Video Communications Inc / Transmedics Group Inc / BioNTech SE / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / Ireland / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Pharmaceuticals / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2026242 / 2065159 / 2544960 / 2229126 / 2270726 / 2382892 / 2657802 / 2684703 / 2707677 / 2862532 / 2799351 / 7103065 / B121557 / 2212922 / B1Y9TB3 / B19FQ48 / 2857817 / B2R3PV1 / 2390817 / 2949758 / B3SWPT2 / B7TL820 / B4MG4Z6 / B7VD3F2 / B8L2798 / BJ0KXV4 / BDZCRX3 / B8DPDT7 / BTN1Y11 / BVVN4Q8 / BYW36M8 / BD9GVY0 / BJFSR88 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJVR9Y9 / BJXBP30 / BHZSB82 / BKC9SX3 / BD6JX35 / BDVLM39 / BDZ30Q0 / BZ0P3Z5 / BYNPPC6 / BP84RX0 / BMDJ397</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / Autodesk Inc / Beasley Broadcast Group Inc / Columbia Sportswear Co / Walt Disney Co / Audacy Inc / OGE Energy Corp / Pfizer Inc / Public Service Enterprise Group Inc / E W Scripps Co / Sinclair Broadcast Group Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Danone SA / Amicus Therapeutics Inc / Netflix Inc / American Water Works Company Inc / Gray Television Inc / Nexstar Media Group Inc / Ameresco Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Hemisphere Media Group Inc / ONE Gas Inc / RingCentral Inc / Sarepta Therapeutics Inc / Medtronic PLC / Eversource Energy / PayPal Holdings Inc / Zai Lab Ltd / Uniqure NV / Evergy Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / iHeartMedia Inc / Turning Point Therapeutics Inc / Covetrus Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / argenx SE / Arvinas Inc / Tegna Inc / DENTSPLY SIRONA Inc / Townsquare Media Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT (BUY) - Lightning Strikes Twice with Immune-Stimulating ADCs; Initiating with a BUY and $42 PT</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BMDJ397 / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2457864 / 2684703 / 7103065 / 2982924 / BFDV8K0 / BMQ5T49 / BKVDFF7 / BYQHPK7 / BL71K91 / BN2R582 / BG0Q4Y1 / BF3NP05</td><td class="leftalignment">Bolt Biotherapeutics Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / ImmunoGen Inc / Pfizer Inc / Novartis AG / Spectrum Pharmaceuticals Inc / MacroGenics Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Zymeworks Inc / Revolution Medicines Inc / Relay Therapeutics Inc / Exicure Inc / Mersana Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Looking Ahead to AD/PD-Epitope Matters</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PRTA=US / BMY=US / RHHBY=US / BIIB=US</td><td class="leftalignment">Prothena Corporation PLC / Bristol-Myers Squibb Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2H20 Recap - Clarity on Zejula NRDL Pricing; Multiple 2021 Catalysts Ahead</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ZLAB=US / BMY=US / A=US / INCY=US / GSK=GB / GSK=US / PRTK=US / REGN=US / TPTX=US / MGNX=US / DCPH=US</td><td class="leftalignment">Zai Lab Ltd / Bristol-Myers Squibb Co / Agilent Technologies Inc / Incyte Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Paratek Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Turning Point Therapeutics Inc / MacroGenics Inc / Deciphera Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jonathan W. Chang, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DE0006231004 / US0116591092 / US0463531089 / US09058V1035 / US1101221083 / US2254471012 / US30231G1022 / US37733W1053 / US4781601046 / US5324571083 / US5370081045 / US66987V1098 / US6701002056 / US6821891057 / US7170811035 / US7392761034 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US9021041085 / US9311421039 / US1667641005 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US13100M5094 / NL0009538784 / US9100471096 / US00164V1035 / US00287Y1091 / US55405Y1001 / US8485771021 / US21240E1055 / US8086251076 / US02376R1023 / US70432V1026 / US69888T2078 / US0465131078 / CA0089118776 / US74736K1016 / US00653A1079 / US05464T1043 / US00773U1088 / SE0009414576 / US5904791358 / US0197701065 / US0144421072 / US09203E1055 / US26142R1041 / CH0499880968 / US30233G2093</td><td class="leftalignment">Infineon Technologies AG / Alaska Air Group Inc / AstraZeneca PLC / BioCryst Pharmaceuticals Inc / Bristol-Myers Squibb Co / Wolfspeed Inc / Exxon Mobil Corp / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Littelfuse Inc / Novartis AG / Novo Nordisk A/S / ON Semiconductor Corp / Pfizer Inc / Power Integrations Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / II-VI Inc / Walmart Inc / Chevron Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Calix Inc / NXP Semiconductors NV / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / MACOM Technology Solutions Holdings Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Science Applications International Corp / American Airlines Group Inc / Paycom Software Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Qorvo Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Oncopeptides AB / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / EyePoint Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (from 1 Mar): Investors still on sidelines, but reassurance from stocks on lower multiples</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4552.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / ROG.S / 4151.T / 4553.T / 4540.T / 6869.T / 4541.T / NVAX.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（3月1日～）: 様子見気分が続くが低バリューション株に安心感ある</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4552.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / ROG.S / 4151.T / 4553.T / 4540.T / 6869.T / 4541.T / NVAX.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">02/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Up YoY for Most Companies- Week 48</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CSGP=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / CoStar Group Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 536</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ICAD=US / LHCG=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / INCY=US / INSP=US / CMS=US / DGX=US / NVS=US / BWAY=US / SNN=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ARNA=US / ATRC=US / BDX=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / LH=US / NBIX=US / PHAR=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / SAGE=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / MD=US / NKTR=US / SLF=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / GOOG=US / DXCM=US / SNSS=US / CHNG=US / PODD=US / EHC=US / TNDM=US / ADUS=US / BLRX=US / ACHC=US / ALSN=US / ABBV=US / AGIO=US / FATE=US / AERI=US / MDWD=US / CTRE=US / AUPH=US / OTIC=US / EKTAY=US / VBLT=US / VCEL=US / NVRO=US / WBA=US / EVH=US / GKOS=US / TDOC=US / NVCR=US / VYGR=US / IONS=US / EDIT=US / NTLA=US / SRTS=US / TCMD=US / IRTC=US / IOVA=US / KALA=US / ATNX=US / RCKT=US / ALLO=US / TMDX=US / PSNL=US / KRTX=US / PNTG=US / ARQT=US / FBRX=US / FMTX=US / CZMWY=US / BIOVF=US / VPAHF=US</td><td class="leftalignment">ICAD Inc / LHC Group Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / Brainsway Ltd / Smith & Nephew PLC / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / SAGE Therapeutics Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Alphabet Inc / Dexcom Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Insulet Corp / Encompass Health Corp / Tandem Diabetes Care Inc / Addus Homecare Corp / BioLine RX Ltd / Acadia Healthcare Company Inc / Allison Transmission Holdings Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Elekta AB (publ) / Vascular Biogenics Ltd / Vericel Corp / Nevro Corp / Walgreens Boots Alliance Inc / Evolent Health Inc / Glaukos Corp / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Personalis Inc / Karuna Therapeutics Inc / Pennant Group Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Forma Therapeutics Holdings Inc / Carl Zeiss Meditec AG / Swedish Orphan Biovitrum AB (publ) / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / New Zealand / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Reports 4Q20, Raising PT to $140</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Celgene Acquisition Boosts N-T Outlook; L-T Visibility Limited</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharmaceutical Industry Pulse</td><td class="leftalignment">English</td><td class="rightalignment">1138</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">2126335 / 2536763 / 2050832 / 2026242 / 2942605 / 2544960 / 2280220 / 2270726 / 2829515 / 2382892 / 2317087 / 2670519 / 2100920 / 2369174 / 2459202 / 2459020 / 2689560 / 2048804 / 2440637 / 2573083 / 2862532 / 2799351 / 2989301 / B121557 / 2713317 / 2857817 / B2R3PV1 / 2598246 / 2390817 / 2949758 / BCZS820 / B8L2798 / BFH3N85 / BFZCHN7 / B95WG16 / BQPVQZ6 / BYVY8G0 / BS7K7C9 / BP4GNK9 / BXDZ9Z0 / BF5L3T2 / BYNZGK1 / BJXBP41 / BD8DJ71 / BJ1FD74 / BKDS4H5 / BL2HYY7 / BNFWR44 / BJ5FZ74 / BFMXGR0 / BZ8VJQ8 / BFXC911 / BZ05388 / BJVR9Y9 / BYQHPK7 / BF3W461 / BYWVTY5 / BYQRFY1 / BZ0P3Z5 / BYQBFS7 / BKWD3M9 / BD8Q1B8 / BFFVVC1 / BP84RX0</td><td class="leftalignment">Bristol-Myers Squibb Co / Lowe's Companies Inc / Ameren Corp / American Electric Power Company Inc / Avista Corp / Beasley Broadcast Group Inc / DTE Energy Co / Walt Disney Co / Edison International / Audacy Inc / Entergy Corp / Exelon Corp / FirstEnergy Corp / Gilead Sciences Inc / IDEXX Laboratories Inc / Intuit Inc / PG&E Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sangamo Therapeutics Inc / E W Scripps Co / Sinclair Broadcast Group Inc / TJX Companies Inc / Mastercard Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / American Water Works Company Inc / Neogenomics Inc / Gray Television Inc / Nexstar Media Group Inc / Fate Therapeutics Inc / Hemisphere Media Group Inc / Veeva Systems Inc / Wix.Com Ltd / Zoetis Inc / Horizon Therapeutics PLC / Alphabet Inc / Nevro Corp / SAGE Therapeutics Inc / Shopify Inc / Elanco Animal Health Inc / Block Inc / Alcon AG / Snap Inc / Revolve Group Inc / Bill.com Holdings Inc / Casper Sleep Inc / Worldline SA / Adaptive Biotechnologies Corp / Evergy Inc / Vistra Corp / Guardant Health Inc / Global Blood Therapeutics Inc / iHeartMedia Inc / Zymeworks Inc / Tandem Diabetes Care Inc / CytomX Therapeutics Inc / Teladoc Health Inc / Tegna Inc / Tabula Rasa HealthCare Inc / Progyny Inc / Tivity Health Inc / Bausch Health Companies Inc / Townsquare Media Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Super-Cyclicals Revisited</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A.N / AEE.N / AES.N / BAX.N / BG.N / BMY.N / BSX.N / CCI.N / CI.N / CL.N / EL.N / FLT.N / KMB.N / KO.N / LLY.N / LSI.N / MDT.N / PM.N / PNW.N / PPCJ.J / SO.N / TAP.N / TMO.N / WMT.N / DRE.N / EQR.N / FLO.N / PG.N / WY.N / DELL.N / CPB.N / W.N / ETR.N / ADML.L / DHR.N / DIS.N / UNH.N / TFX.N / D.N / OGE.N / IPG.N / CLX.N / CAG.N / VNO.N / GLW.N / LH.N / KR.N / GIS.N / XRX.N / NI.N / PCG.N / AMT.N / RMD.N / TDS.N / DTEGN.F / MTD.N / IT.N / PKI.N / WST.N / COO.N / STZ.N / APH.N / NNN.N / PSA.N / ARW.N / EW.N / CPT.N / BXP.N / ACN.N / ARE.N / CHD.N / NUS.N / TWTR.N / ESS.N / HAE.N / FRT.N / UGI.N / OFC.N / CUZ.N / HRL.N / BDN.N / SAM.N / ABC.N / JNPR.N / IRM.N / CNP.N / INTC.OQ / CTSH.OQ / ABMD.OQ / AMGN.OQ / AMAT.OQ / ADSK.OQ / CERN.OQ / CHE.N / CRUS.OQ / FISV.OQ / JKHY.OQ / LRCX.OQ / ATVI.OQ / PAYX.OQ / TEAM.OQ / REGN.OQ / SJM.N / TECH.OQ / TYL.N / QDEL.OQ / SNPS.OQ / ICUI.OQ / IDXX.OQ / QCOM.OQ / INTU.OQ / LFUS.OQ / COST.OQ / XRAY.OQ / NKTR.OQ / DISH.OQ / NTAP.OQ / AMED.OQ / PCTY.OQ / ANSS.OQ / LAMR.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / LITE.OQ / TTWO.OQ / VRSN.OQ / MANH.OQ / ZBRA.OQ / NVDA.OQ / MKSI.OQ / UTHR.OQ / SBAC.OQ / BMRN.OQ / HAIN.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / NXST.OQ / ACAD.OQ / MPWR.OQ / ELS.N / HLF.N / OLED.OQ / SRC.N / CDNS.OQ / LYV.N / FIS.N / ADP.PA / MA.N / WU.N / DEI.N / FSLR.OQ / IPGP.OQ / QGEN.N / PODD.OQ / VMW.N / TDC.N / SATS.OQ / NWSA.OQ / CACI.N / FICO.N / FTNT.OQ / HPP.N / BAH.N / ADSGN.F / HHC.N / MSI.N / HZNP.OQ / ACHC.OQ / ENPH.OQ / EPAM.N / GWRE.N / ADI.OQ / SRPT.OQ / GMED.N / HTA.N / ABBV.N / PRGO.N / WEX.N / CDW.OQ / FOXA.O / SFM.OQ / REXR.N / LDOS.N / PINC.OQ / AGIO.OQ / RNG.N / GLPI.OQ / BRX.N / PTC.OQ / FIVN.OQ / GLOB.N / CTLT.N / CDK.OQ / KEYS.N / PGRE.N / OUT.N / STOR.N / ANTM.N / NEWR.N / QRVO.OQ / SEDG.OQ / ON.OQ / ETSY.OQ / LBRDK.OQ / TDOC.N / CABO.N / ZBH.N / KHC.OQ / GBT.OQ / PEN.N / NVCR.OQ / PSTG.N / SQ.N / IONS.OQ / RETA.OQ / EVBG.OQ / TTD.OQ / LW.N / PK.N / FWONA.OQ / ROKU.OQ / EHC.N / XEL.OQ / SYNH.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / CBRE.N / CDAY.N / AVT.OQ / EVRG.N / ELAN.N / TER.OQ / LNT.OQ / EXC.OQ / MSGS.N / AEP.OQ / 120175706</td><td class="leftalignment">Agilent Technologies Inc / Ameren Corp / AES Corp / Baxter International Inc / Bunge Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Estee Lauder Companies Inc / Fleetcor Technologies Inc / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Life Storage Inc / Medtronic PLC / Philip Morris International Inc / Pinnacle West Capital Corp / PPC Ltd / Southern Co / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Walmart Inc / Duke Realty Corp / Equity Residential / Flowers Foods Inc / Procter & Gamble Co / Weyerhaeuser Co / Dell Technologies Inc / Campbell Soup Co / Wayfair Inc / Entergy Corp / Admiral Group PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Dominion Energy Inc / OGE Energy Corp / Interpublic Group of Companies Inc / Clorox Co / Conagra Brands Inc / Vornado Realty Trust / Corning Inc / Laboratory Corporation of America Holdings / Kroger Co / General Mills Inc / Xerox Holdings Corp / NiSource Inc / PG&E Corp / American Tower Corp / Resmed Inc / Telephone and Data Systems Inc / Deutsche Telekom AG / Mettler-Toledo International Inc / Gartner Inc / PerkinElmer Inc / West Pharmaceutical Services Inc / Cooper Companies Inc / Constellation Brands Inc / Amphenol Corp / National Retail Properties Inc / Public Storage / Arrow Electronics Inc / Edwards Lifesciences Corp / Camden Property Trust / Boston Properties Inc / Accenture PLC / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / NU Skin Enterprises Inc / Twitter Inc / Essex Property Trust Inc / Haemonetics Corp / Federal Realty Investment Trust / UGI Corp / Corporate Office Properties Trust / Cousins Properties Inc / Hormel Foods Corp / Brandywine Realty Trust / Boston Beer Company Inc / Amerisourcebergen Corp / Juniper Networks Inc / Iron Mountain Inc / CenterPoint Energy Inc / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Amgen Inc / Applied Materials Inc / Autodesk Inc / Cerner Corp / Chemed Corp / Cirrus Logic Inc / Fiserv Inc / Jack Henry & Associates Inc / Lam Research Corp / Activision Blizzard Inc / Paychex Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / J M Smucker Co / Bio-Techne Corp / Tyler Technologies Inc / Quidel Corp / Synopsys Inc / ICU Medical Inc / IDEXX Laboratories Inc / Qualcomm Inc / Intuit Inc / Littelfuse Inc / Costco Wholesale Corp / DENTSPLY SIRONA Inc / Nektar Therapeutics / DISH Network Corp / NetApp Inc / Amedisys Inc / Paylocity Holding Corp / ANSYS Inc / Lamar Advertising Co / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Lumentum Holdings Inc / Take-Two Interactive Software Inc / Verisign Inc / Manhattan Associates Inc / Zebra Technologies Corp / NVIDIA Corp / MKS Instruments Inc / United Therapeutics Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / Hain Celestial Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Nexstar Media Group Inc / ACADIA Pharmaceuticals Inc / Monolithic Power Systems Inc / Equity LifeStyle Properties Inc / Herbalife Nutrition Ltd / Universal Display Corp / Spirit Realty Capital Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Mastercard Inc / Western Union Co / Douglas Emmett Inc / First Solar Inc / IPG Photonics Corp / Qiagen NV / Insulet Corp / VMware Inc / Teradata Corp / EchoStar Corp / News Corp / CACI International Inc / Fair Isaac Corp / Fortinet Inc / Hudson Pacific Properties Inc / Booz Allen Hamilton Holding Corp / Adidas AG / Howard Hughes Corp / Motorola Solutions Inc / Horizon Therapeutics PLC / Acadia Healthcare Company Inc / Enphase Energy Inc / Epam Systems Inc / Guidewire Software Inc / Analog Devices Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Healthcare Trust Of America Inc / Abbvie Inc / Perrigo Company PLC / WEX Inc / CDW Corp / Fox Corp / Sprouts Farmers Market Inc / Rexford Industrial Realty Inc / Leidos Holdings Inc / Premier Inc / Agios Pharmaceuticals Inc / RingCentral Inc / Gaming and Leisure Properties Inc / Brixmor Property Group Inc / PTC Inc / Five9 Inc / Globant SA / Catalent Inc / CDK Global Inc / Keysight Technologies Inc / Paramount Group Inc / OUTFRONT Media Inc / STORE Capital Corp / Anthem Inc / New Relic Inc / Qorvo Inc / Solaredge Technologies Inc / ON Semiconductor Corp / ETSY Inc / Liberty Broadband Corp / Teladoc Health Inc / Cable One Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Pure Storage Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Everbridge Inc / Trade Desk Inc / Lamb Weston Holdings Inc / Park Hotels & Resorts Inc / Liberty Media Corp / Roku Inc / Encompass Health Corp / Xcel Energy Inc / Syneos Health Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / CBRE Group Inc / Ceridian HCM Holding Inc / Avnet Inc / Evergy Inc / Elanco Animal Health Inc / Teradyne Inc / Alliant Energy Corp / Exelon Corp / Madison Square Garden Sports Corp / American Electric Power Company Inc / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Bristol-Myers Squibb Co</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Takeaways from Discussion with Innate Pharma Management at GHC</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IPHA=US / BMY=US</td><td class="leftalignment">Innate Pharma SA / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">February 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Trends Continue to Improve as Vaccine Rollout Progresses and Real-World Data Supports Efficacy, Safety of Vaccines</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2973821 / 2050832 / 2026242 / 2270726 / 2542049 / 2345022 / 2100920 / 2367480 / 2638625 / 2645409 / 2680905 / 2684703 / 2048804 / 2730190 / 7103065 / 2971029 / B125XQ6 / B2R3PV1 / B3D7K31 / B3WNNP3 / B7254K9 / B7VD3F2 / B87ZMX0 / BFLR866 / BVVN4Q8 / BYW36M8 / BYNZGK1 / BJ5FZ74 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BJFSR99 / BKTNTR9 / BMDCDP2 / BMDJ085</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Macy's Inc / FirstEnergy Corp / Genuine Parts Co / National Beverage Corp / NiSource Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / LKQ Corp / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / Green Dot Corp / AxoGen Inc / Duke Energy Corp / Palo Alto Networks Inc / Twitter Inc / Eversource Energy / PayPal Holdings Inc / Block Inc / Adaptive Biotechnologies Corp / Evergy Inc / Fox Corp / Vistra Corp / Revance Therapeutics Inc / ViacomCBS Inc / Bigcommerce Holdings Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3621</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Bristol-Myers Squibb Company (BMY) In Cell Therapy Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb sinks 9.2% from 5 week high</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FR0000121014 / GB0004544929 / GB0002875804 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1912161007 / US1925761066 / US2254471012 / US37733W1053 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US6556641008 / US66987V1098 / US6701002056 / US7134481081 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / US9182041080 / US4771431016 / US4198791018 / US80105N1054 / US02209S1033 / US3463751087 / US90385V1070 / US2538681030 / US19239V3024 / US2090341072 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US03027X1000 / US00287Y1091 / NL0010273215 / US4576693075 / US23283R1005 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / US3623931009 / US14862Q1004 / CA0089118776 / US22822V1017 / US29444U7000 / US36165L1089 / KYG4740B1059 / US78410G1040 / US91325V1089 / US83418M1036 / US87105L1044 / US19626G1085 / US5904791358 / KY30744W1070 / US76156B1070 / US55406W1036 / US82489W1071</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Imperial Brands PLC / British American Tobacco PLC / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / Coca-Cola Co / Cohu Inc / Wolfspeed Inc / GlaxoSmithKline PLC / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PepsiCo Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / VF Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Altria Group Inc / FormFactor Inc / Ultra Clean Holdings Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / American Tower Corp / Abbvie Inc / ASML Holding NV / Insmed Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / GTT Communications Inc / Castlight Health Inc / Air Canada / Crown Castle International Corp / Equinix Inc / GDS Holdings Ltd / Ichor Holdings Ltd / SBA Communications Corp / Uniti Group Inc / Solaris Oilfield Infrastructure Inc / Switch Inc / DigitalBridge Group Inc / Mesa Air Group Inc / Farfetch Ltd / Revolve Group Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 MEDACorp IBD Physician Survey Shows Novel Orals Set to Expand Market</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE=US / BMY=US / GILD=US / ARNA=US / NKTR=US / AMTI=US / ABBV=US / TBPH=US / PTGX=US / GOSS=US</td><td class="leftalignment">Pfizer Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Arena Pharmaceuticals Inc / Nektar Therapeutics / Applied Molecular Transport Inc. / Abbvie Inc / Theravance Biopharma Inc / Protagonist Therapeutics Inc / Gossamer Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joseph P. Schwartz / Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : Immunology Market Update - ABBV Remains Optimally Positioned, JNJ Poised for Upside to Estimate, Watching BMY TYK-2 Data</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ABBV.N / JNJ.N / BMY.N</td><td class="leftalignment">Abbvie Inc / Johnson & Johnson / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 12, 2021: Focus on Jan 2021 Rx volumes for branded and generic drugs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 47</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">UTHR=US / XAIR=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / TEVA=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BWAY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / BLUE=US / CHE=US / CYH=US / EW=US / EXAS=US / EXEL=US / GEN=US / ICPT=US / PHG=US / LH=US / REGN=US / USPH=US / UHS=US / VRTX=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / MASI=US / EHC=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / SRPT=US / AGIO=US / CTRE=US / OTIC=US / VBLT=US / WBA=US / NVTA=US / CLLS=US / VKTX=US / EVH=US / CFMS=US / CERC=US / EDIT=US / MDGL=US / IRTC=US / CRSP=US / VERU=US / MBIO=US / MDNA=US / SESN=US / ARVN=US / FREQ=US / BXRX=US / PNTG=US / TARA=US / AYLA=US / FMTX=US / MNKKQ=US / CHGCY=US</td><td class="leftalignment">United Therapeutics Corp / Beyond Air Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Teva Pharmaceutical Industries Ltd / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Brainsway Ltd / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Masimo Corp / Encompass Health Corp / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Walgreens Boots Alliance Inc / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Evolent Health Inc / Conformis Inc / Avalo Therapeutics Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Sesen Bio Inc / Arvinas Inc / Frequency Therapeutics Inc / Baudax Bio Inc / Pennant Group Inc / Protara Therapeutics Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Mallinckrodt PLC / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 535</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Ownership Timelines & Shareholder Analytics (February 2021)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues - Website Introduction Slides</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REL-GB Company reports financial results for the half-year ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REL.L / DMGOa.L / ERM.L / PSON.L / QRT.L / BLPU.L</td><td class="leftalignment">Relx PLC / Daily Mail and General Trust P L C / Euromoney Institutional Investor PLC / Pearson PLC / Quarto Group Inc / Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Bristol Myers Squibb dips 4.7% in past year; Institutional Ownership down 2%</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended February 16,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US -  Dividend Quality Analysis, for the period ended February 16,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">TARA=US / ULTA=US / MRK=US / PFE=US / AMGN=US / BMY=US / INTC=US / AMD=US / GBT=US / MSFT=US / QCOM=US / EPIX=US / NVDA=US / SCI=US / BWAY=US / TSM=US / EMR=US / HUM=US / BKI=US / CVS=US / BLUE=US / EXAS=US / RBC=US / UTHR=US / VRTX=US / RHHBY=US / RNG=US / CEVA=US / MNKD=US / GOOG=US / DENN=US / RXN=US / SFTBY=US / AGIO=US / SABR=US / SEDG=US / CERC=US / EDIT=US / CRSP=US / VERU=US / MBIO=US / SESN=US / ARVN=US / BXRX=US / FMTX=US / CHGCY=US</td><td class="leftalignment">Protara Therapeutics Inc / Ulta Beauty Inc / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Qualcomm Inc / ESSA Pharma Inc / NVIDIA Corp / Service Corporation International / Brainsway Ltd / Taiwan Semiconductor Manufacturing Co Ltd / Emerson Electric Co / Humana Inc / Black Knight Inc / CVS Health Corp / bluebird bio Inc / Exact Sciences Corp / Regal Rexnord Corp / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Roche Holding AG / RingCentral Inc / CEVA Inc / MannKind Corp / Alphabet Inc / Denny's Corp / Zurn Water Solutions Corp / SoftBank Group Corp / Agios Pharmaceuticals Inc / Sabre Corp / Solaredge Technologies Inc / Avalo Therapeutics Inc / Editas Medicine Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Sesen Bio Inc / Arvinas Inc / Baudax Bio Inc / Forma Therapeutics Holdings Inc / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Israel / Japan / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Pharmaceuticals / Semiconductors</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Carefully Building an Oncology and Rare Disease Company; Initiate Outperform</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">TARA=US / MRK=US / PFE=US / BMY=US / RHHBY=US / CERC=US / SESN=US / CHGCY=US</td><td class="leftalignment">Protara Therapeutics Inc / Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Roche Holding AG / Avalo Therapeutics Inc / Sesen Bio Inc / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">U.S./Global Declines Continue as Vaccine Rollout Progresses; Big Pharma’s Fourth-Quarter Earnings Review the Year That Was</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">5671735 / 0989529 / 2367026 / 2577609 / 2126335 / 2516152 / 2778844 / 2026242 / 2208073 / 2280220 / 2270726 / 2542049 / 2100920 / 2415204 / 2459020 / 2684703 / 7103065 / 2822019 / B121557 / 2857817 / B2R3PV1 / B4Y1MH7 / BBFL7S1 / B7VD3F2 / B8CKK03 / BFZCHN7 / B95WG16 / BYRY499 / BYY8XK8 / BYVFC94 / BJF8Q81 / BDHF4K6 / BZ1HM42 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BGT3960 / BJRFSB7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / General Mills Inc / CVS Health Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / American Electric Power Company Inc / Copart Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Intuit Inc / Pfizer Inc / Novartis AG / Advance Auto Parts Inc / Mastercard Inc / Netflix Inc / American Water Works Company Inc / KAR Auction Services Inc / bluebird bio Inc / Duke Energy Corp / Mondelez International Inc / Wix.Com Ltd / Zoetis Inc / Kraft Heinz Co / WEC Energy Group Inc / US Foods Holding Corp / IAA Inc / CRISPR Therapeutics AG / Adyen NV / Warner Music Group Corp / Evergy Inc / Vistra Corp / Orchard Therapeutics PLC / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VNDA-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">VNDA.O / BMY / JNJ / LLY / MRK / NVS / PFE / TTNP.O</td><td class="leftalignment">Vanda Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Global Pharma Model Sweep: Reopening and Washington Headwinds Should Abate in 2H21 as Key Potential Catalysts Approach</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">2126335 / 0989529 / 5671735 / 0925288 / 2516152 / 2778844 / 7103065 / BHC8X90</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0382221051 / US0463531089 / US0530151036 / US0997241064 / US1101221083 / US1311931042 / US30161Q1040 / US3614481030 / US3647601083 / US37733W1053 / US4234521015 / US4663671091 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8552441094 / US8725401090 / US87612E1064 / US9311421039 / US3448491049 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US2533931026 / US25754A2015 / US0491642056 / US1696561059 / PAP310761054 / US79546E1047 / US01748X1028 / US2473617023 / US90384S3031 / US00922R1059 / US58933Y1055 / US9100471096 / US92335C1062 / US00287Y1091 / US5017971046 / IE00B4Q5ZN47 / US55345K1034 / US8485771021 / US21240E1055 / US1220171060 / CA05156V1022 / US02376R1023 / US70438V1061 / US70432V1026 / US0404131064 / US67576A1007 / IE00BQPVQZ61 / US0994061002 / CA0089118776 / US12685J1051 / US26856L1035 / US01345P1066 / CA1350861060 / US8760301072 / US15677J1088 / US5904791358 / CA39342L1085 / CA23126M1023 / US81181C1045 / US55406W1036</td><td class="leftalignment">Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Borgwarner Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Exelixis Inc / GATX Corp / Gap Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Jack in the Box Inc / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / TJX Companies Inc / Target Corp / Walmart Inc / Foot Locker Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / DICK'S Sporting Goods Inc / Domino's Pizza Inc / Atlas Air Worldwide Holdings Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Sally Beauty Holdings Inc / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Air Transport Services Group Inc / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / Abbvie Inc / Bath & Body Works Inc / Jazz Pharmaceuticals PLC / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / Paylocity Holding Corp / Paycom Software Inc / Arista Networks Inc / Ocular Therapeutix Inc / Horizon Therapeutics PLC / Boot Barn Holdings Inc / Air Canada / Cable One Inc / elf Beauty Inc / Albireo Pharma Inc / Canada Goose Holdings Inc / Tapestry Inc / Ceridian HCM Holding Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Curaleaf Holdings Inc / Seagen Inc / MYT Netherlands Parent BV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">2126335 / 2516152 / 2023607 / 2778844 / 2026242 / 2111955 / 2280220 / 2270726 / 2542049 / 2576941 / 2100920 / 2455965 / 2457864 / 2459020 / 2048804 / 2730190 / 2402121 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / B76LYJ2 / BFH3N85 / BYY8XK8 / BP4GNK9 / BYW36M8 / BFZNYB7 / BD9GVY0 / BDHF4K6 / BZBY005 / BKS3SM8 / BQT3XY6 / BZ1HM42 / BR4T3B3 / BMQ5T49 / BWFKZT2 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJXBP30 / BYQHPK7 / BJ9NFQ3 / BK71LY6 / BM8MM05 / BP8XZL1</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Borgwarner Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / FirstEnergy Corp / Biogen Inc / ImmunoGen Inc / Intuit Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Nuance Communications Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Veeva Systems Inc / WEC Energy Group Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Adyen NV / HubSpot Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Neoleukin Therapeutics Inc / WW International Inc / Madison Square Garden Entertainment Corp / Healthequity Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Compelling Efficacy in CM-274 Should Support Opdivo Approval and Uptake; 9ER Still Highly Competitive Despite KN-581 Efficacy</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Bristol Myers Squibb - $80.00 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 46</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Media - Review, refresh, recover</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">GB0006640972 / GB0009039941 / GB0006886666 / GB0007689002 / GB0030026057 / GB0033147751 / GB00B1VQ6H25 / GB00B1ZBKY84 / GB00B01F7T14 / GB00B3CX3644 / GB00BMJ6DW54 / GB00BVYVFW23 / GB00B4T7HX10 / GB00BYM8GJ06 / GB00BGDT3G23 / GB00BFZZM640 / GB00BK71XP16</td><td class="leftalignment">4imprint Group PLC / Reach PLC / Euromoney Institutional Investor PLC / Kin and Carta PLC / Next Fifteen Communications Group PLC / Bloomsbury Publishing PLC / YouGov PLC / Moneysupermarket.Com Group PLC / M&C Saatchi PLC / STV Group PLC / Informa PLC / Auto Trader Group PLC / Learning Technologies Group PLC / Ascential PLC / Rightmove PLC / S4 Capital PLC / Pebble Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Info. Tech./Software / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Malcolm Morgan / Ms. Jessica Pok</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 05, 2021: Focus on Dupixent's resilience</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">02/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Cash Conversion Cycle 2010-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - Keytruda + Lenvima adds incremental challenge for Cabometyx in 1L RCC</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IPN.PA / BMY.N / MRK.N / PFE.N</td><td class="leftalignment">Ipsen SA / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY - Takeaways from Our Oncology Day Fireside Chat w/ Mgmt; Setting the Foundation for Pipeline Growth Acceleration</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Feb. 12, 2021 / 12:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 534</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">BNGO=US / INO=US / AAPL=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / BMY=US / MDT=US / WMT=US / INCY=US / EPIX=US / CMS=US / DGX=US / NVS=US / AZN=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXEL=US / GEN=US / LH=US / NVAX=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / VRTX=US / SGEN=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / SNY=US / MD=US / SLF=US / BIIB=US / ISR=US / MRNA=US / ALNY=US / GOOG=US / DXCM=US / LHCG=US / CHNG=US / INFI=US / ORTX=US / EHC=US / BAYRY=US / SPRO=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / ARCT=US / ABBV=US / PRTA=US / ENTA=US / CTRE=US / WBA=US / NVTA=US / EVH=US / ZBH=US / IONS=US / EDIT=US / AVDL=US / MTEM=US / VERU=US / GMDA=US / NBSE=US / FREQ=US / RCEL=US / PNTG=US / TSHA=US / SIOX=US</td><td class="leftalignment">Bionano Genomics Inc / Inovio Pharmaceuticals Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / Novavax Inc / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / Sanofi SA / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / IsoRay Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Dexcom Inc / LHC Group Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Orchard Therapeutics PLC / Encompass Health Corp / Bayer AG / Spero Therapeutics Inc / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Arcturus Therapeutics Holdings Inc / Abbvie Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Zimmer Biomet Holdings Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Avadel Pharmaceuticals PLC / Molecular Templates Inc / Veru Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Frequency Therapeutics Inc / AVITA Medical Inc / Pennant Group Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">INO=US / TWOU=US / AAPL=US / MRK=US / WSM=US / NKE=US / PFE=US / BMY=US / HD=US / INTC=US / ADI=US / AMD=US / BWA=US / MSFT=US / AMZN=US / QCOM=US / BBY=US / TXN=US / EPIX=US / MPWR=US / NVS=US / SMTC=US / LOW=US / TSM=US / AZN=US / CRY=US / XLNX=US / EXPE=US / JNJ=US / UNH=US / ARCC=US / AVGO=US / BL=US / CRUS=US / IFX=US / FROG=US / MCHP=US / NVAX=US / REGN=US / TSCO=US / UTHR=US / VCTR=US / WTS=US / SGEN=US / RHHBY=US / PYPL=US / SWKS=US / ARES=US / DKS=US / BIIB=US / MRNA=US / ALNY=US / ENS=US / GOOG=US / BJRI=US / PBH=US / DXCM=US / XPO=US / LULU=US / GNRC=US / MXL=US / NXPI=US / ARCT=US / PRTA=US / VRNS=US / GDDY=US / UAA=US / CARG=US / DDOG=US / RCEL=US / SIOX=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / 2U Inc / Apple Inc / Merck & Co Inc / Williams-Sonoma Inc / Nike Inc / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Borgwarner Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / Best Buy Co Inc / Texas Instruments Inc / ESSA Pharma Inc / Monolithic Power Systems Inc / Novartis AG / Semtech Corp / Lowe's Companies Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / CryoLife Inc / Xilinx Inc / Expedia Group Inc / Johnson & Johnson / UnitedHealth Group Inc / Ares Capital Corp / Broadcom Inc / Blackline Inc / Cirrus Logic Inc / Infineon Technologies AG / Jfrog Ltd / Microchip Technology Inc / Novavax Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / United Therapeutics Corp / Victory Capital Holdings Inc / Watts Water Technologies Inc / Seagen Inc / Roche Holding AG / PayPal Holdings Inc / Skyworks Solutions Inc / Ares Management Corp / DICK'S Sporting Goods Inc / Biogen Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / EnerSys / Alphabet Inc / BJ's Restaurants Inc / Prestige Consumer Healthcare Inc / Dexcom Inc / XPO Logistics Inc / Lululemon Athletica Inc / Generac Holdings Inc / Maxlinear Inc / NXP Semiconductors NV / Arcturus Therapeutics Holdings Inc / Prothena Corporation PLC / Varonis Systems Inc / GoDaddy Inc / Under Armour Inc / CarGurus Inc / Datadog Inc / AVITA Medical Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">0925288 / 2126335 / 2681511 / 2023607 / 2486813 / 2973821 / 2050832 / 2111955 / 2216850 / 2222631 / 2270726 / 2542049 / 2576941 / 2328915 / 2100920 / 2613990 / 2471950 / 2707677 / 2503529 / 5531000 / 7103065 / B1F76F9 / B121557 / B067BM3 / B19FQ48 / 2216991 / 2857817 / B0T7YX2 / B2R3PV1 / B0796X4 / 2982924 / B65LWX6 / B7TL820 / B7VD3F2 / BFDV8K0 / BBPK0J0 / B76LYJ2 / BFZCHN7 / BYRY499 / BYY8XK8 / BYW36M8 / BF4VBS8 / BXDZ9Z0 / BFZNYB7 / BD9GVY0 / BZ1LFB2 / BD8DJ71 / BR4T3B3 / BJ2Z0H2 / BGCYWN8 / BKVDFF7 / BLGJ610 / BFNR303 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BL71K91 / BYNQ369 / BYWVTY5 / BMVWYW8 / BDZ30Q0 / BMG75B4 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / PepsiCo Inc / Amgen Inc / Kellogg Co / Alliant Energy Corp / Ameren Corp / Borgwarner Inc / Consolidated Edison Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / FirstEnergy Corp / Illumina Inc / Incyte Corp / Public Service Enterprise Group Inc / World Wrestling Entertainment Inc / MorphoSys AG / Novartis AG / Western Union Co / Mastercard Inc / Molson Coors Beverage Co / Amicus Therapeutics Inc / Tempur Sealy International Inc / Netflix Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Dexcom Inc / Spectrum Pharmaceuticals Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / MacroGenics Inc / Mirati Therapeutics Inc / Vocera Communications Inc / Wix.Com Ltd / Kraft Heinz Co / WEC Energy Group Inc / PayPal Holdings Inc / BioXcel Therapeutics Inc / Shopify Inc / Allogene Therapeutics Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Snap Inc / HubSpot Inc / Pinterest Inc / Xencor Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Northwest Natural Holding Co / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / Revolution Medicines Inc / Albertsons Companies Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Arvinas Inc / Inventiva SA / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q Update Outlines Key Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PRTA=US / BMY=US / RHHBY=US / BIIB=US</td><td class="leftalignment">Prothena Corporation PLC / Bristol-Myers Squibb Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MTEM=US / QSR=US / BMY=US / BWA=US / HRL=US / IO=US / VRTX=US / ARES=US / INFI=US</td><td class="leftalignment">Molecular Templates Inc / Restaurant Brands International Inc / Bristol-Myers Squibb Co / Borgwarner Inc / Hormel Foods Corp / ION Geophysical Corp / Vertex Pharmaceuticals Inc / Ares Management Corp / Infinity Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Lodging & Restaurants / Retailing</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">BMS ETB Partnership Lifts Safety Overhang; Cash Runway into 2H22</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MTEM=US / BMY=US / VRTX=US</td><td class="leftalignment">Molecular Templates Inc / Bristol-Myers Squibb Co / Vertex Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Raising PT to $9 Based on Promising DOR from PD-L1 Low Cohort of MARIO-275</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">INFI=US / BMY=US</td><td class="leftalignment">Infinity Pharmaceuticals Inc / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">KYMR (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Pipeline Degrader Execution Year</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMPRZV5 / 2126335 / 5531000</td><td class="leftalignment">Kymera Therapeutics Inc / Bristol-Myers Squibb Co / MorphoSys AG</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt – ORIC-101 Initial PoC Data On Track in 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BKVDFF7 / 0989529 / 2126335 / 2516152 / 2684703 / 7103065 / 2982924 / BBPK0J0</td><td class="leftalignment">Oric Pharmaceuticals Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Novartis AG / Spectrum Pharmaceuticals Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Continued Near & Long-Term Growth</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2576941 / 2126335 / 2778844 / 2684703</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Short Shots - Charts highlighted: BTG, GOLD, HYLN, ROP, APD, FMC, AZN, BMY, MRK, PFE, BLUE, IMVT, REGN, VRTX, MDLZ, KO, PEP, CLX, PG, UL, WCN, FDS, DNB, CHKP, HUM, FMS, CHTR, LNT, AEP, PNW, XEL, UWMC, CNNE, PGR, SBAC, T, and VZ.</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">VZ.N / APD.N / BMY.N / FMC.N / KO.N / MRK.N / PFE.N / ULVR.L / PG.N / HUM.N / ROP.N / CLX.N / FDS.N / DNB.N / REGN.OQ / CHKP.OQ / CHTR.OQ / BLUE.OQ / VRTX.OQ / WCN.AX / BLHI.PK / AZN.V / MDLZ.OQ / CNNE.N / PEP.OQ / XEL.OQ / LNT.OQ / IMVT.OQ / HYLN.N / UWMC.N</td><td class="leftalignment">Verizon Communications Inc / Air Products and Chemicals Inc / Bristol-Myers Squibb Co / FMC Corp / Coca-Cola Co / Merck & Co Inc / Pfizer Inc / Unilever PLC / Procter & Gamble Co / Humana Inc / Roper Technologies Inc / Clorox Co / Factset Research Systems Inc / Dun & Bradstreet Holdings Inc / Regeneron Pharmaceuticals Inc / Check Point Software Technologies Ltd / Charter Communications Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / White Cliff Minerals Ltd / Blue Holdings Inc / AZN Capital Corp / Mondelez International Inc / Cannae Holdings Inc / PepsiCo Inc / Xcel Energy Inc / Alliant Energy Corp / Immunovant Inc / Hyliion Holdings Corp / UWM Holdings Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended February 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 16,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Re-Accelerating Cabo Growth Heading into Multiple Sources of Near-Term Upside; Maintain BUY, $32 PT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2576941 / 2126335 / 2778844</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2936921 / 2126335 / 2516152 / 2000019 / 2026242 / 2219224 / 2216850 / 2270726 / 2542049 / 2829515 / 2328915 / 2342034 / 2100920 / 2471950 / 2689560 / 2684703 / 2138158 / 5531000 / 7103065 / 2712013 / B17HG57 / B121557 / 2769796 / 2857817 / B2R3PV1 / B7VD3F2 / BFLR866 / BFZCHN7 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BXDZ9Z0 / BJT1RW7 / BZ1LFB2 / BD8DJ71 / BJ2Z0H2 / BJJMGL2 / BFXC911 / BKTNTR9 / BGT3960 / BMDCDP2 / BJRFSB7 / 021513106</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Incyte Corp / PG&E Corp / Pfizer Inc / Sempra Energy / MorphoSys AG / Novartis AG / Global Payments Inc / Cardiovascular Systems Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / American Water Works Company Inc / Duke Energy Corp / Twitter Inc / Wix.Com Ltd / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / Shopify Inc / Lyft Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Pinterest Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Orchard Therapeutics PLC / Bigcommerce Holdings Inc / Immunovant Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IO Expansion to Early-Stage Continues with Opdivo Bladder Cancer Success</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / BMY=US / RHHBY=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Bristol-Myers Squibb</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech - 2020 Deal Scorecard for Cell Therapy & Oncology</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY=US / GILD=US / SGMO=US / ABBV=US / ALLO=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Sangamo Therapeutics Inc / Abbvie Inc / Allogene Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Declines Continue as Vaccine Rollout Ramps Up; IMHE Suggests New Variant Bump May Occur in March/April</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DNB / FISV=US / MRK=US / BSX=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / ADI=US / WEN=US / AMZN=US / BLD=US / TEVA=US / NVDA=US / SLG=US / LOW=US / ENR=US / DIOD=US / IGT=US / CHRS=US / BYD=US / TTWO=US / LEG=US / TTMI=US / ATVI=US / KFRC=US / MGM=US / HUM=US / PENN=US / BKI=US / AVGO=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HAS=US / IBP=US / MAS=US / MHK=US / MCRI=US / REGI=US / SGMO=US / SPG=US / SGMS=US / GPN=US / AUTL=US / DIN=US / ECPG=US / PRAA=US / RRR=US / BIIB=US / TPX=US / EXP=US / CZR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / REX=US / FIS=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / NXPI=US / FBHS=US / ZNGA=US / EA=US / ENPH=US / TILE=US / NDLS=US / VRNS=US / GOOGL=US / LOCO=US / HQY=US / OSH=US / SHAK=US / WING=US / TDOC=US / EDIT=US / 82982L103 / IRTC=US / JELD=US / MPWR-US / CARG=US / BTAI=US / ALLO=US / HARP=US / TCRR=US / FERGY=US / OPCH=US / DKNG=US / AZEK=US / BALY=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Fiserv Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Analog Devices Inc / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / SL Green Realty Corp / Lowe's Companies Inc / Energizer Holdings Inc / Diodes Inc / International Game Technology PLC / Coherus BioSciences Inc / Boyd Gaming Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / TTM Technologies Inc / Activision Blizzard Inc / Kforce Inc / MGM Resorts International / Humana Inc / Penn National Gaming Inc / Black Knight Inc / Broadcom Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hasbro Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Simon Property Group Inc / Scientific Games Corp / Global Payments Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Encore Capital Group Inc / PRA Group Inc / Red Rock Resorts Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / NXP Semiconductors NV / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / Varonis Systems Inc / Alphabet Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Oak Street Health Inc / Shake Shack Inc / Wingstop Inc / Teladoc Health Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Monolithic Power Systems Inc / CarGurus Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Ferguson PLC / Option Care Health Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2126335 / 2778844 / 2026242 / 2942605 / 2175672 / 2542049 / 2576941 / 2684703 / 2048804 / 2440637 / 2402121 / 2883878 / 2931034 / 2795393 / 2712013 / B121557 / B02R1L6 / B2R3PV1 / B3D7K31 / 2679204 / B3SWPT2 / B7TL820 / B7VD3F2 / BJ3V905 / BVVN4Q8 / BYY8XK8 / BQPVQZ6 / BYW36M8 / BDHF4K6 / BJFSR88 / BKTHM05 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BP8XZL1 / BN4NJG4</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / American Electric Power Company Inc / Avista Corp / Cardinal Health Inc / Dominion Energy Inc / Exelixis Inc / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Nuance Communications Inc / Teva Pharmaceutical Industries Ltd / Vertex Pharmaceuticals Inc / Amerisourcebergen Corp / Global Payments Inc / Mastercard Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Align Technology Inc / Ameresco Inc / Meta Platforms Inc / Duke Energy Corp / Endo International PLC / Eversource Energy / WEC Energy Group Inc / Horizon Therapeutics PLC / PayPal Holdings Inc / CRISPR Therapeutics AG / Uniqure NV / Passage Bio Inc / Evergy Inc / ViacomCBS Inc / Roku Inc / Healthequity Inc / Freeline Therapeutics Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Keytruda + Lenvima Shines in RCC: 3 Positive Signals, 4 Remaining Uncertainties</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / BMY=US / EXEL=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Exelixis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: ASCO GU 2021 Hit List - Key Data in Kidney, Bladder & Prostate Cancers</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BMY=US / EXEL=US / AUTL=US / ALLO=US / HARP=US / TCRR=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Exelixis Inc / Autolus Therapeutics PLC / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">4502.T / 4519.T / 4503.T / 4507.T / 4523.T / 4528.T / BMY.N / JNJ.N / 4516.T / 4506.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Chugai Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - Cabometyx readacross: Keynote-581 data mixed at upcoming ASCO GU</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IPN.PA / BMY.N / MRK.N / PFE.N</td><td class="leftalignment">Ipsen SA / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">34</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / JNJ.N / 4516.T / 4506.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Bladder Cancer Updates for Opdivo and Padcev at ASCO-GU; Battle for 1L RCC Supremacy Will Ensue With Full Results on Saturday</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">30161Q104 / 81181C104 / 110122108</td><td class="leftalignment">Exelixis Inc / Seagen Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andy T. Hsieh, PHD / Matt Phipps, PHD / Brittany Woods / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Bristol-Myers Squibb Co: Information Content of Earnings Releases 2015-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Better Late Than Never: Breyanzi Approval Provides a New Opportunity With Potential for Best Mix of Safety and Efficacy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 8 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1156372096 / US1266501006 / US14149Y1082 / US1912161007 / US1925761066 / US2546871060 / US37733W1053 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7134481081 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US9021041085 / US9029251066 / US91347P1057 / US03073E1055 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US3463751087 / US60855R1005 / US90385V1070 / US60871R2094 / US15135B1017 / RDSa.AS / PAP310761054 / US01748X1028 / US2473617023 / US25470F1049 / US58933Y1055 / US25470F3029 / US9100471096 / US00164V1035 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US61174X1090 / US87918A1051 / KYG4740B1059 / LGFb / LGFa / US53115L1044 / US05351X1019 / US49271V1008 / US5904791358 / US28414H1032 / US1255231003 / US35137L1052 / US92556H2067 / US92537N1081 / US6833731044 / US03044L1052 / US62955J1034 / US73739W1045 / 120175706 / 120404208</td><td class="leftalignment">STMicroelectronics NV / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / Brown-Forman Corp / CVS Health Corp / Cardinal Health Inc / Coca-Cola Co / Cohu Inc / Walt Disney Co / GlaxoSmithKline PLC / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / PepsiCo Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / II-VI Inc / USA Truck Inc / Universal Display Corp / Amerisourcebergen Corp / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / FormFactor Inc / Molina Healthcare Inc / Ultra Clean Holdings Inc / Molson Coors Beverage Co / Centene Corp / Royal Dutch Shell PLC / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Discovery Inc / Merck & Co Inc / Discovery Inc / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Monster Beverage Corp / Teladoc Health Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Lions Gate Entertainment Corp / Liberty Oilfield Services Inc / Avaya Holdings Corp / Keurig Dr Pepper Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Cigna Corp / Fox Corp / ViacomCBS Inc / Vertiv Holdings Co / Ontrak Inc / American Well Corp / Nov Inc / Poshmark Inc / Cisco Systems Inc / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Major Pharmaceuticals : 4Q Earnings Season Takeaways - Solid Results, Mixed Stock Performance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 45</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/06/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, BMY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung / Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 533</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">FTNT=US / AAPL=US / IBM=US / MRK=US / BMY=US / DIS=US / INTC=US / ADI=US / AMD=US / MSFT=US / MDT=US / AMZN=US / T=US / ORCL=US / VOD=US / TXN=US / U=US / CG=US / GILD=US / AMT=US / DOX=US / GS=US / AKAM=US / YUM=US / MPWR=US / CHTR=US / GE=US / VZ=US / SMTC=US / CCI=US / UPS=US / AZN=US / ZEN=US / EXC=US / XLNX=US / CSL=US / ATVI=US / MGM=US / CMCSA=US / CI=US / DISH=US / NUAN=US / AMSC=US / AME=US / APPS=US / CMI=US / CAJ=US / CTL=US / CRUS=US / CME=US / EGHT=US / EQIX=US / PHG=US / NBIX=US / PCTY=US / QUIK=US / SBAC=US / SNAP=US / TOSYY=US / VG=US / APO=US / SNOW=US / NET=US / CRNT=US / SYNA=US / FB=US / NFLX=US / TWLO=US / GPRO=US / ERIC=US / PTON=US / RNG=US / CEVA=US / GOOG=US / DLR=US / VIAC=US / DISCA=US / ICE=US / CCOI=US / MWA=US / INFI=US / RSI=US / LLNW=US / LUMN=US / TDC=US / IAC=US / KLR=US / AGCO=US / 005930-KR=US / ALPMY=US / MXL=US / NXPI=US / ANGI=US / SRPT=US / TMUS=US / GTT=US / AVYA=US / GOOGL=US / PAYC=US / SIEGY=US / EKTAY=US / NEWR=US / BILL=US / HPE=US / VYGR=US / DZSI=US / YUMC=US / TEUM=US / HLNE=US / SLNO=US / ATUS=US / VREX=US / ZM=US / FSLY=US / CMBM=US / NLOK=US / DKNG=US / ONDS=US</td><td class="leftalignment">Fortinet Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Medtronic PLC / Amazon.com Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Texas Instruments Inc / Unity Software Inc / Carlyle Group Inc / Gilead Sciences Inc / American Tower Corp / Amdocs Ltd / Goldman Sachs Group Inc / Akamai Technologies Inc / Yum! Brands Inc / Monolithic Power Systems Inc / Charter Communications Inc / General Electric Co / Verizon Communications Inc / Semtech Corp / Crown Castle International Corp / United Parcel Service Inc / AstraZeneca PLC / Zendesk Inc / Exelon Corp / Xilinx Inc / Carlisle Companies Inc / Activision Blizzard Inc / MGM Resorts International / Comcast Corp / Cigna Corp / DISH Network Corp / Nuance Communications Inc / American Superconductor Corp / AMETEK Inc / Digital Turbine Inc / Cummins Inc / Canon Inc / Lumen Technologies Inc / Cirrus Logic Inc / CME Group Inc / 8x8 Inc / Equinix Inc / Koninklijke Philips NV / Neurocrine Biosciences Inc / Paylocity Holding Corp / QuickLogic Corp / SBA Communications Corp / Snap Inc / Toshiba Corp / Vonage Holdings Corp / Apollo Global Management Inc / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Synaptics Inc / Meta Platforms Inc / Netflix Inc / Twilio Inc / GoPro Inc / Telefonaktiebolaget LM Ericsson / Peloton Interactive Inc / RingCentral Inc / CEVA Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Discovery Inc / Intercontinental Exchange Inc / Cogent Communications Holdings Inc / Mueller Water Products Inc / Infinity Pharmaceuticals Inc / Rush Street Interactive Inc / Limelight Networks Inc / Lumen Technologies Inc / Teradata Corp / IAC/Interactivecorp / Kaleyra Inc / AGCO Corp / Farfetch Ltd / Astellas Pharma Inc / Maxlinear Inc / NXP Semiconductors NV / Angi Inc / Sarepta Therapeutics Inc / T-Mobile US Inc / GTT Communications Inc / Avaya Holdings Corp / Alphabet Inc / Paycom Software Inc / Siemens AG / Elekta AB (publ) / New Relic Inc / Bill.com Holdings Inc / Hewlett Packard Enterprise Co / Voyager Therapeutics Inc / DZS Inc / Yum China Holdings Inc / Pareteum Corp / Hamilton Lane Inc / Soleno Therapeutics Inc / Altice USA Inc / Varex Imaging Corp / Zoom Video Communications Inc / Fastly Inc / Cambium Networks Corp / NortonLifeLock Inc / DraftKings Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Japan / Netherlands / Sweden / United States / Guernsey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Machinery / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / BMY=US / ADI=US / RRC=US / T=US / TXN=US / GILD=US / AMT=US / PEB=US / DGX=US / H=US / CRM=US / V=US / MTN=US / VZ=US / MAR=US / ATVI=US / ESS=US / HLT=US / MANH=US / PENN=US / CI=US / RCL=US / AIR=US / ARCC=US / ARW=US / AVT=US / CCL=US / CHH=US / DRH=US / EXPO=US / MAIN=US / MCHP=US / ORCC=US / PCTY=US / SHOP=US / SNAP=US / VSEC=US / POST=US / LCI=US / AVTR=US / BDN=US / CPT=US / OFC=US / OHI=US / PTON=US / BIIB=US / FLT=US / AINV=US / SHO=US / MPW=US / HST=US / MA=US / EHTH=US / PNNT=US / WH=US / WYND=US / IAC=US / RCUS=US / HGV=US / NXPI=US / RLJ=US / VAC=US / ANGI=US / RHP=US / NCLH=US / TMUS=US / PTCT=US / TSLX=US / 70806A106 / NEWR=US / GSBD=US / ZG=US / WLTW=US / VVV=US / PK=US / LGF.B=US / PLYA=US / RDFN=US / MPWR-US / FSK=US / PLMR=US / BRBR=US / GOCO=US / ONEW=US / FSKR=US / BIGC=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Analog Devices Inc / Range Resources Corp / AT&T Inc / Texas Instruments Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Quest Diagnostics Inc / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Verizon Communications Inc / Marriott International Inc / Activision Blizzard Inc / Essex Property Trust Inc / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Penn National Gaming Inc / Cigna Corp / Royal Caribbean Cruises Ltd / AAR Corp / Ares Capital Corp / Arrow Electronics Inc / Avnet Inc / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Exponent Inc / Main Street Capital Corp / Microchip Technology Inc / Owl Rock Capital Corp / Paylocity Holding Corp / Shopify Inc / Snap Inc / VSE Corp / Post Holdings Inc / Lannett Company Inc / Avantor Inc / Brandywine Realty Trust / Camden Property Trust / Corporate Office Properties Trust / Omega Healthcare Investors Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Apollo Investment Corp / Sunstone Hotel Investors Inc / Medical Properties Trust Inc / Host Hotels & Resorts Inc / Mastercard Inc / eHealth Inc / Pennantpark Investment Corp / Wyndham Hotels & Resorts Inc / Travel + Leisure Co / IAC/Interactivecorp / Arcus Biosciences Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Norwegian Cruise Line Holdings Ltd / T-Mobile US Inc / PTC Therapeutics Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / New Relic Inc / Goldman Sachs BDC Inc / Zillow Group Inc / Willis Towers Watson PLC / Valvoline Inc / Park Hotels & Resorts Inc / Lions Gate Entertainment Corp / Playa Hotels & Resorts NV / Redfin Corp / Monolithic Power Systems Inc / FS KKR Capital Corp / Palomar Holdings Inc / Bellring Brands Inc / Gohealth Inc / OneWater Marine Inc / FS KKR Capital Corp / Bigcommerce Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Liberia / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Strong Revenue Performance and 2021 Outlook With Management’s High Conviction on Opdivo’s Return to Growth</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">V / 0989529 / 2126335 / 2000019 / 2496113 / 2778844 / 2973821 / 2219224 / 2229126 / 2270726 / 2542049 / 2328915 / 2369174 / 2121352 / 2515030 / 2623911 / 2630513 / 2632003 / 2048804 / 2825933 / 2503529 / 2181334 / 2795393 / 2212922 / 2857817 / B2R3PV1 / B570P91 / 2390817 / B7TL820 / B4V9661 / B7VD3F2 / B9M2WX3 / BBGVT40 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BYW36M8 / BF09HX3 / BD8DJ71 / BKDS4H5 / BR4T3B3 / BJ2Z0H2 / BFZ1K46 / BFMXGR0 / BYXJQG9 / BKTNTR9 / BZ1LFG7 / BMH0MR7 / BYQCZ35 / BZ4CHH2 / BNG3RZ7 / 021513106</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Kohls Corp / Merck & Co Inc / Alliant Energy Corp / CMS Energy Corp / Columbia Sportswear Co / Walt Disney Co / Dominion Energy Inc / Nextera Energy Inc / Gilead Sciences Inc / Group 1 Automotive Inc / Lithia Motors Inc / Neurocrine Biosciences Inc / New Jersey Resources Corp / New York Times Co / Pinnacle West Capital Corp / South Jersey Industries Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Amerisourcebergen Corp / NRG Energy Inc / Netflix Inc / American Water Works Company Inc / Lear Corp / Gray Television Inc / Meta Platforms Inc / Ralph Lauren Corp / Duke Energy Corp / Bath & Body Works Inc / News Corp / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Tapestry Inc / Snap Inc / Bill.com Holdings Inc / HubSpot Inc / Pinterest Inc / Spotify Technology SA / Evergy Inc / Spire Inc / ViacomCBS Inc / Roku Inc / Zendesk Inc / Madison Square Garden Sports Corp / Soleno Therapeutics Inc / Leslie's Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">REGN: Our thoughts post the 4Q20 call: Strong base business bolstered by REGN-COV (near-term) and oncology (long-term)</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">REGN.OQ / BMY.N / SASY.PA / TEVA.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Bristol-Myers Squibb Co / Sanofi SA / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BMY.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / PM.N / DUK.N / DIS.N / D.N / FE.N / ITW.N / LIN.N / TWTR.N / MCO.N / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / TTWO.OQ / ILMN.OQ / EQIX.OQ / GPN.N / DLR.N / FIS.N / TDG.N / CME.OQ / TMUS.OQ / SPG.NZ / IQV.N / PEP.OQ / NWL.OQ</td><td class="leftalignment">Boeing Co / Bristol-Myers Squibb Co / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / Philip Morris International Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Illinois Tool Works Inc / Linde PLC / Twitter Inc / Moody's Corp / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Take-Two Interactive Software Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Digital Realty Trust Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / T-Mobile US Inc / Stride Property Ltd / IQVIA Holdings Inc / PepsiCo Inc / Newell Brands Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY: 4Q20 Postview – Beats, modest raise, still lots of catalysts</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : 4Q Takeaways / Model Update – No Surprises with 2021 Guidance, Attractive Catalyst Path Ahead</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Good Q and 2021 outlook; Bumping up estimates and PT to $66</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY=US</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 4Q20 Earnings Highlights — What Mattered for Credit Part IV</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CI.N / MRK.N / BAX.N / BDX.N / BMY.N / DGX.N / ABC.N</td><td class="leftalignment">Cigna Corp / Merck & Co Inc / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Quest Diagnostics Inc / Amerisourcebergen Corp</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BMY - BMY 4Q20 - They said what?! Highlights from conference call that just ended</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Thoughts on ASCO GU</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BMY=US / AZN=US / INFI=US / ALPMY=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / AstraZeneca PLC / Infinity Pharmaceuticals Inc / Astellas Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Feb 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PINS.N / APD.N / BAX.N / BDX.N / BMY.N / BP.L / CI.N / CMS.N / F.N / FLT.N / HIG.N / IBM.N / IP.N / MRK.N / PM.N / RL.N / SLB.N / DGX.N / HAL.N / LEA.N / CMI.N / IEX.N / PH.N / DBKGn.DE / CLX.N / YUM.N / UNM.N / WEC.N / XOM.N / HSY.N / AMT.N / MTD.N / BLL.N / SNA.N / ESS.N / ABC.N / PRU.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / SBUX.OQ / ODFL.OQ / MCHP.OQ / GILD.OQ / TPR.N / AMZN.OQ / COLM.OQ / 0700.HK / ARWR.OQ / NOV.N / RDSa.L / ICE.N / 9999.HK / DECK.N / NWSA.OQ / FTNT.OQ / MSI.N / BKR.N / CG.OQ / TMUS.OQ / FTV.N / DXC.N / LYFT.OQ / BYND.OQ / UBER.N / ZM.OQ / NLOK.OQ / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Pinterest Inc / Air Products and Chemicals Inc / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / BP PLC / Cigna Corp / CMS Energy Corp / Ford Motor Co / Fleetcor Technologies Inc / Hartford Financial Services Group Inc / International Business Machines Corp / International Paper Co / Merck & Co Inc / Philip Morris International Inc / Ralph Lauren Corp / Schlumberger NV / Quest Diagnostics Inc / Halliburton Co / Lear Corp / Cummins Inc / IDEX Corp / Parker-Hannifin Corp / Deutsche Bank AG / Clorox Co / Yum! Brands Inc / Unum Group / WEC Energy Group Inc / Exxon Mobil Corp / Hershey Co / American Tower Corp / Mettler-Toledo International Inc / Ball Corp / Snap-On Inc / Essex Property Trust Inc / Amerisourcebergen Corp / Prudential Financial Inc / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Starbucks Corp / Old Dominion Freight Line Inc / Microchip Technology Inc / Gilead Sciences Inc / Tapestry Inc / Amazon.com Inc / Columbia Sportswear Co / Tencent Holdings Ltd / Arrowhead Pharmaceuticals Inc / Nov Inc / Royal Dutch Shell PLC / Intercontinental Exchange Inc / NetEase Inc / Deckers Outdoor Corp / News Corp / Fortinet Inc / Motorola Solutions Inc / Baker Hughes Co / Carlyle Group Inc / T-Mobile US Inc / Fortive Corp / DXC Technology Co / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / NortonLifeLock Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Bristol-Myers Squibb Company : 4Q First Impressions: 2021 Guidance Largely As Expected; Solid 4Q Results with Healthy Core Product Growth</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4 Beat; 2021 EPS Guidance Raised; Outlook Reiterated</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Brief of Bristol-Myers Squibb Co conference call, Feb. 04, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BMY.N - Event Transcript of Bristol-Myers Squibb Co conference call, Feb. 04, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMY: 4Q20 Revenue and EPS Beat, with Revlimid Upside Surprise; 2021 EPS Guidance Revised Upward</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2126335</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fourth-Quarter Quick Take: Revenue Beat and Raised EPS Guidance a Solid Start; Opdivo Return to Growth Remains a 2021 Focus</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4:20 EPS, Revenue Beat; 2021 Guidance Above Expectations</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / MET.N / DUK.N / DIS.N / FE.N / ITW.N / HSY.N / LIN.N / TWTR.N / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / TTWO.OQ / ILMN.OQ / EQIX.OQ / GPN.N / DLR.N / FIS.N / TDG.N / CME.OQ / ABBV.N / PYPL.OQ / SPG.NZ / IQV.N / PEP.OQ / CTVA.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / FirstEnergy Corp / Illinois Tool Works Inc / Hershey Co / Linde PLC / Twitter Inc / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Take-Two Interactive Software Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Digital Realty Trust Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / Abbvie Inc / PayPal Holdings Inc / Stride Property Ltd / IQVIA Holdings Inc / PepsiCo Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REL-GB -  Dividend Quality Analysis, for the period ended September 02,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REL.L / DMGOa.L / ERM.L / PSON.L / QRT.L / BLPU.L</td><td class="leftalignment">Relx PLC / Daily Mail and General Trust P L C / Euromoney Institutional Investor PLC / Pearson PLC / Quarto Group Inc / Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for BMY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 01,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US -  Dividend Quality Analysis, for the period ended November 16,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Egypt / Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VRTX-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">VRTX.O / BMY / JNJ / MRK / GILD.O / ENTA.O / ABBV.K / ENZN.PK</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Gilead Sciences Inc / Enanta Pharmaceuticals Inc / Abbvie Inc / Enzon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Bristol Myers Squibb's Q4?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Merck Q4 Earnings Preview: Keytruda And Gardasil In Focus</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / PFE.N / PM.N / HUM.N / FE.N / ITW.N / XOM.N / LIN.N / TWTR.N / AMGN.OQ / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / EQIX.OQ / GPN.N / FIS.N / TDG.N / CME.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / IQV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Humana Inc / FirstEnergy Corp / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Twitter Inc / Amgen Inc / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Equinix Inc / Global Payments Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / IQVIA Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: 2021 Catalysts & NPV sensitivity analysis</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S / ARGX.OQ / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG / argenx SE / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Otezla’s Time as Preferred Oral May Be TYK-ing Away as Deucravacitinib Shows Superiority in Second Phase III Psoriasis Trial</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">EL=US / HON=US / AAPL=US / BMY=US / MSFT=US / C=US / AMZN=US / QCOM=US / TXN=US / BAC=US / USB=US / WFC=US / GS=US / MPWR=US / JPM=US / HBAN=US / SYK=US / SMTC=US / JNJ=US / PNC=US / COF=US / AVGO=US / CRUS=US / MS=US / VRTX=US / RHHBY=US / JEF=US / SIVB=US / SWKS=US / TFC=US / GOOG=US / FIS=US / CFG=US / NXPI=US / WWD=US / 2454-TW=US / EA=US / ABBV=US / PRTA=US / QRVO=US / ZBH=US / HPE=US / AKTS=US / IRTC=US / FREQ=US</td><td class="leftalignment">Estee Lauder Companies Inc / Honeywell International Inc / Apple Inc / Bristol-Myers Squibb Co / Microsoft Corp / Citigroup Inc / Amazon.com Inc / Qualcomm Inc / Texas Instruments Inc / Bank of America Corp / US Bancorp / Wells Fargo & Co / Goldman Sachs Group Inc / Monolithic Power Systems Inc / JPMorgan Chase & Co / Huntington Bancshares Inc / Stryker Corp / Semtech Corp / Johnson & Johnson / PNC Financial Services Group Inc / Capital One Financial Corp / Broadcom Inc / Cirrus Logic Inc / Morgan Stanley / Vertex Pharmaceuticals Inc / Roche Holding AG / Jefferies Financial Group Inc / SVB Financial Group / Skyworks Solutions Inc / Truist Financial Corp / Alphabet Inc / Fidelity National Information Services Inc / Citizens Financial Group Inc / NXP Semiconductors NV / Woodward Inc / MediaTek Inc / Electronic Arts Inc / Abbvie Inc / Prothena Corporation PLC / Qorvo Inc / Zimmer Biomet Holdings Inc / Hewlett Packard Enterprise Co / Akoustis Technologies Inc / iRhythm Technologies Inc / Frequency Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / Netherlands / United States</td><td class="leftalignment">Banks / Biotechnology / Conglomerates / Financial Services / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Semiconductors</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Broad Domestic Declines Continue as Vaccine Rollout Continues to Ramp Up; IHME Projects Variants May Extend Pandemic Tail</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / EBAY=US / TXN=US / TEVA=US / GILD=US / PEB=US / CONE=US / LOW=US / FMS=US / HSII=US / DIOD=US / CHRS=US / TTWO=US / LEG=US / ATVI=US / KFRC=US / MAC=US / KFY=US / AMN=US / CBRL=US / CSTR=US / DRI=US / DRH=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MHK=US / ASGN=US / REGN=US / REGI=US / RHI=US / ROLL=US / SKY=US / THO=US / CCRN=US / MTCH=US / VNO=US / FFIN=US / GBCI=US / DIN=US / PTON=US / RPD=US / TPX=US / EXP=US / BECN=US / SHO=US / DLR=US / PLAY=US / BAH=US / WMG=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / EHC=US / NMTR=US / IAC=US / JACK=US / RCUS=US / TREX=US / NXPI=US / WWD=US / RLJ=US / FBHS=US / ANGI=US / EA=US / RHP=US / TILE=US / IBTX=US / NDLS=US / PINC=US / CNCE=US / MTNB=US / LOCO=US / ANTM=US / WBA=US / SHAK=US / ON=US / WING=US / ARGX=US / 82982L103 / PK=US / GDS=US / JELD=US / SWCH=US / FERGY=US / ARQT=US / AZEK=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / eBay Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Pebblebrook Hotel Trust / CyrusOne Inc / Lowe's Companies Inc / Fresenius Medical Care AG & Co KGaA / Heidrick & Struggles International Inc / Diodes Inc / Coherus BioSciences Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Macerich Co / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / RBC Bearings Inc / Skyline Champion Corp / Thor Industries Inc / Cross Country Healthcare Inc / Match Group Inc / Vornado Realty Trust / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Peloton Interactive Inc / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Booz Allen Hamilton Holding Corp / Warner Music Group Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / 9 Meters Biopharma Inc / IAC/Interactivecorp / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Premier Inc / Concert Pharmaceuticals Inc / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Switch Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cayman Islands / Germany / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2026242 / 2942605 / 2270726 / 2542049 / 2576941 / 2328915 / 2100920 / 2415204 / 2684703 / 2048804 / 2931034 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B1HJLW5 / 2390817 / B7TL820 / B7VD3F2 / BJ0XLZ3 / BH65L93 / BFLR866 / BYY8XK8 / BQPVQZ6 / BFNF1D6 / BJLKVS6 / BFZ1K46 / BLGJ610 / BFMXGR0 / BKTNTR9 / BKX9VD3 / BDVLM39 / BJRFSB7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Avista Corp / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Pfizer Inc / Pinnacle West Capital Corp / Vertex Pharmaceuticals Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / Emergent BioSolutions Inc / Gray Television Inc / Meta Platforms Inc / Duke Energy Corp / Heron Therapeutics Inc / Seacoast Banking Corporation of Florida / Twitter Inc / WEC Energy Group Inc / Horizon Therapeutics PLC / Amneal Pharmaceuticals Inc / Phathom Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / ViacomCBS Inc / Arcutis Biotherapeutics Inc / argenx SE / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Competitor Data at ASCO GU 2021; Phase III CLEAR/KN-581 Regimen Likely Active, but CM-9ER Sets High Bar</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">2576941 / 2126335 / 2778844 / 2684703 / 7103065</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Seamus Fernandez</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BDX.N / BMY.N / BSX.N / CI.N / EL.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / HD.N / ITW.N / XOM.N / LIN.N / ARE.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / QCOM.OQ / GILD.OQ / AMZN.OQ / TTWO.OQ / GPN.N / VRTX.OQ / ICE.N / TDG.N / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Home Depot Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Intercontinental Exchange Inc / TransDigm Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">SPA Revitalizes Birtamimab</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PRTA=US / BMY=US / RHHBY=US</td><td class="leftalignment">Prothena Corporation PLC / Bristol-Myers Squibb Co / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Tidbits From WCLC: Updates for Sotorasib and AMG 757 and Thoughts on Results From KEYNOTE-598</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">110122108 / 03116210</td><td class="leftalignment">Bristol-Myers Squibb Co / Amgen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Arcutis roflumilast could be potential competition for Otezla in mild/mod plaque psoriasis</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / ARQT.OQ / BMY=US / AMGN.OQ / ARQT=US</td><td class="leftalignment">Amgen Inc / Arcutis Biotherapeutics Inc / Bristol-Myers Squibb Co / Amgen Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Bristol Myers Squibb Company(BMY) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">110122108</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 01 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MOGa / US0079731008 / US0116591092 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US14149Y1082 / US1925761066 / US22284P1057 / US2910111044 / US3021301094 / US3695501086 / US37733W1053 / US4385161066 / US4433201062 / US4448591028 / US4456581077 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US58155Q1031 / US6558441084 / US6668071029 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8552441094 / US87612E1064 / US8807701029 / US9029251066 / US9078181081 / US91324P1021 / US91347P1057 / US9311421039 / US9507551086 / CA1363751027 / US03073E1055 / CA13645T1003 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US25754A2015 / US0042251084 / US02043Q1076 / US15135B1017 / US12541W2098 / ACOR.OQ / US1696561059 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US8485771021 / US60468T1051 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US00653A1079 / US9741551033 / US70450Y1038 / US40434L1052 / US05464T1043 / US00773U1088 / US16119P1084 / IE00BY7QL619 / KYG4740B1059 / CA87241L1094 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US1010441053 / US05351X1019 / US5904791358 / US0197701065 / US1255231003 / US8740602052 / US24703L2025 / US0144421072 / US55087P1049 / US90353T1007 / US18453H1068 / US70614W1009 / US09203E1055 / US4432011082 / CH0499880968</td><td class="leftalignment">Moog Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cardinal Health Inc / Cohu Inc / Covenant Logistics Group Inc / Emerson Electric Co / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Honeywell International Inc / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Mckesson Corp / Norfolk Southern Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Target Corp / Teradyne Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Universal Display Corp / Walmart Inc / Werner Enterprises Inc / Canadian National Railway Co / Amerisourcebergen Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Centene Corp / CH Robinson Worldwide Inc / Acorda Therapeutics Inc / Chipotle Mexican Grill Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / HP Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / Johnson Controls International PLC / Ichor Holdings Ltd / TFI International Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Boston Omaha Corp / Avaya Holdings Corp / Mesa Air Group Inc / Allogene Therapeutics Inc / Cigna Corp / Takeda Pharmaceutical Co Ltd / Dell Technologies Inc / Alector Inc / Lyft Inc / Uber Technologies Inc / Clear Channel Outdoor Holdings Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / Howmet Aerospace Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">WMB=US / LLY=US / AMGN=US / BMY=US / CL=US / AMZN=US / INCY=US / KMI=US / AMT=US / CHTR=US / CRM=US / PAA=US / CCI=US / BRO=US / MANH=US / CMCSA=US / CHD=US / COLL=US / AJG=US / MPLX=US / OKE=US / SBAC=US / TRGP=US / WIX=US / HTH=US / CVX=US / EPD=US / CGEN=US / CFR=US / SIVB=US / ABCB=US / DCP=US / SSB=US / BDSI=US / MMP=US / BIIB=US / MOG.A=US / EXP=US / BAH=US / EHTH=US / PAGP=US / SMLP=US / MODN=US / PTCT=US / CEQP=US / GOOGL=US / WVE=US / WLTW=US / EVBG=US / IRTC=US / RTLR=US / LHX=US</td><td class="leftalignment">Williams Companies Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Amazon.com Inc / Incyte Corp / Kinder Morgan Inc / American Tower Corp / Charter Communications Inc / Salesforce.Com Inc / Plains All American Pipeline LP / Crown Castle International Corp / Brown & Brown Inc / Manhattan Associates Inc / Comcast Corp / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Arthur J Gallagher & Co / MPLX LP / ONEOK Inc / SBA Communications Corp / Targa Resources Corp / Wix.Com Ltd / Hilltop Holdings Inc / Chevron Corp / Enterprise Products Partners LP / Compugen Ltd / Cullen/Frost Bankers Inc / SVB Financial Group / Ameris Bancorp / DCP Midstream LP / SouthState Corp / BioDelivery Sciences International Inc / Magellan Midstream Partners LP / Biogen Inc / Moog Inc / Eagle Materials Inc / Booz Allen Hamilton Holding Corp / eHealth Inc / Plains GP Holdings LP / Summit Midstream Partners LP / Model N Inc / PTC Therapeutics Inc / Crestwood Equity Partners LP / Alphabet Inc / WAVE Life Sciences Ltd / Willis Towers Watson PLC / Everbridge Inc / iRhythm Technologies Inc / Rattler Midstream LP / L3harris Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / CAT.N / HON.N / ITW.N / XOM.N / LIN.N / ARE.N / CVX.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / CHTR.OQ / GPN.N / VRTX.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Caterpillar Inc / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Charter Communications Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma 4Q Earnings Season : What to Watch for the Week Ahead (ABBV, BMY, MRK, PFE)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / ABBV.N / MRK.N / PFE.N / LLY.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Abbvie Inc / Merck & Co Inc / Pfizer Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Xiling Chen / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Bloomsbury Publishing PLC Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BLPU.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Apparel & Textiles / Appliances / Automotive / Broadcasting & Cable / Building & Building Materials / Consumer / Electronics / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Photography / Publishing / Retailing / Services / Tire & Rubber / Internet / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Above Jan 2020 Baseline- Week 45</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 532</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">We highlight recent examples of drugs approved and still in review following FDA extension</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US / BMY=US / PTCT=US</td><td class="leftalignment">Biogen Inc / Bristol-Myers Squibb Co / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Investec UK Daily: 29/01/2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.L / APH.L / GNS.L / BVIC.L / HIK.L / PARA.L / CVSG.L / CLIN.L / CARDC.L / BOWL.L</td><td class="leftalignment">Bloomsbury Publishing PLC / Alliance Pharma PLC / Genus PLC / Britvic PLC / Hikma Pharmaceuticals PLC / Paragon Banking Group PLC / CVS Group PLC / Clinigen Group PLC / Card Factory PLC / Hollywood Bowl Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Alastair P. Reid / Mr. Ben Hunt, CFA, CFA / Dr. Andrew M. Whitney / Dr Jens Lindqvist / Mr. Ian Gordon / Ms. Kate S. Calvert / Nicola V. Mallard / Ross Broadfoot</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Peel Hunt</td><td class="leftalignment">Bloomsbury Publishing (Add) - Trading update – profit well ahead</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GB0033147751</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Malcolm Morgan / Ms. Jessica Pok</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Investec Bank (UK) Plc</td><td class="leftalignment">Bloomsbury Publishing : Content really is king - Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY.L</td><td class="leftalignment">Bloomsbury Publishing PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom</td><td class="leftalignment">Advertising / Broadcasting & Cable / Media / Publishing / Marketing</td><td class="leftalignment">Europe</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Alastair P. Reid / Ross Broadfoot</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / ITW.N / XOM.N / LIN.N / V.N / ARE.N / CVX.N / AMGN.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / CHTR.OQ / EXPE.OQ / VRTX.OQ / CMCSA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / OTIS.N</td><td class="leftalignment">Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Expedia Group Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / PEP=US / PFE=US / AMGN=US / BMY=US / KO=US / AMD=US / CL=US / T=US / PEB=US / SLG=US / PLUG=US / H=US / MTN=US / VZ=US / SYK=US / CCI=US / ENR=US / PB=US / SWN=US / XLNX=US / BRO=US / MAR=US / LSTR=US / HLT=US / NWL=US / RCL=US / FLO=US / APH=US / ARW=US / AVT=US / CCL=US / CENT=US / CHH=US / CHD=US / DRH=US / EPC=US / EXAS=US / AJG=US / HAIN=US / NOW=US / MNRO=US / REGN=US / SMG=US / POST=US / R=US / FB=US / FBK=US / MKL=US / DRE=US / SBSI=US / NTRA=US / MGPI=US / MNST=US / JRVR=US / NOMD=US / STRO=US / SHO=US / FRPT=US / THS=US / HST=US / XPO=US / ELF=US / SAIA=US / TEL=US / NMTR=US / WH=US / NXGN=US / WYND=US / ATSG=US / NEO=US / AAN=US / KNSL=US / HGV=US / NXPI=US / RLJ=US / VAC=US / BCEI=US / RHP=US / ABBV=US / NCLH=US / VCYT=US / ARCB=US / LOB=US / WLTW=US / PK=US / PLYA=US / PETQ=US / KDP=US / HARP=US / PLMR=US / PSNL=US / BRBR=US / REYN=US / HYFM=US</td><td class="leftalignment">CACI International Inc / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / Advanced Micro Devices Inc / Colgate-Palmolive Co / AT&T Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Plug Power Inc / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Stryker Corp / Crown Castle International Corp / Energizer Holdings Inc / Prosperity Bancshares Inc / Southwestern Energy Co / Xilinx Inc / Brown & Brown Inc / Marriott International Inc / Landstar System Inc / Hilton Worldwide Holdings Inc / Newell Brands Inc / Royal Caribbean Cruises Ltd / Flowers Foods Inc / Amphenol Corp / Arrow Electronics Inc / Avnet Inc / Carnival Corp / Central Garden & Pet Co / Choice Hotels International Inc / Church & Dwight Co Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Exact Sciences Corp / Arthur J Gallagher & Co / Hain Celestial Group Inc / ServiceNow Inc / Monro Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Post Holdings Inc / Ryder System Inc / Meta Platforms Inc / FB Financial Corp / Markel Corp / Duke Realty Corp / Southside Bancshares Inc / Natera Inc / MGP Ingredients Inc / Monster Beverage Corp / James River Group Holdings Ltd / Nomad Foods Ltd / Sutro Biopharma Inc / Sunstone Hotel Investors Inc / Freshpet Inc / TreeHouse Foods Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / elf Beauty Inc / Saia Inc / TE Connectivity Ltd / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / NextGen Healthcare Inc / Travel + Leisure Co / Air Transport Services Group Inc / Neogenomics Inc / Aaron's Company Inc / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Norwegian Cruise Line Holdings Ltd / Veracyte Inc / ArcBest Corp / Live Oak Bancshares Inc / Willis Towers Watson PLC / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / PetIQ Inc / Keurig Dr Pepper Inc / Harpoon Therapeutics Inc / Palomar Holdings Inc / Personalis Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Ireland / Liberia / Luxembourg / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">On a New Level. Raising PT to $37, Reiterating BUY</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">STRO=US / BMY=US</td><td class="leftalignment">Sutro Biopharma Inc / Bristol-Myers Squibb Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 4Q Earnings Preview – 2021 Shaping Up To Be A Solid Year For The Group</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N / ABBV.N / MRK.N / PFE.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Abbvie Inc / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / BMY.N / BSX.N / CI.N / LLY.N / MRK.N / PFE.N / PM.N / T.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / XOM.N / V.N / ARE.N / CVX.N / AMGN.OQ / AAPL.OQ / QCOM.OQ / GILD.OQ / AMZN.OQ / CHTR.OQ / VRTX.OQ / CMCSA.OQ / TSLA.OQ / EA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Exxon Mobil Corp / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Apple Inc / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Charter Communications Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Tesla Inc / Electronic Arts Inc / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Bristol Myers Squibb Stock Can Offer Better Returns Over Eli Lilly</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2270726 / 2542049 / 2829515 / 2382892 / 2670519 / 2328915 / 2459020 / 2689560 / 2680905 / 2684703 / 2048804 / 2730190 / 2862532 / 2138158 / 2503529 / 4595739 / 5531000 / 7103065 / B121557 / B2R3PV1 / B7TL820 / BCBVTX1 / B7VD3F2 / BFLR866 / B76LYJ2 / BTN1Y44 / BYY8XK8 / BNGY4Q0 / BF5L3T2 / BYNZGK1 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BKLCX50</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Walt Disney Co / Dominion Energy Inc / Edison International / Audacy Inc / Exelon Corp / Nextera Energy Inc / Intuit Inc / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / E W Scripps Co / Sempra Energy / World Wrestling Entertainment Inc / Genmab A/S / MorphoSys AG / Novartis AG / Mastercard Inc / American Water Works Company Inc / Meta Platforms Inc / Agios Pharmaceuticals Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Walgreens Boots Alliance Inc / WEC Energy Group Inc / Nextera Energy Partners LP / Elanco Animal Health Inc / Block Inc / Spotify Technology SA / Fox Corp / Spire Inc / ViacomCBS Inc / Health Catalyst Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Bristol-Myers Squibb (BMY US) - The stage is set</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Xian Deng / Mrs. Luisa C. Hector, PHD / Ms. Kerry A. Holford, CFA / Megan Mulcahy</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology 4Q20 Preview: More of the same? Large Cap lethargy, SMid-Cap enthusiasm, against the continuing pandemic backdrop</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">AMGN.OQ / GILD.OQ / BMY.N / LLY.N / PFE.N / REGN.OQ / RARE.OQ / INCY.OQ / NBIX.OQ / ICPT.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / ARNA.OQ / ESPR.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / GLPG.AS / IRWD.OQ / SRPT.OQ / ABBV.N / PTCT.OQ / RNA.OQ / QURE.OQ / FLXN.OQ / ASND.OQ / ANAB.OQ / APLS.OQ / KURA.OQ / NTLA.OQ / ARGX.OQ / IFRX.OQ / SRRK.OQ / CYCN.OQ / ISEE.OQ / STOK.OQ / INBX.OQ / IMVT.OQ / FMTX.OQ / ALXO.OQ / CVAC.OQ / SPRB.OQ / GLTO.OQ / BCAB.OQ / ABCL.OQ</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / Galapagos NV / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Avidity Biosciences Inc / Uniqure NV / Pacira Biosciences Inc / Ascendis Pharma A/S / AnaptysBio Inc / Apellis Pharmaceuticals Inc / Kura Oncology Inc / Intellia Therapeutics Inc / argenx SE / InflaRx NV / Scholar Rock Holding Corp / Cyclerion Therapeutics Inc / Iveric Bio Inc / Stoke Therapeutics Inc / Inhibrx Inc / Immunovant Inc / Forma Therapeutics Holdings Inc / ALX Oncology Holdings Inc / CureVac NV / Spruce Biosciences Inc / Galecto Inc / Bioatla Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Denmark / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Dr. Martin Auster, M.D. / Ms. Judah C. Frommer / Mr. Tiago Fauth / Mark Connolly / Jonathan Woo / Yunhee Park / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Bristol-Myers Squibb Co Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Access to Medicine Foundation</td><td class="leftalignment">2021 Access to Medicine Index (26 Jan 2021)</td><td class="leftalignment">English</td><td class="rightalignment">237</td><td class="leftalignment">4502.T / 4503.T / 4523.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOb.CO / NOVN.S / MRCG.DE / GSK.L / GILD.OQ / 4568.T / BAYGn.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Eisai Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Daiichi Sankyo Co Ltd / Bayer AG / Abbvie Inc</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Team Index</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Declines in Domestic Cases, Hospitalizations, and Deaths Suggest the Beginning of the End as Threat of New Variant Looms</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BMY.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Wolfe Pharma & Biotech* 4Q20 EPS Preview - Model Changes and Updated Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Johnson & Johnson Stock At $160?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / BMY.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Johnson & Johnson / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - January 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079731008 / US0116591092 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US1727551004 / US1924461023 / US1925761066 / US2017231034 / US22284P1057 / US2371941053 / US2829141009 / US3021301094 / US3156161024 / US37733W1053 / US4433201062 / US4456581077 / US4567881085 / US4581401001 / US4663671091 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US5801351017 / US5949181045 / US5951121038 / US6558441084 / US66987V1098 / US6701002056 / US6703461052 / US6795801009 / US7170811035 / US7392761034 / US7475251036 / US7595091023 / US7711951043 / AN8068571086 / US8068821060 / US8168501018 / US8308791024 / US8447411088 / US8552441094 / US8581191009 / US8610121027 / US8807701029 / US9029251066 / US9078181081 / US91347P1057 / US9182041080 / US9507551086 / US9581021055 / CA1363751027 / CA13645T1003 / US9129091081 / US87157D1090 / US9884981013 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US3463751087 / US1572101053 / US90385V1070 / US12541W2098 / US1696561059 / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US3020811044 / US92932M1018 / US01748X1028 / US2473617023 / BMG3922B1072 / IE00B4BNMY34 / US58933Y1055 / US9100471096 / US95058W1009 / US03027X1000 / US29414B1044 / US9837931008 / US00287Y1091 / NL0010273215 / US45845P1084 / US8485771021 / US21240E1055 / US76680R2067 / CA05156V1022 / US02376R1023 / US03937C1053 / US8873991033 / LU0974299876 / CA0089118776 / US22822V1017 / CA76131D1033 / US74736K1016 / US8190471016 / US9741551033 / US5588681057 / US01345P1066 / KYG4740B1059 / US2067871036 / CA87241L1094 / US78410G1040 / CA35805P1071 / US23753F1075 / US23355L1061 / US80689H1023 / US4990491049 / US1858991011 / US30057T1051 / US89854H1023 / US05351X1019 / US11135F1012 / US05455M1009 / US29260V1052 / US5904791358 / US62921N1054 / CA59935V1076 / US4833791035 / US92537N1081 / US39813G1094 / 120175706</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Energy Industries Inc / Alaska Air Group Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cirrus Logic Inc / Cognizant Technology Solutions Corp / Cohu Inc / Commercial Metals Co / Covenant Logistics Group Inc / Darden Restaurants Inc / 8x8 Inc / Expeditors International of Washington Inc / F5 Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Infosys Ltd / Intel Corp / Jack in the Box Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / McDonald's Corp / Microsoft Corp / Micron Technology Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Nucor Corp / Old Dominion Freight Line Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Reliance Steel & Aluminum Co / Roche Holding AG / Schlumberger NV / Schnitzer Steel Industries Inc / Semtech Corp / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Steel Dynamics Inc / STMicroelectronics NV / Teradyne Inc / USA Truck Inc / Union Pacific Corp / Universal Display Corp / VF Corp / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / United States Steel Corp / Synaptics Inc / Yum! Brands Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CEVA Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Exlservice Holdings Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / Genpact Ltd / Accenture PLC / Merck & Co Inc / United Airlines Holdings Inc / Wendys Co / American Tower Corp / Epam Systems Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Intercept Pharmaceuticals Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / RingCentral Inc / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / ArcBest Corp / TimkenSteel Corp / Globant SA / Air Canada / Crown Castle International Corp / Restaurant Brands International Inc / Qorvo Inc / Shake Shack Inc / Wingstop Inc / Madrigal Pharmaceuticals Inc / Albireo Pharma Inc / Ichor Holdings Ltd / Conduent Inc / TFI International Inc / SBA Communications Corp / Freshii Inc / Daseke Inc / DXC Technology Co / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Cleveland-Cliffs Inc / Evoqua Water Technologies Corp / TTEC Holdings Inc / Avaya Holdings Corp / Broadcom Inc / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / NGM Biopharmaceuticals Inc / Milestone Pharmaceuticals Inc / Kaleyra Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / Cisco Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / India / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 0925288 / 2126335 / 2000019 / 2293819 / 2778844 / 2026242 / 2216850 / 2270726 / 2542049 / 2576941 / 2328915 / 2366799 / 2689560 / 2680905 / 2048804 / 2138158 / B121557 / 2857817 / B02R1L6 / B2R3PV1 / B3D7K31 / B570P91 / B4N0JJ6 / B7TL820 / B783TY6 / B7VD3F2 / BBGVT40 / BYY8XK8 / BYVY8G0 / BFZ1K46 / BKTNTR9 / BJDX8Y8 / BQXZP64 / BMTVQT8</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / eBay Inc / Merck & Co Inc / American Electric Power Company Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / Gentex Corp / PG&E Corp / PPL Corp / Pinnacle West Capital Corp / Sempra Energy / Mastercard Inc / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Lear Corp / Visteon Corp / Meta Platforms Inc / Aptiv PLC / Duke Energy Corp / News Corp / WEC Energy Group Inc / Alphabet Inc / Spotify Technology SA / ViacomCBS Inc / Mirum Pharmaceuticals Inc / Wayfair Inc / Goodrx Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fourth Quarter 2020 Biotechnology Earnings Preview: Grace Notes to a Historic Year</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 45337C102 / 09060J106 / 803607100 / 26979610 / 268158201 / 76133010 / 462222100 / 19459J104 / G11196105 / 69366J200 / 37890U108 / 48576A100 / 04683R106</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Incyte Corp / BioDelivery Sciences International Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / Revance Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / Global Blood Therapeutics Inc / Karuna Therapeutics Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues 2021 Strategic Conclusions. Summary slides</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh / Elizabeth Walton / Mr. Dominic Lunn</td></tr>
<tr class="odd"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Above Jan 2020 Baseline- Week 44</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: O'Neil Market View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT=US / JKHY=US / NKE=US / LLY=US / AMAT=US / BMY=US / CLX=US / COST=US / DIS=US / HD=US / TJX=US / AMD=US / MU=US / AMZN=US / QCOM=US / ADBE=US / INCY=US / AMT=US / NVDA=US / CAE=CA / TSN=US / H=US / SFZN=CH / TRU=US / 6981=JP / 7741=JP / 7974=JP / 6861=JP / 2330=TW / ASML=NL / 6146=JP / SWMA=SE / 4552=JP / STM=FR / CRM=US / V=US / 9983=JP / GOLD=US / NOC=US / MLHR=US / KLAC=US / HELE=US / JD.=GB / 177=HK / 6920=JP / CWK=GB / 914=HK / DHR=US / CI=US / UNH=US / INTU=US / JMT=PT / AMED=US / AVGO=US / BL=US / SAM=US / CPRT=US / CW=US / DECK=US / DOCU=US / DG=US / ENTG=US / GLOB=US / HAE=US / ILMN=US / ISRG=US / BOOT=US / LSCC=US / NOW=US / MKSI=US / MRCY=US / MSI=US / TEAM=US / NBIX=US / POOL=US / STAA=US / TFX=US / TSCO=US / VRTX=US / GN=DK / SIM=DK / BBAS3=BR / 2454=TW / GPN=US / CNC=US / PRI=US / FB=US / FND=US / MGRC=US / PRA=US / TW=US / 2688=HK / NFLX=US / TRN=GB / 9938=TW / AON=US / 5904=TW / null / BCO=US / 500331=IN / 005930=KR / 035720=KR / 000660=KR / 051910=KR / FLT=US / VITR=SE / DPZ=US / ISA=CO / TCS=IN / OLED=US / FRPT=US / 500043=IN / 3769=JP / BIMAS=TR / CMG=US / MA=US / 3038=JP / F34=SG / SWEC B=SE / ERF=FR / EDU=US / APX=AU / EKTA B=SE / KORI=FR / 500010=IN / 500696=IN / LULU=US / SLR=ES / MELI=US / TENERGY=GR / FNV=CA / 2175=JP / ATM=NZ / 3141=JP / BIOCON=IN / 2270=SA / 000063=CH / HYQ=DE / 3918=HK / 000858=CH / DABUR=IN / 2382=HK / 098460=KR / CLS=ZA / ZTS=US / 1717=HK / 600519=CH / FTNT=US / ASIANPAINT=IN / KNSL=US / 600276=CH / 600031=CH / 881=HK / NEE=US / TSLA=US / MSCI=US / EDEN=FR / 1066=HK / 3105=TW / FLRY3=BR / PCRX=US / 002179=CH / YNDX=US / 002281=CH / 300015=CH / 4966=TW / ARCE=US / SPLK=US / VGI=TH / ABBV=US / 4587=JP / KER=FR / BURL=US / EA=TH / CHGG=US / TME=US / BOO=GB / GPRK=US / BABA=US / HUBS=US / WLN=FR / XRO=AU / CLNX=ES / INW=IT / SQ=US / COM7=TH / LDO=IT / GPSC=TH / BFIT=NL / 1579=HK / TTD=US / ZTO=US / 603160=CH / 9519=JP / 000661=CH / 178920=KR / AAXN=US / 540376=IN / 240810=KR / VIFN=CH / DNP=PL / GALE=CH / 002271=CH / 2269=HK / 600872=CH / SSRM=CA / 002475=CH / SWCH=US / ORSTED=DK / BPAC3=BR / 207940=KR / 002916=CH / PAGS=US / COLD=US / 300450=CH / CDAY=US / 3711=TW / 603259=CH / TEP=FR / ADYEN=NL / 300750=CH / JUBLFOOD=IN / AVLR=US / 3690=HK / STNE=US / 300699=CH / 300760=CH / YETI=US / 603338=CH / MCG=ZA / PLMR=US / 1873=HK / SRAIL=CH / 1951=HK / 3692=HK / 002690=CH / 6110=HK / 603638=CH / 688139=CH / MELI34=BR / TATACONSUM=IN / IRCTC=IN / CLXC34=BR / 001914=CH / SWEC A=SE</td><td class="leftalignment">Abbott Laboratories / Jack Henry & Associates Inc / Nike Inc / Eli Lilly and Co / Applied Materials Inc / Bristol-Myers Squibb Co / Clorox Co / Costco Wholesale Corp / Walt Disney Co / Home Depot Inc / TJX Companies Inc / Advanced Micro Devices Inc / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Adobe Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / CAE Inc / Tyson Foods Inc / Hyatt Hotels Corp / Siegfried Holding AG / TransUnion / Murata Manufacturing Co Ltd / Hoya Corp / Nintendo Co Ltd / Keyence Corp / Taiwan Semiconductor Manufacturing Co Ltd / ASML Holding NV / Disco Corp / Swedish Match AB / JCR Pharmaceuticals Co Ltd / STMicroelectronics NV / Salesforce.Com Inc / Visa Inc / Fast Retailing Co Ltd / Barrick Gold Corp / Northrop Grumman Corp / MillerKnoll Inc / KLA Corp / Helen of Troy Ltd / JD Sports Fashion PLC / Jiangsu Expressway Co Ltd / Lasertec Corp / Cranswick PLC / Anhui Conch Cement Co Ltd / Danaher Corp / Cigna Corp / UnitedHealth Group Inc / Intuit Inc / Jeronimo Martins SGPS SA / Amedisys Inc / Broadcom Inc / Blackline Inc / Boston Beer Company Inc / Copart Inc / Curtiss-Wright Corp / Deckers Outdoor Corp / DocuSign Inc / Dollar General Corp / Entegris Inc / Globant SA / Haemonetics Corp / Illumina Inc / Intuitive Surgical Inc / Boot Barn Holdings Inc / Lattice Semiconductor Corp / ServiceNow Inc / MKS Instruments Inc / Mercury Systems Inc / Motorola Solutions Inc / Atlassian Corporation PLC / Neurocrine Biosciences Inc / Pool Corp / STAAR Surgical Co / Teleflex Inc / Tractor Supply Co / Vertex Pharmaceuticals Inc / GN Store Nord A/S / Simcorp A/S / Banco do Brasil SA / MediaTek Inc / Global Payments Inc / Centene Corp / Primerica Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / McGrath RentCorp / ProAssurance Corp / Tradeweb Markets Inc / ENN Energy Holdings Ltd / Netflix Inc / Trainline PLC / Taiwan Paiho Ltd / Aon PLC / Poya International Co Ltd / One 97 Communications Ltd / Brinks Co / Pidilite Industries Ltd / Samsung Electronics Co Ltd / Kakao Corp / SK Hynix Inc / LG Chem Ltd / Fleetcor Technologies Inc / Vitrolife AB / Domino's Pizza Inc / Interconnection Electric SA ESP / Tata Consultancy Services Ltd / Universal Display Corp / Freshpet Inc / Bata India Ltd / GMO Payment Gateway Inc / BIM Birlesik Magazalar AS / Chipotle Mexican Grill Inc / Mastercard Inc / Kobe Bussan Co Ltd / Wilmar International Ltd / Sweco AB (publ) / Eurofins Scientific SE / New Oriental Education & Technology Group Inc / Appen Ltd / Elekta AB (publ) / Korian SA / Housing Development Finance Corporation Ltd / Hindustan Unilever Ltd / Lululemon Athletica Inc / Solaria Energia y Medio Ambiente SA / Mercadolibre Inc / Terna Energy SA / Franco-Nevada Corp / SMS Co Ltd / A2 Milk Company Ltd / Welcia Holdings Co Ltd / Biocon Ltd / Saudia Dairy and Foodstuff Company SJSC / ZTE Corp / Hypoport SE / Nagacorp Ltd / Wuliangye Yibin Co Ltd / Dabur India Ltd / Sunny Optical Technology Group Co Ltd / Kohyoung Technology Inc / Clicks Group Ltd / Zoetis Inc / Ausnutria Dairy Corp Ltd / Kweichow Moutai Co Ltd / Fortinet Inc / Asian Paints Ltd / Kinsale Capital Group Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Sany Heavy Industry Co Ltd / Zhongsheng Group Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Edenred SE / Shandong Weigao Group Medical Polymer Co Ltd / WIN Semiconductors Corp / Fleury SA / Pacira Biosciences Inc / AVIC Jonhon Optronic Technology Co Ltd / Yandex NV / Accelink Technologies Co Ltd / Aier Eye Hospital Group Co Ltd / Parade Technologies Ltd / Arco Platform Ltd / Splunk Inc / VGI PCL / Abbvie Inc / PeptiDream Inc / Kering SA / Burlington Stores Inc / Energy Absolute PCL / Chegg Inc / Tencent Music Entertainment Group / boohoo group plc / GeoPark Ltd / Alibaba Group Holding Ltd / HubSpot Inc / Worldline SA / Xero Ltd / Cellnex Telecom SA / Infrastrutture Wireless Italiane SpA / Block Inc / Com7 PCL / Leonardo SpA / Global Power Synergy PCL / Basic Fit NV / Yihai International Holding Ltd / Trade Desk Inc / ZTO Express (Cayman) Inc / Shenzhen Goodix Technology Co., Ltd. / Renova Inc / Changchun High & New Technology Industries Group Inc / PI Advanced Materials Co Ltd / Axon Enterprise Inc / Avenue Supermarts Ltd / Wonik IPS Co Ltd / Vifor Pharma AG / Dino Polska SA / Galenica AG / Beijing Oriental Yuhong Waterproof Technology Co Ltd / WuXi Biologics (Cayman) Inc / Jonjee Hi-tech Industrial and Commercial Holding Co Ltd / SSR Mining Inc / Luxshare Precision Industry Co Ltd / Switch Inc / Orsted A/S / Banco BTG Pactual SA / Samsung Biologics Co Ltd / Shennan Circuits Co Ltd / PagSeguro Digital Ltd / Americold Realty Trust / Wuxi Lead Intelligent Equipment Co Ltd / Ceridian HCM Holding Inc / ASE Technology Holding Co Ltd / WuXi AppTec Co Ltd / Teleperformance SE / Adyen NV / Contemporary Amperex Technology Co Ltd / Jubilant Foodworks Ltd / Avalara Inc / Meituan / StoneCo Ltd / Weihai Guangwei Composites Co Ltd / Shenzhen Mindray Bio-Medical Electronics Co Ltd / Yeti Holdings Inc / Zhejiang Dingli Machinery Co Ltd / MultiChoice Group Ltd / Palomar Holdings Inc / VIVA Biotech Holdings / Stadler Rail AG / Jinxin Fertility Group Ltd / Hansoh Pharmaceutical Group Company Ltd / Hefei Meyer Optoelectronic Technology Inc / Topsports International Holdings Ltd / Yantai Eddie Precision Machinery Co Ltd / Qingdao Haier Biomedical Co Ltd / Mercadolibre Inc / Tata Consumer Products Ltd / Indian Railway Catering and Tourism Corporation Ltd / Clorox Co / China Merchants Property Operation & Service Co Ltd / Sweco AB (publ)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Colombia / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Greece / Hong Kong / Hungary / India / Ireland / Israel / Italy / Japan / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / New Zealand / Philippines / Poland / Portugal / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - FDA Approval in 1L Kidney Cancer as Expected & Should Represent Tailwind for Further Cabo TRx Growth</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2576941 / 2126335 / 2778844 / 2684703</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Seamus Fernandez</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">9ER Early Approval Stands to Expand Both Cabo and Opdivo Opportunity; Safety/QoL Profile Appears Differentiating</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">110122108 / 30161Q104</td><td class="leftalignment">Bristol-Myers Squibb Co / Exelixis Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andy T. Hsieh, PHD / Matt Phipps, PHD / Brittany Woods / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 531</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FR0000121014 / CH0012221716 / US0028962076 / US02553E1064 / US0311001004 / US0320951017 / US0378331005 / US0463531089 / US0530151036 / US1011371077 / US1101221083 / US1264081035 / US1271903049 / US1924221039 / US22160K1051 / US2310211063 / US28176E1082 / US34354P1057 / US3647601083 / US37733W1053 / US45167R1041 / US4581401001 / US4698141078 / US5324571083 / US5949181045 / US66987V1098 / US6701002056 / US7010941042 / US7043261079 / US7170811035 / US7711951043 / US7739031091 / US7766961061 / US7782961038 / US8636671013 / US8725401090 / US87612E1064 / US8793601050 / US9078181081 / US9297401088 / US9311421039 / US9427491025 / US5645631046 / US80105N1054 / US0003752047 / US2538681030 / US6247581084 / US48242W1062 / US92932M1018 / US90384S3031 / US0231112063 / US1940141062 / CA0585861085 / CH0102993182 / US58933Y1055 / IE00B58JVZ52 / US9100471096 / US0995021062 / US7512121010 / US98419M1009 / US00287Y1091 / US98978V1035 / US81762P1021 / US72919P2020 / US23283R1005 / US8086251076 / US5253271028 / CH0210483332 / US70438V1061 / US70432V1026 / US98936J1016 / IE00BLS09M33 / US0994061002 / US29444U7000 / US72703H1014 / GB00BZ09BD16 / US45073V1089 / US34959J1088 / US90138F1021 / US36165L1089 / US74967X1037 / CA1350861060 / US05722G1004 / US87105L1044 / US8760301072 / US30057T1051 / GB00BFMBMT84 / US15677J1088 / US2575541055 / US0937121079 / US28414H1032 / KY30744W1070 / VGG1890L1076 / US70202L1026 / US35952H6018 / US76156B1070 / US88339P1012 / US30068X1037 / US6541101050 / GB00BMVP7Y09 / US6873051022</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abb Ltd / Abercrombie & Fitch Co / American Eagle Outfitters Inc / AMETEK Inc / Amphenol Corp / Apple Inc / AstraZeneca PLC / Automatic Data Processing Inc / Boston Scientific Corp / Bristol-Myers Squibb Co / CSX Corp / CACI International Inc / Cognex Corp / Costco Wholesale Corp / Cummins Inc / Edwards Lifesciences Corp / Flowserve Corp / Gap Inc / GlaxoSmithKline PLC / IDEX Corp / Intel Corp / Jacobs Engineering Group Inc / Eli Lilly and Co / Microsoft Corp / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Paychex Inc / Pfizer Inc / Roche Holding AG / Rockwell Automation Inc / Roper Technologies Inc / Ross Stores Inc / Stryker Corp / TJX Companies Inc / Target Corp / Teledyne Technologies Inc / Union Pacific Corp / Westinghouse Air Brake Technologies Corp / Walmart Inc / Watts Water Technologies Inc / ManTech International Corp / Sanofi SA / Abb Ltd / Digital Realty Trust Inc / Mueller Water Products Inc / KBR Inc / WNS (Holdings) Ltd / Ulta Beauty Inc / Amarin Corporation PLC / Colfax Corp / Ballard Power Systems Inc / TE Connectivity Ltd / Merck & Co Inc / Seagate Technology Holdings PLC / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / Ralph Lauren Corp / Xylem Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / Plug Power Inc / CyrusOne Inc / Science Applications International Corp / Leidos Holdings Inc / Compagnie Financiere Richemont SA / Paylocity Holding Corp / Paycom Software Inc / Zendesk Inc / Pentair PLC / Boot Barn Holdings Inc / Equinix Inc / Planet Fitness Inc / Atlassian Corporation PLC / ITT Inc / Fortive Corp / Twilio Inc / GDS Holdings Ltd / RH / Canada Goose Holdings Inc / Baker Hughes Co / Switch Inc / Tapestry Inc / Evoqua Water Technologies Corp / Sensata Technologies Holding PLC / Ceridian HCM Holding Inc / Domo Inc / Bloom Energy Corp / Elanco Animal Health Inc / Farfetch Ltd / Capri Holdings Ltd / Parsons Corp / Fuelcell Energy Inc / Revolve Group Inc / RealReal Inc / Exagen Inc / Nikola Corp / Royalty Pharma PLC / Orphazyme A/S</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Biotech Sector: Pipeline updates and recent license-out deals accentuate LT potential of high-flying biotechs</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">1952.HK / BGNE.OQ / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / GILD.OQ / INCY.OQ / MGNX.OQ / TPB.N / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / GTH.OQ</td><td class="leftalignment">Everest Medicines Ltd / Beigene Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Incyte Corp / MacroGenics Inc / Turning Point Brands Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Genetron Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4:20 Results Preview/2021 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BGNE (NEUTRAL) - Model Update Post NOVN Collaboration; Incremental Updates on 2021 Key Milestones; Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BYYWPW6 / 5671735 / 0989529 / 0925288 / 2126335 / 2778844 / 2684703 / 2730190 / 7103065</td><td class="leftalignment">Beigene Ltd / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">All the Vectors: New Cases Showing Signs of Slowing as U.S. Mortality Tops 400,000 and Vaccination Rollout Continues</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2936921 / 2126335 / 2516152 / 2050832 / 2270726 / 2542049 / 2415204 / 2455965 / 2657802 / 2684703 / 2048804 / 7103065 / B1F76F9 / B121557 / 2857817 / B02R1L6 / B2R3PV1 / 2679204 / B7TL820 / B7VD3F2 / BFLR866 / BVVN4Q8 / BYY8XK8 / BYW36M8 / BD8DJ71 / BJ2Z0H2 / BLGJ610 / BFMXGR0 / BKC9SX3 / BYTJZL1 / BKT6B38</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Hawaiian Electric Industries Inc / Biogen Inc / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Western Union Co / Mastercard Inc / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Align Technology Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / WEC Energy Group Inc / PayPal Holdings Inc / Snap Inc / Pinterest Inc / Warner Music Group Corp / Evergy Inc / Arcturus Therapeutics Holdings Inc / Zogenix Inc / SmileDirectClub Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Novo Nordisk: Concerns over sustainability of returns overdone</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / MRCG.DE / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe / Selim Gogus</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Downgrade to Underperform</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GILD.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Gilead Sciences Inc / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: PharmaValues 2021 strategic conclusions</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Ms. Gretel Janu / Mr. Dominic Lunn / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Evan D. Seigerman / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Downgrading to Neutral; Reiterate DKK470/share Price Target</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Bristol Myers Squibb climbs 10.4% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">BMY.N</td><td class="leftalignment">Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Pharma : Takeaways from the 2021 J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / LLY.N / ABBV.N / BHC.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Abbvie Inc / Bausch Health Companies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova / Xiling Chen</td></tr>
<tr class="odd"><td class="leftalignment">01/18/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : January - April 2020</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCAb.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / 114556048 / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Svenska Cellulosa SCA AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Stellantis NV / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
</tbody></table>
</body>
</html>